Complications of Care
activeURL
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1182.311Copied!
Version20191111Copied!
PublisherChange Healthcare StewardDate2019-11-11T01:00:18-05:00Expansion
| Code | Display | System |
|---|---|---|
| A36.81 | http://hl7.org/fhir/sid/icd-10-cm | |
| A38.1 | http://hl7.org/fhir/sid/icd-10-cm | |
| A39.50 | http://hl7.org/fhir/sid/icd-10-cm | |
| A39.51 | http://hl7.org/fhir/sid/icd-10-cm | |
| A39.52 | http://hl7.org/fhir/sid/icd-10-cm | |
| A39.53 | http://hl7.org/fhir/sid/icd-10-cm | |
| B26.82 | http://hl7.org/fhir/sid/icd-10-cm | |
| B33.20 | http://hl7.org/fhir/sid/icd-10-cm | |
| B33.21 | http://hl7.org/fhir/sid/icd-10-cm | |
| B33.22 | http://hl7.org/fhir/sid/icd-10-cm | |
| B33.23 | http://hl7.org/fhir/sid/icd-10-cm | |
| B33.24 | http://hl7.org/fhir/sid/icd-10-cm | |
| B37.6 | http://hl7.org/fhir/sid/icd-10-cm | |
| B44.81 | http://hl7.org/fhir/sid/icd-10-cm | |
| B58.81 | http://hl7.org/fhir/sid/icd-10-cm | |
| C00.0 | http://hl7.org/fhir/sid/icd-10-cm | |
| C00.1 | http://hl7.org/fhir/sid/icd-10-cm | |
| C00.2 | http://hl7.org/fhir/sid/icd-10-cm | |
| C00.3 | http://hl7.org/fhir/sid/icd-10-cm | |
| C00.4 | http://hl7.org/fhir/sid/icd-10-cm |
systemhttp://hl7.org/fhir/sid/icd-10-cm
Complications of Care
This value set includes codes from the following code systems:
- Include these codes as defined in
http://hl7.org/fhir/sid/icd-10-cmCode Display A36.81 Diphtheritic cardiomyopathy A38.1 Scarlet fever with myocarditis A39.50 Meningococcal carditis, unspecified A39.51 Meningococcal endocarditis A39.52 Meningococcal myocarditis A39.53 Meningococcal pericarditis B26.82 Mumps myocarditis B33.20 Viral carditis, unspecified B33.21 Viral endocarditis B33.22 Viral myocarditis B33.23 Viral pericarditis B33.24 Viral cardiomyopathy B37.6 Candidal endocarditis B44.81 Allergic bronchopulmonary aspergillosis B58.81 Toxoplasma myocarditis C00.0 Malignant neoplasm of external upper lip C00.1 Malignant neoplasm of external lower lip C00.2 Malignant neoplasm of external lip, unspecified C00.3 Malignant neoplasm of upper lip, inner aspect C00.4 Malignant neoplasm of lower lip, inner aspect C00.5 Malignant neoplasm of lip, unspecified, inner aspect C00.6 Malignant neoplasm of commissure of lip, unspecified C00.8 Malignant neoplasm of overlapping sites of lip C00.9 Malignant neoplasm of lip, unspecified C01 Malignant neoplasm of base of tongue C02.0 Malignant neoplasm of dorsal surface of tongue C02.1 Malignant neoplasm of border of tongue C02.2 Malignant neoplasm of ventral surface of tongue C02.3 Malignant neoplasm of anterior two-thirds of tongue, part unspecified C02.4 Malignant neoplasm of lingual tonsil C02.8 Malignant neoplasm of overlapping sites of tongue C02.9 Malignant neoplasm of tongue, unspecified C03.0 Malignant neoplasm of upper gum C03.1 Malignant neoplasm of lower gum C03.9 Malignant neoplasm of gum, unspecified C04.0 Malignant neoplasm of anterior floor of mouth C04.1 Malignant neoplasm of lateral floor of mouth C04.8 Malignant neoplasm of overlapping sites of floor of mouth C04.9 Malignant neoplasm of floor of mouth, unspecified C05.0 Malignant neoplasm of hard palate C05.1 Malignant neoplasm of soft palate C05.2 Malignant neoplasm of uvula C05.8 Malignant neoplasm of overlapping sites of palate C05.9 Malignant neoplasm of palate, unspecified C06.0 Malignant neoplasm of cheek mucosa C06.1 Malignant neoplasm of vestibule of mouth C06.2 Malignant neoplasm of retromolar area C06.80 Malignant neoplasm of overlapping sites of unspecified parts of mouth C06.89 Malignant neoplasm of overlapping sites of other parts of mouth C06.9 Malignant neoplasm of mouth, unspecified C07 Malignant neoplasm of parotid gland C08.0 Malignant neoplasm of submandibular gland C08.1 Malignant neoplasm of sublingual gland C08.9 Malignant neoplasm of major salivary gland, unspecified C09.0 Malignant neoplasm of tonsillar fossa C09.1 Malignant neoplasm of tonsillar pillar (anterior) (posterior) C09.8 Malignant neoplasm of overlapping sites of tonsil C09.9 Malignant neoplasm of tonsil, unspecified C10.0 Malignant neoplasm of vallecula C10.1 Malignant neoplasm of anterior surface of epiglottis C10.2 Malignant neoplasm of lateral wall of oropharynx C10.3 Malignant neoplasm of posterior wall of oropharynx C10.4 Malignant neoplasm of branchial cleft C10.8 Malignant neoplasm of overlapping sites of oropharynx C10.9 Malignant neoplasm of oropharynx, unspecified C11.0 Malignant neoplasm of superior wall of nasopharynx C11.1 Malignant neoplasm of posterior wall of nasopharynx C11.2 Malignant neoplasm of lateral wall of nasopharynx C11.3 Malignant neoplasm of anterior wall of nasopharynx C11.8 Malignant neoplasm of overlapping sites of nasopharynx C11.9 Malignant neoplasm of nasopharynx, unspecified C12 Malignant neoplasm of pyriform sinus C13.0 Malignant neoplasm of postcricoid region C13.1 Malignant neoplasm of aryepiglottic fold, hypopharyngeal aspect C13.2 Malignant neoplasm of posterior wall of hypopharynx C13.8 Malignant neoplasm of overlapping sites of hypopharynx C13.9 Malignant neoplasm of hypopharynx, unspecified C14.0 Malignant neoplasm of pharynx, unspecified C14.2 Malignant neoplasm of Waldeyer's ring C14.8 Malignant neoplasm of overlapping sites of lip, oral cavity and pharynx C15.3 Malignant neoplasm of upper third of esophagus C15.4 Malignant neoplasm of middle third of esophagus C15.5 Malignant neoplasm of lower third of esophagus C15.8 Malignant neoplasm of overlapping sites of esophagus C15.9 Malignant neoplasm of esophagus, unspecified C16.0 Malignant neoplasm of cardia C16.1 Malignant neoplasm of fundus of stomach C16.2 Malignant neoplasm of body of stomach C16.3 Malignant neoplasm of pyloric antrum C16.4 Malignant neoplasm of pylorus C16.5 Malignant neoplasm of lesser curvature of stomach, unspecified C16.6 Malignant neoplasm of greater curvature of stomach, unspecified C16.8 Malignant neoplasm of overlapping sites of stomach C16.9 Malignant neoplasm of stomach, unspecified C17.0 Malignant neoplasm of duodenum C17.1 Malignant neoplasm of jejunum C17.2 Malignant neoplasm of ileum C17.3 Meckel's diverticulum, malignant C17.8 Malignant neoplasm of overlapping sites of small intestine C17.9 Malignant neoplasm of small intestine, unspecified C18.0 Malignant neoplasm of cecum C18.1 Malignant neoplasm of appendix C18.2 Malignant neoplasm of ascending colon C18.3 Malignant neoplasm of hepatic flexure C18.4 Malignant neoplasm of transverse colon C18.5 Malignant neoplasm of splenic flexure C18.6 Malignant neoplasm of descending colon C18.7 Malignant neoplasm of sigmoid colon C18.8 Malignant neoplasm of overlapping sites of colon C18.9 Malignant neoplasm of colon, unspecified C19 Malignant neoplasm of rectosigmoid junction C20 Malignant neoplasm of rectum C21.0 Malignant neoplasm of anus, unspecified C21.1 Malignant neoplasm of anal canal C21.2 Malignant neoplasm of cloacogenic zone C21.8 Malignant neoplasm of overlapping sites of rectum, anus and anal canal C22.0 Liver cell carcinoma C22.1 Intrahepatic bile duct carcinoma C22.2 Hepatoblastoma C22.3 Angiosarcoma of liver C22.4 Other sarcomas of liver C22.7 Other specified carcinomas of liver C22.8 Malignant neoplasm of liver, primary, unspecified as to type C22.9 Malignant neoplasm of liver, not specified as primary or secondary C23 Malignant neoplasm of gallbladder C24.0 Malignant neoplasm of extrahepatic bile duct C24.1 Malignant neoplasm of ampulla of Vater C24.8 Malignant neoplasm of overlapping sites of biliary tract C24.9 Malignant neoplasm of biliary tract, unspecified C25.0 Malignant neoplasm of head of pancreas C25.1 Malignant neoplasm of body of pancreas C25.2 Malignant neoplasm of tail of pancreas C25.3 Malignant neoplasm of pancreatic duct C25.4 Malignant neoplasm of endocrine pancreas C25.7 Malignant neoplasm of other parts of pancreas C25.8 Malignant neoplasm of overlapping sites of pancreas C25.9 Malignant neoplasm of pancreas, unspecified C26.0 Malignant neoplasm of intestinal tract, part unspecified C26.1 Malignant neoplasm of spleen C26.9 Malignant neoplasm of ill-defined sites within the digestive system C30.0 Malignant neoplasm of nasal cavity C30.1 Malignant neoplasm of middle ear C31.0 Malignant neoplasm of maxillary sinus C31.1 Malignant neoplasm of ethmoidal sinus C31.2 Malignant neoplasm of frontal sinus C31.3 Malignant neoplasm of sphenoid sinus C31.8 Malignant neoplasm of overlapping sites of accessory sinuses C31.9 Malignant neoplasm of accessory sinus, unspecified C32.0 Malignant neoplasm of glottis C32.1 Malignant neoplasm of supraglottis C32.2 Malignant neoplasm of subglottis C32.3 Malignant neoplasm of laryngeal cartilage C32.8 Malignant neoplasm of overlapping sites of larynx C32.9 Malignant neoplasm of larynx, unspecified C33 Malignant neoplasm of trachea C34.00 Malignant neoplasm of unspecified main bronchus C34.01 Malignant neoplasm of right main bronchus C34.02 Malignant neoplasm of left main bronchus C34.10 Malignant neoplasm of upper lobe, unspecified bronchus or lung C34.11 Malignant neoplasm of upper lobe, right bronchus or lung C34.12 Malignant neoplasm of upper lobe, left bronchus or lung C34.2 Malignant neoplasm of middle lobe, bronchus or lung C34.30 Malignant neoplasm of lower lobe, unspecified bronchus or lung C34.31 Malignant neoplasm of lower lobe, right bronchus or lung C34.32 Malignant neoplasm of lower lobe, left bronchus or lung C34.80 Malignant neoplasm of overlapping sites of unspecified bronchus and lung C34.81 Malignant neoplasm of overlapping sites of right bronchus and lung C34.82 Malignant neoplasm of overlapping sites of left bronchus and lung C34.90 Malignant neoplasm of unspecified part of unspecified bronchus or lung C34.91 Malignant neoplasm of unspecified part of right bronchus or lung C34.92 Malignant neoplasm of unspecified part of left bronchus or lung C37 Malignant neoplasm of thymus C38.0 Malignant neoplasm of heart C38.1 Malignant neoplasm of anterior mediastinum C38.2 Malignant neoplasm of posterior mediastinum C38.3 Malignant neoplasm of mediastinum, part unspecified C38.4 Malignant neoplasm of pleura C38.8 Malignant neoplasm of overlapping sites of heart, mediastinum and pleura C39.0 Malignant neoplasm of upper respiratory tract, part unspecified C39.9 Malignant neoplasm of lower respiratory tract, part unspecified C40.00 Malignant neoplasm of scapula and long bones of unspecified upper limb C40.01 Malignant neoplasm of scapula and long bones of right upper limb C40.02 Malignant neoplasm of scapula and long bones of left upper limb C40.10 Malignant neoplasm of short bones of unspecified upper limb C40.11 Malignant neoplasm of short bones of right upper limb C40.12 Malignant neoplasm of short bones of left upper limb C40.20 Malignant neoplasm of long bones of unspecified lower limb C40.21 Malignant neoplasm of long bones of right lower limb C40.22 Malignant neoplasm of long bones of left lower limb C40.30 Malignant neoplasm of short bones of unspecified lower limb C40.31 Malignant neoplasm of short bones of right lower limb C40.32 Malignant neoplasm of short bones of left lower limb C40.80 Malignant neoplasm of overlapping sites of bone and articular cartilage of unspecified limb C40.81 Malignant neoplasm of overlapping sites of bone and articular cartilage of right limb C40.82 Malignant neoplasm of overlapping sites of bone and articular cartilage of left limb C40.90 Malignant neoplasm of unspecified bones and articular cartilage of unspecified limb C40.91 Malignant neoplasm of unspecified bones and articular cartilage of right limb C40.92 Malignant neoplasm of unspecified bones and articular cartilage of left limb C41.0 Malignant neoplasm of bones of skull and face C41.1 Malignant neoplasm of mandible C41.2 Malignant neoplasm of vertebral column C41.3 Malignant neoplasm of ribs, sternum and clavicle C41.4 Malignant neoplasm of pelvic bones, sacrum and coccyx C41.9 Malignant neoplasm of bone and articular cartilage, unspecified C43.0 Malignant melanoma of lip C43.10 Malignant melanoma of unspecified eyelid, including canthus C43.11 Malignant melanoma of right eyelid, including canthus C43.111 Malignant melanoma of right upper eyelid, including canthus C43.112 Malignant melanoma of right lower eyelid, including canthus C43.12 Malignant melanoma of left eyelid, including canthus C43.121 Malignant melanoma of left upper eyelid, including canthus C43.122 Malignant melanoma of left lower eyelid, including canthus C43.20 Malignant melanoma of unspecified ear and external auricular canal C43.21 Malignant melanoma of right ear and external auricular canal C43.22 Malignant melanoma of left ear and external auricular canal C43.30 Malignant melanoma of unspecified part of face C43.31 Malignant melanoma of nose C43.39 Malignant melanoma of other parts of face C43.4 Malignant melanoma of scalp and neck C43.51 Malignant melanoma of anal skin C43.52 Malignant melanoma of skin of breast C43.59 Malignant melanoma of other part of trunk C43.60 Malignant melanoma of unspecified upper limb, including shoulder C43.61 Malignant melanoma of right upper limb, including shoulder C43.62 Malignant melanoma of left upper limb, including shoulder C43.70 Malignant melanoma of unspecified lower limb, including hip C43.71 Malignant melanoma of right lower limb, including hip C43.72 Malignant melanoma of left lower limb, including hip C43.8 Malignant melanoma of overlapping sites of skin C43.9 Malignant melanoma of skin, unspecified C44.00 Unspecified malignant neoplasm of skin of lip C44.01 Basal cell carcinoma of skin of lip C44.02 Squamous cell carcinoma of skin of lip C44.09 Other specified malignant neoplasm of skin of lip C44.101 Unspecified malignant neoplasm of skin of unspecified eyelid, including canthus C44.102 Unspecified malignant neoplasm of skin of right eyelid, including canthus C44.1021 Unspecified malignant neoplasm of skin of right upper eyelid, including canthus C44.1022 Unspecified malignant neoplasm of skin of right lower eyelid, including canthus C44.109 Unspecified malignant neoplasm of skin of left eyelid, including canthus C44.1091 Unspecified malignant neoplasm of skin of left upper eyelid, including canthus C44.1092 Unspecified malignant neoplasm of skin of left lower eyelid, including canthus C44.111 Basal cell carcinoma of skin of unspecified eyelid, including canthus C44.112 Basal cell carcinoma of skin of right eyelid, including canthus C44.1121 Basal cell carcinoma of skin of right upper eyelid, including canthus C44.1122 Basal cell carcinoma of skin of right lower eyelid, including canthus C44.119 Basal cell carcinoma of skin of left eyelid, including canthus C44.1191 Basal cell carcinoma of skin of left upper eyelid, including canthus C44.1192 Basal cell carcinoma of skin of left lower eyelid, including canthus C44.121 Squamous cell carcinoma of skin of unspecified eyelid, including canthus C44.122 Squamous cell carcinoma of skin of right eyelid, including canthus C44.1221 Squamous cell carcinoma of skin of right upper eyelid, including canthus C44.1222 Squamous cell carcinoma of skin of right lower eyelid, including canthus C44.129 Squamous cell carcinoma of skin of left eyelid, including canthus C44.1291 Squamous cell carcinoma of skin of left upper eyelid, including canthus C44.1292 Squamous cell carcinoma of skin of left lower eyelid, including canthus C44.131 Sebaceous cell carcinoma of skin of unspecified eyelid, including canthus C44.1321 Sebaceous cell carcinoma of skin of right upper eyelid, including canthus C44.1322 Sebaceous cell carcinoma of skin of right lower eyelid, including canthus C44.1391 Sebaceous cell carcinoma of skin of left upper eyelid, including canthus C44.1392 Sebaceous cell carcinoma of skin of left lower eyelid, including canthus C44.191 Other specified malignant neoplasm of skin of unspecified eyelid, including canthus C44.192 Other specified malignant neoplasm of skin of right eyelid, including canthus C44.1921 Other specified malignant neoplasm of skin of right upper eyelid, including canthus C44.1922 Other specified malignant neoplasm of skin of right lower eyelid, including canthus C44.199 Other specified malignant neoplasm of skin of left eyelid, including canthus C44.1991 Other specified malignant neoplasm of skin of left upper eyelid, including canthus C44.1992 Other specified malignant neoplasm of skin of left lower eyelid, including canthus C44.201 Unspecified malignant neoplasm of skin of unspecified ear and external auricular canal C44.202 Unspecified malignant neoplasm of skin of right ear and external auricular canal C44.209 Unspecified malignant neoplasm of skin of left ear and external auricular canal C44.211 Basal cell carcinoma of skin of unspecified ear and external auricular canal C44.212 Basal cell carcinoma of skin of right ear and external auricular canal C44.219 Basal cell carcinoma of skin of left ear and external auricular canal C44.221 Squamous cell carcinoma of skin of unspecified ear and external auricular canal C44.222 Squamous cell carcinoma of skin of right ear and external auricular canal C44.229 Squamous cell carcinoma of skin of left ear and external auricular canal C44.291 Other specified malignant neoplasm of skin of unspecified ear and external auricular canal C44.292 Other specified malignant neoplasm of skin of right ear and external auricular canal C44.299 Other specified malignant neoplasm of skin of left ear and external auricular canal C44.300 Unspecified malignant neoplasm of skin of unspecified part of face C44.301 Unspecified malignant neoplasm of skin of nose C44.309 Unspecified malignant neoplasm of skin of other parts of face C44.310 Basal cell carcinoma of skin of unspecified parts of face C44.311 Basal cell carcinoma of skin of nose C44.319 Basal cell carcinoma of skin of other parts of face C44.320 Squamous cell carcinoma of skin of unspecified parts of face C44.321 Squamous cell carcinoma of skin of nose C44.329 Squamous cell carcinoma of skin of other parts of face C44.390 Other specified malignant neoplasm of skin of unspecified parts of face C44.391 Other specified malignant neoplasm of skin of nose C44.399 Other specified malignant neoplasm of skin of other parts of face C44.40 Unspecified malignant neoplasm of skin of scalp and neck C44.41 Basal cell carcinoma of skin of scalp and neck C44.42 Squamous cell carcinoma of skin of scalp and neck C44.49 Other specified malignant neoplasm of skin of scalp and neck C44.500 Unspecified malignant neoplasm of anal skin C44.501 Unspecified malignant neoplasm of skin of breast C44.509 Unspecified malignant neoplasm of skin of other part of trunk C44.510 Basal cell carcinoma of anal skin C44.511 Basal cell carcinoma of skin of breast C44.519 Basal cell carcinoma of skin of other part of trunk C44.520 Squamous cell carcinoma of anal skin C44.521 Squamous cell carcinoma of skin of breast C44.529 Squamous cell carcinoma of skin of other part of trunk C44.590 Other specified malignant neoplasm of anal skin C44.591 Other specified malignant neoplasm of skin of breast C44.599 Other specified malignant neoplasm of skin of other part of trunk C44.601 Unspecified malignant neoplasm of skin of unspecified upper limb, including shoulder C44.602 Unspecified malignant neoplasm of skin of right upper limb, including shoulder C44.609 Unspecified malignant neoplasm of skin of left upper limb, including shoulder C44.611 Basal cell carcinoma of skin of unspecified upper limb, including shoulder C44.612 Basal cell carcinoma of skin of right upper limb, including shoulder C44.619 Basal cell carcinoma of skin of left upper limb, including shoulder C44.621 Squamous cell carcinoma of skin of unspecified upper limb, including shoulder C44.622 Squamous cell carcinoma of skin of right upper limb, including shoulder C44.629 Squamous cell carcinoma of skin of left upper limb, including shoulder C44.691 Other specified malignant neoplasm of skin of unspecified upper limb, including shoulder C44.692 Other specified malignant neoplasm of skin of right upper limb, including shoulder C44.699 Other specified malignant neoplasm of skin of left upper limb, including shoulder C44.701 Unspecified malignant neoplasm of skin of unspecified lower limb, including hip C44.702 Unspecified malignant neoplasm of skin of right lower limb, including hip C44.709 Unspecified malignant neoplasm of skin of left lower limb, including hip C44.711 Basal cell carcinoma of skin of unspecified lower limb, including hip C44.712 Basal cell carcinoma of skin of right lower limb, including hip C44.719 Basal cell carcinoma of skin of left lower limb, including hip C44.721 Squamous cell carcinoma of skin of unspecified lower limb, including hip C44.722 Squamous cell carcinoma of skin of right lower limb, including hip C44.729 Squamous cell carcinoma of skin of left lower limb, including hip C44.791 Other specified malignant neoplasm of skin of unspecified lower limb, including hip C44.792 Other specified malignant neoplasm of skin of right lower limb, including hip C44.799 Other specified malignant neoplasm of skin of left lower limb, including hip C44.80 Unspecified malignant neoplasm of overlapping sites of skin C44.81 Basal cell carcinoma of overlapping sites of skin C44.82 Squamous cell carcinoma of overlapping sites of skin C44.89 Other specified malignant neoplasm of overlapping sites of skin C44.90 Unspecified malignant neoplasm of skin, unspecified C44.91 Basal cell carcinoma of skin, unspecified C44.92 Squamous cell carcinoma of skin, unspecified C44.99 Other specified malignant neoplasm of skin, unspecified C45.0 Mesothelioma of pleura C45.1 Mesothelioma of peritoneum C45.2 Mesothelioma of pericardium C45.7 Mesothelioma of other sites C45.9 Mesothelioma, unspecified C46.0 Kaposi's sarcoma of skin C46.1 Kaposi's sarcoma of soft tissue C46.2 Kaposi's sarcoma of palate C46.3 Kaposi's sarcoma of lymph nodes C46.4 Kaposi's sarcoma of gastrointestinal sites C46.50 Kaposi's sarcoma of unspecified lung C46.51 Kaposi's sarcoma of right lung C46.52 Kaposi's sarcoma of left lung C46.7 Kaposi's sarcoma of other sites C46.9 Kaposi's sarcoma, unspecified C47.0 Malignant neoplasm of peripheral nerves of head, face and neck C47.10 Malignant neoplasm of peripheral nerves of unspecified upper limb, including shoulder C47.11 Malignant neoplasm of peripheral nerves of right upper limb, including shoulder C47.12 Malignant neoplasm of peripheral nerves of left upper limb, including shoulder C47.20 Malignant neoplasm of peripheral nerves of unspecified lower limb, including hip C47.21 Malignant neoplasm of peripheral nerves of right lower limb, including hip C47.22 Malignant neoplasm of peripheral nerves of left lower limb, including hip C47.3 Malignant neoplasm of peripheral nerves of thorax C47.4 Malignant neoplasm of peripheral nerves of abdomen C47.5 Malignant neoplasm of peripheral nerves of pelvis C47.6 Malignant neoplasm of peripheral nerves of trunk, unspecified C47.8 Malignant neoplasm of overlapping sites of peripheral nerves and autonomic nervous system C47.9 Malignant neoplasm of peripheral nerves and autonomic nervous system, unspecified C48.0 Malignant neoplasm of retroperitoneum C48.1 Malignant neoplasm of specified parts of peritoneum C48.2 Malignant neoplasm of peritoneum, unspecified C48.8 Malignant neoplasm of overlapping sites of retroperitoneum and peritoneum C49.0 Malignant neoplasm of connective and soft tissue of head, face and neck C49.10 Malignant neoplasm of connective and soft tissue of unspecified upper limb, including shoulder C49.11 Malignant neoplasm of connective and soft tissue of right upper limb, including shoulder C49.12 Malignant neoplasm of connective and soft tissue of left upper limb, including shoulder C49.20 Malignant neoplasm of connective and soft tissue of unspecified lower limb, including hip C49.21 Malignant neoplasm of connective and soft tissue of right lower limb, including hip C49.22 Malignant neoplasm of connective and soft tissue of left lower limb, including hip C49.3 Malignant neoplasm of connective and soft tissue of thorax C49.4 Malignant neoplasm of connective and soft tissue of abdomen C49.5 Malignant neoplasm of connective and soft tissue of pelvis C49.6 Malignant neoplasm of connective and soft tissue of trunk, unspecified C49.8 Malignant neoplasm of overlapping sites of connective and soft tissue C49.9 Malignant neoplasm of connective and soft tissue, unspecified C49.A0 Gastrointestinal stromal tumor, unspecified site C49.A1 Gastrointestinal stromal tumor of esophagus C49.A2 Gastrointestinal stromal tumor of stomach C49.A3 Gastrointestinal stromal tumor of small intestine C49.A4 Gastrointestinal stromal tumor of large intestine C49.A5 Gastrointestinal stromal tumor of rectum C49.A9 Gastrointestinal stromal tumor of other sites C4A.0 Merkel cell carcinoma of lip C4A.10 Merkel cell carcinoma of unspecified eyelid, including canthus C4A.11 Merkel cell carcinoma of right eyelid, including canthus C4A.111 Merkel cell carcinoma of right upper eyelid, including canthus C4A.112 Merkel cell carcinoma of right lower eyelid, including canthus C4A.12 Merkel cell carcinoma of left eyelid, including canthus C4A.121 Merkel cell carcinoma of left upper eyelid, including canthus C4A.122 Merkel cell carcinoma of left lower eyelid, including canthus C4A.20 Merkel cell carcinoma of unspecified ear and external auricular canal C4A.21 Merkel cell carcinoma of right ear and external auricular canal C4A.22 Merkel cell carcinoma of left ear and external auricular canal C4A.30 Merkel cell carcinoma of unspecified part of face C4A.31 Merkel cell carcinoma of nose C4A.39 Merkel cell carcinoma of other parts of face C4A.4 Merkel cell carcinoma of scalp and neck C4A.51 Merkel cell carcinoma of anal skin C4A.52 Merkel cell carcinoma of skin of breast C4A.59 Merkel cell carcinoma of other part of trunk C4A.60 Merkel cell carcinoma of unspecified upper limb, including shoulder C4A.61 Merkel cell carcinoma of right upper limb, including shoulder C4A.62 Merkel cell carcinoma of left upper limb, including shoulder C4A.70 Merkel cell carcinoma of unspecified lower limb, including hip C4A.71 Merkel cell carcinoma of right lower limb, including hip C4A.72 Merkel cell carcinoma of left lower limb, including hip C4A.8 Merkel cell carcinoma of overlapping sites C4A.9 Merkel cell carcinoma, unspecified C50.011 Malignant neoplasm of nipple and areola, right female breast C50.012 Malignant neoplasm of nipple and areola, left female breast C50.019 Malignant neoplasm of nipple and areola, unspecified female breast C50.021 Malignant neoplasm of nipple and areola, right male breast C50.022 Malignant neoplasm of nipple and areola, left male breast C50.029 Malignant neoplasm of nipple and areola, unspecified male breast C50.111 Malignant neoplasm of central portion of right female breast C50.112 Malignant neoplasm of central portion of left female breast C50.119 Malignant neoplasm of central portion of unspecified female breast C50.121 Malignant neoplasm of central portion of right male breast C50.122 Malignant neoplasm of central portion of left male breast C50.129 Malignant neoplasm of central portion of unspecified male breast C50.211 Malignant neoplasm of upper-inner quadrant of right female breast C50.212 Malignant neoplasm of upper-inner quadrant of left female breast C50.219 Malignant neoplasm of upper-inner quadrant of unspecified female breast C50.221 Malignant neoplasm of upper-inner quadrant of right male breast C50.222 Malignant neoplasm of upper-inner quadrant of left male breast C50.229 Malignant neoplasm of upper-inner quadrant of unspecified male breast C50.311 Malignant neoplasm of lower-inner quadrant of right female breast C50.312 Malignant neoplasm of lower-inner quadrant of left female breast C50.319 Malignant neoplasm of lower-inner quadrant of unspecified female breast C50.321 Malignant neoplasm of lower-inner quadrant of right male breast C50.322 Malignant neoplasm of lower-inner quadrant of left male breast C50.329 Malignant neoplasm of lower-inner quadrant of unspecified male breast C50.411 Malignant neoplasm of upper-outer quadrant of right female breast C50.412 Malignant neoplasm of upper-outer quadrant of left female breast C50.419 Malignant neoplasm of upper-outer quadrant of unspecified female breast C50.421 Malignant neoplasm of upper-outer quadrant of right male breast C50.422 Malignant neoplasm of upper-outer quadrant of left male breast C50.429 Malignant neoplasm of upper-outer quadrant of unspecified male breast C50.511 Malignant neoplasm of lower-outer quadrant of right female breast C50.512 Malignant neoplasm of lower-outer quadrant of left female breast C50.519 Malignant neoplasm of lower-outer quadrant of unspecified female breast C50.521 Malignant neoplasm of lower-outer quadrant of right male breast C50.522 Malignant neoplasm of lower-outer quadrant of left male breast C50.529 Malignant neoplasm of lower-outer quadrant of unspecified male breast C50.611 Malignant neoplasm of axillary tail of right female breast C50.612 Malignant neoplasm of axillary tail of left female breast C50.619 Malignant neoplasm of axillary tail of unspecified female breast C50.621 Malignant neoplasm of axillary tail of right male breast C50.622 Malignant neoplasm of axillary tail of left male breast C50.629 Malignant neoplasm of axillary tail of unspecified male breast C50.811 Malignant neoplasm of overlapping sites of right female breast C50.812 Malignant neoplasm of overlapping sites of left female breast C50.819 Malignant neoplasm of overlapping sites of unspecified female breast C50.821 Malignant neoplasm of overlapping sites of right male breast C50.822 Malignant neoplasm of overlapping sites of left male breast C50.829 Malignant neoplasm of overlapping sites of unspecified male breast C50.911 Malignant neoplasm of unspecified site of right female breast C50.912 Malignant neoplasm of unspecified site of left female breast C50.919 Malignant neoplasm of unspecified site of unspecified female breast C50.921 Malignant neoplasm of unspecified site of right male breast C50.922 Malignant neoplasm of unspecified site of left male breast C50.929 Malignant neoplasm of unspecified site of unspecified male breast C51.0 Malignant neoplasm of labium majus C51.1 Malignant neoplasm of labium minus C51.2 Malignant neoplasm of clitoris C51.8 Malignant neoplasm of overlapping sites of vulva C51.9 Malignant neoplasm of vulva, unspecified C52 Malignant neoplasm of vagina C53.0 Malignant neoplasm of endocervix C53.1 Malignant neoplasm of exocervix C53.8 Malignant neoplasm of overlapping sites of cervix uteri C53.9 Malignant neoplasm of cervix uteri, unspecified C54.0 Malignant neoplasm of isthmus uteri C54.1 Malignant neoplasm of endometrium C54.2 Malignant neoplasm of myometrium C54.3 Malignant neoplasm of fundus uteri C54.8 Malignant neoplasm of overlapping sites of corpus uteri C54.9 Malignant neoplasm of corpus uteri, unspecified C55 Malignant neoplasm of uterus, part unspecified C56.1 Malignant neoplasm of right ovary C56.2 Malignant neoplasm of left ovary C56.9 Malignant neoplasm of unspecified ovary C57.00 Malignant neoplasm of unspecified fallopian tube C57.01 Malignant neoplasm of right fallopian tube C57.02 Malignant neoplasm of left fallopian tube C57.10 Malignant neoplasm of unspecified broad ligament C57.11 Malignant neoplasm of right broad ligament C57.12 Malignant neoplasm of left broad ligament C57.20 Malignant neoplasm of unspecified round ligament C57.21 Malignant neoplasm of right round ligament C57.22 Malignant neoplasm of left round ligament C57.3 Malignant neoplasm of parametrium C57.4 Malignant neoplasm of uterine adnexa, unspecified C57.7 Malignant neoplasm of other specified female genital organs C57.8 Malignant neoplasm of overlapping sites of female genital organs C57.9 Malignant neoplasm of female genital organ, unspecified C58 Malignant neoplasm of placenta C60.0 Malignant neoplasm of prepuce C60.1 Malignant neoplasm of glans penis C60.2 Malignant neoplasm of body of penis C60.8 Malignant neoplasm of overlapping sites of penis C60.9 Malignant neoplasm of penis, unspecified C61 Malignant neoplasm of prostate C62.00 Malignant neoplasm of unspecified undescended testis C62.01 Malignant neoplasm of undescended right testis C62.02 Malignant neoplasm of undescended left testis C62.10 Malignant neoplasm of unspecified descended testis C62.11 Malignant neoplasm of descended right testis C62.12 Malignant neoplasm of descended left testis C62.90 Malignant neoplasm of unspecified testis, unspecified whether descended or undescended C62.91 Malignant neoplasm of right testis, unspecified whether descended or undescended C62.92 Malignant neoplasm of left testis, unspecified whether descended or undescended C63.00 Malignant neoplasm of unspecified epididymis C63.01 Malignant neoplasm of right epididymis C63.02 Malignant neoplasm of left epididymis C63.10 Malignant neoplasm of unspecified spermatic cord C63.11 Malignant neoplasm of right spermatic cord C63.12 Malignant neoplasm of left spermatic cord C63.2 Malignant neoplasm of scrotum C63.7 Malignant neoplasm of other specified male genital organs C63.8 Malignant neoplasm of overlapping sites of male genital organs C63.9 Malignant neoplasm of male genital organ, unspecified C64.1 Malignant neoplasm of right kidney, except renal pelvis C64.2 Malignant neoplasm of left kidney, except renal pelvis C64.9 Malignant neoplasm of unspecified kidney, except renal pelvis C65.1 Malignant neoplasm of right renal pelvis C65.2 Malignant neoplasm of left renal pelvis C65.9 Malignant neoplasm of unspecified renal pelvis C66.1 Malignant neoplasm of right ureter C66.2 Malignant neoplasm of left ureter C66.9 Malignant neoplasm of unspecified ureter C67.0 Malignant neoplasm of trigone of bladder C67.1 Malignant neoplasm of dome of bladder C67.2 Malignant neoplasm of lateral wall of bladder C67.3 Malignant neoplasm of anterior wall of bladder C67.4 Malignant neoplasm of posterior wall of bladder C67.5 Malignant neoplasm of bladder neck C67.6 Malignant neoplasm of ureteric orifice C67.7 Malignant neoplasm of urachus C67.8 Malignant neoplasm of overlapping sites of bladder C67.9 Malignant neoplasm of bladder, unspecified C68.0 Malignant neoplasm of urethra C68.1 Malignant neoplasm of paraurethral glands C68.8 Malignant neoplasm of overlapping sites of urinary organs C68.9 Malignant neoplasm of urinary organ, unspecified C69.00 Malignant neoplasm of unspecified conjunctiva C69.01 Malignant neoplasm of right conjunctiva C69.02 Malignant neoplasm of left conjunctiva C69.10 Malignant neoplasm of unspecified cornea C69.11 Malignant neoplasm of right cornea C69.12 Malignant neoplasm of left cornea C69.20 Malignant neoplasm of unspecified retina C69.21 Malignant neoplasm of right retina C69.22 Malignant neoplasm of left retina C69.30 Malignant neoplasm of unspecified choroid C69.31 Malignant neoplasm of right choroid C69.32 Malignant neoplasm of left choroid C69.40 Malignant neoplasm of unspecified ciliary body C69.41 Malignant neoplasm of right ciliary body C69.42 Malignant neoplasm of left ciliary body C69.50 Malignant neoplasm of unspecified lacrimal gland and duct C69.51 Malignant neoplasm of right lacrimal gland and duct C69.52 Malignant neoplasm of left lacrimal gland and duct C69.60 Malignant neoplasm of unspecified orbit C69.61 Malignant neoplasm of right orbit C69.62 Malignant neoplasm of left orbit C69.80 Malignant neoplasm of overlapping sites of unspecified eye and adnexa C69.81 Malignant neoplasm of overlapping sites of right eye and adnexa C69.82 Malignant neoplasm of overlapping sites of left eye and adnexa C69.90 Malignant neoplasm of unspecified site of unspecified eye C69.91 Malignant neoplasm of unspecified site of right eye C69.92 Malignant neoplasm of unspecified site of left eye C70.0 Malignant neoplasm of cerebral meninges C70.1 Malignant neoplasm of spinal meninges C70.9 Malignant neoplasm of meninges, unspecified C71.0 Malignant neoplasm of cerebrum, except lobes and ventricles C71.1 Malignant neoplasm of frontal lobe C71.2 Malignant neoplasm of temporal lobe C71.3 Malignant neoplasm of parietal lobe C71.4 Malignant neoplasm of occipital lobe C71.5 Malignant neoplasm of cerebral ventricle C71.6 Malignant neoplasm of cerebellum C71.7 Malignant neoplasm of brain stem C71.8 Malignant neoplasm of overlapping sites of brain C71.9 Malignant neoplasm of brain, unspecified C72.0 Malignant neoplasm of spinal cord C72.1 Malignant neoplasm of cauda equina C72.20 Malignant neoplasm of unspecified olfactory nerve C72.21 Malignant neoplasm of right olfactory nerve C72.22 Malignant neoplasm of left olfactory nerve C72.30 Malignant neoplasm of unspecified optic nerve C72.31 Malignant neoplasm of right optic nerve C72.32 Malignant neoplasm of left optic nerve C72.40 Malignant neoplasm of unspecified acoustic nerve C72.41 Malignant neoplasm of right acoustic nerve C72.42 Malignant neoplasm of left acoustic nerve C72.50 Malignant neoplasm of unspecified cranial nerve C72.59 Malignant neoplasm of other cranial nerves C72.9 Malignant neoplasm of central nervous system, unspecified C73 Malignant neoplasm of thyroid gland C74.00 Malignant neoplasm of cortex of unspecified adrenal gland C74.01 Malignant neoplasm of cortex of right adrenal gland C74.02 Malignant neoplasm of cortex of left adrenal gland C74.10 Malignant neoplasm of medulla of unspecified adrenal gland C74.11 Malignant neoplasm of medulla of right adrenal gland C74.12 Malignant neoplasm of medulla of left adrenal gland C74.90 Malignant neoplasm of unspecified part of unspecified adrenal gland C74.91 Malignant neoplasm of unspecified part of right adrenal gland C74.92 Malignant neoplasm of unspecified part of left adrenal gland C75.0 Malignant neoplasm of parathyroid gland C75.1 Malignant neoplasm of pituitary gland C75.2 Malignant neoplasm of craniopharyngeal duct C75.3 Malignant neoplasm of pineal gland C75.4 Malignant neoplasm of carotid body C75.5 Malignant neoplasm of aortic body and other paraganglia C75.8 Malignant neoplasm with pluriglandular involvement, unspecified C75.9 Malignant neoplasm of endocrine gland, unspecified C76.0 Malignant neoplasm of head, face and neck C76.1 Malignant neoplasm of thorax C76.2 Malignant neoplasm of abdomen C76.3 Malignant neoplasm of pelvis C76.40 Malignant neoplasm of unspecified upper limb C76.41 Malignant neoplasm of right upper limb C76.42 Malignant neoplasm of left upper limb C76.50 Malignant neoplasm of unspecified lower limb C76.51 Malignant neoplasm of right lower limb C76.52 Malignant neoplasm of left lower limb C76.8 Malignant neoplasm of other specified ill-defined sites C77.0 Secondary and unspecified malignant neoplasm of lymph nodes of head, face and neck C77.1 Secondary and unspecified malignant neoplasm of intrathoracic lymph nodes C77.2 Secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes C77.3 Secondary and unspecified malignant neoplasm of axilla and upper limb lymph nodes C77.4 Secondary and unspecified malignant neoplasm of inguinal and lower limb lymph nodes C77.5 Secondary and unspecified malignant neoplasm of intrapelvic lymph nodes C77.8 Secondary and unspecified malignant neoplasm of lymph nodes of multiple regions C77.9 Secondary and unspecified malignant neoplasm of lymph node, unspecified C78.00 Secondary malignant neoplasm of unspecified lung C78.01 Secondary malignant neoplasm of right lung C78.02 Secondary malignant neoplasm of left lung C78.1 Secondary malignant neoplasm of mediastinum C78.2 Secondary malignant neoplasm of pleura C78.30 Secondary malignant neoplasm of unspecified respiratory organ C78.39 Secondary malignant neoplasm of other respiratory organs C78.4 Secondary malignant neoplasm of small intestine C78.5 Secondary malignant neoplasm of large intestine and rectum C78.6 Secondary malignant neoplasm of retroperitoneum and peritoneum C78.7 Secondary malignant neoplasm of liver and intrahepatic bile duct C78.80 Secondary malignant neoplasm of unspecified digestive organ C78.89 Secondary malignant neoplasm of other digestive organs C79.00 Secondary malignant neoplasm of unspecified kidney and renal pelvis C79.01 Secondary malignant neoplasm of right kidney and renal pelvis C79.02 Secondary malignant neoplasm of left kidney and renal pelvis C79.10 Secondary malignant neoplasm of unspecified urinary organs C79.11 Secondary malignant neoplasm of bladder C79.19 Secondary malignant neoplasm of other urinary organs C79.2 Secondary malignant neoplasm of skin C79.31 Secondary malignant neoplasm of brain C79.32 Secondary malignant neoplasm of cerebral meninges C79.40 Secondary malignant neoplasm of unspecified part of nervous system C79.49 Secondary malignant neoplasm of other parts of nervous system C79.51 Secondary malignant neoplasm of bone C79.52 Secondary malignant neoplasm of bone marrow C79.60 Secondary malignant neoplasm of unspecified ovary C79.61 Secondary malignant neoplasm of right ovary C79.62 Secondary malignant neoplasm of left ovary C79.70 Secondary malignant neoplasm of unspecified adrenal gland C79.71 Secondary malignant neoplasm of right adrenal gland C79.72 Secondary malignant neoplasm of left adrenal gland C79.81 Secondary malignant neoplasm of breast C79.82 Secondary malignant neoplasm of genital organs C79.89 Secondary malignant neoplasm of other specified sites C79.9 Secondary malignant neoplasm of unspecified site C7A.00 Malignant carcinoid tumor of unspecified site C7A.010 Malignant carcinoid tumor of the duodenum C7A.011 Malignant carcinoid tumor of the jejunum C7A.012 Malignant carcinoid tumor of the ileum C7A.019 Malignant carcinoid tumor of the small intestine, unspecified portion C7A.020 Malignant carcinoid tumor of the appendix C7A.021 Malignant carcinoid tumor of the cecum C7A.022 Malignant carcinoid tumor of the ascending colon C7A.023 Malignant carcinoid tumor of the transverse colon C7A.024 Malignant carcinoid tumor of the descending colon C7A.025 Malignant carcinoid tumor of the sigmoid colon C7A.026 Malignant carcinoid tumor of the rectum C7A.029 Malignant carcinoid tumor of the large intestine, unspecified portion C7A.090 Malignant carcinoid tumor of the bronchus and lung C7A.091 Malignant carcinoid tumor of the thymus C7A.092 Malignant carcinoid tumor of the stomach C7A.093 Malignant carcinoid tumor of the kidney C7A.094 Malignant carcinoid tumor of the foregut, unspecified C7A.095 Malignant carcinoid tumor of the midgut, unspecified C7A.096 Malignant carcinoid tumor of the hindgut, unspecified C7A.098 Malignant carcinoid tumors of other sites C7A.1 Malignant poorly differentiated neuroendocrine tumors C7A.8 Other malignant neuroendocrine tumors C7B.00 Secondary carcinoid tumors, unspecified site C7B.01 Secondary carcinoid tumors of distant lymph nodes C7B.02 Secondary carcinoid tumors of liver C7B.03 Secondary carcinoid tumors of bone C7B.04 Secondary carcinoid tumors of peritoneum C7B.09 Secondary carcinoid tumors of other sites C7B.1 Secondary Merkel cell carcinoma C7B.8 Other secondary neuroendocrine tumors C80.0 Disseminated malignant neoplasm, unspecified C80.1 Malignant (primary) neoplasm, unspecified C80.2 Malignant neoplasm associated with transplanted organ C81.00 Nodular lymphocyte predominant Hodgkin lymphoma, unspecified site C81.01 Nodular lymphocyte predominant Hodgkin lymphoma, lymph nodes of head, face, and neck C81.02 Nodular lymphocyte predominant Hodgkin lymphoma, intrathoracic lymph nodes C81.03 Nodular lymphocyte predominant Hodgkin lymphoma, intra-abdominal lymph nodes C81.04 Nodular lymphocyte predominant Hodgkin lymphoma, lymph nodes of axilla and upper limb C81.05 Nodular lymphocyte predominant Hodgkin lymphoma, lymph nodes of inguinal region and lower limb C81.06 Nodular lymphocyte predominant Hodgkin lymphoma, intrapelvic lymph nodes C81.07 Nodular lymphocyte predominant Hodgkin lymphoma, spleen C81.08 Nodular lymphocyte predominant Hodgkin lymphoma, lymph nodes of multiple sites C81.09 Nodular lymphocyte predominant Hodgkin lymphoma, extranodal and solid organ sites C81.10 Nodular sclerosis Hodgkin lymphoma, unspecified site C81.11 Nodular sclerosis Hodgkin lymphoma, lymph nodes of head, face, and neck C81.12 Nodular sclerosis Hodgkin lymphoma, intrathoracic lymph nodes C81.13 Nodular sclerosis Hodgkin lymphoma, intra-abdominal lymph nodes C81.14 Nodular sclerosis Hodgkin lymphoma, lymph nodes of axilla and upper limb C81.15 Nodular sclerosis Hodgkin lymphoma, lymph nodes of inguinal region and lower limb C81.16 Nodular sclerosis Hodgkin lymphoma, intrapelvic lymph nodes C81.17 Nodular sclerosis Hodgkin lymphoma, spleen C81.18 Nodular sclerosis Hodgkin lymphoma, lymph nodes of multiple sites C81.19 Nodular sclerosis Hodgkin lymphoma, extranodal and solid organ sites C81.20 Mixed cellularity Hodgkin lymphoma, unspecified site C81.21 Mixed cellularity Hodgkin lymphoma, lymph nodes of head, face, and neck C81.22 Mixed cellularity Hodgkin lymphoma, intrathoracic lymph nodes C81.23 Mixed cellularity Hodgkin lymphoma, intra-abdominal lymph nodes C81.24 Mixed cellularity Hodgkin lymphoma, lymph nodes of axilla and upper limb C81.25 Mixed cellularity Hodgkin lymphoma, lymph nodes of inguinal region and lower limb C81.26 Mixed cellularity Hodgkin lymphoma, intrapelvic lymph nodes C81.27 Mixed cellularity Hodgkin lymphoma, spleen C81.28 Mixed cellularity Hodgkin lymphoma, lymph nodes of multiple sites C81.29 Mixed cellularity Hodgkin lymphoma, extranodal and solid organ sites C81.30 Lymphocyte depleted Hodgkin lymphoma, unspecified site C81.31 Lymphocyte depleted Hodgkin lymphoma, lymph nodes of head, face, and neck C81.32 Lymphocyte depleted Hodgkin lymphoma, intrathoracic lymph nodes C81.33 Lymphocyte depleted Hodgkin lymphoma, intra-abdominal lymph nodes C81.34 Lymphocyte depleted Hodgkin lymphoma, lymph nodes of axilla and upper limb C81.35 Lymphocyte depleted Hodgkin lymphoma, lymph nodes of inguinal region and lower limb C81.36 Lymphocyte depleted Hodgkin lymphoma, intrapelvic lymph nodes C81.37 Lymphocyte depleted Hodgkin lymphoma, spleen C81.38 Lymphocyte depleted Hodgkin lymphoma, lymph nodes of multiple sites C81.39 Lymphocyte depleted Hodgkin lymphoma, extranodal and solid organ sites C81.40 Lymphocyte-rich Hodgkin lymphoma, unspecified site C81.41 Lymphocyte-rich Hodgkin lymphoma, lymph nodes of head, face, and neck C81.42 Lymphocyte-rich Hodgkin lymphoma, intrathoracic lymph nodes C81.43 Lymphocyte-rich Hodgkin lymphoma, intra-abdominal lymph nodes C81.44 Lymphocyte-rich Hodgkin lymphoma, lymph nodes of axilla and upper limb C81.45 Lymphocyte-rich Hodgkin lymphoma, lymph nodes of inguinal region and lower limb C81.46 Lymphocyte-rich Hodgkin lymphoma, intrapelvic lymph nodes C81.47 Lymphocyte-rich Hodgkin lymphoma, spleen C81.48 Lymphocyte-rich Hodgkin lymphoma, lymph nodes of multiple sites C81.49 Lymphocyte-rich Hodgkin lymphoma, extranodal and solid organ sites C81.70 Other Hodgkin lymphoma, unspecified site C81.71 Other Hodgkin lymphoma, lymph nodes of head, face, and neck C81.72 Other Hodgkin lymphoma, intrathoracic lymph nodes C81.73 Other Hodgkin lymphoma, intra-abdominal lymph nodes C81.74 Other Hodgkin lymphoma, lymph nodes of axilla and upper limb C81.75 Other Hodgkin lymphoma, lymph nodes of inguinal region and lower limb C81.76 Other Hodgkin lymphoma, intrapelvic lymph nodes C81.77 Other Hodgkin lymphoma, spleen C81.78 Other Hodgkin lymphoma, lymph nodes of multiple sites C81.79 Other Hodgkin lymphoma, extranodal and solid organ sites C81.90 Hodgkin lymphoma, unspecified, unspecified site C81.91 Hodgkin lymphoma, unspecified, lymph nodes of head, face, and neck C81.92 Hodgkin lymphoma, unspecified, intrathoracic lymph nodes C81.93 Hodgkin lymphoma, unspecified, intra-abdominal lymph nodes C81.94 Hodgkin lymphoma, unspecified, lymph nodes of axilla and upper limb C81.95 Hodgkin lymphoma, unspecified, lymph nodes of inguinal region and lower limb C81.96 Hodgkin lymphoma, unspecified, intrapelvic lymph nodes C81.97 Hodgkin lymphoma, unspecified, spleen C81.98 Hodgkin lymphoma, unspecified, lymph nodes of multiple sites C81.99 Hodgkin lymphoma, unspecified, extranodal and solid organ sites C82.00 Follicular lymphoma grade I, unspecified site C82.01 Follicular lymphoma grade I, lymph nodes of head, face, and neck C82.02 Follicular lymphoma grade I, intrathoracic lymph nodes C82.03 Follicular lymphoma grade I, intra-abdominal lymph nodes C82.04 Follicular lymphoma grade I, lymph nodes of axilla and upper limb C82.05 Follicular lymphoma grade I, lymph nodes of inguinal region and lower limb C82.06 Follicular lymphoma grade I, intrapelvic lymph nodes C82.07 Follicular lymphoma grade I, spleen C82.08 Follicular lymphoma grade I, lymph nodes of multiple sites C82.09 Follicular lymphoma grade I, extranodal and solid organ sites C82.10 Follicular lymphoma grade II, unspecified site C82.11 Follicular lymphoma grade II, lymph nodes of head, face, and neck C82.12 Follicular lymphoma grade II, intrathoracic lymph nodes C82.13 Follicular lymphoma grade II, intra-abdominal lymph nodes C82.14 Follicular lymphoma grade II, lymph nodes of axilla and upper limb C82.15 Follicular lymphoma grade II, lymph nodes of inguinal region and lower limb C82.16 Follicular lymphoma grade II, intrapelvic lymph nodes C82.17 Follicular lymphoma grade II, spleen C82.18 Follicular lymphoma grade II, lymph nodes of multiple sites C82.19 Follicular lymphoma grade II, extranodal and solid organ sites C82.20 Follicular lymphoma grade III, unspecified, unspecified site C82.21 Follicular lymphoma grade III, unspecified, lymph nodes of head, face, and neck C82.22 Follicular lymphoma grade III, unspecified, intrathoracic lymph nodes C82.23 Follicular lymphoma grade III, unspecified, intra-abdominal lymph nodes C82.24 Follicular lymphoma grade III, unspecified, lymph nodes of axilla and upper limb C82.25 Follicular lymphoma grade III, unspecified, lymph nodes of inguinal region and lower limb C82.26 Follicular lymphoma grade III, unspecified, intrapelvic lymph nodes C82.27 Follicular lymphoma grade III, unspecified, spleen C82.28 Follicular lymphoma grade III, unspecified, lymph nodes of multiple sites C82.29 Follicular lymphoma grade III, unspecified, extranodal and solid organ sites C82.30 Follicular lymphoma grade IIIa, unspecified site C82.31 Follicular lymphoma grade IIIa, lymph nodes of head, face, and neck C82.32 Follicular lymphoma grade IIIa, intrathoracic lymph nodes C82.33 Follicular lymphoma grade IIIa, intra-abdominal lymph nodes C82.34 Follicular lymphoma grade IIIa, lymph nodes of axilla and upper limb C82.35 Follicular lymphoma grade IIIa, lymph nodes of inguinal region and lower limb C82.36 Follicular lymphoma grade IIIa, intrapelvic lymph nodes C82.37 Follicular lymphoma grade IIIa, spleen C82.38 Follicular lymphoma grade IIIa, lymph nodes of multiple sites C82.39 Follicular lymphoma grade IIIa, extranodal and solid organ sites C82.40 Follicular lymphoma grade IIIb, unspecified site C82.41 Follicular lymphoma grade IIIb, lymph nodes of head, face, and neck C82.42 Follicular lymphoma grade IIIb, intrathoracic lymph nodes C82.43 Follicular lymphoma grade IIIb, intra-abdominal lymph nodes C82.44 Follicular lymphoma grade IIIb, lymph nodes of axilla and upper limb C82.45 Follicular lymphoma grade IIIb, lymph nodes of inguinal region and lower limb C82.46 Follicular lymphoma grade IIIb, intrapelvic lymph nodes C82.47 Follicular lymphoma grade IIIb, spleen C82.48 Follicular lymphoma grade IIIb, lymph nodes of multiple sites C82.49 Follicular lymphoma grade IIIb, extranodal and solid organ sites C82.50 Diffuse follicle center lymphoma, unspecified site C82.51 Diffuse follicle center lymphoma, lymph nodes of head, face, and neck C82.52 Diffuse follicle center lymphoma, intrathoracic lymph nodes C82.53 Diffuse follicle center lymphoma, intra-abdominal lymph nodes C82.54 Diffuse follicle center lymphoma, lymph nodes of axilla and upper limb C82.55 Diffuse follicle center lymphoma, lymph nodes of inguinal region and lower limb C82.56 Diffuse follicle center lymphoma, intrapelvic lymph nodes C82.57 Diffuse follicle center lymphoma, spleen C82.58 Diffuse follicle center lymphoma, lymph nodes of multiple sites C82.59 Diffuse follicle center lymphoma, extranodal and solid organ sites C82.60 Cutaneous follicle center lymphoma, unspecified site C82.61 Cutaneous follicle center lymphoma, lymph nodes of head, face, and neck C82.62 Cutaneous follicle center lymphoma, intrathoracic lymph nodes C82.63 Cutaneous follicle center lymphoma, intra-abdominal lymph nodes C82.64 Cutaneous follicle center lymphoma, lymph nodes of axilla and upper limb C82.65 Cutaneous follicle center lymphoma, lymph nodes of inguinal region and lower limb C82.66 Cutaneous follicle center lymphoma, intrapelvic lymph nodes C82.67 Cutaneous follicle center lymphoma, spleen C82.68 Cutaneous follicle center lymphoma, lymph nodes of multiple sites C82.69 Cutaneous follicle center lymphoma, extranodal and solid organ sites C82.80 Other types of follicular lymphoma, unspecified site C82.81 Other types of follicular lymphoma, lymph nodes of head, face, and neck C82.82 Other types of follicular lymphoma, intrathoracic lymph nodes C82.83 Other types of follicular lymphoma, intra-abdominal lymph nodes C82.84 Other types of follicular lymphoma, lymph nodes of axilla and upper limb C82.85 Other types of follicular lymphoma, lymph nodes of inguinal region and lower limb C82.86 Other types of follicular lymphoma, intrapelvic lymph nodes C82.87 Other types of follicular lymphoma, spleen C82.88 Other types of follicular lymphoma, lymph nodes of multiple sites C82.89 Other types of follicular lymphoma, extranodal and solid organ sites C82.90 Follicular lymphoma, unspecified, unspecified site C82.91 Follicular lymphoma, unspecified, lymph nodes of head, face, and neck C82.92 Follicular lymphoma, unspecified, intrathoracic lymph nodes C82.93 Follicular lymphoma, unspecified, intra-abdominal lymph nodes C82.94 Follicular lymphoma, unspecified, lymph nodes of axilla and upper limb C82.95 Follicular lymphoma, unspecified, lymph nodes of inguinal region and lower limb C82.96 Follicular lymphoma, unspecified, intrapelvic lymph nodes C82.97 Follicular lymphoma, unspecified, spleen C82.98 Follicular lymphoma, unspecified, lymph nodes of multiple sites C82.99 Follicular lymphoma, unspecified, extranodal and solid organ sites C83.00 Small cell B-cell lymphoma, unspecified site C83.01 Small cell B-cell lymphoma, lymph nodes of head, face, and neck C83.02 Small cell B-cell lymphoma, intrathoracic lymph nodes C83.03 Small cell B-cell lymphoma, intra-abdominal lymph nodes C83.04 Small cell B-cell lymphoma, lymph nodes of axilla and upper limb C83.05 Small cell B-cell lymphoma, lymph nodes of inguinal region and lower limb C83.06 Small cell B-cell lymphoma, intrapelvic lymph nodes C83.07 Small cell B-cell lymphoma, spleen C83.08 Small cell B-cell lymphoma, lymph nodes of multiple sites C83.09 Small cell B-cell lymphoma, extranodal and solid organ sites C83.10 Mantle cell lymphoma, unspecified site C83.11 Mantle cell lymphoma, lymph nodes of head, face, and neck C83.12 Mantle cell lymphoma, intrathoracic lymph nodes C83.13 Mantle cell lymphoma, intra-abdominal lymph nodes C83.14 Mantle cell lymphoma, lymph nodes of axilla and upper limb C83.15 Mantle cell lymphoma, lymph nodes of inguinal region and lower limb C83.16 Mantle cell lymphoma, intrapelvic lymph nodes C83.17 Mantle cell lymphoma, spleen C83.18 Mantle cell lymphoma, lymph nodes of multiple sites C83.19 Mantle cell lymphoma, extranodal and solid organ sites C83.30 Diffuse large B-cell lymphoma, unspecified site C83.31 Diffuse large B-cell lymphoma, lymph nodes of head, face, and neck C83.32 Diffuse large B-cell lymphoma, intrathoracic lymph nodes C83.33 Diffuse large B-cell lymphoma, intra-abdominal lymph nodes C83.34 Diffuse large B-cell lymphoma, lymph nodes of axilla and upper limb C83.35 Diffuse large B-cell lymphoma, lymph nodes of inguinal region and lower limb C83.36 Diffuse large B-cell lymphoma, intrapelvic lymph nodes C83.37 Diffuse large B-cell lymphoma, spleen C83.38 Diffuse large B-cell lymphoma, lymph nodes of multiple sites C83.39 Diffuse large B-cell lymphoma, extranodal and solid organ sites C83.50 Lymphoblastic (diffuse) lymphoma, unspecified site C83.51 Lymphoblastic (diffuse) lymphoma, lymph nodes of head, face, and neck C83.52 Lymphoblastic (diffuse) lymphoma, intrathoracic lymph nodes C83.53 Lymphoblastic (diffuse) lymphoma, intra-abdominal lymph nodes C83.54 Lymphoblastic (diffuse) lymphoma, lymph nodes of axilla and upper limb C83.55 Lymphoblastic (diffuse) lymphoma, lymph nodes of inguinal region and lower limb C83.56 Lymphoblastic (diffuse) lymphoma, intrapelvic lymph nodes C83.57 Lymphoblastic (diffuse) lymphoma, spleen C83.58 Lymphoblastic (diffuse) lymphoma, lymph nodes of multiple sites C83.59 Lymphoblastic (diffuse) lymphoma, extranodal and solid organ sites C83.70 Burkitt lymphoma, unspecified site C83.71 Burkitt lymphoma, lymph nodes of head, face, and neck C83.72 Burkitt lymphoma, intrathoracic lymph nodes C83.73 Burkitt lymphoma, intra-abdominal lymph nodes C83.74 Burkitt lymphoma, lymph nodes of axilla and upper limb C83.75 Burkitt lymphoma, lymph nodes of inguinal region and lower limb C83.76 Burkitt lymphoma, intrapelvic lymph nodes C83.77 Burkitt lymphoma, spleen C83.78 Burkitt lymphoma, lymph nodes of multiple sites C83.79 Burkitt lymphoma, extranodal and solid organ sites C83.80 Other non-follicular lymphoma, unspecified site C83.81 Other non-follicular lymphoma, lymph nodes of head, face, and neck C83.82 Other non-follicular lymphoma, intrathoracic lymph nodes C83.83 Other non-follicular lymphoma, intra-abdominal lymph nodes C83.84 Other non-follicular lymphoma, lymph nodes of axilla and upper limb C83.85 Other non-follicular lymphoma, lymph nodes of inguinal region and lower limb C83.86 Other non-follicular lymphoma, intrapelvic lymph nodes C83.87 Other non-follicular lymphoma, spleen C83.88 Other non-follicular lymphoma, lymph nodes of multiple sites C83.89 Other non-follicular lymphoma, extranodal and solid organ sites C83.90 Non-follicular (diffuse) lymphoma, unspecified, unspecified site C83.91 Non-follicular (diffuse) lymphoma, unspecified, lymph nodes of head, face, and neck C83.92 Non-follicular (diffuse) lymphoma, unspecified, intrathoracic lymph nodes C83.93 Non-follicular (diffuse) lymphoma, unspecified, intra-abdominal lymph nodes C83.94 Non-follicular (diffuse) lymphoma, unspecified, lymph nodes of axilla and upper limb C83.95 Non-follicular (diffuse) lymphoma, unspecified, lymph nodes of inguinal region and lower limb C83.96 Non-follicular (diffuse) lymphoma, unspecified, intrapelvic lymph nodes C83.97 Non-follicular (diffuse) lymphoma, unspecified, spleen C83.98 Non-follicular (diffuse) lymphoma, unspecified, lymph nodes of multiple sites C83.99 Non-follicular (diffuse) lymphoma, unspecified, extranodal and solid organ sites C84.00 Mycosis fungoides, unspecified site C84.01 Mycosis fungoides, lymph nodes of head, face, and neck C84.02 Mycosis fungoides, intrathoracic lymph nodes C84.03 Mycosis fungoides, intra-abdominal lymph nodes C84.04 Mycosis fungoides, lymph nodes of axilla and upper limb C84.05 Mycosis fungoides, lymph nodes of inguinal region and lower limb C84.06 Mycosis fungoides, intrapelvic lymph nodes C84.07 Mycosis fungoides, spleen C84.08 Mycosis fungoides, lymph nodes of multiple sites C84.09 Mycosis fungoides, extranodal and solid organ sites C84.10 Sézary disease, unspecified site C84.11 Sézary disease, lymph nodes of head, face, and neck C84.12 Sézary disease, intrathoracic lymph nodes C84.13 Sézary disease, intra-abdominal lymph nodes C84.14 Sézary disease, lymph nodes of axilla and upper limb C84.15 Sézary disease, lymph nodes of inguinal region and lower limb C84.16 Sézary disease, intrapelvic lymph nodes C84.17 Sézary disease, spleen C84.18 Sézary disease, lymph nodes of multiple sites C84.19 Sézary disease, extranodal and solid organ sites C84.40 Peripheral T-cell lymphoma, not classified, unspecified site C84.41 Peripheral T-cell lymphoma, not classified, lymph nodes of head, face, and neck C84.42 Peripheral T-cell lymphoma, not classified, intrathoracic lymph nodes C84.43 Peripheral T-cell lymphoma, not classified, intra-abdominal lymph nodes C84.44 Peripheral T-cell lymphoma, not classified, lymph nodes of axilla and upper limb C84.45 Peripheral T-cell lymphoma, not classified, lymph nodes of inguinal region and lower limb C84.46 Peripheral T-cell lymphoma, not classified, intrapelvic lymph nodes C84.47 Peripheral T-cell lymphoma, not classified, spleen C84.48 Peripheral T-cell lymphoma, not classified, lymph nodes of multiple sites C84.49 Peripheral T-cell lymphoma, not classified, extranodal and solid organ sites C84.60 Anaplastic large cell lymphoma, ALK-positive, unspecified site C84.61 Anaplastic large cell lymphoma, ALK-positive, lymph nodes of head, face, and neck C84.62 Anaplastic large cell lymphoma, ALK-positive, intrathoracic lymph nodes C84.63 Anaplastic large cell lymphoma, ALK-positive, intra-abdominal lymph nodes C84.64 Anaplastic large cell lymphoma, ALK-positive, lymph nodes of axilla and upper limb C84.65 Anaplastic large cell lymphoma, ALK-positive, lymph nodes of inguinal region and lower limb C84.66 Anaplastic large cell lymphoma, ALK-positive, intrapelvic lymph nodes C84.67 Anaplastic large cell lymphoma, ALK-positive, spleen C84.68 Anaplastic large cell lymphoma, ALK-positive, lymph nodes of multiple sites C84.69 Anaplastic large cell lymphoma, ALK-positive, extranodal and solid organ sites C84.70 Anaplastic large cell lymphoma, ALK-negative, unspecified site C84.71 Anaplastic large cell lymphoma, ALK-negative, lymph nodes of head, face, and neck C84.72 Anaplastic large cell lymphoma, ALK-negative, intrathoracic lymph nodes C84.73 Anaplastic large cell lymphoma, ALK-negative, intra-abdominal lymph nodes C84.74 Anaplastic large cell lymphoma, ALK-negative, lymph nodes of axilla and upper limb C84.75 Anaplastic large cell lymphoma, ALK-negative, lymph nodes of inguinal region and lower limb C84.76 Anaplastic large cell lymphoma, ALK-negative, intrapelvic lymph nodes C84.77 Anaplastic large cell lymphoma, ALK-negative, spleen C84.78 Anaplastic large cell lymphoma, ALK-negative, lymph nodes of multiple sites C84.79 Anaplastic large cell lymphoma, ALK-negative, extranodal and solid organ sites C84.90 Mature T/NK-cell lymphomas, unspecified, unspecified site C84.91 Mature T/NK-cell lymphomas, unspecified, lymph nodes of head, face, and neck C84.92 Mature T/NK-cell lymphomas, unspecified, intrathoracic lymph nodes C84.93 Mature T/NK-cell lymphomas, unspecified, intra-abdominal lymph nodes C84.94 Mature T/NK-cell lymphomas, unspecified, lymph nodes of axilla and upper limb C84.95 Mature T/NK-cell lymphomas, unspecified, lymph nodes of inguinal region and lower limb C84.96 Mature T/NK-cell lymphomas, unspecified, intrapelvic lymph nodes C84.97 Mature T/NK-cell lymphomas, unspecified, spleen C84.98 Mature T/NK-cell lymphomas, unspecified, lymph nodes of multiple sites C84.99 Mature T/NK-cell lymphomas, unspecified, extranodal and solid organ sites C84.A0 Cutaneous T-cell lymphoma, unspecified, unspecified site C84.A1 Cutaneous T-cell lymphoma, unspecified lymph nodes of head, face, and neck C84.A2 Cutaneous T-cell lymphoma, unspecified, intrathoracic lymph nodes C84.A3 Cutaneous T-cell lymphoma, unspecified, intra-abdominal lymph nodes C84.A4 Cutaneous T-cell lymphoma, unspecified, lymph nodes of axilla and upper limb C84.A5 Cutaneous T-cell lymphoma, unspecified, lymph nodes of inguinal region and lower limb C84.A6 Cutaneous T-cell lymphoma, unspecified, intrapelvic lymph nodes C84.A7 Cutaneous T-cell lymphoma, unspecified, spleen C84.A8 Cutaneous T-cell lymphoma, unspecified, lymph nodes of multiple sites C84.A9 Cutaneous T-cell lymphoma, unspecified, extranodal and solid organ sites C84.Z0 Other mature T/NK-cell lymphomas, unspecified site C84.Z1 Other mature T/NK-cell lymphomas, lymph nodes of head, face, and neck C84.Z2 Other mature T/NK-cell lymphomas, intrathoracic lymph nodes C84.Z3 Other mature T/NK-cell lymphomas, intra-abdominal lymph nodes C84.Z4 Other mature T/NK-cell lymphomas, lymph nodes of axilla and upper limb C84.Z5 Other mature T/NK-cell lymphomas, lymph nodes of inguinal region and lower limb C84.Z6 Other mature T/NK-cell lymphomas, intrapelvic lymph nodes C84.Z7 Other mature T/NK-cell lymphomas, spleen C84.Z8 Other mature T/NK-cell lymphomas, lymph nodes of multiple sites C84.Z9 Other mature T/NK-cell lymphomas, extranodal and solid organ sites C85.10 Unspecified B-cell lymphoma, unspecified site C85.11 Unspecified B-cell lymphoma, lymph nodes of head, face, and neck C85.12 Unspecified B-cell lymphoma, intrathoracic lymph nodes C85.13 Unspecified B-cell lymphoma, intra-abdominal lymph nodes C85.14 Unspecified B-cell lymphoma, lymph nodes of axilla and upper limb C85.15 Unspecified B-cell lymphoma, lymph nodes of inguinal region and lower limb C85.16 Unspecified B-cell lymphoma, intrapelvic lymph nodes C85.17 Unspecified B-cell lymphoma, spleen C85.18 Unspecified B-cell lymphoma, lymph nodes of multiple sites C85.19 Unspecified B-cell lymphoma, extranodal and solid organ sites C85.20 Mediastinal (thymic) large B-cell lymphoma, unspecified site C85.21 Mediastinal (thymic) large B-cell lymphoma, lymph nodes of head, face, and neck C85.22 Mediastinal (thymic) large B-cell lymphoma, intrathoracic lymph nodes C85.23 Mediastinal (thymic) large B-cell lymphoma, intra-abdominal lymph nodes C85.24 Mediastinal (thymic) large B-cell lymphoma, lymph nodes of axilla and upper limb C85.25 Mediastinal (thymic) large B-cell lymphoma, lymph nodes of inguinal region and lower limb C85.26 Mediastinal (thymic) large B-cell lymphoma, intrapelvic lymph nodes C85.27 Mediastinal (thymic) large B-cell lymphoma, spleen C85.28 Mediastinal (thymic) large B-cell lymphoma, lymph nodes of multiple sites C85.29 Mediastinal (thymic) large B-cell lymphoma, extranodal and solid organ sites C85.80 Other specified types of non-Hodgkin lymphoma, unspecified site C85.81 Other specified types of non-Hodgkin lymphoma, lymph nodes of head, face, and neck C85.82 Other specified types of non-Hodgkin lymphoma, intrathoracic lymph nodes C85.83 Other specified types of non-Hodgkin lymphoma, intra-abdominal lymph nodes C85.84 Other specified types of non-Hodgkin lymphoma, lymph nodes of axilla and upper limb C85.85 Other specified types of non-Hodgkin lymphoma, lymph nodes of inguinal region and lower limb C85.86 Other specified types of non-Hodgkin lymphoma, intrapelvic lymph nodes C85.87 Other specified types of non-Hodgkin lymphoma, spleen C85.88 Other specified types of non-Hodgkin lymphoma, lymph nodes of multiple sites C85.89 Other specified types of non-Hodgkin lymphoma, extranodal and solid organ sites C85.90 Non-Hodgkin lymphoma, unspecified, unspecified site C85.91 Non-Hodgkin lymphoma, unspecified, lymph nodes of head, face, and neck C85.92 Non-Hodgkin lymphoma, unspecified, intrathoracic lymph nodes C85.93 Non-Hodgkin lymphoma, unspecified, intra-abdominal lymph nodes C85.94 Non-Hodgkin lymphoma, unspecified, lymph nodes of axilla and upper limb C85.95 Non-Hodgkin lymphoma, unspecified, lymph nodes of inguinal region and lower limb C85.96 Non-Hodgkin lymphoma, unspecified, intrapelvic lymph nodes C85.97 Non-Hodgkin lymphoma, unspecified, spleen C85.98 Non-Hodgkin lymphoma, unspecified, lymph nodes of multiple sites C85.99 Non-Hodgkin lymphoma, unspecified, extranodal and solid organ sites C86.0 Extranodal NK/T-cell lymphoma, nasal type C86.1 Hepatosplenic T-cell lymphoma C86.2 Enteropathy-type (intestinal) T-cell lymphoma C86.3 Subcutaneous panniculitis-like T-cell lymphoma C86.4 Blastic NK-cell lymphoma C86.5 Angioimmunoblastic T-cell lymphoma C86.6 Primary cutaneous CD30-positive T-cell proliferations C88.0 Waldenström macroglobulinemia C88.2 Heavy chain disease C88.3 Immunoproliferative small intestinal disease C88.4 Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma] C88.8 Other malignant immunoproliferative diseases C88.9 Malignant immunoproliferative disease, unspecified C90.00 Multiple myeloma not having achieved remission C90.01 Multiple myeloma in remission C90.02 Multiple myeloma in relapse C90.10 Plasma cell leukemia not having achieved remission C90.11 Plasma cell leukemia in remission C90.12 Plasma cell leukemia in relapse C90.20 Extramedullary plasmacytoma not having achieved remission C90.21 Extramedullary plasmacytoma in remission C90.22 Extramedullary plasmacytoma in relapse C90.30 Solitary plasmacytoma not having achieved remission C90.31 Solitary plasmacytoma in remission C90.32 Solitary plasmacytoma in relapse C91.00 Acute lymphoblastic leukemia not having achieved remission C91.01 Acute lymphoblastic leukemia, in remission C91.02 Acute lymphoblastic leukemia, in relapse C91.10 Chronic lymphocytic leukemia of B-cell type not having achieved remission C91.11 Chronic lymphocytic leukemia of B-cell type in remission C91.12 Chronic lymphocytic leukemia of B-cell type in relapse C91.30 Prolymphocytic leukemia of B-cell type not having achieved remission C91.31 Prolymphocytic leukemia of B-cell type, in remission C91.32 Prolymphocytic leukemia of B-cell type, in relapse C91.40 Hairy cell leukemia not having achieved remission C91.41 Hairy cell leukemia, in remission C91.42 Hairy cell leukemia, in relapse C91.50 Adult T-cell lymphoma/leukemia (HTLV-1-associated) not having achieved remission C91.51 Adult T-cell lymphoma/leukemia (HTLV-1-associated), in remission C91.52 Adult T-cell lymphoma/leukemia (HTLV-1-associated), in relapse C91.60 Prolymphocytic leukemia of T-cell type not having achieved remission C91.61 Prolymphocytic leukemia of T-cell type, in remission C91.62 Prolymphocytic leukemia of T-cell type, in relapse C91.90 Lymphoid leukemia, unspecified not having achieved remission C91.91 Lymphoid leukemia, unspecified, in remission C91.92 Lymphoid leukemia, unspecified, in relapse C91.A0 Mature B-cell leukemia Burkitt-type not having achieved remission C91.A1 Mature B-cell leukemia Burkitt-type, in remission C91.A2 Mature B-cell leukemia Burkitt-type, in relapse C91.Z0 Other lymphoid leukemia not having achieved remission C91.Z1 Other lymphoid leukemia, in remission C91.Z2 Other lymphoid leukemia, in relapse C92.00 Acute myeloblastic leukemia, not having achieved remission C92.01 Acute myeloblastic leukemia, in remission C92.02 Acute myeloblastic leukemia, in relapse C92.10 Chronic myeloid leukemia, BCR/ABL-positive, not having achieved remission C92.11 Chronic myeloid leukemia, BCR/ABL-positive, in remission C92.12 Chronic myeloid leukemia, BCR/ABL-positive, in relapse C92.20 Atypical chronic myeloid leukemia, BCR/ABL-negative, not having achieved remission C92.21 Atypical chronic myeloid leukemia, BCR/ABL-negative, in remission C92.22 Atypical chronic myeloid leukemia, BCR/ABL-negative, in relapse C92.30 Myeloid sarcoma, not having achieved remission C92.31 Myeloid sarcoma, in remission C92.32 Myeloid sarcoma, in relapse C92.40 Acute promyelocytic leukemia, not having achieved remission C92.41 Acute promyelocytic leukemia, in remission C92.42 Acute promyelocytic leukemia, in relapse C92.50 Acute myelomonocytic leukemia, not having achieved remission C92.51 Acute myelomonocytic leukemia, in remission C92.52 Acute myelomonocytic leukemia, in relapse C92.60 Acute myeloid leukemia with 11q23-abnormality not having achieved remission C92.61 Acute myeloid leukemia with 11q23-abnormality in remission C92.62 Acute myeloid leukemia with 11q23-abnormality in relapse C92.90 Myeloid leukemia, unspecified, not having achieved remission C92.91 Myeloid leukemia, unspecified in remission C92.92 Myeloid leukemia, unspecified in relapse C92.A0 Acute myeloid leukemia with multilineage dysplasia, not having achieved remission C92.A1 Acute myeloid leukemia with multilineage dysplasia, in remission C92.A2 Acute myeloid leukemia with multilineage dysplasia, in relapse C92.Z0 Other myeloid leukemia not having achieved remission C92.Z1 Other myeloid leukemia, in remission C92.Z2 Other myeloid leukemia, in relapse C93.00 Acute monoblastic/monocytic leukemia, not having achieved remission C93.01 Acute monoblastic/monocytic leukemia, in remission C93.02 Acute monoblastic/monocytic leukemia, in relapse C93.10 Chronic myelomonocytic leukemia not having achieved remission C93.11 Chronic myelomonocytic leukemia, in remission C93.12 Chronic myelomonocytic leukemia, in relapse C93.30 Juvenile myelomonocytic leukemia, not having achieved remission C93.31 Juvenile myelomonocytic leukemia, in remission C93.32 Juvenile myelomonocytic leukemia, in relapse C93.90 Monocytic leukemia, unspecified, not having achieved remission C93.91 Monocytic leukemia, unspecified in remission C93.92 Monocytic leukemia, unspecified in relapse C93.Z0 Other monocytic leukemia, not having achieved remission C93.Z1 Other monocytic leukemia, in remission C93.Z2 Other monocytic leukemia, in relapse C94.00 Acute erythroid leukemia, not having achieved remission C94.01 Acute erythroid leukemia, in remission C94.02 Acute erythroid leukemia, in relapse C94.20 Acute megakaryoblastic leukemia not having achieved remission C94.21 Acute megakaryoblastic leukemia, in remission C94.22 Acute megakaryoblastic leukemia, in relapse C94.30 Mast cell leukemia not having achieved remission C94.31 Mast cell leukemia, in remission C94.32 Mast cell leukemia, in relapse C94.40 Acute panmyelosis with myelofibrosis not having achieved remission C94.41 Acute panmyelosis with myelofibrosis, in remission C94.42 Acute panmyelosis with myelofibrosis, in relapse C94.6 Myelodysplastic disease, not classified C94.80 Other specified leukemias not having achieved remission C94.81 Other specified leukemias, in remission C94.82 Other specified leukemias, in relapse C95.00 Acute leukemia of unspecified cell type not having achieved remission C95.01 Acute leukemia of unspecified cell type, in remission C95.02 Acute leukemia of unspecified cell type, in relapse C95.10 Chronic leukemia of unspecified cell type not having achieved remission C95.11 Chronic leukemia of unspecified cell type, in remission C95.12 Chronic leukemia of unspecified cell type, in relapse C95.90 Leukemia, unspecified not having achieved remission C95.91 Leukemia, unspecified, in remission C95.92 Leukemia, unspecified, in relapse C96.0 Multifocal and multisystemic (disseminated) Langerhans-cell histiocytosis C96.2 Malignant mast cell neoplasm C96.20 Malignant mast cell neoplasm, unspecified C96.21 Aggressive systemic mastocytosis C96.22 Mast cell sarcoma C96.29 Other malignant mast cell neoplasm C96.4 Sarcoma of dendritic cells (accessory cells) C96.5 Multifocal and unisystemic Langerhans-cell histiocytosis C96.6 Unifocal Langerhans-cell histiocytosis C96.9 Malignant neoplasm of lymphoid, hematopoietic and related tissue, unspecified C96.A Histiocytic sarcoma C96.Z Other specified malignant neoplasms of lymphoid, hematopoietic and related tissue D00.00 Carcinoma in situ of oral cavity, unspecified site D00.01 Carcinoma in situ of labial mucosa and vermilion border D00.02 Carcinoma in situ of buccal mucosa D00.03 Carcinoma in situ of gingiva and edentulous alveolar ridge D00.04 Carcinoma in situ of soft palate D00.05 Carcinoma in situ of hard palate D00.06 Carcinoma in situ of floor of mouth D00.07 Carcinoma in situ of tongue D00.08 Carcinoma in situ of pharynx D00.1 Carcinoma in situ of esophagus D00.2 Carcinoma in situ of stomach D01.0 Carcinoma in situ of colon D01.1 Carcinoma in situ of rectosigmoid junction D01.2 Carcinoma in situ of rectum D01.3 Carcinoma in situ of anus and anal canal D01.40 Carcinoma in situ of unspecified part of intestine D01.49 Carcinoma in situ of other parts of intestine D01.5 Carcinoma in situ of liver, gallbladder and bile ducts D01.7 Carcinoma in situ of other specified digestive organs D01.9 Carcinoma in situ of digestive organ, unspecified D02.0 Carcinoma in situ of larynx D02.1 Carcinoma in situ of trachea D02.20 Carcinoma in situ of unspecified bronchus and lung D02.21 Carcinoma in situ of right bronchus and lung D02.22 Carcinoma in situ of left bronchus and lung D02.3 Carcinoma in situ of other parts of respiratory system D02.4 Carcinoma in situ of respiratory system, unspecified D03.0 Melanoma in situ of lip D03.10 Melanoma in situ of unspecified eyelid, including canthus D03.11 Melanoma in situ of right eyelid, including canthus D03.111 Melanoma in situ of right upper eyelid, including canthus D03.112 Melanoma in situ of right lower eyelid, including canthus D03.12 Melanoma in situ of left eyelid, including canthus D03.121 Melanoma in situ of left upper eyelid, including canthus D03.122 Melanoma in situ of left lower eyelid, including canthus D03.20 Melanoma in situ of unspecified ear and external auricular canal D03.21 Melanoma in situ of right ear and external auricular canal D03.22 Melanoma in situ of left ear and external auricular canal D03.30 Melanoma in situ of unspecified part of face D03.39 Melanoma in situ of other parts of face D03.4 Melanoma in situ of scalp and neck D03.51 Melanoma in situ of anal skin D03.52 Melanoma in situ of breast (skin) (soft tissue) D03.59 Melanoma in situ of other part of trunk D03.60 Melanoma in situ of unspecified upper limb, including shoulder D03.61 Melanoma in situ of right upper limb, including shoulder D03.62 Melanoma in situ of left upper limb, including shoulder D03.70 Melanoma in situ of unspecified lower limb, including hip D03.71 Melanoma in situ of right lower limb, including hip D03.72 Melanoma in situ of left lower limb, including hip D03.8 Melanoma in situ of other sites D03.9 Melanoma in situ, unspecified D04.0 Carcinoma in situ of skin of lip D04.10 Carcinoma in situ of skin of unspecified eyelid, including canthus D04.11 Carcinoma in situ of skin of right eyelid, including canthus D04.111 Carcinoma in situ of skin of right upper eyelid, including canthus D04.112 Carcinoma in situ of skin of right lower eyelid, including canthus D04.12 Carcinoma in situ of skin of left eyelid, including canthus D04.121 Carcinoma in situ of skin of left upper eyelid, including canthus D04.122 Carcinoma in situ of skin of left lower eyelid, including canthus D04.20 Carcinoma in situ of skin of unspecified ear and external auricular canal D04.21 Carcinoma in situ of skin of right ear and external auricular canal D04.22 Carcinoma in situ of skin of left ear and external auricular canal D04.30 Carcinoma in situ of skin of unspecified part of face D04.39 Carcinoma in situ of skin of other parts of face D04.4 Carcinoma in situ of skin of scalp and neck D04.5 Carcinoma in situ of skin of trunk D04.60 Carcinoma in situ of skin of unspecified upper limb, including shoulder D04.61 Carcinoma in situ of skin of right upper limb, including shoulder D04.62 Carcinoma in situ of skin of left upper limb, including shoulder D04.70 Carcinoma in situ of skin of unspecified lower limb, including hip D04.71 Carcinoma in situ of skin of right lower limb, including hip D04.72 Carcinoma in situ of skin of left lower limb, including hip D04.8 Carcinoma in situ of skin of other sites D04.9 Carcinoma in situ of skin, unspecified D05.00 Lobular carcinoma in situ of unspecified breast D05.01 Lobular carcinoma in situ of right breast D05.02 Lobular carcinoma in situ of left breast D05.10 Intraductal carcinoma in situ of unspecified breast D05.11 Intraductal carcinoma in situ of right breast D05.12 Intraductal carcinoma in situ of left breast D05.80 Other specified type of carcinoma in situ of unspecified breast D05.81 Other specified type of carcinoma in situ of right breast D05.82 Other specified type of carcinoma in situ of left breast D05.90 Unspecified type of carcinoma in situ of unspecified breast D05.91 Unspecified type of carcinoma in situ of right breast D05.92 Unspecified type of carcinoma in situ of left breast D06.0 Carcinoma in situ of endocervix D06.1 Carcinoma in situ of exocervix D06.7 Carcinoma in situ of other parts of cervix D06.9 Carcinoma in situ of cervix, unspecified D07.0 Carcinoma in situ of endometrium D07.1 Carcinoma in situ of vulva D07.2 Carcinoma in situ of vagina D07.30 Carcinoma in situ of unspecified female genital organs D07.39 Carcinoma in situ of other female genital organs D07.4 Carcinoma in situ of penis D07.5 Carcinoma in situ of prostate D07.60 Carcinoma in situ of unspecified male genital organs D07.61 Carcinoma in situ of scrotum D07.69 Carcinoma in situ of other male genital organs D09.0 Carcinoma in situ of bladder D09.10 Carcinoma in situ of unspecified urinary organ D09.19 Carcinoma in situ of other urinary organs D09.20 Carcinoma in situ of unspecified eye D09.21 Carcinoma in situ of right eye D09.22 Carcinoma in situ of left eye D09.3 Carcinoma in situ of thyroid and other endocrine glands D09.8 Carcinoma in situ of other specified sites D09.9 Carcinoma in situ, unspecified D10.0 Benign neoplasm of lip D10.1 Benign neoplasm of tongue D10.2 Benign neoplasm of floor of mouth D10.30 Benign neoplasm of unspecified part of mouth D10.39 Benign neoplasm of other parts of mouth D10.4 Benign neoplasm of tonsil D10.5 Benign neoplasm of other parts of oropharynx D10.6 Benign neoplasm of nasopharynx D10.7 Benign neoplasm of hypopharynx D10.9 Benign neoplasm of pharynx, unspecified D11.0 Benign neoplasm of parotid gland D11.7 Benign neoplasm of other major salivary glands D11.9 Benign neoplasm of major salivary gland, unspecified D12.0 Benign neoplasm of cecum D12.1 Benign neoplasm of appendix D12.2 Benign neoplasm of ascending colon D12.3 Benign neoplasm of transverse colon D12.4 Benign neoplasm of descending colon D12.5 Benign neoplasm of sigmoid colon D12.6 Benign neoplasm of colon, unspecified D12.7 Benign neoplasm of rectosigmoid junction D12.8 Benign neoplasm of rectum D12.9 Benign neoplasm of anus and anal canal D13.0 Benign neoplasm of esophagus D13.1 Benign neoplasm of stomach D13.2 Benign neoplasm of duodenum D13.30 Benign neoplasm of unspecified part of small intestine D13.39 Benign neoplasm of other parts of small intestine D13.4 Benign neoplasm of liver D13.5 Benign neoplasm of extrahepatic bile ducts D13.6 Benign neoplasm of pancreas D13.7 Benign neoplasm of endocrine pancreas D13.9 Benign neoplasm of ill-defined sites within the digestive system D14.0 Benign neoplasm of middle ear, nasal cavity and accessory sinuses D14.1 Benign neoplasm of larynx D14.2 Benign neoplasm of trachea D14.30 Benign neoplasm of unspecified bronchus and lung D14.31 Benign neoplasm of right bronchus and lung D14.32 Benign neoplasm of left bronchus and lung D14.4 Benign neoplasm of respiratory system, unspecified D15.0 Benign neoplasm of thymus D15.1 Benign neoplasm of heart D15.2 Benign neoplasm of mediastinum D15.7 Benign neoplasm of other specified intrathoracic organs D15.9 Benign neoplasm of intrathoracic organ, unspecified D16.00 Benign neoplasm of scapula and long bones of unspecified upper limb D16.01 Benign neoplasm of scapula and long bones of right upper limb D16.02 Benign neoplasm of scapula and long bones of left upper limb D16.10 Benign neoplasm of short bones of unspecified upper limb D16.11 Benign neoplasm of short bones of right upper limb D16.12 Benign neoplasm of short bones of left upper limb D16.20 Benign neoplasm of long bones of unspecified lower limb D16.21 Benign neoplasm of long bones of right lower limb D16.22 Benign neoplasm of long bones of left lower limb D16.30 Benign neoplasm of short bones of unspecified lower limb D16.31 Benign neoplasm of short bones of right lower limb D16.32 Benign neoplasm of short bones of left lower limb D16.4 Benign neoplasm of bones of skull and face D16.5 Benign neoplasm of lower jaw bone D16.6 Benign neoplasm of vertebral column D16.7 Benign neoplasm of ribs, sternum and clavicle D16.8 Benign neoplasm of pelvic bones, sacrum and coccyx D16.9 Benign neoplasm of bone and articular cartilage, unspecified D17.0 Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck D17.1 Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk D17.20 Benign lipomatous neoplasm of skin and subcutaneous tissue of unspecified limb D17.21 Benign lipomatous neoplasm of skin and subcutaneous tissue of right arm D17.22 Benign lipomatous neoplasm of skin and subcutaneous tissue of left arm D17.23 Benign lipomatous neoplasm of skin and subcutaneous tissue of right leg D17.24 Benign lipomatous neoplasm of skin and subcutaneous tissue of left leg D17.30 Benign lipomatous neoplasm of skin and subcutaneous tissue of unspecified sites D17.39 Benign lipomatous neoplasm of skin and subcutaneous tissue of other sites D17.4 Benign lipomatous neoplasm of intrathoracic organs D17.5 Benign lipomatous neoplasm of intra-abdominal organs D17.6 Benign lipomatous neoplasm of spermatic cord D17.71 Benign lipomatous neoplasm of kidney D17.72 Benign lipomatous neoplasm of other genitourinary organ D17.79 Benign lipomatous neoplasm of other sites D17.9 Benign lipomatous neoplasm, unspecified D18.00 Hemangioma unspecified site D18.01 Hemangioma of skin and subcutaneous tissue D18.02 Hemangioma of intracranial structures D18.03 Hemangioma of intra-abdominal structures D18.09 Hemangioma of other sites D18.1 Lymphangioma, any site D19.0 Benign neoplasm of mesothelial tissue of pleura D19.1 Benign neoplasm of mesothelial tissue of peritoneum D19.7 Benign neoplasm of mesothelial tissue of other sites D19.9 Benign neoplasm of mesothelial tissue, unspecified D20.0 Benign neoplasm of soft tissue of retroperitoneum D20.1 Benign neoplasm of soft tissue of peritoneum D21.0 Benign neoplasm of connective and other soft tissue of head, face and neck D21.10 Benign neoplasm of connective and other soft tissue of unspecified upper limb, including shoulder D21.11 Benign neoplasm of connective and other soft tissue of right upper limb, including shoulder D21.12 Benign neoplasm of connective and other soft tissue of left upper limb, including shoulder D21.20 Benign neoplasm of connective and other soft tissue of unspecified lower limb, including hip D21.21 Benign neoplasm of connective and other soft tissue of right lower limb, including hip D21.22 Benign neoplasm of connective and other soft tissue of left lower limb, including hip D21.3 Benign neoplasm of connective and other soft tissue of thorax D21.4 Benign neoplasm of connective and other soft tissue of abdomen D21.5 Benign neoplasm of connective and other soft tissue of pelvis D21.6 Benign neoplasm of connective and other soft tissue of trunk, unspecified D21.9 Benign neoplasm of connective and other soft tissue, unspecified D22.0 Melanocytic nevi of lip D22.10 Melanocytic nevi of unspecified eyelid, including canthus D22.11 Melanocytic nevi of right eyelid, including canthus D22.111 Melanocytic nevi of right upper eyelid, including canthus D22.112 Melanocytic nevi of right lower eyelid, including canthus D22.12 Melanocytic nevi of left eyelid, including canthus D22.121 Melanocytic nevi of left upper eyelid, including canthus D22.122 Melanocytic nevi of left lower eyelid, including canthus D22.20 Melanocytic nevi of unspecified ear and external auricular canal D22.21 Melanocytic nevi of right ear and external auricular canal D22.22 Melanocytic nevi of left ear and external auricular canal D22.30 Melanocytic nevi of unspecified part of face D22.39 Melanocytic nevi of other parts of face D22.4 Melanocytic nevi of scalp and neck D22.5 Melanocytic nevi of trunk D22.60 Melanocytic nevi of unspecified upper limb, including shoulder D22.61 Melanocytic nevi of right upper limb, including shoulder D22.62 Melanocytic nevi of left upper limb, including shoulder D22.70 Melanocytic nevi of unspecified lower limb, including hip D22.71 Melanocytic nevi of right lower limb, including hip D22.72 Melanocytic nevi of left lower limb, including hip D22.9 Melanocytic nevi, unspecified D23.0 Other benign neoplasm of skin of lip D23.10 Other benign neoplasm of skin of unspecified eyelid, including canthus D23.11 Other benign neoplasm of skin of right eyelid, including canthus D23.111 Other benign neoplasm of skin of right upper eyelid, including canthus D23.112 Other benign neoplasm of skin of right lower eyelid, including canthus D23.12 Other benign neoplasm of skin of left eyelid, including canthus D23.121 Other benign neoplasm of skin of left upper eyelid, including canthus D23.122 Other benign neoplasm of skin of left lower eyelid, including canthus D23.20 Other benign neoplasm of skin of unspecified ear and external auricular canal D23.21 Other benign neoplasm of skin of right ear and external auricular canal D23.22 Other benign neoplasm of skin of left ear and external auricular canal D23.30 Other benign neoplasm of skin of unspecified part of face D23.39 Other benign neoplasm of skin of other parts of face D23.4 Other benign neoplasm of skin of scalp and neck D23.5 Other benign neoplasm of skin of trunk D23.60 Other benign neoplasm of skin of unspecified upper limb, including shoulder D23.61 Other benign neoplasm of skin of right upper limb, including shoulder D23.62 Other benign neoplasm of skin of left upper limb, including shoulder D23.70 Other benign neoplasm of skin of unspecified lower limb, including hip D23.71 Other benign neoplasm of skin of right lower limb, including hip D23.72 Other benign neoplasm of skin of left lower limb, including hip D23.9 Other benign neoplasm of skin, unspecified D24.1 Benign neoplasm of right breast D24.2 Benign neoplasm of left breast D24.9 Benign neoplasm of unspecified breast D25.0 Submucous leiomyoma of uterus D25.1 Intramural leiomyoma of uterus D25.2 Subserosal leiomyoma of uterus D25.9 Leiomyoma of uterus, unspecified D26.0 Other benign neoplasm of cervix uteri D26.1 Other benign neoplasm of corpus uteri D26.7 Other benign neoplasm of other parts of uterus D26.9 Other benign neoplasm of uterus, unspecified D27.0 Benign neoplasm of right ovary D27.1 Benign neoplasm of left ovary D27.9 Benign neoplasm of unspecified ovary D28.0 Benign neoplasm of vulva D28.1 Benign neoplasm of vagina D28.2 Benign neoplasm of uterine tubes and ligaments D28.7 Benign neoplasm of other specified female genital organs D28.9 Benign neoplasm of female genital organ, unspecified D29.0 Benign neoplasm of penis D29.1 Benign neoplasm of prostate D29.20 Benign neoplasm of unspecified testis D29.21 Benign neoplasm of right testis D29.22 Benign neoplasm of left testis D29.30 Benign neoplasm of unspecified epididymis D29.31 Benign neoplasm of right epididymis D29.32 Benign neoplasm of left epididymis D29.4 Benign neoplasm of scrotum D29.8 Benign neoplasm of other specified male genital organs D29.9 Benign neoplasm of male genital organ, unspecified D30.00 Benign neoplasm of unspecified kidney D30.01 Benign neoplasm of right kidney D30.02 Benign neoplasm of left kidney D30.10 Benign neoplasm of unspecified renal pelvis D30.11 Benign neoplasm of right renal pelvis D30.12 Benign neoplasm of left renal pelvis D30.20 Benign neoplasm of unspecified ureter D30.21 Benign neoplasm of right ureter D30.22 Benign neoplasm of left ureter D30.3 Benign neoplasm of bladder D30.4 Benign neoplasm of urethra D30.8 Benign neoplasm of other specified urinary organs D30.9 Benign neoplasm of urinary organ, unspecified D31.00 Benign neoplasm of unspecified conjunctiva D31.01 Benign neoplasm of right conjunctiva D31.02 Benign neoplasm of left conjunctiva D31.10 Benign neoplasm of unspecified cornea D31.11 Benign neoplasm of right cornea D31.12 Benign neoplasm of left cornea D31.20 Benign neoplasm of unspecified retina D31.21 Benign neoplasm of right retina D31.22 Benign neoplasm of left retina D31.30 Benign neoplasm of unspecified choroid D31.31 Benign neoplasm of right choroid D31.32 Benign neoplasm of left choroid D31.40 Benign neoplasm of unspecified ciliary body D31.41 Benign neoplasm of right ciliary body D31.42 Benign neoplasm of left ciliary body D31.50 Benign neoplasm of unspecified lacrimal gland and duct D31.51 Benign neoplasm of right lacrimal gland and duct D31.52 Benign neoplasm of left lacrimal gland and duct D31.60 Benign neoplasm of unspecified site of unspecified orbit D31.61 Benign neoplasm of unspecified site of right orbit D31.62 Benign neoplasm of unspecified site of left orbit D31.90 Benign neoplasm of unspecified part of unspecified eye D31.91 Benign neoplasm of unspecified part of right eye D31.92 Benign neoplasm of unspecified part of left eye D32.0 Benign neoplasm of cerebral meninges D32.1 Benign neoplasm of spinal meninges D32.9 Benign neoplasm of meninges, unspecified D33.0 Benign neoplasm of brain, supratentorial D33.1 Benign neoplasm of brain, infratentorial D33.2 Benign neoplasm of brain, unspecified D33.3 Benign neoplasm of cranial nerves D33.4 Benign neoplasm of spinal cord D33.7 Benign neoplasm of other specified parts of central nervous system D33.9 Benign neoplasm of central nervous system, unspecified D34 Benign neoplasm of thyroid gland D35.00 Benign neoplasm of unspecified adrenal gland D35.01 Benign neoplasm of right adrenal gland D35.02 Benign neoplasm of left adrenal gland D35.1 Benign neoplasm of parathyroid gland D35.2 Benign neoplasm of pituitary gland D35.3 Benign neoplasm of craniopharyngeal duct D35.4 Benign neoplasm of pineal gland D35.5 Benign neoplasm of carotid body D35.6 Benign neoplasm of aortic body and other paraganglia D35.7 Benign neoplasm of other specified endocrine glands D35.9 Benign neoplasm of endocrine gland, unspecified D36.0 Benign neoplasm of lymph nodes D36.10 Benign neoplasm of peripheral nerves and autonomic nervous system, unspecified D36.11 Benign neoplasm of peripheral nerves and autonomic nervous system of face, head, and neck D36.12 Benign neoplasm of peripheral nerves and autonomic nervous system, upper limb, including shoulder D36.13 Benign neoplasm of peripheral nerves and autonomic nervous system of lower limb, including hip D36.14 Benign neoplasm of peripheral nerves and autonomic nervous system of thorax D36.15 Benign neoplasm of peripheral nerves and autonomic nervous system of abdomen D36.16 Benign neoplasm of peripheral nerves and autonomic nervous system of pelvis D36.17 Benign neoplasm of peripheral nerves and autonomic nervous system of trunk, unspecified D36.7 Benign neoplasm of other specified sites D36.9 Benign neoplasm, unspecified site D37.01 Neoplasm of uncertain behavior of lip D37.02 Neoplasm of uncertain behavior of tongue D37.030 Neoplasm of uncertain behavior of the parotid salivary glands D37.031 Neoplasm of uncertain behavior of the sublingual salivary glands D37.032 Neoplasm of uncertain behavior of the submandibular salivary glands D37.039 Neoplasm of uncertain behavior of the major salivary glands, unspecified D37.04 Neoplasm of uncertain behavior of the minor salivary glands D37.05 Neoplasm of uncertain behavior of pharynx D37.09 Neoplasm of uncertain behavior of other specified sites of the oral cavity D37.1 Neoplasm of uncertain behavior of stomach D37.2 Neoplasm of uncertain behavior of small intestine D37.3 Neoplasm of uncertain behavior of appendix D37.4 Neoplasm of uncertain behavior of colon D37.5 Neoplasm of uncertain behavior of rectum D37.6 Neoplasm of uncertain behavior of liver, gallbladder and bile ducts D37.8 Neoplasm of uncertain behavior of other specified digestive organs D37.9 Neoplasm of uncertain behavior of digestive organ, unspecified D38.0 Neoplasm of uncertain behavior of larynx D38.1 Neoplasm of uncertain behavior of trachea, bronchus and lung D38.2 Neoplasm of uncertain behavior of pleura D38.3 Neoplasm of uncertain behavior of mediastinum D38.4 Neoplasm of uncertain behavior of thymus D38.5 Neoplasm of uncertain behavior of other respiratory organs D38.6 Neoplasm of uncertain behavior of respiratory organ, unspecified D39.0 Neoplasm of uncertain behavior of uterus D39.10 Neoplasm of uncertain behavior of unspecified ovary D39.11 Neoplasm of uncertain behavior of right ovary D39.12 Neoplasm of uncertain behavior of left ovary D39.2 Neoplasm of uncertain behavior of placenta D39.8 Neoplasm of uncertain behavior of other specified female genital organs D39.9 Neoplasm of uncertain behavior of female genital organ, unspecified D3A.00 Benign carcinoid tumor of unspecified site D3A.010 Benign carcinoid tumor of the duodenum D3A.011 Benign carcinoid tumor of the jejunum D3A.012 Benign carcinoid tumor of the ileum D3A.019 Benign carcinoid tumor of the small intestine, unspecified portion D3A.020 Benign carcinoid tumor of the appendix D3A.021 Benign carcinoid tumor of the cecum D3A.022 Benign carcinoid tumor of the ascending colon D3A.023 Benign carcinoid tumor of the transverse colon D3A.024 Benign carcinoid tumor of the descending colon D3A.025 Benign carcinoid tumor of the sigmoid colon D3A.026 Benign carcinoid tumor of the rectum D3A.029 Benign carcinoid tumor of the large intestine, unspecified portion D3A.090 Benign carcinoid tumor of the bronchus and lung D3A.091 Benign carcinoid tumor of the thymus D3A.092 Benign carcinoid tumor of the stomach D3A.093 Benign carcinoid tumor of the kidney D3A.094 Benign carcinoid tumor of the foregut, unspecified D3A.095 Benign carcinoid tumor of the midgut, unspecified D3A.096 Benign carcinoid tumor of the hindgut, unspecified D3A.098 Benign carcinoid tumors of other sites D3A.8 Other benign neuroendocrine tumors D40.0 Neoplasm of uncertain behavior of prostate D40.10 Neoplasm of uncertain behavior of unspecified testis D40.11 Neoplasm of uncertain behavior of right testis D40.12 Neoplasm of uncertain behavior of left testis D40.8 Neoplasm of uncertain behavior of other specified male genital organs D40.9 Neoplasm of uncertain behavior of male genital organ, unspecified D41.00 Neoplasm of uncertain behavior of unspecified kidney D41.01 Neoplasm of uncertain behavior of right kidney D41.02 Neoplasm of uncertain behavior of left kidney D41.10 Neoplasm of uncertain behavior of unspecified renal pelvis D41.11 Neoplasm of uncertain behavior of right renal pelvis D41.12 Neoplasm of uncertain behavior of left renal pelvis D41.20 Neoplasm of uncertain behavior of unspecified ureter D41.21 Neoplasm of uncertain behavior of right ureter D41.22 Neoplasm of uncertain behavior of left ureter D41.3 Neoplasm of uncertain behavior of urethra D41.4 Neoplasm of uncertain behavior of bladder D41.8 Neoplasm of uncertain behavior of other specified urinary organs D41.9 Neoplasm of uncertain behavior of unspecified urinary organ D42.0 Neoplasm of uncertain behavior of cerebral meninges D42.1 Neoplasm of uncertain behavior of spinal meninges D42.9 Neoplasm of uncertain behavior of meninges, unspecified D43.0 Neoplasm of uncertain behavior of brain, supratentorial D43.1 Neoplasm of uncertain behavior of brain, infratentorial D43.2 Neoplasm of uncertain behavior of brain, unspecified D43.3 Neoplasm of uncertain behavior of cranial nerves D43.4 Neoplasm of uncertain behavior of spinal cord D43.8 Neoplasm of uncertain behavior of other specified parts of central nervous system D43.9 Neoplasm of uncertain behavior of central nervous system, unspecified D44.0 Neoplasm of uncertain behavior of thyroid gland D44.10 Neoplasm of uncertain behavior of unspecified adrenal gland D44.11 Neoplasm of uncertain behavior of right adrenal gland D44.12 Neoplasm of uncertain behavior of left adrenal gland D44.2 Neoplasm of uncertain behavior of parathyroid gland D44.3 Neoplasm of uncertain behavior of pituitary gland D44.4 Neoplasm of uncertain behavior of craniopharyngeal duct D44.5 Neoplasm of uncertain behavior of pineal gland D44.6 Neoplasm of uncertain behavior of carotid body D44.7 Neoplasm of uncertain behavior of aortic body and other paraganglia D44.9 Neoplasm of uncertain behavior of unspecified endocrine gland D45 Polycythemia vera D46.0 Refractory anemia without ring sideroblasts, so stated D46.1 Refractory anemia with ring sideroblasts D46.20 Refractory anemia with excess of blasts, unspecified D46.21 Refractory anemia with excess of blasts 1 D46.22 Refractory anemia with excess of blasts 2 D46.4 Refractory anemia, unspecified D46.9 Myelodysplastic syndrome, unspecified D46.A Refractory cytopenia with multilineage dysplasia D46.B Refractory cytopenia with multilineage dysplasia and ring sideroblasts D46.C Myelodysplastic syndrome with isolated del(5q) chromosomal abnormality D46.Z Other myelodysplastic syndromes D47.0 Mast cell neoplasms of uncertain behavior D47.01 Cutaneous mastocytosis D47.02 Systemic mastocytosis D47.09 Other mast cell neoplasms of uncertain behavior D47.1 Chronic myeloproliferative disease D47.2 Monoclonal gammopathy D47.3 Essential (hemorrhagic) thrombocythemia D47.4 Osteomyelofibrosis D47.9 Neoplasm of uncertain behavior of lymphoid, hematopoietic and related tissue, unspecified D47.Z1 Post-transplant lymphoproliferative disorder (PTLD) D47.Z2 Castleman disease D47.Z9 Other specified neoplasms of uncertain behavior of lymphoid, hematopoietic and related tissue D48.0 Neoplasm of uncertain behavior of bone and articular cartilage D48.1 Neoplasm of uncertain behavior of connective and other soft tissue D48.2 Neoplasm of uncertain behavior of peripheral nerves and autonomic nervous system D48.3 Neoplasm of uncertain behavior of retroperitoneum D48.4 Neoplasm of uncertain behavior of peritoneum D48.5 Neoplasm of uncertain behavior of skin D48.60 Neoplasm of uncertain behavior of unspecified breast D48.61 Neoplasm of uncertain behavior of right breast D48.62 Neoplasm of uncertain behavior of left breast D48.7 Neoplasm of uncertain behavior of other specified sites D48.9 Neoplasm of uncertain behavior, unspecified D49.0 Neoplasm of unspecified behavior of digestive system D49.1 Neoplasm of unspecified behavior of respiratory system D49.2 Neoplasm of unspecified behavior of bone, soft tissue, and skin D49.3 Neoplasm of unspecified behavior of breast D49.4 Neoplasm of unspecified behavior of bladder D49.5 Neoplasm of unspecified behavior of other genitourinary organs D49.511 Neoplasm of unspecified behavior of right kidney D49.512 Neoplasm of unspecified behavior of left kidney D49.519 Neoplasm of unspecified behavior of unspecified kidney D49.59 Neoplasm of unspecified behavior of other genitourinary organ D49.6 Neoplasm of unspecified behavior of brain D49.7 Neoplasm of unspecified behavior of endocrine glands and other parts of nervous system D49.81 Neoplasm of unspecified behavior of retina and choroid D49.89 Neoplasm of unspecified behavior of other specified sites D49.9 Neoplasm of unspecified behavior of unspecified site E31.22 Multiple endocrine neoplasia [MEN] type IIA E31.23 Multiple endocrine neoplasia [MEN] type IIB G43.601 Persistent migraine aura with cerebral infarction, not intractable, with status migrainosus G43.609 Persistent migraine aura with cerebral infarction, not intractable, without status migrainosus G43.611 Persistent migraine aura with cerebral infarction, intractable, with status migrainosus G43.619 Persistent migraine aura with cerebral infarction, intractable, without status migrainosus G45.0 Vertebro-basilar artery syndrome G45.1 Carotid artery syndrome (hemispheric) G45.2 Multiple and bilateral precerebral artery syndromes G45.3 Amaurosis fugax G45.4 Transient global amnesia G45.8 Other transient cerebral ischemic attacks and related syndromes G45.9 Transient cerebral ischemic attack, unspecified G46.0 Middle cerebral artery syndrome G46.1 Anterior cerebral artery syndrome G46.2 Posterior cerebral artery syndrome G46.3 Brain stem stroke syndrome G46.4 Cerebellar stroke syndrome G46.5 Pure motor lacunar syndrome G46.6 Pure sensory lacunar syndrome G46.7 Other lacunar syndromes G46.8 Other vascular syndromes of brain in cerebrovascular diseases G93.3 Postviral fatigue syndrome I01.0 Acute rheumatic pericarditis I01.1 Acute rheumatic endocarditis I01.2 Acute rheumatic myocarditis I01.8 Other acute rheumatic heart disease I01.9 Acute rheumatic heart disease, unspecified I02.0 Rheumatic chorea with heart involvement I05.0 Rheumatic mitral stenosis I05.1 Rheumatic mitral insufficiency I05.2 Rheumatic mitral stenosis with insufficiency I05.8 Other rheumatic mitral valve diseases I05.9 Rheumatic mitral valve disease, unspecified I06.0 Rheumatic aortic stenosis I06.1 Rheumatic aortic insufficiency I06.2 Rheumatic aortic stenosis with insufficiency I06.8 Other rheumatic aortic valve diseases I06.9 Rheumatic aortic valve disease, unspecified I07.0 Rheumatic tricuspid stenosis I07.1 Rheumatic tricuspid insufficiency I07.2 Rheumatic tricuspid stenosis and insufficiency I07.8 Other rheumatic tricuspid valve diseases I07.9 Rheumatic tricuspid valve disease, unspecified I08.0 Rheumatic disorders of both mitral and aortic valves I08.1 Rheumatic disorders of both mitral and tricuspid valves I08.2 Rheumatic disorders of both aortic and tricuspid valves I08.3 Combined rheumatic disorders of mitral, aortic and tricuspid valves I08.8 Other rheumatic multiple valve diseases I08.9 Rheumatic multiple valve disease, unspecified I09.0 Rheumatic myocarditis I09.1 Rheumatic diseases of endocardium, valve unspecified I09.2 Chronic rheumatic pericarditis I09.81 Rheumatic heart failure I09.89 Other specified rheumatic heart diseases I09.9 Rheumatic heart disease, unspecified I10 Essential (primary) hypertension I11.0 Hypertensive heart disease with heart failure I11.9 Hypertensive heart disease without heart failure I12.0 Hypertensive chronic kidney disease with stage 5 chronic kidney disease or end stage renal disease I12.9 Hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease I13.0 Hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease I13.10 Hypertensive heart and chronic kidney disease without heart failure, with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease I13.11 Hypertensive heart and chronic kidney disease without heart failure, with stage 5 chronic kidney disease, or end stage renal disease I13.2 Hypertensive heart and chronic kidney disease with heart failure and with stage 5 chronic kidney disease, or end stage renal disease I15.0 Renovascular hypertension I15.1 Hypertension secondary to other renal disorders I15.2 Hypertension secondary to endocrine disorders I15.8 Other secondary hypertension I15.9 Secondary hypertension, unspecified I16.0 Hypertensive urgency I16.1 Hypertensive emergency I16.9 Hypertensive crisis, unspecified I20.0 Unstable angina I20.1 Angina pectoris with documented spasm I20.8 Other forms of angina pectoris I20.9 Angina pectoris, unspecified I21.01 ST elevation (STEMI) myocardial infarction involving left main coronary artery I21.02 ST elevation (STEMI) myocardial infarction involving left anterior descending coronary artery I21.09 ST elevation (STEMI) myocardial infarction involving other coronary artery of anterior wall I21.11 ST elevation (STEMI) myocardial infarction involving right coronary artery I21.19 ST elevation (STEMI) myocardial infarction involving other coronary artery of inferior wall I21.21 ST elevation (STEMI) myocardial infarction involving left circumflex coronary artery I21.29 ST elevation (STEMI) myocardial infarction involving other sites I21.3 ST elevation (STEMI) myocardial infarction of unspecified site I21.4 Non-ST elevation (NSTEMI) myocardial infarction I21.9 Acute myocardial infarction, unspecified I21.A1 Myocardial infarction type 2 I21.A9 Other myocardial infarction type I22.0 Subsequent ST elevation (STEMI) myocardial infarction of anterior wall I22.1 Subsequent ST elevation (STEMI) myocardial infarction of inferior wall I22.2 Subsequent non-ST elevation (NSTEMI) myocardial infarction I22.8 Subsequent ST elevation (STEMI) myocardial infarction of other sites I22.9 Subsequent ST elevation (STEMI) myocardial infarction of unspecified site I23.0 Hemopericardium as current complication following acute myocardial infarction I23.1 Atrial septal defect as current complication following acute myocardial infarction I23.2 Ventricular septal defect as current complication following acute myocardial infarction I23.3 Rupture of cardiac wall without hemopericardium as current complication following acute myocardial infarction I23.4 Rupture of chordae tendineae as current complication following acute myocardial infarction I23.5 Rupture of papillary muscle as current complication following acute myocardial infarction I23.6 Thrombosis of atrium, auricular appendage, and ventricle as current complications following acute myocardial infarction I23.7 Postinfarction angina I23.8 Other current complications following acute myocardial infarction I24.0 Acute coronary thrombosis not resulting in myocardial infarction I24.1 Dressler's syndrome I24.8 Other forms of acute ischemic heart disease I24.9 Acute ischemic heart disease, unspecified I25.10 Atherosclerotic heart disease of native coronary artery without angina pectoris I25.110 Atherosclerotic heart disease of native coronary artery with unstable angina pectoris I25.111 Atherosclerotic heart disease of native coronary artery with angina pectoris with documented spasm I25.118 Atherosclerotic heart disease of native coronary artery with other forms of angina pectoris I25.119 Atherosclerotic heart disease of native coronary artery with unspecified angina pectoris I25.2 Old myocardial infarction I25.3 Aneurysm of heart I25.41 Coronary artery aneurysm I25.42 Coronary artery dissection I25.5 Ischemic cardiomyopathy I25.6 Silent myocardial ischemia I25.750 Atherosclerosis of native coronary artery of transplanted heart with unstable angina I25.751 Atherosclerosis of native coronary artery of transplanted heart with angina pectoris with documented spasm I25.758 Atherosclerosis of native coronary artery of transplanted heart with other forms of angina pectoris I25.759 Atherosclerosis of native coronary artery of transplanted heart with unspecified angina pectoris I25.811 Atherosclerosis of native coronary artery of transplanted heart without angina pectoris I25.82 Chronic total occlusion of coronary artery I25.83 Coronary atherosclerosis due to lipid rich plaque I25.84 Coronary atherosclerosis due to calcified coronary lesion I25.89 Other forms of chronic ischemic heart disease I25.9 Chronic ischemic heart disease, unspecified I26.01 Septic pulmonary embolism with acute cor pulmonale I26.02 Saddle embolus of pulmonary artery with acute cor pulmonale I26.09 Other pulmonary embolism with acute cor pulmonale I26.90 Septic pulmonary embolism without acute cor pulmonale I26.92 Saddle embolus of pulmonary artery without acute cor pulmonale I26.99 Other pulmonary embolism without acute cor pulmonale I27.0 Primary pulmonary hypertension I27.1 Kyphoscoliotic heart disease I27.2 Other secondary pulmonary hypertension I27.20 Pulmonary hypertension, unspecified I27.21 Secondary pulmonary arterial hypertension I27.22 Pulmonary hypertension due to left heart disease I27.23 Pulmonary hypertension due to lung diseases and hypoxia I27.24 Chronic thromboembolic pulmonary hypertension I27.29 Other secondary pulmonary hypertension I27.81 Cor pulmonale (chronic) I27.82 Chronic pulmonary embolism I27.83 Eisenmenger's syndrome I27.89 Other specified pulmonary heart diseases I27.9 Pulmonary heart disease, unspecified I28.0 Arteriovenous fistula of pulmonary vessels I28.1 Aneurysm of pulmonary artery I28.8 Other diseases of pulmonary vessels I28.9 Disease of pulmonary vessels, unspecified I30.0 Acute nonspecific idiopathic pericarditis I30.1 Infective pericarditis I30.8 Other forms of acute pericarditis I30.9 Acute pericarditis, unspecified I31.0 Chronic adhesive pericarditis I31.1 Chronic constrictive pericarditis I31.2 Hemopericardium, not elsewhere classified I31.3 Pericardial effusion (noninflammatory) I31.4 Cardiac tamponade I31.8 Other specified diseases of pericardium I31.9 Disease of pericardium, unspecified I32 Pericarditis in diseases classified elsewhere I33.0 Acute and subacute infective endocarditis I33.9 Acute and subacute endocarditis, unspecified I34.0 Nonrheumatic mitral (valve) insufficiency I34.1 Nonrheumatic mitral (valve) prolapse I34.2 Nonrheumatic mitral (valve) stenosis I34.8 Other nonrheumatic mitral valve disorders I34.9 Nonrheumatic mitral valve disorder, unspecified I35.0 Nonrheumatic aortic (valve) stenosis I35.1 Nonrheumatic aortic (valve) insufficiency I35.2 Nonrheumatic aortic (valve) stenosis with insufficiency I35.8 Other nonrheumatic aortic valve disorders I35.9 Nonrheumatic aortic valve disorder, unspecified I36.0 Nonrheumatic tricuspid (valve) stenosis I36.1 Nonrheumatic tricuspid (valve) insufficiency I36.2 Nonrheumatic tricuspid (valve) stenosis with insufficiency I36.8 Other nonrheumatic tricuspid valve disorders I36.9 Nonrheumatic tricuspid valve disorder, unspecified I37.0 Nonrheumatic pulmonary valve stenosis I37.1 Nonrheumatic pulmonary valve insufficiency I37.2 Nonrheumatic pulmonary valve stenosis with insufficiency I37.8 Other nonrheumatic pulmonary valve disorders I37.9 Nonrheumatic pulmonary valve disorder, unspecified I38 Endocarditis, valve unspecified I39 Endocarditis and heart valve disorders in diseases classified elsewhere I40.0 Infective myocarditis I40.1 Isolated myocarditis I40.8 Other acute myocarditis I40.9 Acute myocarditis, unspecified I41 Myocarditis in diseases classified elsewhere I42.0 Dilated cardiomyopathy I42.1 Obstructive hypertrophic cardiomyopathy I42.2 Other hypertrophic cardiomyopathy I42.3 Endomyocardial (eosinophilic) disease I42.4 Endocardial fibroelastosis I42.5 Other restrictive cardiomyopathy I42.7 Cardiomyopathy due to drug and external agent I42.8 Other cardiomyopathies I42.9 Cardiomyopathy, unspecified I43 Cardiomyopathy in diseases classified elsewhere I44.0 Atrioventricular block, first degree I44.1 Atrioventricular block, second degree I44.2 Atrioventricular block, complete I44.30 Unspecified atrioventricular block I44.39 Other atrioventricular block I44.4 Left anterior fascicular block I44.5 Left posterior fascicular block I44.60 Unspecified fascicular block I44.69 Other fascicular block I44.7 Left bundle-branch block, unspecified I45.0 Right fascicular block I45.10 Unspecified right bundle-branch block I45.19 Other right bundle-branch block I45.2 Bifascicular block I45.3 Trifascicular block I45.4 Nonspecific intraventricular block I45.5 Other specified heart block I45.6 Pre-excitation syndrome I45.81 Long QT syndrome I45.89 Other specified conduction disorders I45.9 Conduction disorder, unspecified I46.2 Cardiac arrest due to underlying cardiac condition I46.8 Cardiac arrest due to other underlying condition I46.9 Cardiac arrest, cause unspecified I47.0 Re-entry ventricular arrhythmia I47.1 Supraventricular tachycardia I47.2 Ventricular tachycardia I47.9 Paroxysmal tachycardia, unspecified I48.0 Paroxysmal atrial fibrillation I48.1 Persistent atrial fibrillation I48.2 Chronic atrial fibrillation I48.3 Typical atrial flutter I48.4 Atypical atrial flutter I48.91 Unspecified atrial fibrillation I48.92 Unspecified atrial flutter I49.01 Ventricular fibrillation I49.02 Ventricular flutter I49.1 Atrial premature depolarization I49.2 Junctional premature depolarization I49.3 Ventricular premature depolarization I49.40 Unspecified premature depolarization I49.49 Other premature depolarization I49.5 Sick sinus syndrome I49.8 Other specified cardiac arrhythmias I49.9 Cardiac arrhythmia, unspecified I50.1 Left ventricular failure, unspecified I50.20 Unspecified systolic (congestive) heart failure I50.21 Acute systolic (congestive) heart failure I50.22 Chronic systolic (congestive) heart failure I50.23 Acute on chronic systolic (congestive) heart failure I50.30 Unspecified diastolic (congestive) heart failure I50.31 Acute diastolic (congestive) heart failure I50.32 Chronic diastolic (congestive) heart failure I50.33 Acute on chronic diastolic (congestive) heart failure I50.40 Unspecified combined systolic (congestive) and diastolic (congestive) heart failure I50.41 Acute combined systolic (congestive) and diastolic (congestive) heart failure I50.42 Chronic combined systolic (congestive) and diastolic (congestive) heart failure I50.43 Acute on chronic combined systolic (congestive) and diastolic (congestive) heart failure I50.810 Right heart failure, unspecified I50.811 Acute right heart failure I50.812 Chronic right heart failure I50.813 Acute on chronic right heart failure I50.814 Right heart failure due to left heart failure I50.82 Biventricular heart failure I50.83 High output heart failure I50.84 End stage heart failure I50.89 Other heart failure I50.9 Heart failure, unspecified I51.0 Cardiac septal defect, acquired I51.1 Rupture of chordae tendineae, not elsewhere classified I51.2 Rupture of papillary muscle, not elsewhere classified I51.3 Intracardiac thrombosis, not elsewhere classified I51.4 Myocarditis, unspecified I51.5 Myocardial degeneration I51.7 Cardiomegaly I51.81 Takotsubo syndrome I51.89 Other ill-defined heart diseases I51.9 Heart disease, unspecified I52 Other heart disorders in diseases classified elsewhere I60.00 Nontraumatic subarachnoid hemorrhage from unspecified carotid siphon and bifurcation I60.01 Nontraumatic subarachnoid hemorrhage from right carotid siphon and bifurcation I60.02 Nontraumatic subarachnoid hemorrhage from left carotid siphon and bifurcation I60.10 Nontraumatic subarachnoid hemorrhage from unspecified middle cerebral artery I60.11 Nontraumatic subarachnoid hemorrhage from right middle cerebral artery I60.12 Nontraumatic subarachnoid hemorrhage from left middle cerebral artery I60.2 Nontraumatic subarachnoid hemorrhage from anterior communicating artery I60.30 Nontraumatic subarachnoid hemorrhage from unspecified posterior communicating artery I60.31 Nontraumatic subarachnoid hemorrhage from right posterior communicating artery I60.32 Nontraumatic subarachnoid hemorrhage from left posterior communicating artery I60.4 Nontraumatic subarachnoid hemorrhage from basilar artery I60.50 Nontraumatic subarachnoid hemorrhage from unspecified vertebral artery I60.51 Nontraumatic subarachnoid hemorrhage from right vertebral artery I60.52 Nontraumatic subarachnoid hemorrhage from left vertebral artery I60.6 Nontraumatic subarachnoid hemorrhage from other intracranial arteries I60.7 Nontraumatic subarachnoid hemorrhage from unspecified intracranial artery I60.8 Other nontraumatic subarachnoid hemorrhage I60.9 Nontraumatic subarachnoid hemorrhage, unspecified I61.0 Nontraumatic intracerebral hemorrhage in hemisphere, subcortical I61.1 Nontraumatic intracerebral hemorrhage in hemisphere, cortical I61.2 Nontraumatic intracerebral hemorrhage in hemisphere, unspecified I61.3 Nontraumatic intracerebral hemorrhage in brain stem I61.4 Nontraumatic intracerebral hemorrhage in cerebellum I61.5 Nontraumatic intracerebral hemorrhage, intraventricular I61.6 Nontraumatic intracerebral hemorrhage, multiple localized I61.8 Other nontraumatic intracerebral hemorrhage I61.9 Nontraumatic intracerebral hemorrhage, unspecified I62.00 Nontraumatic subdural hemorrhage, unspecified I62.01 Nontraumatic acute subdural hemorrhage I62.02 Nontraumatic subacute subdural hemorrhage I62.03 Nontraumatic chronic subdural hemorrhage I62.1 Nontraumatic extradural hemorrhage I62.9 Nontraumatic intracranial hemorrhage, unspecified I63.00 Cerebral infarction due to thrombosis of unspecified precerebral artery I63.011 Cerebral infarction due to thrombosis of right vertebral artery I63.012 Cerebral infarction due to thrombosis of left vertebral artery I63.013 Cerebral infarction due to thrombosis of bilateral vertebral arteries I63.019 Cerebral infarction due to thrombosis of unspecified vertebral artery I63.02 Cerebral infarction due to thrombosis of basilar artery I63.031 Cerebral infarction due to thrombosis of right carotid artery I63.032 Cerebral infarction due to thrombosis of left carotid artery I63.033 Cerebral infarction due to thrombosis of bilateral carotid arteries I63.039 Cerebral infarction due to thrombosis of unspecified carotid artery I63.09 Cerebral infarction due to thrombosis of other precerebral artery I63.10 Cerebral infarction due to embolism of unspecified precerebral artery I63.111 Cerebral infarction due to embolism of right vertebral artery I63.112 Cerebral infarction due to embolism of left vertebral artery I63.113 Cerebral infarction due to embolism of bilateral vertebral arteries I63.119 Cerebral infarction due to embolism of unspecified vertebral artery I63.12 Cerebral infarction due to embolism of basilar artery I63.131 Cerebral infarction due to embolism of right carotid artery I63.132 Cerebral infarction due to embolism of left carotid artery I63.133 Cerebral infarction due to embolism of bilateral carotid arteries I63.139 Cerebral infarction due to embolism of unspecified carotid artery I63.19 Cerebral infarction due to embolism of other precerebral artery I63.20 Cerebral infarction due to unspecified occlusion or stenosis of unspecified precerebral arteries I63.211 Cerebral infarction due to unspecified occlusion or stenosis of right vertebral artery I63.212 Cerebral infarction due to unspecified occlusion or stenosis of left vertebral artery I63.213 Cerebral infarction due to unspecified occlusion or stenosis of bilateral vertebral arteries I63.219 Cerebral infarction due to unspecified occlusion or stenosis of unspecified vertebral artery I63.22 Cerebral infarction due to unspecified occlusion or stenosis of basilar artery I63.231 Cerebral infarction due to unspecified occlusion or stenosis of right carotid arteries I63.232 Cerebral infarction due to unspecified occlusion or stenosis of left carotid arteries I63.233 Cerebral infarction due to unspecified occlusion or stenosis of bilateral carotid arteries I63.239 Cerebral infarction due to unspecified occlusion or stenosis of unspecified carotid artery I63.29 Cerebral infarction due to unspecified occlusion or stenosis of other precerebral arteries I63.30 Cerebral infarction due to thrombosis of unspecified cerebral artery I63.311 Cerebral infarction due to thrombosis of right middle cerebral artery I63.312 Cerebral infarction due to thrombosis of left middle cerebral artery I63.313 Cerebral infarction due to thrombosis of bilateral middle cerebral arteries I63.319 Cerebral infarction due to thrombosis of unspecified middle cerebral artery I63.321 Cerebral infarction due to thrombosis of right anterior cerebral artery I63.322 Cerebral infarction due to thrombosis of left anterior cerebral artery I63.323 Cerebral infarction due to thrombosis of bilateral anterior cerebral arteries I63.329 Cerebral infarction due to thrombosis of unspecified anterior cerebral artery I63.331 Cerebral infarction due to thrombosis of right posterior cerebral artery I63.332 Cerebral infarction due to thrombosis of left posterior cerebral artery I63.333 Cerebral infarction due to thrombosis of bilateral posterior cerebral arteries I63.339 Cerebral infarction due to thrombosis of unspecified posterior cerebral artery I63.341 Cerebral infarction due to thrombosis of right cerebellar artery I63.342 Cerebral infarction due to thrombosis of left cerebellar artery I63.343 Cerebral infarction due to thrombosis of bilateral cerebellar arteries I63.349 Cerebral infarction due to thrombosis of unspecified cerebellar artery I63.39 Cerebral infarction due to thrombosis of other cerebral artery I63.40 Cerebral infarction due to embolism of unspecified cerebral artery I63.411 Cerebral infarction due to embolism of right middle cerebral artery I63.412 Cerebral infarction due to embolism of left middle cerebral artery I63.413 Cerebral infarction due to embolism of bilateral middle cerebral arteries I63.419 Cerebral infarction due to embolism of unspecified middle cerebral artery I63.421 Cerebral infarction due to embolism of right anterior cerebral artery I63.422 Cerebral infarction due to embolism of left anterior cerebral artery I63.423 Cerebral infarction due to embolism of bilateral anterior cerebral arteries I63.429 Cerebral infarction due to embolism of unspecified anterior cerebral artery I63.431 Cerebral infarction due to embolism of right posterior cerebral artery I63.432 Cerebral infarction due to embolism of left posterior cerebral artery I63.433 Cerebral infarction due to embolism of bilateral posterior cerebral arteries I63.439 Cerebral infarction due to embolism of unspecified posterior cerebral artery I63.441 Cerebral infarction due to embolism of right cerebellar artery I63.442 Cerebral infarction due to embolism of left cerebellar artery I63.443 Cerebral infarction due to embolism of bilateral cerebellar arteries I63.449 Cerebral infarction due to embolism of unspecified cerebellar artery I63.49 Cerebral infarction due to embolism of other cerebral artery I63.50 Cerebral infarction due to unspecified occlusion or stenosis of unspecified cerebral artery I63.511 Cerebral infarction due to unspecified occlusion or stenosis of right middle cerebral artery I63.512 Cerebral infarction due to unspecified occlusion or stenosis of left middle cerebral artery I63.513 Cerebral infarction due to unspecified occlusion or stenosis of bilateral middle cerebral arteries I63.519 Cerebral infarction due to unspecified occlusion or stenosis of unspecified middle cerebral artery I63.521 Cerebral infarction due to unspecified occlusion or stenosis of right anterior cerebral artery I63.522 Cerebral infarction due to unspecified occlusion or stenosis of left anterior cerebral artery I63.523 Cerebral infarction due to unspecified occlusion or stenosis of bilateral anterior cerebral arteries I63.529 Cerebral infarction due to unspecified occlusion or stenosis of unspecified anterior cerebral artery I63.531 Cerebral infarction due to unspecified occlusion or stenosis of right posterior cerebral artery I63.532 Cerebral infarction due to unspecified occlusion or stenosis of left posterior cerebral artery I63.533 Cerebral infarction due to unspecified occlusion or stenosis of bilateral posterior cerebral arteries I63.539 Cerebral infarction due to unspecified occlusion or stenosis of unspecified posterior cerebral artery I63.541 Cerebral infarction due to unspecified occlusion or stenosis of right cerebellar artery I63.542 Cerebral infarction due to unspecified occlusion or stenosis of left cerebellar artery I63.543 Cerebral infarction due to unspecified occlusion or stenosis of bilateral cerebellar arteries I63.549 Cerebral infarction due to unspecified occlusion or stenosis of unspecified cerebellar artery I63.59 Cerebral infarction due to unspecified occlusion or stenosis of other cerebral artery I63.6 Cerebral infarction due to cerebral venous thrombosis, nonpyogenic I63.8 Other cerebral infarction I63.81 Other cerebral infarction due to occlusion or stenosis of small artery I63.89 Other cerebral infarction I63.9 Cerebral infarction, unspecified I65.01 Occlusion and stenosis of right vertebral artery I65.02 Occlusion and stenosis of left vertebral artery I65.03 Occlusion and stenosis of bilateral vertebral arteries I65.09 Occlusion and stenosis of unspecified vertebral artery I65.1 Occlusion and stenosis of basilar artery I65.21 Occlusion and stenosis of right carotid artery I65.22 Occlusion and stenosis of left carotid artery I65.23 Occlusion and stenosis of bilateral carotid arteries I65.29 Occlusion and stenosis of unspecified carotid artery I65.8 Occlusion and stenosis of other precerebral arteries I65.9 Occlusion and stenosis of unspecified precerebral artery I66.01 Occlusion and stenosis of right middle cerebral artery I66.02 Occlusion and stenosis of left middle cerebral artery I66.03 Occlusion and stenosis of bilateral middle cerebral arteries I66.09 Occlusion and stenosis of unspecified middle cerebral artery I66.11 Occlusion and stenosis of right anterior cerebral artery I66.12 Occlusion and stenosis of left anterior cerebral artery I66.13 Occlusion and stenosis of bilateral anterior cerebral arteries I66.19 Occlusion and stenosis of unspecified anterior cerebral artery I66.21 Occlusion and stenosis of right posterior cerebral artery I66.22 Occlusion and stenosis of left posterior cerebral artery I66.23 Occlusion and stenosis of bilateral posterior cerebral arteries I66.29 Occlusion and stenosis of unspecified posterior cerebral artery I66.3 Occlusion and stenosis of cerebellar arteries I66.8 Occlusion and stenosis of other cerebral arteries I66.9 Occlusion and stenosis of unspecified cerebral artery I67.0 Dissection of cerebral arteries, nonruptured I67.1 Cerebral aneurysm, nonruptured I67.2 Cerebral atherosclerosis I67.4 Hypertensive encephalopathy I67.5 Moyamoya disease I67.6 Nonpyogenic thrombosis of intracranial venous system I67.7 Cerebral arteritis, not elsewhere classified I67.81 Acute cerebrovascular insufficiency I67.82 Cerebral ischemia I67.83 Posterior reversible encephalopathy syndrome I67.841 Reversible cerebrovascular vasoconstriction syndrome I67.848 Other cerebrovascular vasospasm and vasoconstriction I67.850 Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy I67.858 Other hereditary cerebrovascular disease I67.89 Other cerebrovascular disease I67.9 Cerebrovascular disease, unspecified I68.0 Cerebral amyloid angiopathy I68.2 Cerebral arteritis in other diseases classified elsewhere I68.8 Other cerebrovascular disorders in diseases classified elsewhere I69.00 Unspecified sequelae of nontraumatic subarachnoid hemorrhage I69.01 Cognitive deficits following nontraumatic subarachnoid hemorrhage I69.010 Attention and concentration deficit following nontraumatic subarachnoid hemorrhage I69.011 Memory deficit following nontraumatic subarachnoid hemorrhage I69.012 Visuospatial deficit and spatial neglect following nontraumatic subarachnoid hemorrhage I69.013 Psychomotor deficit following nontraumatic subarachnoid hemorrhage I69.014 Frontal lobe and executive function deficit following nontraumatic subarachnoid hemorrhage I69.015 Cognitive social or emotional deficit following nontraumatic subarachnoid hemorrhage I69.018 Other symptoms and signs involving cognitive functions following nontraumatic subarachnoid hemorrhage I69.019 Unspecified symptoms and signs involving cognitive functions following nontraumatic subarachnoid hemorrhage I69.020 Aphasia following nontraumatic subarachnoid hemorrhage I69.021 Dysphasia following nontraumatic subarachnoid hemorrhage I69.022 Dysarthria following nontraumatic subarachnoid hemorrhage I69.023 Fluency disorder following nontraumatic subarachnoid hemorrhage I69.028 Other speech and language deficits following nontraumatic subarachnoid hemorrhage I69.031 Monoplegia of upper limb following nontraumatic subarachnoid hemorrhage affecting right dominant side I69.032 Monoplegia of upper limb following nontraumatic subarachnoid hemorrhage affecting left dominant side I69.033 Monoplegia of upper limb following nontraumatic subarachnoid hemorrhage affecting right non-dominant side I69.034 Monoplegia of upper limb following nontraumatic subarachnoid hemorrhage affecting left non-dominant side I69.039 Monoplegia of upper limb following nontraumatic subarachnoid hemorrhage affecting unspecified side I69.041 Monoplegia of lower limb following nontraumatic subarachnoid hemorrhage affecting right dominant side I69.042 Monoplegia of lower limb following nontraumatic subarachnoid hemorrhage affecting left dominant side I69.043 Monoplegia of lower limb following nontraumatic subarachnoid hemorrhage affecting right non-dominant side I69.044 Monoplegia of lower limb following nontraumatic subarachnoid hemorrhage affecting left non-dominant side I69.049 Monoplegia of lower limb following nontraumatic subarachnoid hemorrhage affecting unspecified side I69.051 Hemiplegia and hemiparesis following nontraumatic subarachnoid hemorrhage affecting right dominant side I69.052 Hemiplegia and hemiparesis following nontraumatic subarachnoid hemorrhage affecting left dominant side I69.053 Hemiplegia and hemiparesis following nontraumatic subarachnoid hemorrhage affecting right non-dominant side I69.054 Hemiplegia and hemiparesis following nontraumatic subarachnoid hemorrhage affecting left non-dominant side I69.059 Hemiplegia and hemiparesis following nontraumatic subarachnoid hemorrhage affecting unspecified side I69.061 Other paralytic syndrome following nontraumatic subarachnoid hemorrhage affecting right dominant side I69.062 Other paralytic syndrome following nontraumatic subarachnoid hemorrhage affecting left dominant side I69.063 Other paralytic syndrome following nontraumatic subarachnoid hemorrhage affecting right non-dominant side I69.064 Other paralytic syndrome following nontraumatic subarachnoid hemorrhage affecting left non-dominant side I69.065 Other paralytic syndrome following nontraumatic subarachnoid hemorrhage, bilateral I69.069 Other paralytic syndrome following nontraumatic subarachnoid hemorrhage affecting unspecified side I69.090 Apraxia following nontraumatic subarachnoid hemorrhage I69.091 Dysphagia following nontraumatic subarachnoid hemorrhage I69.092 Facial weakness following nontraumatic subarachnoid hemorrhage I69.093 Ataxia following nontraumatic subarachnoid hemorrhage I69.098 Other sequelae following nontraumatic subarachnoid hemorrhage I69.10 Unspecified sequelae of nontraumatic intracerebral hemorrhage I69.11 Cognitive deficits following nontraumatic intracerebral hemorrhage I69.110 Attention and concentration deficit following nontraumatic intracerebral hemorrhage I69.111 Memory deficit following nontraumatic intracerebral hemorrhage I69.112 Visuospatial deficit and spatial neglect following nontraumatic intracerebral hemorrhage I69.113 Psychomotor deficit following nontraumatic intracerebral hemorrhage I69.114 Frontal lobe and executive function deficit following nontraumatic intracerebral hemorrhage I69.115 Cognitive social or emotional deficit following nontraumatic intracerebral hemorrhage I69.118 Other symptoms and signs involving cognitive functions following nontraumatic intracerebral hemorrhage I69.119 Unspecified symptoms and signs involving cognitive functions following nontraumatic intracerebral hemorrhage I69.120 Aphasia following nontraumatic intracerebral hemorrhage I69.121 Dysphasia following nontraumatic intracerebral hemorrhage I69.122 Dysarthria following nontraumatic intracerebral hemorrhage I69.123 Fluency disorder following nontraumatic intracerebral hemorrhage I69.128 Other speech and language deficits following nontraumatic intracerebral hemorrhage I69.131 Monoplegia of upper limb following nontraumatic intracerebral hemorrhage affecting right dominant side I69.132 Monoplegia of upper limb following nontraumatic intracerebral hemorrhage affecting left dominant side I69.133 Monoplegia of upper limb following nontraumatic intracerebral hemorrhage affecting right non-dominant side I69.134 Monoplegia of upper limb following nontraumatic intracerebral hemorrhage affecting left non-dominant side I69.139 Monoplegia of upper limb following nontraumatic intracerebral hemorrhage affecting unspecified side I69.141 Monoplegia of lower limb following nontraumatic intracerebral hemorrhage affecting right dominant side I69.142 Monoplegia of lower limb following nontraumatic intracerebral hemorrhage affecting left dominant side I69.143 Monoplegia of lower limb following nontraumatic intracerebral hemorrhage affecting right non-dominant side I69.144 Monoplegia of lower limb following nontraumatic intracerebral hemorrhage affecting left non-dominant side I69.149 Monoplegia of lower limb following nontraumatic intracerebral hemorrhage affecting unspecified side I69.151 Hemiplegia and hemiparesis following nontraumatic intracerebral hemorrhage affecting right dominant side I69.152 Hemiplegia and hemiparesis following nontraumatic intracerebral hemorrhage affecting left dominant side I69.153 Hemiplegia and hemiparesis following nontraumatic intracerebral hemorrhage affecting right non-dominant side I69.154 Hemiplegia and hemiparesis following nontraumatic intracerebral hemorrhage affecting left non-dominant side I69.159 Hemiplegia and hemiparesis following nontraumatic intracerebral hemorrhage affecting unspecified side I69.161 Other paralytic syndrome following nontraumatic intracerebral hemorrhage affecting right dominant side I69.162 Other paralytic syndrome following nontraumatic intracerebral hemorrhage affecting left dominant side I69.163 Other paralytic syndrome following nontraumatic intracerebral hemorrhage affecting right non-dominant side I69.164 Other paralytic syndrome following nontraumatic intracerebral hemorrhage affecting left non-dominant side I69.165 Other paralytic syndrome following nontraumatic intracerebral hemorrhage, bilateral I69.169 Other paralytic syndrome following nontraumatic intracerebral hemorrhage affecting unspecified side I69.190 Apraxia following nontraumatic intracerebral hemorrhage I69.191 Dysphagia following nontraumatic intracerebral hemorrhage I69.192 Facial weakness following nontraumatic intracerebral hemorrhage I69.193 Ataxia following nontraumatic intracerebral hemorrhage I69.198 Other sequelae of nontraumatic intracerebral hemorrhage I69.20 Unspecified sequelae of other nontraumatic intracranial hemorrhage I69.21 Cognitive deficits following other nontraumatic intracranial hemorrhage I69.210 Attention and concentration deficit following other nontraumatic intracranial hemorrhage I69.211 Memory deficit following other nontraumatic intracranial hemorrhage I69.212 Visuospatial deficit and spatial neglect following other nontraumatic intracranial hemorrhage I69.213 Psychomotor deficit following other nontraumatic intracranial hemorrhage I69.214 Frontal lobe and executive function deficit following other nontraumatic intracranial hemorrhage I69.215 Cognitive social or emotional deficit following other nontraumatic intracranial hemorrhage I69.218 Other symptoms and signs involving cognitive functions following other nontraumatic intracranial hemorrhage I69.219 Unspecified symptoms and signs involving cognitive functions following other nontraumatic intracranial hemorrhage I69.220 Aphasia following other nontraumatic intracranial hemorrhage I69.221 Dysphasia following other nontraumatic intracranial hemorrhage I69.222 Dysarthria following other nontraumatic intracranial hemorrhage I69.223 Fluency disorder following other nontraumatic intracranial hemorrhage I69.228 Other speech and language deficits following other nontraumatic intracranial hemorrhage I69.231 Monoplegia of upper limb following other nontraumatic intracranial hemorrhage affecting right dominant side I69.232 Monoplegia of upper limb following other nontraumatic intracranial hemorrhage affecting left dominant side I69.233 Monoplegia of upper limb following other nontraumatic intracranial hemorrhage affecting right non-dominant side I69.234 Monoplegia of upper limb following other nontraumatic intracranial hemorrhage affecting left non-dominant side I69.239 Monoplegia of upper limb following other nontraumatic intracranial hemorrhage affecting unspecified side I69.241 Monoplegia of lower limb following other nontraumatic intracranial hemorrhage affecting right dominant side I69.242 Monoplegia of lower limb following other nontraumatic intracranial hemorrhage affecting left dominant side I69.243 Monoplegia of lower limb following other nontraumatic intracranial hemorrhage affecting right non-dominant side I69.244 Monoplegia of lower limb following other nontraumatic intracranial hemorrhage affecting left non-dominant side I69.249 Monoplegia of lower limb following other nontraumatic intracranial hemorrhage affecting unspecified side I69.251 Hemiplegia and hemiparesis following other nontraumatic intracranial hemorrhage affecting right dominant side I69.252 Hemiplegia and hemiparesis following other nontraumatic intracranial hemorrhage affecting left dominant side I69.253 Hemiplegia and hemiparesis following other nontraumatic intracranial hemorrhage affecting right non-dominant side I69.254 Hemiplegia and hemiparesis following other nontraumatic intracranial hemorrhage affecting left non-dominant side I69.259 Hemiplegia and hemiparesis following other nontraumatic intracranial hemorrhage affecting unspecified side I69.261 Other paralytic syndrome following other nontraumatic intracranial hemorrhage affecting right dominant side I69.262 Other paralytic syndrome following other nontraumatic intracranial hemorrhage affecting left dominant side I69.263 Other paralytic syndrome following other nontraumatic intracranial hemorrhage affecting right non-dominant side I69.264 Other paralytic syndrome following other nontraumatic intracranial hemorrhage affecting left non-dominant side I69.265 Other paralytic syndrome following other nontraumatic intracranial hemorrhage, bilateral I69.269 Other paralytic syndrome following other nontraumatic intracranial hemorrhage affecting unspecified side I69.290 Apraxia following other nontraumatic intracranial hemorrhage I69.291 Dysphagia following other nontraumatic intracranial hemorrhage I69.292 Facial weakness following other nontraumatic intracranial hemorrhage I69.293 Ataxia following other nontraumatic intracranial hemorrhage I69.298 Other sequelae of other nontraumatic intracranial hemorrhage I69.30 Unspecified sequelae of cerebral infarction I69.31 Cognitive deficits following cerebral infarction I69.310 Attention and concentration deficit following cerebral infarction I69.311 Memory deficit following cerebral infarction I69.312 Visuospatial deficit and spatial neglect following cerebral infarction I69.313 Psychomotor deficit following cerebral infarction I69.314 Frontal lobe and executive function deficit following cerebral infarction I69.315 Cognitive social or emotional deficit following cerebral infarction I69.318 Other symptoms and signs involving cognitive functions following cerebral infarction I69.319 Unspecified symptoms and signs involving cognitive functions following cerebral infarction I69.320 Aphasia following cerebral infarction I69.321 Dysphasia following cerebral infarction I69.322 Dysarthria following cerebral infarction I69.323 Fluency disorder following cerebral infarction I69.328 Other speech and language deficits following cerebral infarction I69.331 Monoplegia of upper limb following cerebral infarction affecting right dominant side I69.332 Monoplegia of upper limb following cerebral infarction affecting left dominant side I69.333 Monoplegia of upper limb following cerebral infarction affecting right non-dominant side I69.334 Monoplegia of upper limb following cerebral infarction affecting left non-dominant side I69.339 Monoplegia of upper limb following cerebral infarction affecting unspecified side I69.341 Monoplegia of lower limb following cerebral infarction affecting right dominant side I69.342 Monoplegia of lower limb following cerebral infarction affecting left dominant side I69.343 Monoplegia of lower limb following cerebral infarction affecting right non-dominant side I69.344 Monoplegia of lower limb following cerebral infarction affecting left non-dominant side I69.349 Monoplegia of lower limb following cerebral infarction affecting unspecified side I69.351 Hemiplegia and hemiparesis following cerebral infarction affecting right dominant side I69.352 Hemiplegia and hemiparesis following cerebral infarction affecting left dominant side I69.353 Hemiplegia and hemiparesis following cerebral infarction affecting right non-dominant side I69.354 Hemiplegia and hemiparesis following cerebral infarction affecting left non-dominant side I69.359 Hemiplegia and hemiparesis following cerebral infarction affecting unspecified side I69.361 Other paralytic syndrome following cerebral infarction affecting right dominant side I69.362 Other paralytic syndrome following cerebral infarction affecting left dominant side I69.363 Other paralytic syndrome following cerebral infarction affecting right non-dominant side I69.364 Other paralytic syndrome following cerebral infarction affecting left non-dominant side I69.365 Other paralytic syndrome following cerebral infarction, bilateral I69.369 Other paralytic syndrome following cerebral infarction affecting unspecified side I69.390 Apraxia following cerebral infarction I69.391 Dysphagia following cerebral infarction I69.392 Facial weakness following cerebral infarction I69.393 Ataxia following cerebral infarction I69.398 Other sequelae of cerebral infarction I69.80 Unspecified sequelae of other cerebrovascular disease I69.81 Cognitive deficits following other cerebrovascular disease I69.810 Attention and concentration deficit following other cerebrovascular disease I69.811 Memory deficit following other cerebrovascular disease I69.812 Visuospatial deficit and spatial neglect following other cerebrovascular disease I69.813 Psychomotor deficit following other cerebrovascular disease I69.814 Frontal lobe and executive function deficit following other cerebrovascular disease I69.815 Cognitive social or emotional deficit following other cerebrovascular disease I69.818 Other symptoms and signs involving cognitive functions following other cerebrovascular disease I69.819 Unspecified symptoms and signs involving cognitive functions following other cerebrovascular disease I69.820 Aphasia following other cerebrovascular disease I69.821 Dysphasia following other cerebrovascular disease I69.822 Dysarthria following other cerebrovascular disease I69.823 Fluency disorder following other cerebrovascular disease I69.828 Other speech and language deficits following other cerebrovascular disease I69.831 Monoplegia of upper limb following other cerebrovascular disease affecting right dominant side I69.832 Monoplegia of upper limb following other cerebrovascular disease affecting left dominant side I69.833 Monoplegia of upper limb following other cerebrovascular disease affecting right non-dominant side I69.834 Monoplegia of upper limb following other cerebrovascular disease affecting left non-dominant side I69.839 Monoplegia of upper limb following other cerebrovascular disease affecting unspecified side I69.841 Monoplegia of lower limb following other cerebrovascular disease affecting right dominant side I69.842 Monoplegia of lower limb following other cerebrovascular disease affecting left dominant side I69.843 Monoplegia of lower limb following other cerebrovascular disease affecting right non-dominant side I69.844 Monoplegia of lower limb following other cerebrovascular disease affecting left non-dominant side I69.849 Monoplegia of lower limb following other cerebrovascular disease affecting unspecified side I69.851 Hemiplegia and hemiparesis following other cerebrovascular disease affecting right dominant side I69.852 Hemiplegia and hemiparesis following other cerebrovascular disease affecting left dominant side I69.853 Hemiplegia and hemiparesis following other cerebrovascular disease affecting right non-dominant side I69.854 Hemiplegia and hemiparesis following other cerebrovascular disease affecting left non-dominant side I69.859 Hemiplegia and hemiparesis following other cerebrovascular disease affecting unspecified side I69.861 Other paralytic syndrome following other cerebrovascular disease affecting right dominant side I69.862 Other paralytic syndrome following other cerebrovascular disease affecting left dominant side I69.863 Other paralytic syndrome following other cerebrovascular disease affecting right non-dominant side I69.864 Other paralytic syndrome following other cerebrovascular disease affecting left non-dominant side I69.865 Other paralytic syndrome following other cerebrovascular disease, bilateral I69.869 Other paralytic syndrome following other cerebrovascular disease affecting unspecified side I69.890 Apraxia following other cerebrovascular disease I69.891 Dysphagia following other cerebrovascular disease I69.892 Facial weakness following other cerebrovascular disease I69.893 Ataxia following other cerebrovascular disease I69.898 Other sequelae of other cerebrovascular disease I69.90 Unspecified sequelae of unspecified cerebrovascular disease I69.91 Cognitive deficits following unspecified cerebrovascular disease I69.910 Attention and concentration deficit following unspecified cerebrovascular disease I69.911 Memory deficit following unspecified cerebrovascular disease I69.912 Visuospatial deficit and spatial neglect following unspecified cerebrovascular disease I69.913 Psychomotor deficit following unspecified cerebrovascular disease I69.914 Frontal lobe and executive function deficit following unspecified cerebrovascular disease I69.915 Cognitive social or emotional deficit following unspecified cerebrovascular disease I69.918 Other symptoms and signs involving cognitive functions following unspecified cerebrovascular disease I69.919 Unspecified symptoms and signs involving cognitive functions following unspecified cerebrovascular disease I69.920 Aphasia following unspecified cerebrovascular disease I69.921 Dysphasia following unspecified cerebrovascular disease I69.922 Dysarthria following unspecified cerebrovascular disease I69.923 Fluency disorder following unspecified cerebrovascular disease I69.928 Other speech and language deficits following unspecified cerebrovascular disease I69.931 Monoplegia of upper limb following unspecified cerebrovascular disease affecting right dominant side I69.932 Monoplegia of upper limb following unspecified cerebrovascular disease affecting left dominant side I69.933 Monoplegia of upper limb following unspecified cerebrovascular disease affecting right non-dominant side I69.934 Monoplegia of upper limb following unspecified cerebrovascular disease affecting left non-dominant side I69.939 Monoplegia of upper limb following unspecified cerebrovascular disease affecting unspecified side I69.941 Monoplegia of lower limb following unspecified cerebrovascular disease affecting right dominant side I69.942 Monoplegia of lower limb following unspecified cerebrovascular disease affecting left dominant side I69.943 Monoplegia of lower limb following unspecified cerebrovascular disease affecting right non-dominant side I69.944 Monoplegia of lower limb following unspecified cerebrovascular disease affecting left non-dominant side I69.949 Monoplegia of lower limb following unspecified cerebrovascular disease affecting unspecified side I69.951 Hemiplegia and hemiparesis following unspecified cerebrovascular disease affecting right dominant side I69.952 Hemiplegia and hemiparesis following unspecified cerebrovascular disease affecting left dominant side I69.953 Hemiplegia and hemiparesis following unspecified cerebrovascular disease affecting right non-dominant side I69.954 Hemiplegia and hemiparesis following unspecified cerebrovascular disease affecting left non-dominant side I69.959 Hemiplegia and hemiparesis following unspecified cerebrovascular disease affecting unspecified side I69.961 Other paralytic syndrome following unspecified cerebrovascular disease affecting right dominant side I69.962 Other paralytic syndrome following unspecified cerebrovascular disease affecting left dominant side I69.963 Other paralytic syndrome following unspecified cerebrovascular disease affecting right non-dominant side I69.964 Other paralytic syndrome following unspecified cerebrovascular disease affecting left non-dominant side I69.965 Other paralytic syndrome following unspecified cerebrovascular disease, bilateral I69.969 Other paralytic syndrome following unspecified cerebrovascular disease affecting unspecified side I69.990 Apraxia following unspecified cerebrovascular disease I69.991 Dysphagia following unspecified cerebrovascular disease I69.992 Facial weakness following unspecified cerebrovascular disease I69.993 Ataxia following unspecified cerebrovascular disease I69.998 Other sequelae following unspecified cerebrovascular disease I70.0 Atherosclerosis of aorta I70.1 Atherosclerosis of renal artery I70.201 Unspecified atherosclerosis of native arteries of extremities, right leg I70.202 Unspecified atherosclerosis of native arteries of extremities, left leg I70.203 Unspecified atherosclerosis of native arteries of extremities, bilateral legs I70.208 Unspecified atherosclerosis of native arteries of extremities, other extremity I70.209 Unspecified atherosclerosis of native arteries of extremities, unspecified extremity I70.211 Atherosclerosis of native arteries of extremities with intermittent claudication, right leg I70.212 Atherosclerosis of native arteries of extremities with intermittent claudication, left leg I70.213 Atherosclerosis of native arteries of extremities with intermittent claudication, bilateral legs I70.218 Atherosclerosis of native arteries of extremities with intermittent claudication, other extremity I70.219 Atherosclerosis of native arteries of extremities with intermittent claudication, unspecified extremity I70.221 Atherosclerosis of native arteries of extremities with rest pain, right leg I70.222 Atherosclerosis of native arteries of extremities with rest pain, left leg I70.223 Atherosclerosis of native arteries of extremities with rest pain, bilateral legs I70.228 Atherosclerosis of native arteries of extremities with rest pain, other extremity I70.229 Atherosclerosis of native arteries of extremities with rest pain, unspecified extremity I70.231 Atherosclerosis of native arteries of right leg with ulceration of thigh I70.232 Atherosclerosis of native arteries of right leg with ulceration of calf I70.233 Atherosclerosis of native arteries of right leg with ulceration of ankle I70.234 Atherosclerosis of native arteries of right leg with ulceration of heel and midfoot I70.235 Atherosclerosis of native arteries of right leg with ulceration of other part of foot I70.238 Atherosclerosis of native arteries of right leg with ulceration of other part of lower leg I70.239 Atherosclerosis of native arteries of right leg with ulceration of unspecified site I70.241 Atherosclerosis of native arteries of left leg with ulceration of thigh I70.242 Atherosclerosis of native arteries of left leg with ulceration of calf I70.243 Atherosclerosis of native arteries of left leg with ulceration of ankle I70.244 Atherosclerosis of native arteries of left leg with ulceration of heel and midfoot I70.245 Atherosclerosis of native arteries of left leg with ulceration of other part of foot I70.248 Atherosclerosis of native arteries of left leg with ulceration of other part of lower leg I70.249 Atherosclerosis of native arteries of left leg with ulceration of unspecified site I70.25 Atherosclerosis of native arteries of other extremities with ulceration I70.261 Atherosclerosis of native arteries of extremities with gangrene, right leg I70.262 Atherosclerosis of native arteries of extremities with gangrene, left leg I70.263 Atherosclerosis of native arteries of extremities with gangrene, bilateral legs I70.268 Atherosclerosis of native arteries of extremities with gangrene, other extremity I70.269 Atherosclerosis of native arteries of extremities with gangrene, unspecified extremity I70.291 Other atherosclerosis of native arteries of extremities, right leg I70.292 Other atherosclerosis of native arteries of extremities, left leg I70.293 Other atherosclerosis of native arteries of extremities, bilateral legs I70.298 Other atherosclerosis of native arteries of extremities, other extremity I70.299 Other atherosclerosis of native arteries of extremities, unspecified extremity I70.8 Atherosclerosis of other arteries I70.90 Unspecified atherosclerosis I70.91 Generalized atherosclerosis I70.92 Chronic total occlusion of artery of the extremities I71.00 Dissection of unspecified site of aorta I71.01 Dissection of thoracic aorta I71.02 Dissection of abdominal aorta I71.03 Dissection of thoracoabdominal aorta I71.1 Thoracic aortic aneurysm, ruptured I71.2 Thoracic aortic aneurysm, without rupture I71.3 Abdominal aortic aneurysm, ruptured I71.4 Abdominal aortic aneurysm, without rupture I71.5 Thoracoabdominal aortic aneurysm, ruptured I71.6 Thoracoabdominal aortic aneurysm, without rupture I71.8 Aortic aneurysm of unspecified site, ruptured I71.9 Aortic aneurysm of unspecified site, without rupture I72.0 Aneurysm of carotid artery I72.1 Aneurysm of artery of upper extremity I72.2 Aneurysm of renal artery I72.3 Aneurysm of iliac artery I72.4 Aneurysm of artery of lower extremity I72.5 Aneurysm of other precerebral arteries I72.6 Aneurysm of vertebral artery I72.8 Aneurysm of other specified arteries I72.9 Aneurysm of unspecified site I73.00 Raynaud's syndrome without gangrene I73.01 Raynaud's syndrome with gangrene I73.1 Thromboangiitis obliterans [Buerger's disease] I73.81 Erythromelalgia I73.89 Other specified peripheral vascular diseases I73.9 Peripheral vascular disease, unspecified I74.01 Saddle embolus of abdominal aorta I74.09 Other arterial embolism and thrombosis of abdominal aorta I74.10 Embolism and thrombosis of unspecified parts of aorta I74.11 Embolism and thrombosis of thoracic aorta I74.19 Embolism and thrombosis of other parts of aorta I74.2 Embolism and thrombosis of arteries of the upper extremities I74.3 Embolism and thrombosis of arteries of the lower extremities I74.4 Embolism and thrombosis of arteries of extremities, unspecified I74.5 Embolism and thrombosis of iliac artery I74.8 Embolism and thrombosis of other arteries I74.9 Embolism and thrombosis of unspecified artery I75.011 Atheroembolism of right upper extremity I75.012 Atheroembolism of left upper extremity I75.013 Atheroembolism of bilateral upper extremities I75.019 Atheroembolism of unspecified upper extremity I75.021 Atheroembolism of right lower extremity I75.022 Atheroembolism of left lower extremity I75.023 Atheroembolism of bilateral lower extremities I75.029 Atheroembolism of unspecified lower extremity I75.81 Atheroembolism of kidney I75.89 Atheroembolism of other site I77.0 Arteriovenous fistula, acquired I77.1 Stricture of artery I77.2 Rupture of artery I77.3 Arterial fibromuscular dysplasia I77.4 Celiac artery compression syndrome I77.5 Necrosis of artery I77.6 Arteritis, unspecified I77.70 Dissection of unspecified artery I77.71 Dissection of carotid artery I77.72 Dissection of iliac artery I77.73 Dissection of renal artery I77.74 Dissection of vertebral artery I77.75 Dissection of other precerebral arteries I77.76 Dissection of artery of upper extremity I77.77 Dissection of artery of lower extremity I77.79 Dissection of other specified artery I77.810 Thoracic aortic ectasia I77.811 Abdominal aortic ectasia I77.812 Thoracoabdominal aortic ectasia I77.819 Aortic ectasia, unspecified site I77.89 Other specified disorders of arteries and arterioles I77.9 Disorder of arteries and arterioles, unspecified I78.0 Hereditary hemorrhagic telangiectasia I78.1 Nevus, non-neoplastic I78.8 Other diseases of capillaries I78.9 Disease of capillaries, unspecified I79.0 Aneurysm of aorta in diseases classified elsewhere I79.1 Aortitis in diseases classified elsewhere I79.8 Other disorders of arteries, arterioles and capillaries in diseases classified elsewhere I80.00 Phlebitis and thrombophlebitis of superficial vessels of unspecified lower extremity I80.01 Phlebitis and thrombophlebitis of superficial vessels of right lower extremity I80.02 Phlebitis and thrombophlebitis of superficial vessels of left lower extremity I80.03 Phlebitis and thrombophlebitis of superficial vessels of lower extremities, bilateral I80.10 Phlebitis and thrombophlebitis of unspecified femoral vein I80.11 Phlebitis and thrombophlebitis of right femoral vein I80.12 Phlebitis and thrombophlebitis of left femoral vein I80.13 Phlebitis and thrombophlebitis of femoral vein, bilateral I80.201 Phlebitis and thrombophlebitis of unspecified deep vessels of right lower extremity I80.202 Phlebitis and thrombophlebitis of unspecified deep vessels of left lower extremity I80.203 Phlebitis and thrombophlebitis of unspecified deep vessels of lower extremities, bilateral I80.209 Phlebitis and thrombophlebitis of unspecified deep vessels of unspecified lower extremity I80.211 Phlebitis and thrombophlebitis of right iliac vein I80.212 Phlebitis and thrombophlebitis of left iliac vein I80.213 Phlebitis and thrombophlebitis of iliac vein, bilateral I80.219 Phlebitis and thrombophlebitis of unspecified iliac vein I80.221 Phlebitis and thrombophlebitis of right popliteal vein I80.222 Phlebitis and thrombophlebitis of left popliteal vein I80.223 Phlebitis and thrombophlebitis of popliteal vein, bilateral I80.229 Phlebitis and thrombophlebitis of unspecified popliteal vein I80.231 Phlebitis and thrombophlebitis of right tibial vein I80.232 Phlebitis and thrombophlebitis of left tibial vein I80.233 Phlebitis and thrombophlebitis of tibial vein, bilateral I80.239 Phlebitis and thrombophlebitis of unspecified tibial vein I80.291 Phlebitis and thrombophlebitis of other deep vessels of right lower extremity I80.292 Phlebitis and thrombophlebitis of other deep vessels of left lower extremity I80.293 Phlebitis and thrombophlebitis of other deep vessels of lower extremity, bilateral I80.299 Phlebitis and thrombophlebitis of other deep vessels of unspecified lower extremity I80.3 Phlebitis and thrombophlebitis of lower extremities, unspecified I80.8 Phlebitis and thrombophlebitis of other sites I80.9 Phlebitis and thrombophlebitis of unspecified site I81 Portal vein thrombosis I82.0 Budd-Chiari syndrome I82.1 Thrombophlebitis migrans I82.210 Acute embolism and thrombosis of superior vena cava I82.211 Chronic embolism and thrombosis of superior vena cava I82.220 Acute embolism and thrombosis of inferior vena cava I82.221 Chronic embolism and thrombosis of inferior vena cava I82.290 Acute embolism and thrombosis of other thoracic veins I82.291 Chronic embolism and thrombosis of other thoracic veins I82.3 Embolism and thrombosis of renal vein I82.401 Acute embolism and thrombosis of unspecified deep veins of right lower extremity I82.402 Acute embolism and thrombosis of unspecified deep veins of left lower extremity I82.403 Acute embolism and thrombosis of unspecified deep veins of lower extremity, bilateral I82.409 Acute embolism and thrombosis of unspecified deep veins of unspecified lower extremity I82.411 Acute embolism and thrombosis of right femoral vein I82.412 Acute embolism and thrombosis of left femoral vein I82.413 Acute embolism and thrombosis of femoral vein, bilateral I82.419 Acute embolism and thrombosis of unspecified femoral vein I82.421 Acute embolism and thrombosis of right iliac vein I82.422 Acute embolism and thrombosis of left iliac vein I82.423 Acute embolism and thrombosis of iliac vein, bilateral I82.429 Acute embolism and thrombosis of unspecified iliac vein I82.431 Acute embolism and thrombosis of right popliteal vein I82.432 Acute embolism and thrombosis of left popliteal vein I82.433 Acute embolism and thrombosis of popliteal vein, bilateral I82.439 Acute embolism and thrombosis of unspecified popliteal vein I82.441 Acute embolism and thrombosis of right tibial vein I82.442 Acute embolism and thrombosis of left tibial vein I82.443 Acute embolism and thrombosis of tibial vein, bilateral I82.449 Acute embolism and thrombosis of unspecified tibial vein I82.491 Acute embolism and thrombosis of other specified deep vein of right lower extremity I82.492 Acute embolism and thrombosis of other specified deep vein of left lower extremity I82.493 Acute embolism and thrombosis of other specified deep vein of lower extremity, bilateral I82.499 Acute embolism and thrombosis of other specified deep vein of unspecified lower extremity I82.4Y1 Acute embolism and thrombosis of unspecified deep veins of right proximal lower extremity I82.4Y2 Acute embolism and thrombosis of unspecified deep veins of left proximal lower extremity I82.4Y3 Acute embolism and thrombosis of unspecified deep veins of proximal lower extremity, bilateral I82.4Y9 Acute embolism and thrombosis of unspecified deep veins of unspecified proximal lower extremity I82.4Z1 Acute embolism and thrombosis of unspecified deep veins of right distal lower extremity I82.4Z2 Acute embolism and thrombosis of unspecified deep veins of left distal lower extremity I82.4Z3 Acute embolism and thrombosis of unspecified deep veins of distal lower extremity, bilateral I82.4Z9 Acute embolism and thrombosis of unspecified deep veins of unspecified distal lower extremity I82.501 Chronic embolism and thrombosis of unspecified deep veins of right lower extremity I82.502 Chronic embolism and thrombosis of unspecified deep veins of left lower extremity I82.503 Chronic embolism and thrombosis of unspecified deep veins of lower extremity, bilateral I82.509 Chronic embolism and thrombosis of unspecified deep veins of unspecified lower extremity I82.511 Chronic embolism and thrombosis of right femoral vein I82.512 Chronic embolism and thrombosis of left femoral vein I82.513 Chronic embolism and thrombosis of femoral vein, bilateral I82.519 Chronic embolism and thrombosis of unspecified femoral vein I82.521 Chronic embolism and thrombosis of right iliac vein I82.522 Chronic embolism and thrombosis of left iliac vein I82.523 Chronic embolism and thrombosis of iliac vein, bilateral I82.529 Chronic embolism and thrombosis of unspecified iliac vein I82.531 Chronic embolism and thrombosis of right popliteal vein I82.532 Chronic embolism and thrombosis of left popliteal vein I82.533 Chronic embolism and thrombosis of popliteal vein, bilateral I82.539 Chronic embolism and thrombosis of unspecified popliteal vein I82.541 Chronic embolism and thrombosis of right tibial vein I82.542 Chronic embolism and thrombosis of left tibial vein I82.543 Chronic embolism and thrombosis of tibial vein, bilateral I82.549 Chronic embolism and thrombosis of unspecified tibial vein I82.591 Chronic embolism and thrombosis of other specified deep vein of right lower extremity I82.592 Chronic embolism and thrombosis of other specified deep vein of left lower extremity I82.593 Chronic embolism and thrombosis of other specified deep vein of lower extremity, bilateral I82.599 Chronic embolism and thrombosis of other specified deep vein of unspecified lower extremity I82.5Y1 Chronic embolism and thrombosis of unspecified deep veins of right proximal lower extremity I82.5Y2 Chronic embolism and thrombosis of unspecified deep veins of left proximal lower extremity I82.5Y3 Chronic embolism and thrombosis of unspecified deep veins of proximal lower extremity, bilateral I82.5Y9 Chronic embolism and thrombosis of unspecified deep veins of unspecified proximal lower extremity I82.5Z1 Chronic embolism and thrombosis of unspecified deep veins of right distal lower extremity I82.5Z2 Chronic embolism and thrombosis of unspecified deep veins of left distal lower extremity I82.5Z3 Chronic embolism and thrombosis of unspecified deep veins of distal lower extremity, bilateral I82.5Z9 Chronic embolism and thrombosis of unspecified deep veins of unspecified distal lower extremity I82.601 Acute embolism and thrombosis of unspecified veins of right upper extremity I82.602 Acute embolism and thrombosis of unspecified veins of left upper extremity I82.603 Acute embolism and thrombosis of unspecified veins of upper extremity, bilateral I82.609 Acute embolism and thrombosis of unspecified veins of unspecified upper extremity I82.611 Acute embolism and thrombosis of superficial veins of right upper extremity I82.612 Acute embolism and thrombosis of superficial veins of left upper extremity I82.613 Acute embolism and thrombosis of superficial veins of upper extremity, bilateral I82.619 Acute embolism and thrombosis of superficial veins of unspecified upper extremity I82.621 Acute embolism and thrombosis of deep veins of right upper extremity I82.622 Acute embolism and thrombosis of deep veins of left upper extremity I82.623 Acute embolism and thrombosis of deep veins of upper extremity, bilateral I82.629 Acute embolism and thrombosis of deep veins of unspecified upper extremity I82.701 Chronic embolism and thrombosis of unspecified veins of right upper extremity I82.702 Chronic embolism and thrombosis of unspecified veins of left upper extremity I82.703 Chronic embolism and thrombosis of unspecified veins of upper extremity, bilateral I82.709 Chronic embolism and thrombosis of unspecified veins of unspecified upper extremity I82.711 Chronic embolism and thrombosis of superficial veins of right upper extremity I82.712 Chronic embolism and thrombosis of superficial veins of left upper extremity I82.713 Chronic embolism and thrombosis of superficial veins of upper extremity, bilateral I82.719 Chronic embolism and thrombosis of superficial veins of unspecified upper extremity I82.721 Chronic embolism and thrombosis of deep veins of right upper extremity I82.722 Chronic embolism and thrombosis of deep veins of left upper extremity I82.723 Chronic embolism and thrombosis of deep veins of upper extremity, bilateral I82.729 Chronic embolism and thrombosis of deep veins of unspecified upper extremity I82.811 Embolism and thrombosis of superficial veins of right lower extremity I82.812 Embolism and thrombosis of superficial veins of left lower extremity I82.813 Embolism and thrombosis of superficial veins of lower extremities, bilateral I82.819 Embolism and thrombosis of superficial veins of unspecified lower extremity I82.890 Acute embolism and thrombosis of other specified veins I82.891 Chronic embolism and thrombosis of other specified veins I82.90 Acute embolism and thrombosis of unspecified vein I82.91 Chronic embolism and thrombosis of unspecified vein I82.A11 Acute embolism and thrombosis of right axillary vein I82.A12 Acute embolism and thrombosis of left axillary vein I82.A13 Acute embolism and thrombosis of axillary vein, bilateral I82.A19 Acute embolism and thrombosis of unspecified axillary vein I82.A21 Chronic embolism and thrombosis of right axillary vein I82.A22 Chronic embolism and thrombosis of left axillary vein I82.A23 Chronic embolism and thrombosis of axillary vein, bilateral I82.A29 Chronic embolism and thrombosis of unspecified axillary vein I82.B11 Acute embolism and thrombosis of right subclavian vein I82.B12 Acute embolism and thrombosis of left subclavian vein I82.B13 Acute embolism and thrombosis of subclavian vein, bilateral I82.B19 Acute embolism and thrombosis of unspecified subclavian vein I82.B21 Chronic embolism and thrombosis of right subclavian vein I82.B22 Chronic embolism and thrombosis of left subclavian vein I82.B23 Chronic embolism and thrombosis of subclavian vein, bilateral I82.B29 Chronic embolism and thrombosis of unspecified subclavian vein I82.C11 Acute embolism and thrombosis of right internal jugular vein I82.C12 Acute embolism and thrombosis of left internal jugular vein I82.C13 Acute embolism and thrombosis of internal jugular vein, bilateral I82.C19 Acute embolism and thrombosis of unspecified internal jugular vein I82.C21 Chronic embolism and thrombosis of right internal jugular vein I82.C22 Chronic embolism and thrombosis of left internal jugular vein I82.C23 Chronic embolism and thrombosis of internal jugular vein, bilateral I82.C29 Chronic embolism and thrombosis of unspecified internal jugular vein I83.001 Varicose veins of unspecified lower extremity with ulcer of thigh I83.002 Varicose veins of unspecified lower extremity with ulcer of calf I83.003 Varicose veins of unspecified lower extremity with ulcer of ankle I83.004 Varicose veins of unspecified lower extremity with ulcer of heel and midfoot I83.005 Varicose veins of unspecified lower extremity with ulcer other part of foot I83.008 Varicose veins of unspecified lower extremity with ulcer other part of lower leg I83.009 Varicose veins of unspecified lower extremity with ulcer of unspecified site I83.011 Varicose veins of right lower extremity with ulcer of thigh I83.012 Varicose veins of right lower extremity with ulcer of calf I83.013 Varicose veins of right lower extremity with ulcer of ankle I83.014 Varicose veins of right lower extremity with ulcer of heel and midfoot I83.015 Varicose veins of right lower extremity with ulcer other part of foot I83.018 Varicose veins of right lower extremity with ulcer other part of lower leg I83.019 Varicose veins of right lower extremity with ulcer of unspecified site I83.021 Varicose veins of left lower extremity with ulcer of thigh I83.022 Varicose veins of left lower extremity with ulcer of calf I83.023 Varicose veins of left lower extremity with ulcer of ankle I83.024 Varicose veins of left lower extremity with ulcer of heel and midfoot I83.025 Varicose veins of left lower extremity with ulcer other part of foot I83.028 Varicose veins of left lower extremity with ulcer other part of lower leg I83.029 Varicose veins of left lower extremity with ulcer of unspecified site I83.10 Varicose veins of unspecified lower extremity with inflammation I83.11 Varicose veins of right lower extremity with inflammation I83.12 Varicose veins of left lower extremity with inflammation I83.201 Varicose veins of unspecified lower extremity with both ulcer of thigh and inflammation I83.202 Varicose veins of unspecified lower extremity with both ulcer of calf and inflammation I83.203 Varicose veins of unspecified lower extremity with both ulcer of ankle and inflammation I83.204 Varicose veins of unspecified lower extremity with both ulcer of heel and midfoot and inflammation I83.205 Varicose veins of unspecified lower extremity with both ulcer other part of foot and inflammation I83.208 Varicose veins of unspecified lower extremity with both ulcer of other part of lower extremity and inflammation I83.209 Varicose veins of unspecified lower extremity with both ulcer of unspecified site and inflammation I83.211 Varicose veins of right lower extremity with both ulcer of thigh and inflammation I83.212 Varicose veins of right lower extremity with both ulcer of calf and inflammation I83.213 Varicose veins of right lower extremity with both ulcer of ankle and inflammation I83.214 Varicose veins of right lower extremity with both ulcer of heel and midfoot and inflammation I83.215 Varicose veins of right lower extremity with both ulcer other part of foot and inflammation I83.218 Varicose veins of right lower extremity with both ulcer of other part of lower extremity and inflammation I83.219 Varicose veins of right lower extremity with both ulcer of unspecified site and inflammation I83.221 Varicose veins of left lower extremity with both ulcer of thigh and inflammation I83.222 Varicose veins of left lower extremity with both ulcer of calf and inflammation I83.223 Varicose veins of left lower extremity with both ulcer of ankle and inflammation I83.224 Varicose veins of left lower extremity with both ulcer of heel and midfoot and inflammation I83.225 Varicose veins of left lower extremity with both ulcer other part of foot and inflammation I83.228 Varicose veins of left lower extremity with both ulcer of other part of lower extremity and inflammation I83.229 Varicose veins of left lower extremity with both ulcer of unspecified site and inflammation I83.811 Varicose veins of right lower extremity with pain I83.812 Varicose veins of left lower extremity with pain I83.813 Varicose veins of bilateral lower extremities with pain I83.819 Varicose veins of unspecified lower extremity with pain I83.891 Varicose veins of right lower extremity with other complications I83.892 Varicose veins of left lower extremity with other complications I83.893 Varicose veins of bilateral lower extremities with other complications I83.899 Varicose veins of unspecified lower extremity with other complications I83.90 Asymptomatic varicose veins of unspecified lower extremity I83.91 Asymptomatic varicose veins of right lower extremity I83.92 Asymptomatic varicose veins of left lower extremity I83.93 Asymptomatic varicose veins of bilateral lower extremities I86.0 Sublingual varices I86.1 Scrotal varices I86.2 Pelvic varices I86.3 Vulval varices I86.4 Gastric varices I86.8 Varicose veins of other specified sites I87.001 Postthrombotic syndrome without complications of right lower extremity I87.002 Postthrombotic syndrome without complications of left lower extremity I87.003 Postthrombotic syndrome without complications of bilateral lower extremity I87.009 Postthrombotic syndrome without complications of unspecified extremity I87.011 Postthrombotic syndrome with ulcer of right lower extremity I87.012 Postthrombotic syndrome with ulcer of left lower extremity I87.013 Postthrombotic syndrome with ulcer of bilateral lower extremity I87.019 Postthrombotic syndrome with ulcer of unspecified lower extremity I87.021 Postthrombotic syndrome with inflammation of right lower extremity I87.022 Postthrombotic syndrome with inflammation of left lower extremity I87.023 Postthrombotic syndrome with inflammation of bilateral lower extremity I87.029 Postthrombotic syndrome with inflammation of unspecified lower extremity I87.031 Postthrombotic syndrome with ulcer and inflammation of right lower extremity I87.032 Postthrombotic syndrome with ulcer and inflammation of left lower extremity I87.033 Postthrombotic syndrome with ulcer and inflammation of bilateral lower extremity I87.039 Postthrombotic syndrome with ulcer and inflammation of unspecified lower extremity I87.091 Postthrombotic syndrome with other complications of right lower extremity I87.092 Postthrombotic syndrome with other complications of left lower extremity I87.093 Postthrombotic syndrome with other complications of bilateral lower extremity I87.099 Postthrombotic syndrome with other complications of unspecified lower extremity I87.1 Compression of vein I87.2 Venous insufficiency (chronic) (peripheral) I87.301 Chronic venous hypertension (idiopathic) without complications of right lower extremity I87.302 Chronic venous hypertension (idiopathic) without complications of left lower extremity I87.303 Chronic venous hypertension (idiopathic) without complications of bilateral lower extremity I87.309 Chronic venous hypertension (idiopathic) without complications of unspecified lower extremity I87.311 Chronic venous hypertension (idiopathic) with ulcer of right lower extremity I87.312 Chronic venous hypertension (idiopathic) with ulcer of left lower extremity I87.313 Chronic venous hypertension (idiopathic) with ulcer of bilateral lower extremity I87.319 Chronic venous hypertension (idiopathic) with ulcer of unspecified lower extremity I87.321 Chronic venous hypertension (idiopathic) with inflammation of right lower extremity I87.322 Chronic venous hypertension (idiopathic) with inflammation of left lower extremity I87.323 Chronic venous hypertension (idiopathic) with inflammation of bilateral lower extremity I87.329 Chronic venous hypertension (idiopathic) with inflammation of unspecified lower extremity I87.331 Chronic venous hypertension (idiopathic) with ulcer and inflammation of right lower extremity I87.332 Chronic venous hypertension (idiopathic) with ulcer and inflammation of left lower extremity I87.333 Chronic venous hypertension (idiopathic) with ulcer and inflammation of bilateral lower extremity I87.339 Chronic venous hypertension (idiopathic) with ulcer and inflammation of unspecified lower extremity I87.391 Chronic venous hypertension (idiopathic) with other complications of right lower extremity I87.392 Chronic venous hypertension (idiopathic) with other complications of left lower extremity I87.393 Chronic venous hypertension (idiopathic) with other complications of bilateral lower extremity I87.399 Chronic venous hypertension (idiopathic) with other complications of unspecified lower extremity I87.8 Other specified disorders of veins I87.9 Disorder of vein, unspecified I88.0 Nonspecific mesenteric lymphadenitis I88.1 Chronic lymphadenitis, except mesenteric I88.8 Other nonspecific lymphadenitis I88.9 Nonspecific lymphadenitis, unspecified I89.0 Lymphedema, not elsewhere classified I89.1 Lymphangitis I89.8 Other specified noninfective disorders of lymphatic vessels and lymph nodes I89.9 Noninfective disorder of lymphatic vessels and lymph nodes, unspecified I95.0 Idiopathic hypotension I95.1 Orthostatic hypotension I95.89 Other hypotension I95.9 Hypotension, unspecified I96 Gangrene, not elsewhere classified I99.8 Other disorder of circulatory system I99.9 Unspecified disorder of circulatory system J10.82 Influenza due to other identified influenza virus with myocarditis J30.5 Allergic rhinitis due to food J85.0 Gangrene and necrosis of lung J91.0 Malignant pleural effusion K31.7 Polyp of stomach and duodenum K52.2 Allergic and dietetic gastroenteritis and colitis K52.21 Food protein-induced enterocolitis syndrome K52.22 Food protein-induced enteropathy K52.29 Other allergic and dietetic gastroenteritis and colitis K55.0 Acute vascular disorders of intestine K55.011 Focal (segmental) acute (reversible) ischemia of small intestine K55.012 Diffuse acute (reversible) ischemia of small intestine K55.019 Acute (reversible) ischemia of small intestine, extent unspecified K55.021 Focal (segmental) acute infarction of small intestine K55.022 Diffuse acute infarction of small intestine K55.029 Acute infarction of small intestine, extent unspecified K55.031 Focal (segmental) acute (reversible) ischemia of large intestine K55.032 Diffuse acute (reversible) ischemia of large intestine K55.039 Acute (reversible) ischemia of large intestine, extent unspecified K55.041 Focal (segmental) acute infarction of large intestine K55.042 Diffuse acute infarction of large intestine K55.049 Acute infarction of large intestine, extent unspecified K55.051 Focal (segmental) acute (reversible) ischemia of intestine, part unspecified K55.052 Diffuse acute (reversible) ischemia of intestine, part unspecified K55.059 Acute (reversible) ischemia of intestine, part and extent unspecified K55.061 Focal (segmental) acute infarction of intestine, part unspecified K55.062 Diffuse acute infarction of intestine, part unspecified K55.069 Acute infarction of intestine, part and extent unspecified K55.1 Chronic vascular disorders of intestine K55.8 Other vascular disorders of intestine K55.9 Vascular disorder of intestine, unspecified K63.5 Polyp of colon K64.0 First degree hemorrhoids K64.1 Second degree hemorrhoids K64.2 Third degree hemorrhoids K64.3 Fourth degree hemorrhoids K64.4 Residual hemorrhoidal skin tags K64.5 Perianal venous thrombosis K64.8 Other hemorrhoids K64.9 Unspecified hemorrhoids K90.41 Non-celiac gluten sensitivity L04.0 Acute lymphadenitis of face, head and neck L04.1 Acute lymphadenitis of trunk L04.2 Acute lymphadenitis of upper limb L04.3 Acute lymphadenitis of lower limb L04.8 Acute lymphadenitis of other sites L04.9 Acute lymphadenitis, unspecified L20.0 Besnier's prurigo L20.81 Atopic neurodermatitis L20.82 Flexural eczema L20.83 Infantile (acute) (chronic) eczema L20.84 Intrinsic (allergic) eczema L20.89 Other atopic dermatitis L20.9 Atopic dermatitis, unspecified L22 Diaper dermatitis L23.0 Allergic contact dermatitis due to metals L23.1 Allergic contact dermatitis due to adhesives L23.2 Allergic contact dermatitis due to cosmetics L23.3 Allergic contact dermatitis due to drugs in contact with skin L23.4 Allergic contact dermatitis due to dyes L23.5 Allergic contact dermatitis due to other chemical products L23.6 Allergic contact dermatitis due to food in contact with the skin L23.7 Allergic contact dermatitis due to plants, except food L23.81 Allergic contact dermatitis due to animal (cat) (dog) dander L23.89 Allergic contact dermatitis due to other agents L23.9 Allergic contact dermatitis, unspecified cause L24.0 Irritant contact dermatitis due to detergents L24.1 Irritant contact dermatitis due to oils and greases L24.2 Irritant contact dermatitis due to solvents L24.3 Irritant contact dermatitis due to cosmetics L24.4 Irritant contact dermatitis due to drugs in contact with skin L24.5 Irritant contact dermatitis due to other chemical products L24.6 Irritant contact dermatitis due to food in contact with skin L24.7 Irritant contact dermatitis due to plants, except food L24.81 Irritant contact dermatitis due to metals L24.89 Irritant contact dermatitis due to other agents L24.9 Irritant contact dermatitis, unspecified cause L25.0 Unspecified contact dermatitis due to cosmetics L25.1 Unspecified contact dermatitis due to drugs in contact with skin L25.2 Unspecified contact dermatitis due to dyes L25.3 Unspecified contact dermatitis due to other chemical products L25.4 Unspecified contact dermatitis due to food in contact with skin L25.5 Unspecified contact dermatitis due to plants, except food L25.8 Unspecified contact dermatitis due to other agents L25.9 Unspecified contact dermatitis, unspecified cause L27.0 Generalized skin eruption due to drugs and medicaments taken internally L27.1 Localized skin eruption due to drugs and medicaments taken internally L27.2 Dermatitis due to ingested food L27.8 Dermatitis due to other substances taken internally L27.9 Dermatitis due to unspecified substance taken internally L30.0 Nummular dermatitis L30.2 Cutaneous autosensitization L30.8 Other specified dermatitis L30.9 Dermatitis, unspecified L50.0 Allergic urticaria L50.1 Idiopathic urticaria L50.2 Urticaria due to cold and heat L50.3 Dermatographic urticaria L50.4 Vibratory urticaria L50.5 Cholinergic urticaria L50.6 Contact urticaria L50.8 Other urticaria L50.9 Urticaria, unspecified L56.0 Drug phototoxic response L56.1 Drug photoallergic response L56.2 Photocontact dermatitis [berloque dermatitis] L56.3 Solar urticaria L56.4 Polymorphous light eruption L56.8 Other specified acute skin changes due to ultraviolet radiation L56.9 Acute skin change due to ultraviolet radiation, unspecified L57.8 Other skin changes due to chronic exposure to nonionizing radiation L57.9 Skin changes due to chronic exposure to nonionizing radiation, unspecified L58.0 Acute radiodermatitis L58.1 Chronic radiodermatitis L58.9 Radiodermatitis, unspecified L59.0 Erythema ab igne [dermatitis ab igne] L59.8 Other specified disorders of the skin and subcutaneous tissue related to radiation L59.9 Disorder of the skin and subcutaneous tissue related to radiation, unspecified M31.0 Hypersensitivity angiitis N26.2 Page kidney R00.0 Tachycardia, unspecified R00.1 Bradycardia, unspecified R00.2 Palpitations R00.8 Other abnormalities of heart beat R00.9 Unspecified abnormalities of heart beat R01.0 Benign and innocent cardiac murmurs R01.1 Cardiac murmur, unspecified R01.2 Other cardiac sounds R03.0 Elevated blood-pressure reading, without diagnosis of hypertension R03.1 Nonspecific low blood-pressure reading R07.2 Precordial pain R07.82 Intercostal pain R07.89 Other chest pain R07.9 Chest pain, unspecified R09.89 Other specified symptoms and signs involving the circulatory and respiratory systems R10.0 Acute abdomen R10.10 Upper abdominal pain, unspecified R10.11 Right upper quadrant pain R10.12 Left upper quadrant pain R10.13 Epigastric pain R10.2 Pelvic and perineal pain R10.30 Lower abdominal pain, unspecified R10.31 Right lower quadrant pain R10.32 Left lower quadrant pain R10.33 Periumbilical pain R10.811 Right upper quadrant abdominal tenderness R10.812 Left upper quadrant abdominal tenderness R10.813 Right lower quadrant abdominal tenderness R10.814 Left lower quadrant abdominal tenderness R10.815 Periumbilic abdominal tenderness R10.816 Epigastric abdominal tenderness R10.817 Generalized abdominal tenderness R10.819 Abdominal tenderness, unspecified site R10.821 Right upper quadrant rebound abdominal tenderness R10.822 Left upper quadrant rebound abdominal tenderness R10.823 Right lower quadrant rebound abdominal tenderness R10.824 Left lower quadrant rebound abdominal tenderness R10.825 Periumbilic rebound abdominal tenderness R10.826 Epigastric rebound abdominal tenderness R10.827 Generalized rebound abdominal tenderness R10.829 Rebound abdominal tenderness, unspecified site R10.84 Generalized abdominal pain R10.9 Unspecified abdominal pain R11.0 Nausea R11.10 Vomiting, unspecified R11.11 Vomiting without nausea R11.12 Projectile vomiting R11.14 Bilious vomiting R11.2 Nausea with vomiting, unspecified R18.0 Malignant ascites R29.700 NIHSS score 0 R29.701 NIHSS score 1 R29.702 NIHSS score 2 R29.703 NIHSS score 3 R29.704 NIHSS score 4 R29.705 NIHSS score 5 R29.706 NIHSS score 6 R29.707 NIHSS score 7 R29.708 NIHSS score 8 R29.709 NIHSS score 9 R29.710 NIHSS score 10 R29.711 NIHSS score 11 R29.712 NIHSS score 12 R29.713 NIHSS score 13 R29.714 NIHSS score 14 R29.715 NIHSS score 15 R29.716 NIHSS score 16 R29.717 NIHSS score 17 R29.718 NIHSS score 18 R29.719 NIHSS score 19 R29.720 NIHSS score 20 R29.721 NIHSS score 21 R29.722 NIHSS score 22 R29.723 NIHSS score 23 R29.724 NIHSS score 24 R29.725 NIHSS score 25 R29.726 NIHSS score 26 R29.727 NIHSS score 27 R29.728 NIHSS score 28 R29.729 NIHSS score 29 R29.730 NIHSS score 30 R29.731 NIHSS score 31 R29.732 NIHSS score 32 R29.733 NIHSS score 33 R29.734 NIHSS score 34 R29.735 NIHSS score 35 R29.736 NIHSS score 36 R29.737 NIHSS score 37 R29.738 NIHSS score 38 R29.739 NIHSS score 39 R29.740 NIHSS score 40 R29.741 NIHSS score 41 R29.742 NIHSS score 42 R50.81 Fever presenting with conditions classified elsewhere R50.9 Fever, unspecified R53.0 Neoplastic (malignant) related fatigue R53.1 Weakness R53.81 Other malaise R53.82 Chronic fatigue, unspecified R53.83 Other fatigue R55 Syncope and collapse R57.0 Cardiogenic shock R57.1 Hypovolemic shock R57.8 Other shock R57.9 Shock, unspecified R58 Hemorrhage, not elsewhere classified R59.0 Localized enlarged lymph nodes R59.1 Generalized enlarged lymph nodes R59.9 Enlarged lymph nodes, unspecified R65.21 Severe sepsis with septic shock R78.71 Abnormal lead level in blood R78.79 Finding of abnormal level of heavy metals in blood R78.89 Finding of other specified substances, not normally found in blood R78.9 Finding of unspecified substance, not normally found in blood R79.0 Abnormal level of blood mineral R79.1 Abnormal coagulation profile R79.81 Abnormal blood-gas level R79.82 Elevated C-reactive protein (CRP) R79.89 Other specified abnormal findings of blood chemistry R79.9 Abnormal finding of blood chemistry, unspecified R83.0 Abnormal level of enzymes in cerebrospinal fluid R83.1 Abnormal level of hormones in cerebrospinal fluid R83.2 Abnormal level of other drugs, medicaments and biological substances in cerebrospinal fluid R83.3 Abnormal level of substances chiefly nonmedicinal as to source in cerebrospinal fluid R83.4 Abnormal immunological findings in cerebrospinal fluid R83.5 Abnormal microbiological findings in cerebrospinal fluid R83.6 Abnormal cytological findings in cerebrospinal fluid R83.8 Other abnormal findings in cerebrospinal fluid R83.9 Unspecified abnormal finding in cerebrospinal fluid R84.0 Abnormal level of enzymes in specimens from respiratory organs and thorax R84.1 Abnormal level of hormones in specimens from respiratory organs and thorax R84.2 Abnormal level of other drugs, medicaments and biological substances in specimens from respiratory organs and thorax R84.3 Abnormal level of substances chiefly nonmedicinal as to source in specimens from respiratory organs and thorax R84.4 Abnormal immunological findings in specimens from respiratory organs and thorax R84.5 Abnormal microbiological findings in specimens from respiratory organs and thorax R84.6 Abnormal cytological findings in specimens from respiratory organs and thorax R84.7 Abnormal histological findings in specimens from respiratory organs and thorax R84.8 Other abnormal findings in specimens from respiratory organs and thorax R84.9 Unspecified abnormal finding in specimens from respiratory organs and thorax R85.0 Abnormal level of enzymes in specimens from digestive organs and abdominal cavity R85.1 Abnormal level of hormones in specimens from digestive organs and abdominal cavity R85.2 Abnormal level of other drugs, medicaments and biological substances in specimens from digestive organs and abdominal cavity R85.3 Abnormal level of substances chiefly nonmedicinal as to source in specimens from digestive organs and abdominal cavity R85.4 Abnormal immunological findings in specimens from digestive organs and abdominal cavity R85.5 Abnormal microbiological findings in specimens from digestive organs and abdominal cavity R85.610 Atypical squamous cells of undetermined significance on cytologic smear of anus (ASC-US) R85.611 Atypical squamous cells cannot exclude high grade squamous intraepithelial lesion on cytologic smear of anus (ASC-H) R85.612 Low grade squamous intraepithelial lesion on cytologic smear of anus (LGSIL) R85.613 High grade squamous intraepithelial lesion on cytologic smear of anus (HGSIL) R85.614 Cytologic evidence of malignancy on smear of anus R85.615 Unsatisfactory cytologic smear of anus R85.616 Satisfactory anal smear but lacking transformation zone R85.618 Other abnormal cytological findings on specimens from anus R85.619 Unspecified abnormal cytological findings in specimens from anus R85.69 Abnormal cytological findings in specimens from other digestive organs and abdominal cavity R85.7 Abnormal histological findings in specimens from digestive organs and abdominal cavity R85.89 Other abnormal findings in specimens from digestive organs and abdominal cavity R85.9 Unspecified abnormal finding in specimens from digestive organs and abdominal cavity R86.0 Abnormal level of enzymes in specimens from male genital organs R86.1 Abnormal level of hormones in specimens from male genital organs R86.2 Abnormal level of other drugs, medicaments and biological substances in specimens from male genital organs R86.3 Abnormal level of substances chiefly nonmedicinal as to source in specimens from male genital organs R86.4 Abnormal immunological findings in specimens from male genital organs R86.5 Abnormal microbiological findings in specimens from male genital organs R86.6 Abnormal cytological findings in specimens from male genital organs R86.7 Abnormal histological findings in specimens from male genital organs R86.8 Other abnormal findings in specimens from male genital organs R86.9 Unspecified abnormal finding in specimens from male genital organs R87.0 Abnormal level of enzymes in specimens from female genital organs R87.1 Abnormal level of hormones in specimens from female genital organs R87.2 Abnormal level of other drugs, medicaments and biological substances in specimens from female genital organs R87.3 Abnormal level of substances chiefly nonmedicinal as to source in specimens from female genital organs R87.4 Abnormal immunological findings in specimens from female genital organs R87.5 Abnormal microbiological findings in specimens from female genital organs R87.610 Atypical squamous cells of undetermined significance on cytologic smear of cervix (ASC-US) R87.611 Atypical squamous cells cannot exclude high grade squamous intraepithelial lesion on cytologic smear of cervix (ASC-H) R87.612 Low grade squamous intraepithelial lesion on cytologic smear of cervix (LGSIL) R87.613 High grade squamous intraepithelial lesion on cytologic smear of cervix (HGSIL) R87.614 Cytologic evidence of malignancy on smear of cervix R87.615 Unsatisfactory cytologic smear of cervix R87.616 Satisfactory cervical smear but lacking transformation zone R87.618 Other abnormal cytological findings on specimens from cervix uteri R87.619 Unspecified abnormal cytological findings in specimens from cervix uteri R87.620 Atypical squamous cells of undetermined significance on cytologic smear of vagina (ASC-US) R87.621 Atypical squamous cells cannot exclude high grade squamous intraepithelial lesion on cytologic smear of vagina (ASC-H) R87.622 Low grade squamous intraepithelial lesion on cytologic smear of vagina (LGSIL) R87.623 High grade squamous intraepithelial lesion on cytologic smear of vagina (HGSIL) R87.624 Cytologic evidence of malignancy on smear of vagina R87.625 Unsatisfactory cytologic smear of vagina R87.628 Other abnormal cytological findings on specimens from vagina R87.629 Unspecified abnormal cytological findings in specimens from vagina R87.69 Abnormal cytological findings in specimens from other female genital organs R87.7 Abnormal histological findings in specimens from female genital organs R87.89 Other abnormal findings in specimens from female genital organs R87.9 Unspecified abnormal finding in specimens from female genital organs R88.8 Abnormal findings in other body fluids and substances R89.0 Abnormal level of enzymes in specimens from other organs, systems and tissues R89.1 Abnormal level of hormones in specimens from other organs, systems and tissues R89.2 Abnormal level of other drugs, medicaments and biological substances in specimens from other organs, systems and tissues R89.3 Abnormal level of substances chiefly nonmedicinal as to source in specimens from other organs, systems and tissues R89.4 Abnormal immunological findings in specimens from other organs, systems and tissues R89.5 Abnormal microbiological findings in specimens from other organs, systems and tissues R89.6 Abnormal cytological findings in specimens from other organs, systems and tissues R89.7 Abnormal histological findings in specimens from other organs, systems and tissues R89.8 Other abnormal findings in specimens from other organs, systems and tissues R89.9 Unspecified abnormal finding in specimens from other organs, systems and tissues R90.81 Abnormal echoencephalogram R90.89 Other abnormal findings on diagnostic imaging of central nervous system R92.2 Inconclusive mammogram R92.8 Other abnormal and inconclusive findings on diagnostic imaging of breast R93.0 Abnormal findings on diagnostic imaging of skull and head, not elsewhere classified R93.1 Abnormal findings on diagnostic imaging of heart and coronary circulation R93.2 Abnormal findings on diagnostic imaging of liver and biliary tract R93.3 Abnormal findings on diagnostic imaging of other parts of digestive tract R93.4 Abnormal findings on diagnostic imaging of urinary organs R93.41 Abnormal radiologic findings on diagnostic imaging of renal pelvis, ureter, or bladder R93.421 Abnormal radiologic findings on diagnostic imaging of right kidney R93.422 Abnormal radiologic findings on diagnostic imaging of left kidney R93.429 Abnormal radiologic findings on diagnostic imaging of unspecified kidney R93.49 Abnormal radiologic findings on diagnostic imaging of other urinary organs R93.5 Abnormal findings on diagnostic imaging of other abdominal regions, including retroperitoneum R93.6 Abnormal findings on diagnostic imaging of limbs R93.7 Abnormal findings on diagnostic imaging of other parts of musculoskeletal system R93.8 Abnormal findings on diagnostic imaging of other specified body structures R93.811 Abnormal radiologic findings on diagnostic imaging of right testicle R93.812 Abnormal radiologic findings on diagnostic imaging of left testicle R93.813 Abnormal radiologic findings on diagnostic imaging of testicles, bilateral R93.819 Abnormal radiologic findings on diagnostic imaging of unspecified testicle R93.89 Abnormal findings on diagnostic imaging of other specified body structures R93.9 Diagnostic imaging inconclusive due to excess body fat of patient R94.01 Abnormal electroencephalogram [EEG] R94.02 Abnormal brain scan R94.09 Abnormal results of other function studies of central nervous system R94.110 Abnormal electro-oculogram [EOG] R94.111 Abnormal electroretinogram [ERG] R94.112 Abnormal visually evoked potential [VEP] R94.113 Abnormal oculomotor study R94.118 Abnormal results of other function studies of eye R94.120 Abnormal auditory function study R94.121 Abnormal vestibular function study R94.128 Abnormal results of other function studies of ear and other special senses R94.130 Abnormal response to nerve stimulation, unspecified R94.131 Abnormal electromyogram [EMG] R94.138 Abnormal results of other function studies of peripheral nervous system R94.2 Abnormal results of pulmonary function studies R94.30 Abnormal result of cardiovascular function study, unspecified R94.31 Abnormal electrocardiogram [ECG] [EKG] R94.39 Abnormal result of other cardiovascular function study R94.4 Abnormal results of kidney function studies R94.5 Abnormal results of liver function studies R94.6 Abnormal results of thyroid function studies R94.7 Abnormal results of other endocrine function studies R94.8 Abnormal results of function studies of other organs and systems R97.0 Elevated carcinoembryonic antigen [CEA] R97.1 Elevated cancer antigen 125 [CA 125] R97.2 Elevated prostate specific antigen [PSA] R97.20 Elevated prostate specific antigen [PSA] R97.21 Rising PSA following treatment for malignant neoplasm of prostate R97.8 Other abnormal tumor markers T78.00XA Anaphylactic reaction due to unspecified food, initial encounter T78.00XD Anaphylactic reaction due to unspecified food, subsequent encounter T78.00XS Anaphylactic reaction due to unspecified food, sequela T78.01XA Anaphylactic reaction due to peanuts, initial encounter T78.01XD Anaphylactic reaction due to peanuts, subsequent encounter T78.01XS Anaphylactic reaction due to peanuts, sequela T78.02XA Anaphylactic reaction due to shellfish (crustaceans), initial encounter T78.02XD Anaphylactic reaction due to shellfish (crustaceans), subsequent encounter T78.02XS Anaphylactic reaction due to shellfish (crustaceans), sequela T78.03XA Anaphylactic reaction due to other fish, initial encounter T78.03XD Anaphylactic reaction due to other fish, subsequent encounter T78.03XS Anaphylactic reaction due to other fish, sequela T78.04XA Anaphylactic reaction due to fruits and vegetables, initial encounter T78.04XD Anaphylactic reaction due to fruits and vegetables, subsequent encounter T78.04XS Anaphylactic reaction due to fruits and vegetables, sequela T78.05XA Anaphylactic reaction due to tree nuts and seeds, initial encounter T78.05XD Anaphylactic reaction due to tree nuts and seeds, subsequent encounter T78.05XS Anaphylactic reaction due to tree nuts and seeds, sequela T78.06XA Anaphylactic reaction due to food additives, initial encounter T78.06XD Anaphylactic reaction due to food additives, subsequent encounter T78.06XS Anaphylactic reaction due to food additives, sequela T78.07XA Anaphylactic reaction due to milk and dairy products, initial encounter T78.07XD Anaphylactic reaction due to milk and dairy products, subsequent encounter T78.07XS Anaphylactic reaction due to milk and dairy products, sequela T78.08XA Anaphylactic reaction due to eggs, initial encounter T78.08XD Anaphylactic reaction due to eggs, subsequent encounter T78.08XS Anaphylactic reaction due to eggs, sequela T78.09XA Anaphylactic reaction due to other food products, initial encounter T78.09XD Anaphylactic reaction due to other food products, subsequent encounter T78.09XS Anaphylactic reaction due to other food products, sequela T78.1XXA Other adverse food reactions, not elsewhere classified, initial encounter T78.1XXD Other adverse food reactions, not elsewhere classified, subsequent encounter T78.1XXS Other adverse food reactions, not elsewhere classified, sequela T78.2XXA Anaphylactic shock, unspecified, initial encounter T78.40XA Allergy, unspecified, initial encounter T78.49XA Other allergy, initial encounter Z00.00 Encounter for general adult medical examination without abnormal findings Z00.01 Encounter for general adult medical examination with abnormal findings Z00.110 Health examination for newborn under 8 days old Z00.111 Health examination for newborn 8 to 28 days old Z00.121 Encounter for routine child health examination with abnormal findings Z00.129 Encounter for routine child health examination without abnormal findings Z00.2 Encounter for examination for period of rapid growth in childhood Z00.3 Encounter for examination for adolescent development state Z00.5 Encounter for examination of potential donor of organ and tissue Z00.6 Encounter for examination for normal comparison and control in clinical research program Z00.70 Encounter for examination for period of delayed growth in childhood without abnormal findings Z00.71 Encounter for examination for period of delayed growth in childhood with abnormal findings Z00.8 Encounter for other general examination Z01.00 Encounter for examination of eyes and vision without abnormal findings Z01.01 Encounter for examination of eyes and vision with abnormal findings Z01.10 Encounter for examination of ears and hearing without abnormal findings Z01.110 Encounter for hearing examination following failed hearing screening Z01.118 Encounter for examination of ears and hearing with other abnormal findings Z01.12 Encounter for hearing conservation and treatment Z01.20 Encounter for dental examination and cleaning without abnormal findings Z01.21 Encounter for dental examination and cleaning with abnormal findings Z01.30 Encounter for examination of blood pressure without abnormal findings Z01.31 Encounter for examination of blood pressure with abnormal findings Z01.411 Encounter for gynecological examination (general) (routine) with abnormal findings Z01.419 Encounter for gynecological examination (general) (routine) without abnormal findings Z01.42 Encounter for cervical smear to confirm findings of recent normal smear following initial abnormal smear Z01.810 Encounter for preprocedural cardiovascular examination Z01.811 Encounter for preprocedural respiratory examination Z01.812 Encounter for preprocedural laboratory examination Z01.818 Encounter for other preprocedural examination Z01.82 Encounter for allergy testing Z01.83 Encounter for blood typing Z01.84 Encounter for antibody response examination Z01.89 Encounter for other specified special examinations Z02.0 Encounter for examination for admission to educational institution Z02.1 Encounter for pre-employment examination Z02.2 Encounter for examination for admission to residential institution Z02.3 Encounter for examination for recruitment to armed forces Z02.4 Encounter for examination for driving license Z02.5 Encounter for examination for participation in sport Z02.6 Encounter for examination for insurance purposes Z02.71 Encounter for disability determination Z02.79 Encounter for issue of other medical certificate Z02.81 Encounter for paternity testing Z02.82 Encounter for adoption services Z02.83 Encounter for blood-alcohol and blood-drug test Z02.89 Encounter for other administrative examinations Z02.9 Encounter for administrative examinations, unspecified Z03.6 Encounter for observation for suspected toxic effect from ingested substance ruled out Z03.71 Encounter for suspected problem with amniotic cavity and membrane ruled out Z03.72 Encounter for suspected placental problem ruled out Z03.73 Encounter for suspected fetal anomaly ruled out Z03.74 Encounter for suspected problem with fetal growth ruled out Z03.75 Encounter for suspected cervical shortening ruled out Z03.79 Encounter for other suspected maternal and fetal conditions ruled out Z03.89 Encounter for observation for other suspected diseases and conditions ruled out Z04.41 Encounter for examination and observation following alleged adult rape Z04.42 Encounter for examination and observation following alleged child rape Z04.71 Encounter for examination and observation following alleged adult physical abuse Z04.72 Encounter for examination and observation following alleged child physical abuse Z04.8 Encounter for examination and observation for other specified reasons Z04.81 Encounter for examination and observation of victim following forced sexual exploitation Z04.82 Encounter for examination and observation of victim following forced labor exploitation Z04.89 Encounter for examination and observation for other specified reasons Z04.9 Encounter for examination and observation for unspecified reason Z05.0 Observation and evaluation of newborn for suspected cardiac condition ruled out Z05.2 Observation and evaluation of newborn for suspected neurological condition ruled out Z05.3 Observation and evaluation of newborn for suspected respiratory condition ruled out Z05.41 Observation and evaluation of newborn for suspected genetic condition ruled out Z05.42 Observation and evaluation of newborn for suspected metabolic condition ruled out Z05.43 Observation and evaluation of newborn for suspected immunologic condition ruled out Z05.5 Observation and evaluation of newborn for suspected gastrointestinal condition ruled out Z05.6 Observation and evaluation of newborn for suspected genitourinary condition ruled out Z05.71 Observation and evaluation of newborn for suspected skin and subcutaneous tissue condition ruled out Z05.72 Observation and evaluation of newborn for suspected musculoskeletal condition ruled out Z05.73 Observation and evaluation of newborn for suspected connective tissue condition ruled out Z05.8 Observation and evaluation of newborn for other specified suspected condition ruled out Z05.9 Observation and evaluation of newborn for unspecified suspected condition ruled out Z08 Encounter for follow-up examination after completed treatment for malignant neoplasm Z09 Encounter for follow-up examination after completed treatment for conditions other than malignant neoplasm Z12.0 Encounter for screening for malignant neoplasm of stomach Z12.10 Encounter for screening for malignant neoplasm of intestinal tract, unspecified Z12.11 Encounter for screening for malignant neoplasm of colon Z12.12 Encounter for screening for malignant neoplasm of rectum Z12.13 Encounter for screening for malignant neoplasm of small intestine Z12.2 Encounter for screening for malignant neoplasm of respiratory organs Z12.31 Encounter for screening mammogram for malignant neoplasm of breast Z12.39 Encounter for other screening for malignant neoplasm of breast Z12.4 Encounter for screening for malignant neoplasm of cervix Z12.5 Encounter for screening for malignant neoplasm of prostate Z12.6 Encounter for screening for malignant neoplasm of bladder Z12.71 Encounter for screening for malignant neoplasm of testis Z12.72 Encounter for screening for malignant neoplasm of vagina Z12.73 Encounter for screening for malignant neoplasm of ovary Z12.79 Encounter for screening for malignant neoplasm of other genitourinary organs Z12.81 Encounter for screening for malignant neoplasm of oral cavity Z12.82 Encounter for screening for malignant neoplasm of nervous system Z12.83 Encounter for screening for malignant neoplasm of skin Z12.89 Encounter for screening for malignant neoplasm of other sites Z12.9 Encounter for screening for malignant neoplasm, site unspecified Z13.0 Encounter for screening for diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism Z13.1 Encounter for screening for diabetes mellitus Z13.21 Encounter for screening for nutritional disorder Z13.220 Encounter for screening for lipoid disorders Z13.228 Encounter for screening for other metabolic disorders Z13.29 Encounter for screening for other suspected endocrine disorder Z13.5 Encounter for screening for eye and ear disorders Z13.6 Encounter for screening for cardiovascular disorders Z13.71 Encounter for nonprocreative screening for genetic disease carrier status Z13.79 Encounter for other screening for genetic and chromosomal anomalies Z13.810 Encounter for screening for upper gastrointestinal disorder Z13.811 Encounter for screening for lower gastrointestinal disorder Z13.818 Encounter for screening for other digestive system disorders Z13.820 Encounter for screening for osteoporosis Z13.828 Encounter for screening for other musculoskeletal disorder Z13.83 Encounter for screening for respiratory disorder NEC Z13.84 Encounter for screening for dental disorders Z13.850 Encounter for screening for traumatic brain injury Z13.858 Encounter for screening for other nervous system disorders Z13.88 Encounter for screening for disorder due to exposure to contaminants Z13.89 Encounter for screening for other disorder Z13.9 Encounter for screening, unspecified Z32.00 Encounter for pregnancy test, result unknown Z32.02 Encounter for pregnancy test, result negative Z32.2 Encounter for childbirth instruction Z32.3 Encounter for childcare instruction Z36 Encounter for antenatal screening of mother Z36.0 Encounter for antenatal screening for chromosomal anomalies Z36.1 Encounter for antenatal screening for raised alphafetoprotein level Z36.2 Encounter for other antenatal screening follow-up Z36.3 Encounter for antenatal screening for malformations Z36.4 Encounter for antenatal screening for fetal growth retardation Z36.5 Encounter for antenatal screening for isoimmunization Z36.81 Encounter for antenatal screening for hydrops fetalis Z36.82 Encounter for antenatal screening for nuchal translucency Z36.83 Encounter for fetal screening for congenital cardiac abnormalities Z36.84 Encounter for antenatal screening for fetal lung maturity Z36.85 Encounter for antenatal screening for Streptococcus B Z36.86 Encounter for antenatal screening for cervical length Z36.87 Encounter for antenatal screening for uncertain dates Z36.88 Encounter for antenatal screening for fetal macrosomia Z36.89 Encounter for other specified antenatal screening Z36.8A Encounter for antenatal screening for other genetic defects Z36.9 Encounter for antenatal screening, unspecified Z42.1 Encounter for breast reconstruction following mastectomy Z42.8 Encounter for other plastic and reconstructive surgery following medical procedure or healed injury Z43.8 Encounter for attention to other artificial openings Z43.9 Encounter for attention to unspecified artificial opening Z44.001 Encounter for fitting and adjustment of unspecified right artificial arm Z44.002 Encounter for fitting and adjustment of unspecified left artificial arm Z44.009 Encounter for fitting and adjustment of unspecified artificial arm, unspecified arm Z44.011 Encounter for fitting and adjustment of complete right artificial arm Z44.012 Encounter for fitting and adjustment of complete left artificial arm Z44.019 Encounter for fitting and adjustment of complete artificial arm, unspecified arm Z44.021 Encounter for fitting and adjustment of partial artificial right arm Z44.022 Encounter for fitting and adjustment of partial artificial left arm Z44.029 Encounter for fitting and adjustment of partial artificial arm, unspecified arm Z44.101 Encounter for fitting and adjustment of unspecified right artificial leg Z44.102 Encounter for fitting and adjustment of unspecified left artificial leg Z44.109 Encounter for fitting and adjustment of unspecified artificial leg, unspecified leg Z44.111 Encounter for fitting and adjustment of complete right artificial leg Z44.112 Encounter for fitting and adjustment of complete left artificial leg Z44.119 Encounter for fitting and adjustment of complete artificial leg, unspecified leg Z44.121 Encounter for fitting and adjustment of partial artificial right leg Z44.122 Encounter for fitting and adjustment of partial artificial left leg Z44.129 Encounter for fitting and adjustment of partial artificial leg, unspecified leg Z44.30 Encounter for fitting and adjustment of external breast prosthesis, unspecified breast Z44.31 Encounter for fitting and adjustment of external right breast prosthesis Z44.32 Encounter for fitting and adjustment of external left breast prosthesis Z44.8 Encounter for fitting and adjustment of other external prosthetic devices Z44.9 Encounter for fitting and adjustment of unspecified external prosthetic device Z45.010 Encounter for checking and testing of cardiac pacemaker pulse generator [battery] Z45.018 Encounter for adjustment and management of other part of cardiac pacemaker Z45.02 Encounter for adjustment and management of automatic implantable cardiac defibrillator Z45.09 Encounter for adjustment and management of other cardiac device Z45.1 Encounter for adjustment and management of infusion pump Z45.2 Encounter for adjustment and management of vascular access device Z45.31 Encounter for adjustment and management of implanted visual substitution device Z45.320 Encounter for adjustment and management of bone conduction device Z45.321 Encounter for adjustment and management of cochlear device Z45.328 Encounter for adjustment and management of other implanted hearing device Z45.41 Encounter for adjustment and management of cerebrospinal fluid drainage device Z45.42 Encounter for adjustment and management of neurostimulator Z45.49 Encounter for adjustment and management of other implanted nervous system device Z45.811 Encounter for adjustment or removal of right breast implant Z45.812 Encounter for adjustment or removal of left breast implant Z45.819 Encounter for adjustment or removal of unspecified breast implant Z45.82 Encounter for adjustment or removal of myringotomy device (stent) (tube) Z45.89 Encounter for adjustment and management of other implanted devices Z45.9 Encounter for adjustment and management of unspecified implanted device Z46.82 Encounter for fitting and adjustment of non-vascular catheter Z46.89 Encounter for fitting and adjustment of other specified devices Z46.9 Encounter for fitting and adjustment of unspecified device Z47.1 Aftercare following joint replacement surgery Z47.2 Encounter for removal of internal fixation device Z47.31 Aftercare following explantation of shoulder joint prosthesis Z47.32 Aftercare following explantation of hip joint prosthesis Z47.33 Aftercare following explantation of knee joint prosthesis Z47.81 Encounter for orthopedic aftercare following surgical amputation Z47.82 Encounter for orthopedic aftercare following scoliosis surgery Z47.89 Encounter for other orthopedic aftercare Z48.00 Encounter for change or removal of nonsurgical wound dressing Z48.01 Encounter for change or removal of surgical wound dressing Z48.02 Encounter for removal of sutures Z48.03 Encounter for change or removal of drains Z48.1 Encounter for planned postprocedural wound closure Z48.21 Encounter for aftercare following heart transplant Z48.22 Encounter for aftercare following kidney transplant Z48.23 Encounter for aftercare following liver transplant Z48.24 Encounter for aftercare following lung transplant Z48.280 Encounter for aftercare following heart-lung transplant Z48.288 Encounter for aftercare following multiple organ transplant Z48.290 Encounter for aftercare following bone marrow transplant Z48.298 Encounter for aftercare following other organ transplant Z48.3 Aftercare following surgery for neoplasm Z48.810 Encounter for surgical aftercare following surgery on the sense organs Z48.811 Encounter for surgical aftercare following surgery on the nervous system Z48.812 Encounter for surgical aftercare following surgery on the circulatory system Z48.813 Encounter for surgical aftercare following surgery on the respiratory system Z48.814 Encounter for surgical aftercare following surgery on the teeth or oral cavity Z48.815 Encounter for surgical aftercare following surgery on the digestive system Z48.816 Encounter for surgical aftercare following surgery on the genitourinary system Z48.817 Encounter for surgical aftercare following surgery on the skin and subcutaneous tissue Z48.89 Encounter for other specified surgical aftercare Z51.0 Encounter for antineoplastic radiation therapy Z51.11 Encounter for antineoplastic chemotherapy Z51.12 Encounter for antineoplastic immunotherapy Z51.5 Encounter for palliative care Z51.6 Encounter for desensitization to allergens Z51.81 Encounter for therapeutic drug level monitoring Z51.89 Encounter for other specified aftercare Z55.0 Illiteracy and low-level literacy Z55.1 Schooling unavailable and unattainable Z55.2 Failed school examinations Z55.3 Underachievement in school Z55.4 Educational maladjustment and discord with teachers and classmates Z55.8 Other problems related to education and literacy Z55.9 Problems related to education and literacy, unspecified Z56.0 Unemployment, unspecified Z56.1 Change of job Z56.2 Threat of job loss Z56.3 Stressful work schedule Z56.4 Discord with boss and workmates Z56.5 Uncongenial work environment Z56.6 Other physical and mental strain related to work Z56.81 Sexual harassment on the job Z56.82 Military deployment status Z56.89 Other problems related to employment Z56.9 Unspecified problems related to employment Z57.0 Occupational exposure to noise Z57.1 Occupational exposure to radiation Z57.2 Occupational exposure to dust Z57.31 Occupational exposure to environmental tobacco smoke Z57.39 Occupational exposure to other air contaminants Z57.4 Occupational exposure to toxic agents in agriculture Z57.5 Occupational exposure to toxic agents in other industries Z57.6 Occupational exposure to extreme temperature Z57.7 Occupational exposure to vibration Z57.8 Occupational exposure to other risk factors Z57.9 Occupational exposure to unspecified risk factor Z59.0 Homelessness Z59.1 Inadequate housing Z59.2 Discord with neighbors, lodgers and landlord Z59.3 Problems related to living in residential institution Z59.4 Lack of adequate food and safe drinking water Z59.5 Extreme poverty Z59.6 Low income Z59.7 Insufficient social insurance and welfare support Z59.8 Other problems related to housing and economic circumstances Z59.9 Problem related to housing and economic circumstances, unspecified Z60.0 Problems of adjustment to life-cycle transitions Z60.2 Problems related to living alone Z60.3 Acculturation difficulty Z60.4 Social exclusion and rejection Z60.5 Target of (perceived) adverse discrimination and persecution Z60.8 Other problems related to social environment Z60.9 Problem related to social environment, unspecified Z62.0 Inadequate parental supervision and control Z62.1 Parental overprotection Z62.21 Child in welfare custody Z62.22 Institutional upbringing Z62.29 Other upbringing away from parents Z62.3 Hostility towards and scapegoating of child Z62.6 Inappropriate (excessive) parental pressure Z62.810 Personal history of physical and sexual abuse in childhood Z62.811 Personal history of psychological abuse in childhood Z62.812 Personal history of neglect in childhood Z62.813 Personal history of forced labor or sexual exploitation in childhood Z62.819 Personal history of unspecified abuse in childhood Z62.820 Parent-biological child conflict Z62.821 Parent-adopted child conflict Z62.822 Parent-foster child conflict Z62.890 Parent-child estrangement NEC Z62.891 Sibling rivalry Z62.898 Other specified problems related to upbringing Z62.9 Problem related to upbringing, unspecified Z63.0 Problems in relationship with spouse or partner Z63.1 Problems in relationship with in-laws Z63.31 Absence of family member due to military deployment Z63.32 Other absence of family member Z63.4 Disappearance and death of family member Z63.5 Disruption of family by separation and divorce Z63.6 Dependent relative needing care at home Z63.71 Stress on family due to return of family member from military deployment Z63.72 Alcoholism and drug addiction in family Z63.79 Other stressful life events affecting family and household Z63.8 Other specified problems related to primary support group Z63.9 Problem related to primary support group, unspecified Z64.0 Problems related to unwanted pregnancy Z64.1 Problems related to multiparity Z64.4 Discord with counselors Z65.0 Conviction in civil and criminal proceedings without imprisonment Z65.1 Imprisonment and other incarceration Z65.2 Problems related to release from prison Z65.3 Problems related to other legal circumstances Z65.4 Victim of crime and terrorism Z65.5 Exposure to disaster, war and other hostilities Z65.8 Other specified problems related to psychosocial circumstances Z65.9 Problem related to unspecified psychosocial circumstances Z69.010 Encounter for mental health services for victim of parental child abuse Z69.011 Encounter for mental health services for perpetrator of parental child abuse Z69.020 Encounter for mental health services for victim of non-parental child abuse Z69.021 Encounter for mental health services for perpetrator of non-parental child abuse Z69.11 Encounter for mental health services for victim of spousal or partner abuse Z69.12 Encounter for mental health services for perpetrator of spousal or partner abuse Z69.81 Encounter for mental health services for victim of other abuse Z69.82 Encounter for mental health services for perpetrator of other abuse Z70.0 Counseling related to sexual attitude Z70.1 Counseling related to patient's sexual behavior and orientation Z70.2 Counseling related to sexual behavior and orientation of third party Z70.3 Counseling related to combined concerns regarding sexual attitude, behavior and orientation Z70.8 Other sex counseling Z70.9 Sex counseling, unspecified Z71.0 Person encountering health services to consult on behalf of another person Z71.1 Person with feared health complaint in whom no diagnosis is made Z71.2 Person consulting for explanation of examination or test findings Z71.3 Dietary counseling and surveillance Z71.41 Alcohol abuse counseling and surveillance of alcoholic Z71.42 Counseling for family member of alcoholic Z71.51 Drug abuse counseling and surveillance of drug abuser Z71.52 Counseling for family member of drug abuser Z71.6 Tobacco abuse counseling Z71.7 Human immunodeficiency virus [HIV] counseling Z71.81 Spiritual or religious counseling Z71.82 Exercise counseling Z71.83 Encounter for nonprocreative genetic counseling Z71.89 Other specified counseling Z71.9 Counseling, unspecified Z73.0 Burn-out Z73.1 Type A behavior pattern Z73.2 Lack of relaxation and leisure Z73.3 Stress, not elsewhere classified Z73.4 Inadequate social skills, not elsewhere classified Z73.5 Social role conflict, not elsewhere classified Z73.6 Limitation of activities due to disability Z73.810 Behavioral insomnia of childhood, sleep-onset association type Z73.811 Behavioral insomnia of childhood, limit setting type Z73.812 Behavioral insomnia of childhood, combined type Z73.819 Behavioral insomnia of childhood, unspecified type Z73.89 Other problems related to life management difficulty Z73.9 Problem related to life management difficulty, unspecified Z74.01 Bed confinement status Z74.09 Other reduced mobility Z74.1 Need for assistance with personal care Z74.2 Need for assistance at home and no other household member able to render care Z74.3 Need for continuous supervision Z74.8 Other problems related to care provider dependency Z74.9 Problem related to care provider dependency, unspecified Z75.0 Medical services not available in home Z75.1 Person awaiting admission to adequate facility elsewhere Z75.2 Other waiting period for investigation and treatment Z75.3 Unavailability and inaccessibility of health-care facilities Z75.4 Unavailability and inaccessibility of other helping agencies Z75.5 Holiday relief care Z75.8 Other problems related to medical facilities and other health care Z75.9 Unspecified problem related to medical facilities and other health care Z76.0 Encounter for issue of repeat prescription Z76.1 Encounter for health supervision and care of foundling Z76.2 Encounter for health supervision and care of other healthy infant and child Z76.3 Healthy person accompanying sick person Z76.4 Other boarder to healthcare facility Z76.5 Malingerer [conscious simulation] Z76.81 Expectant parent(s) prebirth pediatrician visit Z76.89 Persons encountering health services in other specified circumstances Z79.01 Long term (current) use of anticoagulants Z79.02 Long term (current) use of antithrombotics/antiplatelets Z79.1 Long term (current) use of non-steroidal anti-inflammatories (NSAID) Z79.2 Long term (current) use of antibiotics Z79.3 Long term (current) use of hormonal contraceptives Z79.4 Long term (current) use of insulin Z79.51 Long term (current) use of inhaled steroids Z79.52 Long term (current) use of systemic steroids Z79.810 Long term (current) use of selective estrogen receptor modulators (SERMs) Z79.811 Long term (current) use of aromatase inhibitors Z79.818 Long term (current) use of other agents affecting estrogen receptors and estrogen levels Z79.82 Long term (current) use of aspirin Z79.83 Long term (current) use of bisphosphonates Z79.84 Long term (current) use of oral hypoglycemic drugs Z79.891 Long term (current) use of opiate analgesic Z79.899 Other long term (current) drug therapy Z85.00 Personal history of malignant neoplasm of unspecified digestive organ Z85.01 Personal history of malignant neoplasm of esophagus Z85.020 Personal history of malignant carcinoid tumor of stomach Z85.028 Personal history of other malignant neoplasm of stomach Z85.030 Personal history of malignant carcinoid tumor of large intestine Z85.038 Personal history of other malignant neoplasm of large intestine Z85.040 Personal history of malignant carcinoid tumor of rectum Z85.048 Personal history of other malignant neoplasm of rectum, rectosigmoid junction, and anus Z85.05 Personal history of malignant neoplasm of liver Z85.060 Personal history of malignant carcinoid tumor of small intestine Z85.068 Personal history of other malignant neoplasm of small intestine Z85.07 Personal history of malignant neoplasm of pancreas Z85.09 Personal history of malignant neoplasm of other digestive organs Z85.110 Personal history of malignant carcinoid tumor of bronchus and lung Z85.118 Personal history of other malignant neoplasm of bronchus and lung Z85.12 Personal history of malignant neoplasm of trachea Z85.20 Personal history of malignant neoplasm of unspecified respiratory organ Z85.21 Personal history of malignant neoplasm of larynx Z85.22 Personal history of malignant neoplasm of nasal cavities, middle ear, and accessory sinuses Z85.230 Personal history of malignant carcinoid tumor of thymus Z85.238 Personal history of other malignant neoplasm of thymus Z85.29 Personal history of malignant neoplasm of other respiratory and intrathoracic organs Z85.3 Personal history of malignant neoplasm of breast Z85.40 Personal history of malignant neoplasm of unspecified female genital organ Z85.41 Personal history of malignant neoplasm of cervix uteri Z85.42 Personal history of malignant neoplasm of other parts of uterus Z85.43 Personal history of malignant neoplasm of ovary Z85.44 Personal history of malignant neoplasm of other female genital organs Z85.45 Personal history of malignant neoplasm of unspecified male genital organ Z85.46 Personal history of malignant neoplasm of prostate Z85.47 Personal history of malignant neoplasm of testis Z85.48 Personal history of malignant neoplasm of epididymis Z85.49 Personal history of malignant neoplasm of other male genital organs Z85.50 Personal history of malignant neoplasm of unspecified urinary tract organ Z85.51 Personal history of malignant neoplasm of bladder Z85.520 Personal history of malignant carcinoid tumor of kidney Z85.528 Personal history of other malignant neoplasm of kidney Z85.53 Personal history of malignant neoplasm of renal pelvis Z85.54 Personal history of malignant neoplasm of ureter Z85.59 Personal history of malignant neoplasm of other urinary tract organ Z85.6 Personal history of leukemia Z85.71 Personal history of Hodgkin lymphoma Z85.72 Personal history of non-Hodgkin lymphomas Z85.79 Personal history of other malignant neoplasms of lymphoid, hematopoietic and related tissues Z85.810 Personal history of malignant neoplasm of tongue Z85.818 Personal history of malignant neoplasm of other sites of lip, oral cavity, and pharynx Z85.819 Personal history of malignant neoplasm of unspecified site of lip, oral cavity, and pharynx Z85.820 Personal history of malignant melanoma of skin Z85.821 Personal history of Merkel cell carcinoma Z85.828 Personal history of other malignant neoplasm of skin Z85.830 Personal history of malignant neoplasm of bone Z85.831 Personal history of malignant neoplasm of soft tissue Z85.840 Personal history of malignant neoplasm of eye Z85.841 Personal history of malignant neoplasm of brain Z85.848 Personal history of malignant neoplasm of other parts of nervous tissue Z85.850 Personal history of malignant neoplasm of thyroid Z85.858 Personal history of malignant neoplasm of other endocrine glands Z85.89 Personal history of malignant neoplasm of other organs and systems Z85.9 Personal history of malignant neoplasm, unspecified Z86.000 Personal history of in-situ neoplasm of breast Z86.001 Personal history of in-situ neoplasm of cervix uteri Z86.008 Personal history of in-situ neoplasm of other site Z86.010 Personal history of colonic polyps Z86.012 Personal history of benign carcinoid tumor Z86.018 Personal history of other benign neoplasm Z86.03 Personal history of neoplasm of uncertain behavior Z86.711 Personal history of pulmonary embolism Z86.718 Personal history of other venous thrombosis and embolism Z86.72 Personal history of thrombophlebitis Z86.73 Personal history of transient ischemic attack (TIA), and cerebral infarction without residual deficits Z86.74 Personal history of sudden cardiac arrest Z86.79 Personal history of other diseases of the circulatory system Z87.892 Personal history of anaphylaxis Z88.0 Allergy status to penicillin Z88.1 Allergy status to other antibiotic agents status Z88.2 Allergy status to sulfonamides status Z88.3 Allergy status to other anti-infective agents status Z88.4 Allergy status to anesthetic agent status Z88.5 Allergy status to narcotic agent status Z88.6 Allergy status to analgesic agent status Z88.7 Allergy status to serum and vaccine status Z88.8 Allergy status to other drugs, medicaments and biological substances status Z88.9 Allergy status to unspecified drugs, medicaments and biological substances status Z91.010 Allergy to peanuts Z91.011 Allergy to milk products Z91.012 Allergy to eggs Z91.013 Allergy to seafood Z91.018 Allergy to other foods Z91.02 Food additives allergy status Z91.030 Bee allergy status Z91.038 Other insect allergy status Z91.040 Latex allergy status Z91.041 Radiographic dye allergy status Z91.048 Other nonmedicinal substance allergy status Z91.09 Other allergy status, other than to drugs and biological substances Z94.1 Heart transplant status Z94.3 Heart and lungs transplant status Z95.0 Presence of cardiac pacemaker Z95.1 Presence of aortocoronary bypass graft Z95.2 Presence of prosthetic heart valve Z95.3 Presence of xenogenic heart valve Z95.4 Presence of other heart-valve replacement Z95.5 Presence of coronary angioplasty implant and graft Z95.810 Presence of automatic (implantable) cardiac defibrillator Z95.811 Presence of heart assist device Z95.812 Presence of fully implantable artificial heart Z95.818 Presence of other cardiac implants and grafts Z95.820 Peripheral vascular angioplasty status with implants and grafts Z95.828 Presence of other vascular implants and grafts Z95.9 Presence of cardiac and vascular implant and graft, unspecified Z98.61 Coronary angioplasty status Z98.62 Peripheral vascular angioplasty status
{
"compose" : {
"exclude" : [ ],
"include" : [ {
"system" : "http://hl7.org/fhir/sid/icd-10-cm",
"extension" : [ {
"extension" : [ {
"valueString" : "concept",
"url" : "path"
}, {
"url" : "count",
"valueInteger" : 3730
} ],
"url" : "http://health-samurai.io/extensions/excised-data"
} ]
} ]
},
"date" : "2019-11-11T01:00:18-05:00",
"meta" : {
"versionId" : "5",
"lastUpdated" : "2019-11-11T01:00:18.000-05:00"
},
"publisher" : "Change Healthcare Steward",
"name" : "Complications of Care",
"resourceType" : "ValueSet",
"extension" : [ {
"url" : "http://health-samurai.io/extensions/source",
"valueCode" : "db"
} ],
"status" : "active",
"id" : "e8bbc478-9936-4f7b-903d-34afea8c7013",
"url" : "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1182.311",
"version" : "20191111",
"text" : {
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">\n <h2>Complications of Care</h2>\n <p>This value set includes codes from the following code systems:</p>\n <ul>\n <li>Include these codes as defined in \n <code>http://hl7.org/fhir/sid/icd-10-cm</code>\n <table class=\"none\">\n <tr>\n <td>\n <b>Code</b>\n </td>\n <td>\n <b>Display</b>\n </td>\n </tr>\n <tr>\n <td>A36.81</td>\n <td>Diphtheritic cardiomyopathy</td>\n <td/>\n </tr>\n <tr>\n <td>A38.1</td>\n <td>Scarlet fever with myocarditis</td>\n <td/>\n </tr>\n <tr>\n <td>A39.50</td>\n <td>Meningococcal carditis, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>A39.51</td>\n <td>Meningococcal endocarditis</td>\n <td/>\n </tr>\n <tr>\n <td>A39.52</td>\n <td>Meningococcal myocarditis</td>\n <td/>\n </tr>\n <tr>\n <td>A39.53</td>\n <td>Meningococcal pericarditis</td>\n <td/>\n </tr>\n <tr>\n <td>B26.82</td>\n <td>Mumps myocarditis</td>\n <td/>\n </tr>\n <tr>\n <td>B33.20</td>\n <td>Viral carditis, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>B33.21</td>\n <td>Viral endocarditis</td>\n <td/>\n </tr>\n <tr>\n <td>B33.22</td>\n <td>Viral myocarditis</td>\n <td/>\n </tr>\n <tr>\n <td>B33.23</td>\n <td>Viral pericarditis</td>\n <td/>\n </tr>\n <tr>\n <td>B33.24</td>\n <td>Viral cardiomyopathy</td>\n <td/>\n </tr>\n <tr>\n <td>B37.6</td>\n <td>Candidal endocarditis</td>\n <td/>\n </tr>\n <tr>\n <td>B44.81</td>\n <td>Allergic bronchopulmonary aspergillosis</td>\n <td/>\n </tr>\n <tr>\n <td>B58.81</td>\n <td>Toxoplasma myocarditis</td>\n <td/>\n </tr>\n <tr>\n <td>C00.0</td>\n <td>Malignant neoplasm of external upper lip</td>\n <td/>\n </tr>\n <tr>\n <td>C00.1</td>\n <td>Malignant neoplasm of external lower lip</td>\n <td/>\n </tr>\n <tr>\n <td>C00.2</td>\n <td>Malignant neoplasm of external lip, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>C00.3</td>\n <td>Malignant neoplasm of upper lip, inner aspect</td>\n <td/>\n </tr>\n <tr>\n <td>C00.4</td>\n <td>Malignant neoplasm of lower lip, inner aspect</td>\n <td/>\n </tr>\n <tr>\n <td>C00.5</td>\n <td>Malignant neoplasm of lip, unspecified, inner aspect</td>\n <td/>\n </tr>\n <tr>\n <td>C00.6</td>\n <td>Malignant neoplasm of commissure of lip, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>C00.8</td>\n <td>Malignant neoplasm of overlapping sites of lip</td>\n <td/>\n </tr>\n <tr>\n <td>C00.9</td>\n <td>Malignant neoplasm of lip, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>C01</td>\n <td>Malignant neoplasm of base of tongue</td>\n <td/>\n </tr>\n <tr>\n <td>C02.0</td>\n <td>Malignant neoplasm of dorsal surface of tongue</td>\n <td/>\n </tr>\n <tr>\n <td>C02.1</td>\n <td>Malignant neoplasm of border of tongue</td>\n <td/>\n </tr>\n <tr>\n <td>C02.2</td>\n <td>Malignant neoplasm of ventral surface of tongue</td>\n <td/>\n </tr>\n <tr>\n <td>C02.3</td>\n <td>Malignant neoplasm of anterior two-thirds of tongue, part unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>C02.4</td>\n <td>Malignant neoplasm of lingual tonsil</td>\n <td/>\n </tr>\n <tr>\n <td>C02.8</td>\n <td>Malignant neoplasm of overlapping sites of tongue</td>\n <td/>\n </tr>\n <tr>\n <td>C02.9</td>\n <td>Malignant neoplasm of tongue, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>C03.0</td>\n <td>Malignant neoplasm of upper gum</td>\n <td/>\n </tr>\n <tr>\n <td>C03.1</td>\n <td>Malignant neoplasm of lower gum</td>\n <td/>\n </tr>\n <tr>\n <td>C03.9</td>\n <td>Malignant neoplasm of gum, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>C04.0</td>\n <td>Malignant neoplasm of anterior floor of mouth</td>\n <td/>\n </tr>\n <tr>\n <td>C04.1</td>\n <td>Malignant neoplasm of lateral floor of mouth</td>\n <td/>\n </tr>\n <tr>\n <td>C04.8</td>\n <td>Malignant neoplasm of overlapping sites of floor of mouth</td>\n <td/>\n </tr>\n <tr>\n <td>C04.9</td>\n <td>Malignant neoplasm of floor of mouth, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>C05.0</td>\n <td>Malignant neoplasm of hard palate</td>\n <td/>\n </tr>\n <tr>\n <td>C05.1</td>\n <td>Malignant neoplasm of soft palate</td>\n <td/>\n </tr>\n <tr>\n <td>C05.2</td>\n <td>Malignant neoplasm of uvula</td>\n <td/>\n </tr>\n <tr>\n <td>C05.8</td>\n <td>Malignant neoplasm of overlapping sites of palate</td>\n <td/>\n </tr>\n <tr>\n <td>C05.9</td>\n <td>Malignant neoplasm of palate, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>C06.0</td>\n <td>Malignant neoplasm of cheek mucosa</td>\n <td/>\n </tr>\n <tr>\n <td>C06.1</td>\n <td>Malignant neoplasm of vestibule of mouth</td>\n <td/>\n </tr>\n <tr>\n <td>C06.2</td>\n <td>Malignant neoplasm of retromolar area</td>\n <td/>\n </tr>\n <tr>\n <td>C06.80</td>\n <td>Malignant neoplasm of overlapping sites of unspecified parts of mouth</td>\n <td/>\n </tr>\n <tr>\n <td>C06.89</td>\n <td>Malignant neoplasm of overlapping sites of other parts of mouth</td>\n <td/>\n </tr>\n <tr>\n <td>C06.9</td>\n <td>Malignant neoplasm of mouth, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>C07</td>\n <td>Malignant neoplasm of parotid gland</td>\n <td/>\n </tr>\n <tr>\n <td>C08.0</td>\n <td>Malignant neoplasm of submandibular gland</td>\n <td/>\n </tr>\n <tr>\n <td>C08.1</td>\n <td>Malignant neoplasm of sublingual gland</td>\n <td/>\n </tr>\n <tr>\n <td>C08.9</td>\n <td>Malignant neoplasm of major salivary gland, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>C09.0</td>\n <td>Malignant neoplasm of tonsillar fossa</td>\n <td/>\n </tr>\n <tr>\n <td>C09.1</td>\n <td>Malignant neoplasm of tonsillar pillar (anterior) (posterior)</td>\n <td/>\n </tr>\n <tr>\n <td>C09.8</td>\n <td>Malignant neoplasm of overlapping sites of tonsil</td>\n <td/>\n </tr>\n <tr>\n <td>C09.9</td>\n <td>Malignant neoplasm of tonsil, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>C10.0</td>\n <td>Malignant neoplasm of vallecula</td>\n <td/>\n </tr>\n <tr>\n <td>C10.1</td>\n <td>Malignant neoplasm of anterior surface of epiglottis</td>\n <td/>\n </tr>\n <tr>\n <td>C10.2</td>\n <td>Malignant neoplasm of lateral wall of oropharynx</td>\n <td/>\n </tr>\n <tr>\n <td>C10.3</td>\n <td>Malignant neoplasm of posterior wall of oropharynx</td>\n <td/>\n </tr>\n <tr>\n <td>C10.4</td>\n <td>Malignant neoplasm of branchial cleft</td>\n <td/>\n </tr>\n <tr>\n <td>C10.8</td>\n <td>Malignant neoplasm of overlapping sites of oropharynx</td>\n <td/>\n </tr>\n <tr>\n <td>C10.9</td>\n <td>Malignant neoplasm of oropharynx, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>C11.0</td>\n <td>Malignant neoplasm of superior wall of nasopharynx</td>\n <td/>\n </tr>\n <tr>\n <td>C11.1</td>\n <td>Malignant neoplasm of posterior wall of nasopharynx</td>\n <td/>\n </tr>\n <tr>\n <td>C11.2</td>\n <td>Malignant neoplasm of lateral wall of nasopharynx</td>\n <td/>\n </tr>\n <tr>\n <td>C11.3</td>\n <td>Malignant neoplasm of anterior wall of nasopharynx</td>\n <td/>\n </tr>\n <tr>\n <td>C11.8</td>\n <td>Malignant neoplasm of overlapping sites of nasopharynx</td>\n <td/>\n </tr>\n <tr>\n <td>C11.9</td>\n <td>Malignant neoplasm of nasopharynx, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>C12</td>\n <td>Malignant neoplasm of pyriform sinus</td>\n <td/>\n </tr>\n <tr>\n <td>C13.0</td>\n <td>Malignant neoplasm of postcricoid region</td>\n <td/>\n </tr>\n <tr>\n <td>C13.1</td>\n <td>Malignant neoplasm of aryepiglottic fold, hypopharyngeal aspect</td>\n <td/>\n </tr>\n <tr>\n <td>C13.2</td>\n <td>Malignant neoplasm of posterior wall of hypopharynx</td>\n <td/>\n </tr>\n <tr>\n <td>C13.8</td>\n <td>Malignant neoplasm of overlapping sites of hypopharynx</td>\n <td/>\n </tr>\n <tr>\n <td>C13.9</td>\n <td>Malignant neoplasm of hypopharynx, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>C14.0</td>\n <td>Malignant neoplasm of pharynx, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>C14.2</td>\n <td>Malignant neoplasm of Waldeyer's ring</td>\n <td/>\n </tr>\n <tr>\n <td>C14.8</td>\n <td>Malignant neoplasm of overlapping sites of lip, oral cavity and pharynx</td>\n <td/>\n </tr>\n <tr>\n <td>C15.3</td>\n <td>Malignant neoplasm of upper third of esophagus</td>\n <td/>\n </tr>\n <tr>\n <td>C15.4</td>\n <td>Malignant neoplasm of middle third of esophagus</td>\n <td/>\n </tr>\n <tr>\n <td>C15.5</td>\n <td>Malignant neoplasm of lower third of esophagus</td>\n <td/>\n </tr>\n <tr>\n <td>C15.8</td>\n <td>Malignant neoplasm of overlapping sites of esophagus</td>\n <td/>\n </tr>\n <tr>\n <td>C15.9</td>\n <td>Malignant neoplasm of esophagus, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>C16.0</td>\n <td>Malignant neoplasm of cardia</td>\n <td/>\n </tr>\n <tr>\n <td>C16.1</td>\n <td>Malignant neoplasm of fundus of stomach</td>\n <td/>\n </tr>\n <tr>\n <td>C16.2</td>\n <td>Malignant neoplasm of body of stomach</td>\n <td/>\n </tr>\n <tr>\n <td>C16.3</td>\n <td>Malignant neoplasm of pyloric antrum</td>\n <td/>\n </tr>\n <tr>\n <td>C16.4</td>\n <td>Malignant neoplasm of pylorus</td>\n <td/>\n </tr>\n <tr>\n <td>C16.5</td>\n <td>Malignant neoplasm of lesser curvature of stomach, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>C16.6</td>\n <td>Malignant neoplasm of greater curvature of stomach, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>C16.8</td>\n <td>Malignant neoplasm of overlapping sites of stomach</td>\n <td/>\n </tr>\n <tr>\n <td>C16.9</td>\n <td>Malignant neoplasm of stomach, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>C17.0</td>\n <td>Malignant neoplasm of duodenum</td>\n <td/>\n </tr>\n <tr>\n <td>C17.1</td>\n <td>Malignant neoplasm of jejunum</td>\n <td/>\n </tr>\n <tr>\n <td>C17.2</td>\n <td>Malignant neoplasm of ileum</td>\n <td/>\n </tr>\n <tr>\n <td>C17.3</td>\n <td>Meckel's diverticulum, malignant</td>\n <td/>\n </tr>\n <tr>\n <td>C17.8</td>\n <td>Malignant neoplasm of overlapping sites of small intestine</td>\n <td/>\n </tr>\n <tr>\n <td>C17.9</td>\n <td>Malignant neoplasm of small intestine, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>C18.0</td>\n <td>Malignant neoplasm of cecum</td>\n <td/>\n </tr>\n <tr>\n <td>C18.1</td>\n <td>Malignant neoplasm of appendix</td>\n <td/>\n </tr>\n <tr>\n <td>C18.2</td>\n <td>Malignant neoplasm of ascending colon</td>\n <td/>\n </tr>\n <tr>\n <td>C18.3</td>\n <td>Malignant neoplasm of hepatic flexure</td>\n <td/>\n </tr>\n <tr>\n <td>C18.4</td>\n <td>Malignant neoplasm of transverse colon</td>\n <td/>\n </tr>\n <tr>\n <td>C18.5</td>\n <td>Malignant neoplasm of splenic flexure</td>\n <td/>\n </tr>\n <tr>\n <td>C18.6</td>\n <td>Malignant neoplasm of descending colon</td>\n <td/>\n </tr>\n <tr>\n <td>C18.7</td>\n <td>Malignant neoplasm of sigmoid colon</td>\n <td/>\n </tr>\n <tr>\n <td>C18.8</td>\n <td>Malignant neoplasm of overlapping sites of colon</td>\n <td/>\n </tr>\n <tr>\n <td>C18.9</td>\n <td>Malignant neoplasm of colon, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>C19</td>\n <td>Malignant neoplasm of rectosigmoid junction</td>\n <td/>\n </tr>\n <tr>\n <td>C20</td>\n <td>Malignant neoplasm of rectum</td>\n <td/>\n </tr>\n <tr>\n <td>C21.0</td>\n <td>Malignant neoplasm of anus, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>C21.1</td>\n <td>Malignant neoplasm of anal canal</td>\n <td/>\n </tr>\n <tr>\n <td>C21.2</td>\n <td>Malignant neoplasm of cloacogenic zone</td>\n <td/>\n </tr>\n <tr>\n <td>C21.8</td>\n <td>Malignant neoplasm of overlapping sites of rectum, anus and anal canal</td>\n <td/>\n </tr>\n <tr>\n <td>C22.0</td>\n <td>Liver cell carcinoma</td>\n <td/>\n </tr>\n <tr>\n <td>C22.1</td>\n <td>Intrahepatic bile duct carcinoma</td>\n <td/>\n </tr>\n <tr>\n <td>C22.2</td>\n <td>Hepatoblastoma</td>\n <td/>\n </tr>\n <tr>\n <td>C22.3</td>\n <td>Angiosarcoma of liver</td>\n <td/>\n </tr>\n <tr>\n <td>C22.4</td>\n <td>Other sarcomas of liver</td>\n <td/>\n </tr>\n <tr>\n <td>C22.7</td>\n <td>Other specified carcinomas of liver</td>\n <td/>\n </tr>\n <tr>\n <td>C22.8</td>\n <td>Malignant neoplasm of liver, primary, unspecified as to type</td>\n <td/>\n </tr>\n <tr>\n <td>C22.9</td>\n <td>Malignant neoplasm of liver, not specified as primary or secondary</td>\n <td/>\n </tr>\n <tr>\n <td>C23</td>\n <td>Malignant neoplasm of gallbladder</td>\n <td/>\n </tr>\n <tr>\n <td>C24.0</td>\n <td>Malignant neoplasm of extrahepatic bile duct</td>\n <td/>\n </tr>\n <tr>\n <td>C24.1</td>\n <td>Malignant neoplasm of ampulla of Vater</td>\n <td/>\n </tr>\n <tr>\n <td>C24.8</td>\n <td>Malignant neoplasm of overlapping sites of biliary tract</td>\n <td/>\n </tr>\n <tr>\n <td>C24.9</td>\n <td>Malignant neoplasm of biliary tract, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>C25.0</td>\n <td>Malignant neoplasm of head of pancreas</td>\n <td/>\n </tr>\n <tr>\n <td>C25.1</td>\n <td>Malignant neoplasm of body of pancreas</td>\n <td/>\n </tr>\n <tr>\n <td>C25.2</td>\n <td>Malignant neoplasm of tail of pancreas</td>\n <td/>\n </tr>\n <tr>\n <td>C25.3</td>\n <td>Malignant neoplasm of pancreatic duct</td>\n <td/>\n </tr>\n <tr>\n <td>C25.4</td>\n <td>Malignant neoplasm of endocrine pancreas</td>\n <td/>\n </tr>\n <tr>\n <td>C25.7</td>\n <td>Malignant neoplasm of other parts of pancreas</td>\n <td/>\n </tr>\n <tr>\n <td>C25.8</td>\n <td>Malignant neoplasm of overlapping sites of pancreas</td>\n <td/>\n </tr>\n <tr>\n <td>C25.9</td>\n <td>Malignant neoplasm of pancreas, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>C26.0</td>\n <td>Malignant neoplasm of intestinal tract, part unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>C26.1</td>\n <td>Malignant neoplasm of spleen</td>\n <td/>\n </tr>\n <tr>\n <td>C26.9</td>\n <td>Malignant neoplasm of ill-defined sites within the digestive system</td>\n <td/>\n </tr>\n <tr>\n <td>C30.0</td>\n <td>Malignant neoplasm of nasal cavity</td>\n <td/>\n </tr>\n <tr>\n <td>C30.1</td>\n <td>Malignant neoplasm of middle ear</td>\n <td/>\n </tr>\n <tr>\n <td>C31.0</td>\n <td>Malignant neoplasm of maxillary sinus</td>\n <td/>\n </tr>\n <tr>\n <td>C31.1</td>\n <td>Malignant neoplasm of ethmoidal sinus</td>\n <td/>\n </tr>\n <tr>\n <td>C31.2</td>\n <td>Malignant neoplasm of frontal sinus</td>\n <td/>\n </tr>\n <tr>\n <td>C31.3</td>\n <td>Malignant neoplasm of sphenoid sinus</td>\n <td/>\n </tr>\n <tr>\n <td>C31.8</td>\n <td>Malignant neoplasm of overlapping sites of accessory sinuses</td>\n <td/>\n </tr>\n <tr>\n <td>C31.9</td>\n <td>Malignant neoplasm of accessory sinus, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>C32.0</td>\n <td>Malignant neoplasm of glottis</td>\n <td/>\n </tr>\n <tr>\n <td>C32.1</td>\n <td>Malignant neoplasm of supraglottis</td>\n <td/>\n </tr>\n <tr>\n <td>C32.2</td>\n <td>Malignant neoplasm of subglottis</td>\n <td/>\n </tr>\n <tr>\n <td>C32.3</td>\n <td>Malignant neoplasm of laryngeal cartilage</td>\n <td/>\n </tr>\n <tr>\n <td>C32.8</td>\n <td>Malignant neoplasm of overlapping sites of larynx</td>\n <td/>\n </tr>\n <tr>\n <td>C32.9</td>\n <td>Malignant neoplasm of larynx, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>C33</td>\n <td>Malignant neoplasm of trachea</td>\n <td/>\n </tr>\n <tr>\n <td>C34.00</td>\n <td>Malignant neoplasm of unspecified main bronchus</td>\n <td/>\n </tr>\n <tr>\n <td>C34.01</td>\n <td>Malignant neoplasm of right main bronchus</td>\n <td/>\n </tr>\n <tr>\n <td>C34.02</td>\n <td>Malignant neoplasm of left main bronchus</td>\n <td/>\n </tr>\n <tr>\n <td>C34.10</td>\n <td>Malignant neoplasm of upper lobe, unspecified bronchus or lung</td>\n <td/>\n </tr>\n <tr>\n <td>C34.11</td>\n <td>Malignant neoplasm of upper lobe, right bronchus or lung</td>\n <td/>\n </tr>\n <tr>\n <td>C34.12</td>\n <td>Malignant neoplasm of upper lobe, left bronchus or lung</td>\n <td/>\n </tr>\n <tr>\n <td>C34.2</td>\n <td>Malignant neoplasm of middle lobe, bronchus or lung</td>\n <td/>\n </tr>\n <tr>\n <td>C34.30</td>\n <td>Malignant neoplasm of lower lobe, unspecified bronchus or lung</td>\n <td/>\n </tr>\n <tr>\n <td>C34.31</td>\n <td>Malignant neoplasm of lower lobe, right bronchus or lung</td>\n <td/>\n </tr>\n <tr>\n <td>C34.32</td>\n <td>Malignant neoplasm of lower lobe, left bronchus or lung</td>\n <td/>\n </tr>\n <tr>\n <td>C34.80</td>\n <td>Malignant neoplasm of overlapping sites of unspecified bronchus and lung</td>\n <td/>\n </tr>\n <tr>\n <td>C34.81</td>\n <td>Malignant neoplasm of overlapping sites of right bronchus and lung</td>\n <td/>\n </tr>\n <tr>\n <td>C34.82</td>\n <td>Malignant neoplasm of overlapping sites of left bronchus and lung</td>\n <td/>\n </tr>\n <tr>\n <td>C34.90</td>\n <td>Malignant neoplasm of unspecified part of unspecified bronchus or lung</td>\n <td/>\n </tr>\n <tr>\n <td>C34.91</td>\n <td>Malignant neoplasm of unspecified part of right bronchus or lung</td>\n <td/>\n </tr>\n <tr>\n <td>C34.92</td>\n <td>Malignant neoplasm of unspecified part of left bronchus or lung</td>\n <td/>\n </tr>\n <tr>\n <td>C37</td>\n <td>Malignant neoplasm of thymus</td>\n <td/>\n </tr>\n <tr>\n <td>C38.0</td>\n <td>Malignant neoplasm of heart</td>\n <td/>\n </tr>\n <tr>\n <td>C38.1</td>\n <td>Malignant neoplasm of anterior mediastinum</td>\n <td/>\n </tr>\n <tr>\n <td>C38.2</td>\n <td>Malignant neoplasm of posterior mediastinum</td>\n <td/>\n </tr>\n <tr>\n <td>C38.3</td>\n <td>Malignant neoplasm of mediastinum, part unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>C38.4</td>\n <td>Malignant neoplasm of pleura</td>\n <td/>\n </tr>\n <tr>\n <td>C38.8</td>\n <td>Malignant neoplasm of overlapping sites of heart, mediastinum and pleura</td>\n <td/>\n </tr>\n <tr>\n <td>C39.0</td>\n <td>Malignant neoplasm of upper respiratory tract, part unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>C39.9</td>\n <td>Malignant neoplasm of lower respiratory tract, part unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>C40.00</td>\n <td>Malignant neoplasm of scapula and long bones of unspecified upper limb</td>\n <td/>\n </tr>\n <tr>\n <td>C40.01</td>\n <td>Malignant neoplasm of scapula and long bones of right upper limb</td>\n <td/>\n </tr>\n <tr>\n <td>C40.02</td>\n <td>Malignant neoplasm of scapula and long bones of left upper limb</td>\n <td/>\n </tr>\n <tr>\n <td>C40.10</td>\n <td>Malignant neoplasm of short bones of unspecified upper limb</td>\n <td/>\n </tr>\n <tr>\n <td>C40.11</td>\n <td>Malignant neoplasm of short bones of right upper limb</td>\n <td/>\n </tr>\n <tr>\n <td>C40.12</td>\n <td>Malignant neoplasm of short bones of left upper limb</td>\n <td/>\n </tr>\n <tr>\n <td>C40.20</td>\n <td>Malignant neoplasm of long bones of unspecified lower limb</td>\n <td/>\n </tr>\n <tr>\n <td>C40.21</td>\n <td>Malignant neoplasm of long bones of right lower limb</td>\n <td/>\n </tr>\n <tr>\n <td>C40.22</td>\n <td>Malignant neoplasm of long bones of left lower limb</td>\n <td/>\n </tr>\n <tr>\n <td>C40.30</td>\n <td>Malignant neoplasm of short bones of unspecified lower limb</td>\n <td/>\n </tr>\n <tr>\n <td>C40.31</td>\n <td>Malignant neoplasm of short bones of right lower limb</td>\n <td/>\n </tr>\n <tr>\n <td>C40.32</td>\n <td>Malignant neoplasm of short bones of left lower limb</td>\n <td/>\n </tr>\n <tr>\n <td>C40.80</td>\n <td>Malignant neoplasm of overlapping sites of bone and articular cartilage of unspecified limb</td>\n <td/>\n </tr>\n <tr>\n <td>C40.81</td>\n <td>Malignant neoplasm of overlapping sites of bone and articular cartilage of right limb</td>\n <td/>\n </tr>\n <tr>\n <td>C40.82</td>\n <td>Malignant neoplasm of overlapping sites of bone and articular cartilage of left limb</td>\n <td/>\n </tr>\n <tr>\n <td>C40.90</td>\n <td>Malignant neoplasm of unspecified bones and articular cartilage of unspecified limb</td>\n <td/>\n </tr>\n <tr>\n <td>C40.91</td>\n <td>Malignant neoplasm of unspecified bones and articular cartilage of right limb</td>\n <td/>\n </tr>\n <tr>\n <td>C40.92</td>\n <td>Malignant neoplasm of unspecified bones and articular cartilage of left limb</td>\n <td/>\n </tr>\n <tr>\n <td>C41.0</td>\n <td>Malignant neoplasm of bones of skull and face</td>\n <td/>\n </tr>\n <tr>\n <td>C41.1</td>\n <td>Malignant neoplasm of mandible</td>\n <td/>\n </tr>\n <tr>\n <td>C41.2</td>\n <td>Malignant neoplasm of vertebral column</td>\n <td/>\n </tr>\n <tr>\n <td>C41.3</td>\n <td>Malignant neoplasm of ribs, sternum and clavicle</td>\n <td/>\n </tr>\n <tr>\n <td>C41.4</td>\n <td>Malignant neoplasm of pelvic bones, sacrum and coccyx</td>\n <td/>\n </tr>\n <tr>\n <td>C41.9</td>\n <td>Malignant neoplasm of bone and articular cartilage, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>C43.0</td>\n <td>Malignant melanoma of lip</td>\n <td/>\n </tr>\n <tr>\n <td>C43.10</td>\n <td>Malignant melanoma of unspecified eyelid, including canthus</td>\n <td/>\n </tr>\n <tr>\n <td>C43.11</td>\n <td>Malignant melanoma of right eyelid, including canthus</td>\n <td/>\n </tr>\n <tr>\n <td>C43.111</td>\n <td>Malignant melanoma of right upper eyelid, including canthus</td>\n <td/>\n </tr>\n <tr>\n <td>C43.112</td>\n <td>Malignant melanoma of right lower eyelid, including canthus</td>\n <td/>\n </tr>\n <tr>\n <td>C43.12</td>\n <td>Malignant melanoma of left eyelid, including canthus</td>\n <td/>\n </tr>\n <tr>\n <td>C43.121</td>\n <td>Malignant melanoma of left upper eyelid, including canthus</td>\n <td/>\n </tr>\n <tr>\n <td>C43.122</td>\n <td>Malignant melanoma of left lower eyelid, including canthus</td>\n <td/>\n </tr>\n <tr>\n <td>C43.20</td>\n <td>Malignant melanoma of unspecified ear and external auricular canal</td>\n <td/>\n </tr>\n <tr>\n <td>C43.21</td>\n <td>Malignant melanoma of right ear and external auricular canal</td>\n <td/>\n </tr>\n <tr>\n <td>C43.22</td>\n <td>Malignant melanoma of left ear and external auricular canal</td>\n <td/>\n </tr>\n <tr>\n <td>C43.30</td>\n <td>Malignant melanoma of unspecified part of face</td>\n <td/>\n </tr>\n <tr>\n <td>C43.31</td>\n <td>Malignant melanoma of nose</td>\n <td/>\n </tr>\n <tr>\n <td>C43.39</td>\n <td>Malignant melanoma of other parts of face</td>\n <td/>\n </tr>\n <tr>\n <td>C43.4</td>\n <td>Malignant melanoma of scalp and neck</td>\n <td/>\n </tr>\n <tr>\n <td>C43.51</td>\n <td>Malignant melanoma of anal skin</td>\n <td/>\n </tr>\n <tr>\n <td>C43.52</td>\n <td>Malignant melanoma of skin of breast</td>\n <td/>\n </tr>\n <tr>\n <td>C43.59</td>\n <td>Malignant melanoma of other part of trunk</td>\n <td/>\n </tr>\n <tr>\n <td>C43.60</td>\n <td>Malignant melanoma of unspecified upper limb, including shoulder</td>\n <td/>\n </tr>\n <tr>\n <td>C43.61</td>\n <td>Malignant melanoma of right upper limb, including shoulder</td>\n <td/>\n </tr>\n <tr>\n <td>C43.62</td>\n <td>Malignant melanoma of left upper limb, including shoulder</td>\n <td/>\n </tr>\n <tr>\n <td>C43.70</td>\n <td>Malignant melanoma of unspecified lower limb, including hip</td>\n <td/>\n </tr>\n <tr>\n <td>C43.71</td>\n <td>Malignant melanoma of right lower limb, including hip</td>\n <td/>\n </tr>\n <tr>\n <td>C43.72</td>\n <td>Malignant melanoma of left lower limb, including hip</td>\n <td/>\n </tr>\n <tr>\n <td>C43.8</td>\n <td>Malignant melanoma of overlapping sites of skin</td>\n <td/>\n </tr>\n <tr>\n <td>C43.9</td>\n <td>Malignant melanoma of skin, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>C44.00</td>\n <td>Unspecified malignant neoplasm of skin of lip</td>\n <td/>\n </tr>\n <tr>\n <td>C44.01</td>\n <td>Basal cell carcinoma of skin of lip</td>\n <td/>\n </tr>\n <tr>\n <td>C44.02</td>\n <td>Squamous cell carcinoma of skin of lip</td>\n <td/>\n </tr>\n <tr>\n <td>C44.09</td>\n <td>Other specified malignant neoplasm of skin of lip</td>\n <td/>\n </tr>\n <tr>\n <td>C44.101</td>\n <td>Unspecified malignant neoplasm of skin of unspecified eyelid, including canthus</td>\n <td/>\n </tr>\n <tr>\n <td>C44.102</td>\n <td>Unspecified malignant neoplasm of skin of right eyelid, including canthus</td>\n <td/>\n </tr>\n <tr>\n <td>C44.1021</td>\n <td>Unspecified malignant neoplasm of skin of right upper eyelid, including canthus</td>\n <td/>\n </tr>\n <tr>\n <td>C44.1022</td>\n <td>Unspecified malignant neoplasm of skin of right lower eyelid, including canthus</td>\n <td/>\n </tr>\n <tr>\n <td>C44.109</td>\n <td>Unspecified malignant neoplasm of skin of left eyelid, including canthus</td>\n <td/>\n </tr>\n <tr>\n <td>C44.1091</td>\n <td>Unspecified malignant neoplasm of skin of left upper eyelid, including canthus</td>\n <td/>\n </tr>\n <tr>\n <td>C44.1092</td>\n <td>Unspecified malignant neoplasm of skin of left lower eyelid, including canthus</td>\n <td/>\n </tr>\n <tr>\n <td>C44.111</td>\n <td>Basal cell carcinoma of skin of unspecified eyelid, including canthus</td>\n <td/>\n </tr>\n <tr>\n <td>C44.112</td>\n <td>Basal cell carcinoma of skin of right eyelid, including canthus</td>\n <td/>\n </tr>\n <tr>\n <td>C44.1121</td>\n <td>Basal cell carcinoma of skin of right upper eyelid, including canthus</td>\n <td/>\n </tr>\n <tr>\n <td>C44.1122</td>\n <td>Basal cell carcinoma of skin of right lower eyelid, including canthus</td>\n <td/>\n </tr>\n <tr>\n <td>C44.119</td>\n <td>Basal cell carcinoma of skin of left eyelid, including canthus</td>\n <td/>\n </tr>\n <tr>\n <td>C44.1191</td>\n <td>Basal cell carcinoma of skin of left upper eyelid, including canthus</td>\n <td/>\n </tr>\n <tr>\n <td>C44.1192</td>\n <td>Basal cell carcinoma of skin of left lower eyelid, including canthus</td>\n <td/>\n </tr>\n <tr>\n <td>C44.121</td>\n <td>Squamous cell carcinoma of skin of unspecified eyelid, including canthus</td>\n <td/>\n </tr>\n <tr>\n <td>C44.122</td>\n <td>Squamous cell carcinoma of skin of right eyelid, including canthus</td>\n <td/>\n </tr>\n <tr>\n <td>C44.1221</td>\n <td>Squamous cell carcinoma of skin of right upper eyelid, including canthus</td>\n <td/>\n </tr>\n <tr>\n <td>C44.1222</td>\n <td>Squamous cell carcinoma of skin of right lower eyelid, including canthus</td>\n <td/>\n </tr>\n <tr>\n <td>C44.129</td>\n <td>Squamous cell carcinoma of skin of left eyelid, including canthus</td>\n <td/>\n </tr>\n <tr>\n <td>C44.1291</td>\n <td>Squamous cell carcinoma of skin of left upper eyelid, including canthus</td>\n <td/>\n </tr>\n <tr>\n <td>C44.1292</td>\n <td>Squamous cell carcinoma of skin of left lower eyelid, including canthus</td>\n <td/>\n </tr>\n <tr>\n <td>C44.131</td>\n <td>Sebaceous cell carcinoma of skin of unspecified eyelid, including canthus</td>\n <td/>\n </tr>\n <tr>\n <td>C44.1321</td>\n <td>Sebaceous cell carcinoma of skin of right upper eyelid, including canthus</td>\n <td/>\n </tr>\n <tr>\n <td>C44.1322</td>\n <td>Sebaceous cell carcinoma of skin of right lower eyelid, including canthus</td>\n <td/>\n </tr>\n <tr>\n <td>C44.1391</td>\n <td>Sebaceous cell carcinoma of skin of left upper eyelid, including canthus</td>\n <td/>\n </tr>\n <tr>\n <td>C44.1392</td>\n <td>Sebaceous cell carcinoma of skin of left lower eyelid, including canthus</td>\n <td/>\n </tr>\n <tr>\n <td>C44.191</td>\n <td>Other specified malignant neoplasm of skin of unspecified eyelid, including canthus</td>\n <td/>\n </tr>\n <tr>\n <td>C44.192</td>\n <td>Other specified malignant neoplasm of skin of right eyelid, including canthus</td>\n <td/>\n </tr>\n <tr>\n <td>C44.1921</td>\n <td>Other specified malignant neoplasm of skin of right upper eyelid, including canthus</td>\n <td/>\n </tr>\n <tr>\n <td>C44.1922</td>\n <td>Other specified malignant neoplasm of skin of right lower eyelid, including canthus</td>\n <td/>\n </tr>\n <tr>\n <td>C44.199</td>\n <td>Other specified malignant neoplasm of skin of left eyelid, including canthus</td>\n <td/>\n </tr>\n <tr>\n <td>C44.1991</td>\n <td>Other specified malignant neoplasm of skin of left upper eyelid, including canthus</td>\n <td/>\n </tr>\n <tr>\n <td>C44.1992</td>\n <td>Other specified malignant neoplasm of skin of left lower eyelid, including canthus</td>\n <td/>\n </tr>\n <tr>\n <td>C44.201</td>\n <td>Unspecified malignant neoplasm of skin of unspecified ear and external auricular canal</td>\n <td/>\n </tr>\n <tr>\n <td>C44.202</td>\n <td>Unspecified malignant neoplasm of skin of right ear and external auricular canal</td>\n <td/>\n </tr>\n <tr>\n <td>C44.209</td>\n <td>Unspecified malignant neoplasm of skin of left ear and external auricular canal</td>\n <td/>\n </tr>\n <tr>\n <td>C44.211</td>\n <td>Basal cell carcinoma of skin of unspecified ear and external auricular canal</td>\n <td/>\n </tr>\n <tr>\n <td>C44.212</td>\n <td>Basal cell carcinoma of skin of right ear and external auricular canal</td>\n <td/>\n </tr>\n <tr>\n <td>C44.219</td>\n <td>Basal cell carcinoma of skin of left ear and external auricular canal</td>\n <td/>\n </tr>\n <tr>\n <td>C44.221</td>\n <td>Squamous cell carcinoma of skin of unspecified ear and external auricular canal</td>\n <td/>\n </tr>\n <tr>\n <td>C44.222</td>\n <td>Squamous cell carcinoma of skin of right ear and external auricular canal</td>\n <td/>\n </tr>\n <tr>\n <td>C44.229</td>\n <td>Squamous cell carcinoma of skin of left ear and external auricular canal</td>\n <td/>\n </tr>\n <tr>\n <td>C44.291</td>\n <td>Other specified malignant neoplasm of skin of unspecified ear and external auricular canal</td>\n <td/>\n </tr>\n <tr>\n <td>C44.292</td>\n <td>Other specified malignant neoplasm of skin of right ear and external auricular canal</td>\n <td/>\n </tr>\n <tr>\n <td>C44.299</td>\n <td>Other specified malignant neoplasm of skin of left ear and external auricular canal</td>\n <td/>\n </tr>\n <tr>\n <td>C44.300</td>\n <td>Unspecified malignant neoplasm of skin of unspecified part of face</td>\n <td/>\n </tr>\n <tr>\n <td>C44.301</td>\n <td>Unspecified malignant neoplasm of skin of nose</td>\n <td/>\n </tr>\n <tr>\n <td>C44.309</td>\n <td>Unspecified malignant neoplasm of skin of other parts of face</td>\n <td/>\n </tr>\n <tr>\n <td>C44.310</td>\n <td>Basal cell carcinoma of skin of unspecified parts of face</td>\n <td/>\n </tr>\n <tr>\n <td>C44.311</td>\n <td>Basal cell carcinoma of skin of nose</td>\n <td/>\n </tr>\n <tr>\n <td>C44.319</td>\n <td>Basal cell carcinoma of skin of other parts of face</td>\n <td/>\n </tr>\n <tr>\n <td>C44.320</td>\n <td>Squamous cell carcinoma of skin of unspecified parts of face</td>\n <td/>\n </tr>\n <tr>\n <td>C44.321</td>\n <td>Squamous cell carcinoma of skin of nose</td>\n <td/>\n </tr>\n <tr>\n <td>C44.329</td>\n <td>Squamous cell carcinoma of skin of other parts of face</td>\n <td/>\n </tr>\n <tr>\n <td>C44.390</td>\n <td>Other specified malignant neoplasm of skin of unspecified parts of face</td>\n <td/>\n </tr>\n <tr>\n <td>C44.391</td>\n <td>Other specified malignant neoplasm of skin of nose</td>\n <td/>\n </tr>\n <tr>\n <td>C44.399</td>\n <td>Other specified malignant neoplasm of skin of other parts of face</td>\n <td/>\n </tr>\n <tr>\n <td>C44.40</td>\n <td>Unspecified malignant neoplasm of skin of scalp and neck</td>\n <td/>\n </tr>\n <tr>\n <td>C44.41</td>\n <td>Basal cell carcinoma of skin of scalp and neck</td>\n <td/>\n </tr>\n <tr>\n <td>C44.42</td>\n <td>Squamous cell carcinoma of skin of scalp and neck</td>\n <td/>\n </tr>\n <tr>\n <td>C44.49</td>\n <td>Other specified malignant neoplasm of skin of scalp and neck</td>\n <td/>\n </tr>\n <tr>\n <td>C44.500</td>\n <td>Unspecified malignant neoplasm of anal skin</td>\n <td/>\n </tr>\n <tr>\n <td>C44.501</td>\n <td>Unspecified malignant neoplasm of skin of breast</td>\n <td/>\n </tr>\n <tr>\n <td>C44.509</td>\n <td>Unspecified malignant neoplasm of skin of other part of trunk</td>\n <td/>\n </tr>\n <tr>\n <td>C44.510</td>\n <td>Basal cell carcinoma of anal skin</td>\n <td/>\n </tr>\n <tr>\n <td>C44.511</td>\n <td>Basal cell carcinoma of skin of breast</td>\n <td/>\n </tr>\n <tr>\n <td>C44.519</td>\n <td>Basal cell carcinoma of skin of other part of trunk</td>\n <td/>\n </tr>\n <tr>\n <td>C44.520</td>\n <td>Squamous cell carcinoma of anal skin</td>\n <td/>\n </tr>\n <tr>\n <td>C44.521</td>\n <td>Squamous cell carcinoma of skin of breast</td>\n <td/>\n </tr>\n <tr>\n <td>C44.529</td>\n <td>Squamous cell carcinoma of skin of other part of trunk</td>\n <td/>\n </tr>\n <tr>\n <td>C44.590</td>\n <td>Other specified malignant neoplasm of anal skin</td>\n <td/>\n </tr>\n <tr>\n <td>C44.591</td>\n <td>Other specified malignant neoplasm of skin of breast</td>\n <td/>\n </tr>\n <tr>\n <td>C44.599</td>\n <td>Other specified malignant neoplasm of skin of other part of trunk</td>\n <td/>\n </tr>\n <tr>\n <td>C44.601</td>\n <td>Unspecified malignant neoplasm of skin of unspecified upper limb, including shoulder</td>\n <td/>\n </tr>\n <tr>\n <td>C44.602</td>\n <td>Unspecified malignant neoplasm of skin of right upper limb, including shoulder</td>\n <td/>\n </tr>\n <tr>\n <td>C44.609</td>\n <td>Unspecified malignant neoplasm of skin of left upper limb, including shoulder</td>\n <td/>\n </tr>\n <tr>\n <td>C44.611</td>\n <td>Basal cell carcinoma of skin of unspecified upper limb, including shoulder</td>\n <td/>\n </tr>\n <tr>\n <td>C44.612</td>\n <td>Basal cell carcinoma of skin of right upper limb, including shoulder</td>\n <td/>\n </tr>\n <tr>\n <td>C44.619</td>\n <td>Basal cell carcinoma of skin of left upper limb, including shoulder</td>\n <td/>\n </tr>\n <tr>\n <td>C44.621</td>\n <td>Squamous cell carcinoma of skin of unspecified upper limb, including shoulder</td>\n <td/>\n </tr>\n <tr>\n <td>C44.622</td>\n <td>Squamous cell carcinoma of skin of right upper limb, including shoulder</td>\n <td/>\n </tr>\n <tr>\n <td>C44.629</td>\n <td>Squamous cell carcinoma of skin of left upper limb, including shoulder</td>\n <td/>\n </tr>\n <tr>\n <td>C44.691</td>\n <td>Other specified malignant neoplasm of skin of unspecified upper limb, including shoulder</td>\n <td/>\n </tr>\n <tr>\n <td>C44.692</td>\n <td>Other specified malignant neoplasm of skin of right upper limb, including shoulder</td>\n <td/>\n </tr>\n <tr>\n <td>C44.699</td>\n <td>Other specified malignant neoplasm of skin of left upper limb, including shoulder</td>\n <td/>\n </tr>\n <tr>\n <td>C44.701</td>\n <td>Unspecified malignant neoplasm of skin of unspecified lower limb, including hip</td>\n <td/>\n </tr>\n <tr>\n <td>C44.702</td>\n <td>Unspecified malignant neoplasm of skin of right lower limb, including hip</td>\n <td/>\n </tr>\n <tr>\n <td>C44.709</td>\n <td>Unspecified malignant neoplasm of skin of left lower limb, including hip</td>\n <td/>\n </tr>\n <tr>\n <td>C44.711</td>\n <td>Basal cell carcinoma of skin of unspecified lower limb, including hip</td>\n <td/>\n </tr>\n <tr>\n <td>C44.712</td>\n <td>Basal cell carcinoma of skin of right lower limb, including hip</td>\n <td/>\n </tr>\n <tr>\n <td>C44.719</td>\n <td>Basal cell carcinoma of skin of left lower limb, including hip</td>\n <td/>\n </tr>\n <tr>\n <td>C44.721</td>\n <td>Squamous cell carcinoma of skin of unspecified lower limb, including hip</td>\n <td/>\n </tr>\n <tr>\n <td>C44.722</td>\n <td>Squamous cell carcinoma of skin of right lower limb, including hip</td>\n <td/>\n </tr>\n <tr>\n <td>C44.729</td>\n <td>Squamous cell carcinoma of skin of left lower limb, including hip</td>\n <td/>\n </tr>\n <tr>\n <td>C44.791</td>\n <td>Other specified malignant neoplasm of skin of unspecified lower limb, including hip</td>\n <td/>\n </tr>\n <tr>\n <td>C44.792</td>\n <td>Other specified malignant neoplasm of skin of right lower limb, including hip</td>\n <td/>\n </tr>\n <tr>\n <td>C44.799</td>\n <td>Other specified malignant neoplasm of skin of left lower limb, including hip</td>\n <td/>\n </tr>\n <tr>\n <td>C44.80</td>\n <td>Unspecified malignant neoplasm of overlapping sites of skin</td>\n <td/>\n </tr>\n <tr>\n <td>C44.81</td>\n <td>Basal cell carcinoma of overlapping sites of skin</td>\n <td/>\n </tr>\n <tr>\n <td>C44.82</td>\n <td>Squamous cell carcinoma of overlapping sites of skin</td>\n <td/>\n </tr>\n <tr>\n <td>C44.89</td>\n <td>Other specified malignant neoplasm of overlapping sites of skin</td>\n <td/>\n </tr>\n <tr>\n <td>C44.90</td>\n <td>Unspecified malignant neoplasm of skin, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>C44.91</td>\n <td>Basal cell carcinoma of skin, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>C44.92</td>\n <td>Squamous cell carcinoma of skin, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>C44.99</td>\n <td>Other specified malignant neoplasm of skin, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>C45.0</td>\n <td>Mesothelioma of pleura</td>\n <td/>\n </tr>\n <tr>\n <td>C45.1</td>\n <td>Mesothelioma of peritoneum</td>\n <td/>\n </tr>\n <tr>\n <td>C45.2</td>\n <td>Mesothelioma of pericardium</td>\n <td/>\n </tr>\n <tr>\n <td>C45.7</td>\n <td>Mesothelioma of other sites</td>\n <td/>\n </tr>\n <tr>\n <td>C45.9</td>\n <td>Mesothelioma, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>C46.0</td>\n <td>Kaposi's sarcoma of skin</td>\n <td/>\n </tr>\n <tr>\n <td>C46.1</td>\n <td>Kaposi's sarcoma of soft tissue</td>\n <td/>\n </tr>\n <tr>\n <td>C46.2</td>\n <td>Kaposi's sarcoma of palate</td>\n <td/>\n </tr>\n <tr>\n <td>C46.3</td>\n <td>Kaposi's sarcoma of lymph nodes</td>\n <td/>\n </tr>\n <tr>\n <td>C46.4</td>\n <td>Kaposi's sarcoma of gastrointestinal sites</td>\n <td/>\n </tr>\n <tr>\n <td>C46.50</td>\n <td>Kaposi's sarcoma of unspecified lung</td>\n <td/>\n </tr>\n <tr>\n <td>C46.51</td>\n <td>Kaposi's sarcoma of right lung</td>\n <td/>\n </tr>\n <tr>\n <td>C46.52</td>\n <td>Kaposi's sarcoma of left lung</td>\n <td/>\n </tr>\n <tr>\n <td>C46.7</td>\n <td>Kaposi's sarcoma of other sites</td>\n <td/>\n </tr>\n <tr>\n <td>C46.9</td>\n <td>Kaposi's sarcoma, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>C47.0</td>\n <td>Malignant neoplasm of peripheral nerves of head, face and neck</td>\n <td/>\n </tr>\n <tr>\n <td>C47.10</td>\n <td>Malignant neoplasm of peripheral nerves of unspecified upper limb, including shoulder</td>\n <td/>\n </tr>\n <tr>\n <td>C47.11</td>\n <td>Malignant neoplasm of peripheral nerves of right upper limb, including shoulder</td>\n <td/>\n </tr>\n <tr>\n <td>C47.12</td>\n <td>Malignant neoplasm of peripheral nerves of left upper limb, including shoulder</td>\n <td/>\n </tr>\n <tr>\n <td>C47.20</td>\n <td>Malignant neoplasm of peripheral nerves of unspecified lower limb, including hip</td>\n <td/>\n </tr>\n <tr>\n <td>C47.21</td>\n <td>Malignant neoplasm of peripheral nerves of right lower limb, including hip</td>\n <td/>\n </tr>\n <tr>\n <td>C47.22</td>\n <td>Malignant neoplasm of peripheral nerves of left lower limb, including hip</td>\n <td/>\n </tr>\n <tr>\n <td>C47.3</td>\n <td>Malignant neoplasm of peripheral nerves of thorax</td>\n <td/>\n </tr>\n <tr>\n <td>C47.4</td>\n <td>Malignant neoplasm of peripheral nerves of abdomen</td>\n <td/>\n </tr>\n <tr>\n <td>C47.5</td>\n <td>Malignant neoplasm of peripheral nerves of pelvis</td>\n <td/>\n </tr>\n <tr>\n <td>C47.6</td>\n <td>Malignant neoplasm of peripheral nerves of trunk, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>C47.8</td>\n <td>Malignant neoplasm of overlapping sites of peripheral nerves and autonomic nervous system</td>\n <td/>\n </tr>\n <tr>\n <td>C47.9</td>\n <td>Malignant neoplasm of peripheral nerves and autonomic nervous system, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>C48.0</td>\n <td>Malignant neoplasm of retroperitoneum</td>\n <td/>\n </tr>\n <tr>\n <td>C48.1</td>\n <td>Malignant neoplasm of specified parts of peritoneum</td>\n <td/>\n </tr>\n <tr>\n <td>C48.2</td>\n <td>Malignant neoplasm of peritoneum, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>C48.8</td>\n <td>Malignant neoplasm of overlapping sites of retroperitoneum and peritoneum</td>\n <td/>\n </tr>\n <tr>\n <td>C49.0</td>\n <td>Malignant neoplasm of connective and soft tissue of head, face and neck</td>\n <td/>\n </tr>\n <tr>\n <td>C49.10</td>\n <td>Malignant neoplasm of connective and soft tissue of unspecified upper limb, including shoulder</td>\n <td/>\n </tr>\n <tr>\n <td>C49.11</td>\n <td>Malignant neoplasm of connective and soft tissue of right upper limb, including shoulder</td>\n <td/>\n </tr>\n <tr>\n <td>C49.12</td>\n <td>Malignant neoplasm of connective and soft tissue of left upper limb, including shoulder</td>\n <td/>\n </tr>\n <tr>\n <td>C49.20</td>\n <td>Malignant neoplasm of connective and soft tissue of unspecified lower limb, including hip</td>\n <td/>\n </tr>\n <tr>\n <td>C49.21</td>\n <td>Malignant neoplasm of connective and soft tissue of right lower limb, including hip</td>\n <td/>\n </tr>\n <tr>\n <td>C49.22</td>\n <td>Malignant neoplasm of connective and soft tissue of left lower limb, including hip</td>\n <td/>\n </tr>\n <tr>\n <td>C49.3</td>\n <td>Malignant neoplasm of connective and soft tissue of thorax</td>\n <td/>\n </tr>\n <tr>\n <td>C49.4</td>\n <td>Malignant neoplasm of connective and soft tissue of abdomen</td>\n <td/>\n </tr>\n <tr>\n <td>C49.5</td>\n <td>Malignant neoplasm of connective and soft tissue of pelvis</td>\n <td/>\n </tr>\n <tr>\n <td>C49.6</td>\n <td>Malignant neoplasm of connective and soft tissue of trunk, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>C49.8</td>\n <td>Malignant neoplasm of overlapping sites of connective and soft tissue</td>\n <td/>\n </tr>\n <tr>\n <td>C49.9</td>\n <td>Malignant neoplasm of connective and soft tissue, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>C49.A0</td>\n <td>Gastrointestinal stromal tumor, unspecified site</td>\n <td/>\n </tr>\n <tr>\n <td>C49.A1</td>\n <td>Gastrointestinal stromal tumor of esophagus</td>\n <td/>\n </tr>\n <tr>\n <td>C49.A2</td>\n <td>Gastrointestinal stromal tumor of stomach</td>\n <td/>\n </tr>\n <tr>\n <td>C49.A3</td>\n <td>Gastrointestinal stromal tumor of small intestine</td>\n <td/>\n </tr>\n <tr>\n <td>C49.A4</td>\n <td>Gastrointestinal stromal tumor of large intestine</td>\n <td/>\n </tr>\n <tr>\n <td>C49.A5</td>\n <td>Gastrointestinal stromal tumor of rectum</td>\n <td/>\n </tr>\n <tr>\n <td>C49.A9</td>\n <td>Gastrointestinal stromal tumor of other sites</td>\n <td/>\n </tr>\n <tr>\n <td>C4A.0</td>\n <td>Merkel cell carcinoma of lip</td>\n <td/>\n </tr>\n <tr>\n <td>C4A.10</td>\n <td>Merkel cell carcinoma of unspecified eyelid, including canthus</td>\n <td/>\n </tr>\n <tr>\n <td>C4A.11</td>\n <td>Merkel cell carcinoma of right eyelid, including canthus</td>\n <td/>\n </tr>\n <tr>\n <td>C4A.111</td>\n <td>Merkel cell carcinoma of right upper eyelid, including canthus</td>\n <td/>\n </tr>\n <tr>\n <td>C4A.112</td>\n <td>Merkel cell carcinoma of right lower eyelid, including canthus</td>\n <td/>\n </tr>\n <tr>\n <td>C4A.12</td>\n <td>Merkel cell carcinoma of left eyelid, including canthus</td>\n <td/>\n </tr>\n <tr>\n <td>C4A.121</td>\n <td>Merkel cell carcinoma of left upper eyelid, including canthus</td>\n <td/>\n </tr>\n <tr>\n <td>C4A.122</td>\n <td>Merkel cell carcinoma of left lower eyelid, including canthus</td>\n <td/>\n </tr>\n <tr>\n <td>C4A.20</td>\n <td>Merkel cell carcinoma of unspecified ear and external auricular canal</td>\n <td/>\n </tr>\n <tr>\n <td>C4A.21</td>\n <td>Merkel cell carcinoma of right ear and external auricular canal</td>\n <td/>\n </tr>\n <tr>\n <td>C4A.22</td>\n <td>Merkel cell carcinoma of left ear and external auricular canal</td>\n <td/>\n </tr>\n <tr>\n <td>C4A.30</td>\n <td>Merkel cell carcinoma of unspecified part of face</td>\n <td/>\n </tr>\n <tr>\n <td>C4A.31</td>\n <td>Merkel cell carcinoma of nose</td>\n <td/>\n </tr>\n <tr>\n <td>C4A.39</td>\n <td>Merkel cell carcinoma of other parts of face</td>\n <td/>\n </tr>\n <tr>\n <td>C4A.4</td>\n <td>Merkel cell carcinoma of scalp and neck</td>\n <td/>\n </tr>\n <tr>\n <td>C4A.51</td>\n <td>Merkel cell carcinoma of anal skin</td>\n <td/>\n </tr>\n <tr>\n <td>C4A.52</td>\n <td>Merkel cell carcinoma of skin of breast</td>\n <td/>\n </tr>\n <tr>\n <td>C4A.59</td>\n <td>Merkel cell carcinoma of other part of trunk</td>\n <td/>\n </tr>\n <tr>\n <td>C4A.60</td>\n <td>Merkel cell carcinoma of unspecified upper limb, including shoulder</td>\n <td/>\n </tr>\n <tr>\n <td>C4A.61</td>\n <td>Merkel cell carcinoma of right upper limb, including shoulder</td>\n <td/>\n </tr>\n <tr>\n <td>C4A.62</td>\n <td>Merkel cell carcinoma of left upper limb, including shoulder</td>\n <td/>\n </tr>\n <tr>\n <td>C4A.70</td>\n <td>Merkel cell carcinoma of unspecified lower limb, including hip</td>\n <td/>\n </tr>\n <tr>\n <td>C4A.71</td>\n <td>Merkel cell carcinoma of right lower limb, including hip</td>\n <td/>\n </tr>\n <tr>\n <td>C4A.72</td>\n <td>Merkel cell carcinoma of left lower limb, including hip</td>\n <td/>\n </tr>\n <tr>\n <td>C4A.8</td>\n <td>Merkel cell carcinoma of overlapping sites</td>\n <td/>\n </tr>\n <tr>\n <td>C4A.9</td>\n <td>Merkel cell carcinoma, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>C50.011</td>\n <td>Malignant neoplasm of nipple and areola, right female breast</td>\n <td/>\n </tr>\n <tr>\n <td>C50.012</td>\n <td>Malignant neoplasm of nipple and areola, left female breast</td>\n <td/>\n </tr>\n <tr>\n <td>C50.019</td>\n <td>Malignant neoplasm of nipple and areola, unspecified female breast</td>\n <td/>\n </tr>\n <tr>\n <td>C50.021</td>\n <td>Malignant neoplasm of nipple and areola, right male breast</td>\n <td/>\n </tr>\n <tr>\n <td>C50.022</td>\n <td>Malignant neoplasm of nipple and areola, left male breast</td>\n <td/>\n </tr>\n <tr>\n <td>C50.029</td>\n <td>Malignant neoplasm of nipple and areola, unspecified male breast</td>\n <td/>\n </tr>\n <tr>\n <td>C50.111</td>\n <td>Malignant neoplasm of central portion of right female breast</td>\n <td/>\n </tr>\n <tr>\n <td>C50.112</td>\n <td>Malignant neoplasm of central portion of left female breast</td>\n <td/>\n </tr>\n <tr>\n <td>C50.119</td>\n <td>Malignant neoplasm of central portion of unspecified female breast</td>\n <td/>\n </tr>\n <tr>\n <td>C50.121</td>\n <td>Malignant neoplasm of central portion of right male breast</td>\n <td/>\n </tr>\n <tr>\n <td>C50.122</td>\n <td>Malignant neoplasm of central portion of left male breast</td>\n <td/>\n </tr>\n <tr>\n <td>C50.129</td>\n <td>Malignant neoplasm of central portion of unspecified male breast</td>\n <td/>\n </tr>\n <tr>\n <td>C50.211</td>\n <td>Malignant neoplasm of upper-inner quadrant of right female breast</td>\n <td/>\n </tr>\n <tr>\n <td>C50.212</td>\n <td>Malignant neoplasm of upper-inner quadrant of left female breast</td>\n <td/>\n </tr>\n <tr>\n <td>C50.219</td>\n <td>Malignant neoplasm of upper-inner quadrant of unspecified female breast</td>\n <td/>\n </tr>\n <tr>\n <td>C50.221</td>\n <td>Malignant neoplasm of upper-inner quadrant of right male breast</td>\n <td/>\n </tr>\n <tr>\n <td>C50.222</td>\n <td>Malignant neoplasm of upper-inner quadrant of left male breast</td>\n <td/>\n </tr>\n <tr>\n <td>C50.229</td>\n <td>Malignant neoplasm of upper-inner quadrant of unspecified male breast</td>\n <td/>\n </tr>\n <tr>\n <td>C50.311</td>\n <td>Malignant neoplasm of lower-inner quadrant of right female breast</td>\n <td/>\n </tr>\n <tr>\n <td>C50.312</td>\n <td>Malignant neoplasm of lower-inner quadrant of left female breast</td>\n <td/>\n </tr>\n <tr>\n <td>C50.319</td>\n <td>Malignant neoplasm of lower-inner quadrant of unspecified female breast</td>\n <td/>\n </tr>\n <tr>\n <td>C50.321</td>\n <td>Malignant neoplasm of lower-inner quadrant of right male breast</td>\n <td/>\n </tr>\n <tr>\n <td>C50.322</td>\n <td>Malignant neoplasm of lower-inner quadrant of left male breast</td>\n <td/>\n </tr>\n <tr>\n <td>C50.329</td>\n <td>Malignant neoplasm of lower-inner quadrant of unspecified male breast</td>\n <td/>\n </tr>\n <tr>\n <td>C50.411</td>\n <td>Malignant neoplasm of upper-outer quadrant of right female breast</td>\n <td/>\n </tr>\n <tr>\n <td>C50.412</td>\n <td>Malignant neoplasm of upper-outer quadrant of left female breast</td>\n <td/>\n </tr>\n <tr>\n <td>C50.419</td>\n <td>Malignant neoplasm of upper-outer quadrant of unspecified female breast</td>\n <td/>\n </tr>\n <tr>\n <td>C50.421</td>\n <td>Malignant neoplasm of upper-outer quadrant of right male breast</td>\n <td/>\n </tr>\n <tr>\n <td>C50.422</td>\n <td>Malignant neoplasm of upper-outer quadrant of left male breast</td>\n <td/>\n </tr>\n <tr>\n <td>C50.429</td>\n <td>Malignant neoplasm of upper-outer quadrant of unspecified male breast</td>\n <td/>\n </tr>\n <tr>\n <td>C50.511</td>\n <td>Malignant neoplasm of lower-outer quadrant of right female breast</td>\n <td/>\n </tr>\n <tr>\n <td>C50.512</td>\n <td>Malignant neoplasm of lower-outer quadrant of left female breast</td>\n <td/>\n </tr>\n <tr>\n <td>C50.519</td>\n <td>Malignant neoplasm of lower-outer quadrant of unspecified female breast</td>\n <td/>\n </tr>\n <tr>\n <td>C50.521</td>\n <td>Malignant neoplasm of lower-outer quadrant of right male breast</td>\n <td/>\n </tr>\n <tr>\n <td>C50.522</td>\n <td>Malignant neoplasm of lower-outer quadrant of left male breast</td>\n <td/>\n </tr>\n <tr>\n <td>C50.529</td>\n <td>Malignant neoplasm of lower-outer quadrant of unspecified male breast</td>\n <td/>\n </tr>\n <tr>\n <td>C50.611</td>\n <td>Malignant neoplasm of axillary tail of right female breast</td>\n <td/>\n </tr>\n <tr>\n <td>C50.612</td>\n <td>Malignant neoplasm of axillary tail of left female breast</td>\n <td/>\n </tr>\n <tr>\n <td>C50.619</td>\n <td>Malignant neoplasm of axillary tail of unspecified female breast</td>\n <td/>\n </tr>\n <tr>\n <td>C50.621</td>\n <td>Malignant neoplasm of axillary tail of right male breast</td>\n <td/>\n </tr>\n <tr>\n <td>C50.622</td>\n <td>Malignant neoplasm of axillary tail of left male breast</td>\n <td/>\n </tr>\n <tr>\n <td>C50.629</td>\n <td>Malignant neoplasm of axillary tail of unspecified male breast</td>\n <td/>\n </tr>\n <tr>\n <td>C50.811</td>\n <td>Malignant neoplasm of overlapping sites of right female breast</td>\n <td/>\n </tr>\n <tr>\n <td>C50.812</td>\n <td>Malignant neoplasm of overlapping sites of left female breast</td>\n <td/>\n </tr>\n <tr>\n <td>C50.819</td>\n <td>Malignant neoplasm of overlapping sites of unspecified female breast</td>\n <td/>\n </tr>\n <tr>\n <td>C50.821</td>\n <td>Malignant neoplasm of overlapping sites of right male breast</td>\n <td/>\n </tr>\n <tr>\n <td>C50.822</td>\n <td>Malignant neoplasm of overlapping sites of left male breast</td>\n <td/>\n </tr>\n <tr>\n <td>C50.829</td>\n <td>Malignant neoplasm of overlapping sites of unspecified male breast</td>\n <td/>\n </tr>\n <tr>\n <td>C50.911</td>\n <td>Malignant neoplasm of unspecified site of right female breast</td>\n <td/>\n </tr>\n <tr>\n <td>C50.912</td>\n <td>Malignant neoplasm of unspecified site of left female breast</td>\n <td/>\n </tr>\n <tr>\n <td>C50.919</td>\n <td>Malignant neoplasm of unspecified site of unspecified female breast</td>\n <td/>\n </tr>\n <tr>\n <td>C50.921</td>\n <td>Malignant neoplasm of unspecified site of right male breast</td>\n <td/>\n </tr>\n <tr>\n <td>C50.922</td>\n <td>Malignant neoplasm of unspecified site of left male breast</td>\n <td/>\n </tr>\n <tr>\n <td>C50.929</td>\n <td>Malignant neoplasm of unspecified site of unspecified male breast</td>\n <td/>\n </tr>\n <tr>\n <td>C51.0</td>\n <td>Malignant neoplasm of labium majus</td>\n <td/>\n </tr>\n <tr>\n <td>C51.1</td>\n <td>Malignant neoplasm of labium minus</td>\n <td/>\n </tr>\n <tr>\n <td>C51.2</td>\n <td>Malignant neoplasm of clitoris</td>\n <td/>\n </tr>\n <tr>\n <td>C51.8</td>\n <td>Malignant neoplasm of overlapping sites of vulva</td>\n <td/>\n </tr>\n <tr>\n <td>C51.9</td>\n <td>Malignant neoplasm of vulva, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>C52</td>\n <td>Malignant neoplasm of vagina</td>\n <td/>\n </tr>\n <tr>\n <td>C53.0</td>\n <td>Malignant neoplasm of endocervix</td>\n <td/>\n </tr>\n <tr>\n <td>C53.1</td>\n <td>Malignant neoplasm of exocervix</td>\n <td/>\n </tr>\n <tr>\n <td>C53.8</td>\n <td>Malignant neoplasm of overlapping sites of cervix uteri</td>\n <td/>\n </tr>\n <tr>\n <td>C53.9</td>\n <td>Malignant neoplasm of cervix uteri, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>C54.0</td>\n <td>Malignant neoplasm of isthmus uteri</td>\n <td/>\n </tr>\n <tr>\n <td>C54.1</td>\n <td>Malignant neoplasm of endometrium</td>\n <td/>\n </tr>\n <tr>\n <td>C54.2</td>\n <td>Malignant neoplasm of myometrium</td>\n <td/>\n </tr>\n <tr>\n <td>C54.3</td>\n <td>Malignant neoplasm of fundus uteri</td>\n <td/>\n </tr>\n <tr>\n <td>C54.8</td>\n <td>Malignant neoplasm of overlapping sites of corpus uteri</td>\n <td/>\n </tr>\n <tr>\n <td>C54.9</td>\n <td>Malignant neoplasm of corpus uteri, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>C55</td>\n <td>Malignant neoplasm of uterus, part unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>C56.1</td>\n <td>Malignant neoplasm of right ovary</td>\n <td/>\n </tr>\n <tr>\n <td>C56.2</td>\n <td>Malignant neoplasm of left ovary</td>\n <td/>\n </tr>\n <tr>\n <td>C56.9</td>\n <td>Malignant neoplasm of unspecified ovary</td>\n <td/>\n </tr>\n <tr>\n <td>C57.00</td>\n <td>Malignant neoplasm of unspecified fallopian tube</td>\n <td/>\n </tr>\n <tr>\n <td>C57.01</td>\n <td>Malignant neoplasm of right fallopian tube</td>\n <td/>\n </tr>\n <tr>\n <td>C57.02</td>\n <td>Malignant neoplasm of left fallopian tube</td>\n <td/>\n </tr>\n <tr>\n <td>C57.10</td>\n <td>Malignant neoplasm of unspecified broad ligament</td>\n <td/>\n </tr>\n <tr>\n <td>C57.11</td>\n <td>Malignant neoplasm of right broad ligament</td>\n <td/>\n </tr>\n <tr>\n <td>C57.12</td>\n <td>Malignant neoplasm of left broad ligament</td>\n <td/>\n </tr>\n <tr>\n <td>C57.20</td>\n <td>Malignant neoplasm of unspecified round ligament</td>\n <td/>\n </tr>\n <tr>\n <td>C57.21</td>\n <td>Malignant neoplasm of right round ligament</td>\n <td/>\n </tr>\n <tr>\n <td>C57.22</td>\n <td>Malignant neoplasm of left round ligament</td>\n <td/>\n </tr>\n <tr>\n <td>C57.3</td>\n <td>Malignant neoplasm of parametrium</td>\n <td/>\n </tr>\n <tr>\n <td>C57.4</td>\n <td>Malignant neoplasm of uterine adnexa, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>C57.7</td>\n <td>Malignant neoplasm of other specified female genital organs</td>\n <td/>\n </tr>\n <tr>\n <td>C57.8</td>\n <td>Malignant neoplasm of overlapping sites of female genital organs</td>\n <td/>\n </tr>\n <tr>\n <td>C57.9</td>\n <td>Malignant neoplasm of female genital organ, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>C58</td>\n <td>Malignant neoplasm of placenta</td>\n <td/>\n </tr>\n <tr>\n <td>C60.0</td>\n <td>Malignant neoplasm of prepuce</td>\n <td/>\n </tr>\n <tr>\n <td>C60.1</td>\n <td>Malignant neoplasm of glans penis</td>\n <td/>\n </tr>\n <tr>\n <td>C60.2</td>\n <td>Malignant neoplasm of body of penis</td>\n <td/>\n </tr>\n <tr>\n <td>C60.8</td>\n <td>Malignant neoplasm of overlapping sites of penis</td>\n <td/>\n </tr>\n <tr>\n <td>C60.9</td>\n <td>Malignant neoplasm of penis, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>C61</td>\n <td>Malignant neoplasm of prostate</td>\n <td/>\n </tr>\n <tr>\n <td>C62.00</td>\n <td>Malignant neoplasm of unspecified undescended testis</td>\n <td/>\n </tr>\n <tr>\n <td>C62.01</td>\n <td>Malignant neoplasm of undescended right testis</td>\n <td/>\n </tr>\n <tr>\n <td>C62.02</td>\n <td>Malignant neoplasm of undescended left testis</td>\n <td/>\n </tr>\n <tr>\n <td>C62.10</td>\n <td>Malignant neoplasm of unspecified descended testis</td>\n <td/>\n </tr>\n <tr>\n <td>C62.11</td>\n <td>Malignant neoplasm of descended right testis</td>\n <td/>\n </tr>\n <tr>\n <td>C62.12</td>\n <td>Malignant neoplasm of descended left testis</td>\n <td/>\n </tr>\n <tr>\n <td>C62.90</td>\n <td>Malignant neoplasm of unspecified testis, unspecified whether descended or undescended</td>\n <td/>\n </tr>\n <tr>\n <td>C62.91</td>\n <td>Malignant neoplasm of right testis, unspecified whether descended or undescended</td>\n <td/>\n </tr>\n <tr>\n <td>C62.92</td>\n <td>Malignant neoplasm of left testis, unspecified whether descended or undescended</td>\n <td/>\n </tr>\n <tr>\n <td>C63.00</td>\n <td>Malignant neoplasm of unspecified epididymis</td>\n <td/>\n </tr>\n <tr>\n <td>C63.01</td>\n <td>Malignant neoplasm of right epididymis</td>\n <td/>\n </tr>\n <tr>\n <td>C63.02</td>\n <td>Malignant neoplasm of left epididymis</td>\n <td/>\n </tr>\n <tr>\n <td>C63.10</td>\n <td>Malignant neoplasm of unspecified spermatic cord</td>\n <td/>\n </tr>\n <tr>\n <td>C63.11</td>\n <td>Malignant neoplasm of right spermatic cord</td>\n <td/>\n </tr>\n <tr>\n <td>C63.12</td>\n <td>Malignant neoplasm of left spermatic cord</td>\n <td/>\n </tr>\n <tr>\n <td>C63.2</td>\n <td>Malignant neoplasm of scrotum</td>\n <td/>\n </tr>\n <tr>\n <td>C63.7</td>\n <td>Malignant neoplasm of other specified male genital organs</td>\n <td/>\n </tr>\n <tr>\n <td>C63.8</td>\n <td>Malignant neoplasm of overlapping sites of male genital organs</td>\n <td/>\n </tr>\n <tr>\n <td>C63.9</td>\n <td>Malignant neoplasm of male genital organ, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>C64.1</td>\n <td>Malignant neoplasm of right kidney, except renal pelvis</td>\n <td/>\n </tr>\n <tr>\n <td>C64.2</td>\n <td>Malignant neoplasm of left kidney, except renal pelvis</td>\n <td/>\n </tr>\n <tr>\n <td>C64.9</td>\n <td>Malignant neoplasm of unspecified kidney, except renal pelvis</td>\n <td/>\n </tr>\n <tr>\n <td>C65.1</td>\n <td>Malignant neoplasm of right renal pelvis</td>\n <td/>\n </tr>\n <tr>\n <td>C65.2</td>\n <td>Malignant neoplasm of left renal pelvis</td>\n <td/>\n </tr>\n <tr>\n <td>C65.9</td>\n <td>Malignant neoplasm of unspecified renal pelvis</td>\n <td/>\n </tr>\n <tr>\n <td>C66.1</td>\n <td>Malignant neoplasm of right ureter</td>\n <td/>\n </tr>\n <tr>\n <td>C66.2</td>\n <td>Malignant neoplasm of left ureter</td>\n <td/>\n </tr>\n <tr>\n <td>C66.9</td>\n <td>Malignant neoplasm of unspecified ureter</td>\n <td/>\n </tr>\n <tr>\n <td>C67.0</td>\n <td>Malignant neoplasm of trigone of bladder</td>\n <td/>\n </tr>\n <tr>\n <td>C67.1</td>\n <td>Malignant neoplasm of dome of bladder</td>\n <td/>\n </tr>\n <tr>\n <td>C67.2</td>\n <td>Malignant neoplasm of lateral wall of bladder</td>\n <td/>\n </tr>\n <tr>\n <td>C67.3</td>\n <td>Malignant neoplasm of anterior wall of bladder</td>\n <td/>\n </tr>\n <tr>\n <td>C67.4</td>\n <td>Malignant neoplasm of posterior wall of bladder</td>\n <td/>\n </tr>\n <tr>\n <td>C67.5</td>\n <td>Malignant neoplasm of bladder neck</td>\n <td/>\n </tr>\n <tr>\n <td>C67.6</td>\n <td>Malignant neoplasm of ureteric orifice</td>\n <td/>\n </tr>\n <tr>\n <td>C67.7</td>\n <td>Malignant neoplasm of urachus</td>\n <td/>\n </tr>\n <tr>\n <td>C67.8</td>\n <td>Malignant neoplasm of overlapping sites of bladder</td>\n <td/>\n </tr>\n <tr>\n <td>C67.9</td>\n <td>Malignant neoplasm of bladder, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>C68.0</td>\n <td>Malignant neoplasm of urethra</td>\n <td/>\n </tr>\n <tr>\n <td>C68.1</td>\n <td>Malignant neoplasm of paraurethral glands</td>\n <td/>\n </tr>\n <tr>\n <td>C68.8</td>\n <td>Malignant neoplasm of overlapping sites of urinary organs</td>\n <td/>\n </tr>\n <tr>\n <td>C68.9</td>\n <td>Malignant neoplasm of urinary organ, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>C69.00</td>\n <td>Malignant neoplasm of unspecified conjunctiva</td>\n <td/>\n </tr>\n <tr>\n <td>C69.01</td>\n <td>Malignant neoplasm of right conjunctiva</td>\n <td/>\n </tr>\n <tr>\n <td>C69.02</td>\n <td>Malignant neoplasm of left conjunctiva</td>\n <td/>\n </tr>\n <tr>\n <td>C69.10</td>\n <td>Malignant neoplasm of unspecified cornea</td>\n <td/>\n </tr>\n <tr>\n <td>C69.11</td>\n <td>Malignant neoplasm of right cornea</td>\n <td/>\n </tr>\n <tr>\n <td>C69.12</td>\n <td>Malignant neoplasm of left cornea</td>\n <td/>\n </tr>\n <tr>\n <td>C69.20</td>\n <td>Malignant neoplasm of unspecified retina</td>\n <td/>\n </tr>\n <tr>\n <td>C69.21</td>\n <td>Malignant neoplasm of right retina</td>\n <td/>\n </tr>\n <tr>\n <td>C69.22</td>\n <td>Malignant neoplasm of left retina</td>\n <td/>\n </tr>\n <tr>\n <td>C69.30</td>\n <td>Malignant neoplasm of unspecified choroid</td>\n <td/>\n </tr>\n <tr>\n <td>C69.31</td>\n <td>Malignant neoplasm of right choroid</td>\n <td/>\n </tr>\n <tr>\n <td>C69.32</td>\n <td>Malignant neoplasm of left choroid</td>\n <td/>\n </tr>\n <tr>\n <td>C69.40</td>\n <td>Malignant neoplasm of unspecified ciliary body</td>\n <td/>\n </tr>\n <tr>\n <td>C69.41</td>\n <td>Malignant neoplasm of right ciliary body</td>\n <td/>\n </tr>\n <tr>\n <td>C69.42</td>\n <td>Malignant neoplasm of left ciliary body</td>\n <td/>\n </tr>\n <tr>\n <td>C69.50</td>\n <td>Malignant neoplasm of unspecified lacrimal gland and duct</td>\n <td/>\n </tr>\n <tr>\n <td>C69.51</td>\n <td>Malignant neoplasm of right lacrimal gland and duct</td>\n <td/>\n </tr>\n <tr>\n <td>C69.52</td>\n <td>Malignant neoplasm of left lacrimal gland and duct</td>\n <td/>\n </tr>\n <tr>\n <td>C69.60</td>\n <td>Malignant neoplasm of unspecified orbit</td>\n <td/>\n </tr>\n <tr>\n <td>C69.61</td>\n <td>Malignant neoplasm of right orbit</td>\n <td/>\n </tr>\n <tr>\n <td>C69.62</td>\n <td>Malignant neoplasm of left orbit</td>\n <td/>\n </tr>\n <tr>\n <td>C69.80</td>\n <td>Malignant neoplasm of overlapping sites of unspecified eye and adnexa</td>\n <td/>\n </tr>\n <tr>\n <td>C69.81</td>\n <td>Malignant neoplasm of overlapping sites of right eye and adnexa</td>\n <td/>\n </tr>\n <tr>\n <td>C69.82</td>\n <td>Malignant neoplasm of overlapping sites of left eye and adnexa</td>\n <td/>\n </tr>\n <tr>\n <td>C69.90</td>\n <td>Malignant neoplasm of unspecified site of unspecified eye</td>\n <td/>\n </tr>\n <tr>\n <td>C69.91</td>\n <td>Malignant neoplasm of unspecified site of right eye</td>\n <td/>\n </tr>\n <tr>\n <td>C69.92</td>\n <td>Malignant neoplasm of unspecified site of left eye</td>\n <td/>\n </tr>\n <tr>\n <td>C70.0</td>\n <td>Malignant neoplasm of cerebral meninges</td>\n <td/>\n </tr>\n <tr>\n <td>C70.1</td>\n <td>Malignant neoplasm of spinal meninges</td>\n <td/>\n </tr>\n <tr>\n <td>C70.9</td>\n <td>Malignant neoplasm of meninges, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>C71.0</td>\n <td>Malignant neoplasm of cerebrum, except lobes and ventricles</td>\n <td/>\n </tr>\n <tr>\n <td>C71.1</td>\n <td>Malignant neoplasm of frontal lobe</td>\n <td/>\n </tr>\n <tr>\n <td>C71.2</td>\n <td>Malignant neoplasm of temporal lobe</td>\n <td/>\n </tr>\n <tr>\n <td>C71.3</td>\n <td>Malignant neoplasm of parietal lobe</td>\n <td/>\n </tr>\n <tr>\n <td>C71.4</td>\n <td>Malignant neoplasm of occipital lobe</td>\n <td/>\n </tr>\n <tr>\n <td>C71.5</td>\n <td>Malignant neoplasm of cerebral ventricle</td>\n <td/>\n </tr>\n <tr>\n <td>C71.6</td>\n <td>Malignant neoplasm of cerebellum</td>\n <td/>\n </tr>\n <tr>\n <td>C71.7</td>\n <td>Malignant neoplasm of brain stem</td>\n <td/>\n </tr>\n <tr>\n <td>C71.8</td>\n <td>Malignant neoplasm of overlapping sites of brain</td>\n <td/>\n </tr>\n <tr>\n <td>C71.9</td>\n <td>Malignant neoplasm of brain, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>C72.0</td>\n <td>Malignant neoplasm of spinal cord</td>\n <td/>\n </tr>\n <tr>\n <td>C72.1</td>\n <td>Malignant neoplasm of cauda equina</td>\n <td/>\n </tr>\n <tr>\n <td>C72.20</td>\n <td>Malignant neoplasm of unspecified olfactory nerve</td>\n <td/>\n </tr>\n <tr>\n <td>C72.21</td>\n <td>Malignant neoplasm of right olfactory nerve</td>\n <td/>\n </tr>\n <tr>\n <td>C72.22</td>\n <td>Malignant neoplasm of left olfactory nerve</td>\n <td/>\n </tr>\n <tr>\n <td>C72.30</td>\n <td>Malignant neoplasm of unspecified optic nerve</td>\n <td/>\n </tr>\n <tr>\n <td>C72.31</td>\n <td>Malignant neoplasm of right optic nerve</td>\n <td/>\n </tr>\n <tr>\n <td>C72.32</td>\n <td>Malignant neoplasm of left optic nerve</td>\n <td/>\n </tr>\n <tr>\n <td>C72.40</td>\n <td>Malignant neoplasm of unspecified acoustic nerve</td>\n <td/>\n </tr>\n <tr>\n <td>C72.41</td>\n <td>Malignant neoplasm of right acoustic nerve</td>\n <td/>\n </tr>\n <tr>\n <td>C72.42</td>\n <td>Malignant neoplasm of left acoustic nerve</td>\n <td/>\n </tr>\n <tr>\n <td>C72.50</td>\n <td>Malignant neoplasm of unspecified cranial nerve</td>\n <td/>\n </tr>\n <tr>\n <td>C72.59</td>\n <td>Malignant neoplasm of other cranial nerves</td>\n <td/>\n </tr>\n <tr>\n <td>C72.9</td>\n <td>Malignant neoplasm of central nervous system, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>C73</td>\n <td>Malignant neoplasm of thyroid gland</td>\n <td/>\n </tr>\n <tr>\n <td>C74.00</td>\n <td>Malignant neoplasm of cortex of unspecified adrenal gland</td>\n <td/>\n </tr>\n <tr>\n <td>C74.01</td>\n <td>Malignant neoplasm of cortex of right adrenal gland</td>\n <td/>\n </tr>\n <tr>\n <td>C74.02</td>\n <td>Malignant neoplasm of cortex of left adrenal gland</td>\n <td/>\n </tr>\n <tr>\n <td>C74.10</td>\n <td>Malignant neoplasm of medulla of unspecified adrenal gland</td>\n <td/>\n </tr>\n <tr>\n <td>C74.11</td>\n <td>Malignant neoplasm of medulla of right adrenal gland</td>\n <td/>\n </tr>\n <tr>\n <td>C74.12</td>\n <td>Malignant neoplasm of medulla of left adrenal gland</td>\n <td/>\n </tr>\n <tr>\n <td>C74.90</td>\n <td>Malignant neoplasm of unspecified part of unspecified adrenal gland</td>\n <td/>\n </tr>\n <tr>\n <td>C74.91</td>\n <td>Malignant neoplasm of unspecified part of right adrenal gland</td>\n <td/>\n </tr>\n <tr>\n <td>C74.92</td>\n <td>Malignant neoplasm of unspecified part of left adrenal gland</td>\n <td/>\n </tr>\n <tr>\n <td>C75.0</td>\n <td>Malignant neoplasm of parathyroid gland</td>\n <td/>\n </tr>\n <tr>\n <td>C75.1</td>\n <td>Malignant neoplasm of pituitary gland</td>\n <td/>\n </tr>\n <tr>\n <td>C75.2</td>\n <td>Malignant neoplasm of craniopharyngeal duct</td>\n <td/>\n </tr>\n <tr>\n <td>C75.3</td>\n <td>Malignant neoplasm of pineal gland</td>\n <td/>\n </tr>\n <tr>\n <td>C75.4</td>\n <td>Malignant neoplasm of carotid body</td>\n <td/>\n </tr>\n <tr>\n <td>C75.5</td>\n <td>Malignant neoplasm of aortic body and other paraganglia</td>\n <td/>\n </tr>\n <tr>\n <td>C75.8</td>\n <td>Malignant neoplasm with pluriglandular involvement, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>C75.9</td>\n <td>Malignant neoplasm of endocrine gland, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>C76.0</td>\n <td>Malignant neoplasm of head, face and neck</td>\n <td/>\n </tr>\n <tr>\n <td>C76.1</td>\n <td>Malignant neoplasm of thorax</td>\n <td/>\n </tr>\n <tr>\n <td>C76.2</td>\n <td>Malignant neoplasm of abdomen</td>\n <td/>\n </tr>\n <tr>\n <td>C76.3</td>\n <td>Malignant neoplasm of pelvis</td>\n <td/>\n </tr>\n <tr>\n <td>C76.40</td>\n <td>Malignant neoplasm of unspecified upper limb</td>\n <td/>\n </tr>\n <tr>\n <td>C76.41</td>\n <td>Malignant neoplasm of right upper limb</td>\n <td/>\n </tr>\n <tr>\n <td>C76.42</td>\n <td>Malignant neoplasm of left upper limb</td>\n <td/>\n </tr>\n <tr>\n <td>C76.50</td>\n <td>Malignant neoplasm of unspecified lower limb</td>\n <td/>\n </tr>\n <tr>\n <td>C76.51</td>\n <td>Malignant neoplasm of right lower limb</td>\n <td/>\n </tr>\n <tr>\n <td>C76.52</td>\n <td>Malignant neoplasm of left lower limb</td>\n <td/>\n </tr>\n <tr>\n <td>C76.8</td>\n <td>Malignant neoplasm of other specified ill-defined sites</td>\n <td/>\n </tr>\n <tr>\n <td>C77.0</td>\n <td>Secondary and unspecified malignant neoplasm of lymph nodes of head, face and neck</td>\n <td/>\n </tr>\n <tr>\n <td>C77.1</td>\n <td>Secondary and unspecified malignant neoplasm of intrathoracic lymph nodes</td>\n <td/>\n </tr>\n <tr>\n <td>C77.2</td>\n <td>Secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes</td>\n <td/>\n </tr>\n <tr>\n <td>C77.3</td>\n <td>Secondary and unspecified malignant neoplasm of axilla and upper limb lymph nodes</td>\n <td/>\n </tr>\n <tr>\n <td>C77.4</td>\n <td>Secondary and unspecified malignant neoplasm of inguinal and lower limb lymph nodes</td>\n <td/>\n </tr>\n <tr>\n <td>C77.5</td>\n <td>Secondary and unspecified malignant neoplasm of intrapelvic lymph nodes</td>\n <td/>\n </tr>\n <tr>\n <td>C77.8</td>\n <td>Secondary and unspecified malignant neoplasm of lymph nodes of multiple regions</td>\n <td/>\n </tr>\n <tr>\n <td>C77.9</td>\n <td>Secondary and unspecified malignant neoplasm of lymph node, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>C78.00</td>\n <td>Secondary malignant neoplasm of unspecified lung</td>\n <td/>\n </tr>\n <tr>\n <td>C78.01</td>\n <td>Secondary malignant neoplasm of right lung</td>\n <td/>\n </tr>\n <tr>\n <td>C78.02</td>\n <td>Secondary malignant neoplasm of left lung</td>\n <td/>\n </tr>\n <tr>\n <td>C78.1</td>\n <td>Secondary malignant neoplasm of mediastinum</td>\n <td/>\n </tr>\n <tr>\n <td>C78.2</td>\n <td>Secondary malignant neoplasm of pleura</td>\n <td/>\n </tr>\n <tr>\n <td>C78.30</td>\n <td>Secondary malignant neoplasm of unspecified respiratory organ</td>\n <td/>\n </tr>\n <tr>\n <td>C78.39</td>\n <td>Secondary malignant neoplasm of other respiratory organs</td>\n <td/>\n </tr>\n <tr>\n <td>C78.4</td>\n <td>Secondary malignant neoplasm of small intestine</td>\n <td/>\n </tr>\n <tr>\n <td>C78.5</td>\n <td>Secondary malignant neoplasm of large intestine and rectum</td>\n <td/>\n </tr>\n <tr>\n <td>C78.6</td>\n <td>Secondary malignant neoplasm of retroperitoneum and peritoneum</td>\n <td/>\n </tr>\n <tr>\n <td>C78.7</td>\n <td>Secondary malignant neoplasm of liver and intrahepatic bile duct</td>\n <td/>\n </tr>\n <tr>\n <td>C78.80</td>\n <td>Secondary malignant neoplasm of unspecified digestive organ</td>\n <td/>\n </tr>\n <tr>\n <td>C78.89</td>\n <td>Secondary malignant neoplasm of other digestive organs</td>\n <td/>\n </tr>\n <tr>\n <td>C79.00</td>\n <td>Secondary malignant neoplasm of unspecified kidney and renal pelvis</td>\n <td/>\n </tr>\n <tr>\n <td>C79.01</td>\n <td>Secondary malignant neoplasm of right kidney and renal pelvis</td>\n <td/>\n </tr>\n <tr>\n <td>C79.02</td>\n <td>Secondary malignant neoplasm of left kidney and renal pelvis</td>\n <td/>\n </tr>\n <tr>\n <td>C79.10</td>\n <td>Secondary malignant neoplasm of unspecified urinary organs</td>\n <td/>\n </tr>\n <tr>\n <td>C79.11</td>\n <td>Secondary malignant neoplasm of bladder</td>\n <td/>\n </tr>\n <tr>\n <td>C79.19</td>\n <td>Secondary malignant neoplasm of other urinary organs</td>\n <td/>\n </tr>\n <tr>\n <td>C79.2</td>\n <td>Secondary malignant neoplasm of skin</td>\n <td/>\n </tr>\n <tr>\n <td>C79.31</td>\n <td>Secondary malignant neoplasm of brain</td>\n <td/>\n </tr>\n <tr>\n <td>C79.32</td>\n <td>Secondary malignant neoplasm of cerebral meninges</td>\n <td/>\n </tr>\n <tr>\n <td>C79.40</td>\n <td>Secondary malignant neoplasm of unspecified part of nervous system</td>\n <td/>\n </tr>\n <tr>\n <td>C79.49</td>\n <td>Secondary malignant neoplasm of other parts of nervous system</td>\n <td/>\n </tr>\n <tr>\n <td>C79.51</td>\n <td>Secondary malignant neoplasm of bone</td>\n <td/>\n </tr>\n <tr>\n <td>C79.52</td>\n <td>Secondary malignant neoplasm of bone marrow</td>\n <td/>\n </tr>\n <tr>\n <td>C79.60</td>\n <td>Secondary malignant neoplasm of unspecified ovary</td>\n <td/>\n </tr>\n <tr>\n <td>C79.61</td>\n <td>Secondary malignant neoplasm of right ovary</td>\n <td/>\n </tr>\n <tr>\n <td>C79.62</td>\n <td>Secondary malignant neoplasm of left ovary</td>\n <td/>\n </tr>\n <tr>\n <td>C79.70</td>\n <td>Secondary malignant neoplasm of unspecified adrenal gland</td>\n <td/>\n </tr>\n <tr>\n <td>C79.71</td>\n <td>Secondary malignant neoplasm of right adrenal gland</td>\n <td/>\n </tr>\n <tr>\n <td>C79.72</td>\n <td>Secondary malignant neoplasm of left adrenal gland</td>\n <td/>\n </tr>\n <tr>\n <td>C79.81</td>\n <td>Secondary malignant neoplasm of breast</td>\n <td/>\n </tr>\n <tr>\n <td>C79.82</td>\n <td>Secondary malignant neoplasm of genital organs</td>\n <td/>\n </tr>\n <tr>\n <td>C79.89</td>\n <td>Secondary malignant neoplasm of other specified sites</td>\n <td/>\n </tr>\n <tr>\n <td>C79.9</td>\n <td>Secondary malignant neoplasm of unspecified site</td>\n <td/>\n </tr>\n <tr>\n <td>C7A.00</td>\n <td>Malignant carcinoid tumor of unspecified site</td>\n <td/>\n </tr>\n <tr>\n <td>C7A.010</td>\n <td>Malignant carcinoid tumor of the duodenum</td>\n <td/>\n </tr>\n <tr>\n <td>C7A.011</td>\n <td>Malignant carcinoid tumor of the jejunum</td>\n <td/>\n </tr>\n <tr>\n <td>C7A.012</td>\n <td>Malignant carcinoid tumor of the ileum</td>\n <td/>\n </tr>\n <tr>\n <td>C7A.019</td>\n <td>Malignant carcinoid tumor of the small intestine, unspecified portion</td>\n <td/>\n </tr>\n <tr>\n <td>C7A.020</td>\n <td>Malignant carcinoid tumor of the appendix</td>\n <td/>\n </tr>\n <tr>\n <td>C7A.021</td>\n <td>Malignant carcinoid tumor of the cecum</td>\n <td/>\n </tr>\n <tr>\n <td>C7A.022</td>\n <td>Malignant carcinoid tumor of the ascending colon</td>\n <td/>\n </tr>\n <tr>\n <td>C7A.023</td>\n <td>Malignant carcinoid tumor of the transverse colon</td>\n <td/>\n </tr>\n <tr>\n <td>C7A.024</td>\n <td>Malignant carcinoid tumor of the descending colon</td>\n <td/>\n </tr>\n <tr>\n <td>C7A.025</td>\n <td>Malignant carcinoid tumor of the sigmoid colon</td>\n <td/>\n </tr>\n <tr>\n <td>C7A.026</td>\n <td>Malignant carcinoid tumor of the rectum</td>\n <td/>\n </tr>\n <tr>\n <td>C7A.029</td>\n <td>Malignant carcinoid tumor of the large intestine, unspecified portion</td>\n <td/>\n </tr>\n <tr>\n <td>C7A.090</td>\n <td>Malignant carcinoid tumor of the bronchus and lung</td>\n <td/>\n </tr>\n <tr>\n <td>C7A.091</td>\n <td>Malignant carcinoid tumor of the thymus</td>\n <td/>\n </tr>\n <tr>\n <td>C7A.092</td>\n <td>Malignant carcinoid tumor of the stomach</td>\n <td/>\n </tr>\n <tr>\n <td>C7A.093</td>\n <td>Malignant carcinoid tumor of the kidney</td>\n <td/>\n </tr>\n <tr>\n <td>C7A.094</td>\n <td>Malignant carcinoid tumor of the foregut, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>C7A.095</td>\n <td>Malignant carcinoid tumor of the midgut, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>C7A.096</td>\n <td>Malignant carcinoid tumor of the hindgut, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>C7A.098</td>\n <td>Malignant carcinoid tumors of other sites</td>\n <td/>\n </tr>\n <tr>\n <td>C7A.1</td>\n <td>Malignant poorly differentiated neuroendocrine tumors</td>\n <td/>\n </tr>\n <tr>\n <td>C7A.8</td>\n <td>Other malignant neuroendocrine tumors</td>\n <td/>\n </tr>\n <tr>\n <td>C7B.00</td>\n <td>Secondary carcinoid tumors, unspecified site</td>\n <td/>\n </tr>\n <tr>\n <td>C7B.01</td>\n <td>Secondary carcinoid tumors of distant lymph nodes</td>\n <td/>\n </tr>\n <tr>\n <td>C7B.02</td>\n <td>Secondary carcinoid tumors of liver</td>\n <td/>\n </tr>\n <tr>\n <td>C7B.03</td>\n <td>Secondary carcinoid tumors of bone</td>\n <td/>\n </tr>\n <tr>\n <td>C7B.04</td>\n <td>Secondary carcinoid tumors of peritoneum</td>\n <td/>\n </tr>\n <tr>\n <td>C7B.09</td>\n <td>Secondary carcinoid tumors of other sites</td>\n <td/>\n </tr>\n <tr>\n <td>C7B.1</td>\n <td>Secondary Merkel cell carcinoma</td>\n <td/>\n </tr>\n <tr>\n <td>C7B.8</td>\n <td>Other secondary neuroendocrine tumors</td>\n <td/>\n </tr>\n <tr>\n <td>C80.0</td>\n <td>Disseminated malignant neoplasm, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>C80.1</td>\n <td>Malignant (primary) neoplasm, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>C80.2</td>\n <td>Malignant neoplasm associated with transplanted organ</td>\n <td/>\n </tr>\n <tr>\n <td>C81.00</td>\n <td>Nodular lymphocyte predominant Hodgkin lymphoma, unspecified site</td>\n <td/>\n </tr>\n <tr>\n <td>C81.01</td>\n <td>Nodular lymphocyte predominant Hodgkin lymphoma, lymph nodes of head, face, and neck</td>\n <td/>\n </tr>\n <tr>\n <td>C81.02</td>\n <td>Nodular lymphocyte predominant Hodgkin lymphoma, intrathoracic lymph nodes</td>\n <td/>\n </tr>\n <tr>\n <td>C81.03</td>\n <td>Nodular lymphocyte predominant Hodgkin lymphoma, intra-abdominal lymph nodes</td>\n <td/>\n </tr>\n <tr>\n <td>C81.04</td>\n <td>Nodular lymphocyte predominant Hodgkin lymphoma, lymph nodes of axilla and upper limb</td>\n <td/>\n </tr>\n <tr>\n <td>C81.05</td>\n <td>Nodular lymphocyte predominant Hodgkin lymphoma, lymph nodes of inguinal region and lower limb</td>\n <td/>\n </tr>\n <tr>\n <td>C81.06</td>\n <td>Nodular lymphocyte predominant Hodgkin lymphoma, intrapelvic lymph nodes</td>\n <td/>\n </tr>\n <tr>\n <td>C81.07</td>\n <td>Nodular lymphocyte predominant Hodgkin lymphoma, spleen</td>\n <td/>\n </tr>\n <tr>\n <td>C81.08</td>\n <td>Nodular lymphocyte predominant Hodgkin lymphoma, lymph nodes of multiple sites</td>\n <td/>\n </tr>\n <tr>\n <td>C81.09</td>\n <td>Nodular lymphocyte predominant Hodgkin lymphoma, extranodal and solid organ sites</td>\n <td/>\n </tr>\n <tr>\n <td>C81.10</td>\n <td>Nodular sclerosis Hodgkin lymphoma, unspecified site</td>\n <td/>\n </tr>\n <tr>\n <td>C81.11</td>\n <td>Nodular sclerosis Hodgkin lymphoma, lymph nodes of head, face, and neck</td>\n <td/>\n </tr>\n <tr>\n <td>C81.12</td>\n <td>Nodular sclerosis Hodgkin lymphoma, intrathoracic lymph nodes</td>\n <td/>\n </tr>\n <tr>\n <td>C81.13</td>\n <td>Nodular sclerosis Hodgkin lymphoma, intra-abdominal lymph nodes</td>\n <td/>\n </tr>\n <tr>\n <td>C81.14</td>\n <td>Nodular sclerosis Hodgkin lymphoma, lymph nodes of axilla and upper limb</td>\n <td/>\n </tr>\n <tr>\n <td>C81.15</td>\n <td>Nodular sclerosis Hodgkin lymphoma, lymph nodes of inguinal region and lower limb</td>\n <td/>\n </tr>\n <tr>\n <td>C81.16</td>\n <td>Nodular sclerosis Hodgkin lymphoma, intrapelvic lymph nodes</td>\n <td/>\n </tr>\n <tr>\n <td>C81.17</td>\n <td>Nodular sclerosis Hodgkin lymphoma, spleen</td>\n <td/>\n </tr>\n <tr>\n <td>C81.18</td>\n <td>Nodular sclerosis Hodgkin lymphoma, lymph nodes of multiple sites</td>\n <td/>\n </tr>\n <tr>\n <td>C81.19</td>\n <td>Nodular sclerosis Hodgkin lymphoma, extranodal and solid organ sites</td>\n <td/>\n </tr>\n <tr>\n <td>C81.20</td>\n <td>Mixed cellularity Hodgkin lymphoma, unspecified site</td>\n <td/>\n </tr>\n <tr>\n <td>C81.21</td>\n <td>Mixed cellularity Hodgkin lymphoma, lymph nodes of head, face, and neck</td>\n <td/>\n </tr>\n <tr>\n <td>C81.22</td>\n <td>Mixed cellularity Hodgkin lymphoma, intrathoracic lymph nodes</td>\n <td/>\n </tr>\n <tr>\n <td>C81.23</td>\n <td>Mixed cellularity Hodgkin lymphoma, intra-abdominal lymph nodes</td>\n <td/>\n </tr>\n <tr>\n <td>C81.24</td>\n <td>Mixed cellularity Hodgkin lymphoma, lymph nodes of axilla and upper limb</td>\n <td/>\n </tr>\n <tr>\n <td>C81.25</td>\n <td>Mixed cellularity Hodgkin lymphoma, lymph nodes of inguinal region and lower limb</td>\n <td/>\n </tr>\n <tr>\n <td>C81.26</td>\n <td>Mixed cellularity Hodgkin lymphoma, intrapelvic lymph nodes</td>\n <td/>\n </tr>\n <tr>\n <td>C81.27</td>\n <td>Mixed cellularity Hodgkin lymphoma, spleen</td>\n <td/>\n </tr>\n <tr>\n <td>C81.28</td>\n <td>Mixed cellularity Hodgkin lymphoma, lymph nodes of multiple sites</td>\n <td/>\n </tr>\n <tr>\n <td>C81.29</td>\n <td>Mixed cellularity Hodgkin lymphoma, extranodal and solid organ sites</td>\n <td/>\n </tr>\n <tr>\n <td>C81.30</td>\n <td>Lymphocyte depleted Hodgkin lymphoma, unspecified site</td>\n <td/>\n </tr>\n <tr>\n <td>C81.31</td>\n <td>Lymphocyte depleted Hodgkin lymphoma, lymph nodes of head, face, and neck</td>\n <td/>\n </tr>\n <tr>\n <td>C81.32</td>\n <td>Lymphocyte depleted Hodgkin lymphoma, intrathoracic lymph nodes</td>\n <td/>\n </tr>\n <tr>\n <td>C81.33</td>\n <td>Lymphocyte depleted Hodgkin lymphoma, intra-abdominal lymph nodes</td>\n <td/>\n </tr>\n <tr>\n <td>C81.34</td>\n <td>Lymphocyte depleted Hodgkin lymphoma, lymph nodes of axilla and upper limb</td>\n <td/>\n </tr>\n <tr>\n <td>C81.35</td>\n <td>Lymphocyte depleted Hodgkin lymphoma, lymph nodes of inguinal region and lower limb</td>\n <td/>\n </tr>\n <tr>\n <td>C81.36</td>\n <td>Lymphocyte depleted Hodgkin lymphoma, intrapelvic lymph nodes</td>\n <td/>\n </tr>\n <tr>\n <td>C81.37</td>\n <td>Lymphocyte depleted Hodgkin lymphoma, spleen</td>\n <td/>\n </tr>\n <tr>\n <td>C81.38</td>\n <td>Lymphocyte depleted Hodgkin lymphoma, lymph nodes of multiple sites</td>\n <td/>\n </tr>\n <tr>\n <td>C81.39</td>\n <td>Lymphocyte depleted Hodgkin lymphoma, extranodal and solid organ sites</td>\n <td/>\n </tr>\n <tr>\n <td>C81.40</td>\n <td>Lymphocyte-rich Hodgkin lymphoma, unspecified site</td>\n <td/>\n </tr>\n <tr>\n <td>C81.41</td>\n <td>Lymphocyte-rich Hodgkin lymphoma, lymph nodes of head, face, and neck</td>\n <td/>\n </tr>\n <tr>\n <td>C81.42</td>\n <td>Lymphocyte-rich Hodgkin lymphoma, intrathoracic lymph nodes</td>\n <td/>\n </tr>\n <tr>\n <td>C81.43</td>\n <td>Lymphocyte-rich Hodgkin lymphoma, intra-abdominal lymph nodes</td>\n <td/>\n </tr>\n <tr>\n <td>C81.44</td>\n <td>Lymphocyte-rich Hodgkin lymphoma, lymph nodes of axilla and upper limb</td>\n <td/>\n </tr>\n <tr>\n <td>C81.45</td>\n <td>Lymphocyte-rich Hodgkin lymphoma, lymph nodes of inguinal region and lower limb</td>\n <td/>\n </tr>\n <tr>\n <td>C81.46</td>\n <td>Lymphocyte-rich Hodgkin lymphoma, intrapelvic lymph nodes</td>\n <td/>\n </tr>\n <tr>\n <td>C81.47</td>\n <td>Lymphocyte-rich Hodgkin lymphoma, spleen</td>\n <td/>\n </tr>\n <tr>\n <td>C81.48</td>\n <td>Lymphocyte-rich Hodgkin lymphoma, lymph nodes of multiple sites</td>\n <td/>\n </tr>\n <tr>\n <td>C81.49</td>\n <td>Lymphocyte-rich Hodgkin lymphoma, extranodal and solid organ sites</td>\n <td/>\n </tr>\n <tr>\n <td>C81.70</td>\n <td>Other Hodgkin lymphoma, unspecified site</td>\n <td/>\n </tr>\n <tr>\n <td>C81.71</td>\n <td>Other Hodgkin lymphoma, lymph nodes of head, face, and neck</td>\n <td/>\n </tr>\n <tr>\n <td>C81.72</td>\n <td>Other Hodgkin lymphoma, intrathoracic lymph nodes</td>\n <td/>\n </tr>\n <tr>\n <td>C81.73</td>\n <td>Other Hodgkin lymphoma, intra-abdominal lymph nodes</td>\n <td/>\n </tr>\n <tr>\n <td>C81.74</td>\n <td>Other Hodgkin lymphoma, lymph nodes of axilla and upper limb</td>\n <td/>\n </tr>\n <tr>\n <td>C81.75</td>\n <td>Other Hodgkin lymphoma, lymph nodes of inguinal region and lower limb</td>\n <td/>\n </tr>\n <tr>\n <td>C81.76</td>\n <td>Other Hodgkin lymphoma, intrapelvic lymph nodes</td>\n <td/>\n </tr>\n <tr>\n <td>C81.77</td>\n <td>Other Hodgkin lymphoma, spleen</td>\n <td/>\n </tr>\n <tr>\n <td>C81.78</td>\n <td>Other Hodgkin lymphoma, lymph nodes of multiple sites</td>\n <td/>\n </tr>\n <tr>\n <td>C81.79</td>\n <td>Other Hodgkin lymphoma, extranodal and solid organ sites</td>\n <td/>\n </tr>\n <tr>\n <td>C81.90</td>\n <td>Hodgkin lymphoma, unspecified, unspecified site</td>\n <td/>\n </tr>\n <tr>\n <td>C81.91</td>\n <td>Hodgkin lymphoma, unspecified, lymph nodes of head, face, and neck</td>\n <td/>\n </tr>\n <tr>\n <td>C81.92</td>\n <td>Hodgkin lymphoma, unspecified, intrathoracic lymph nodes</td>\n <td/>\n </tr>\n <tr>\n <td>C81.93</td>\n <td>Hodgkin lymphoma, unspecified, intra-abdominal lymph nodes</td>\n <td/>\n </tr>\n <tr>\n <td>C81.94</td>\n <td>Hodgkin lymphoma, unspecified, lymph nodes of axilla and upper limb</td>\n <td/>\n </tr>\n <tr>\n <td>C81.95</td>\n <td>Hodgkin lymphoma, unspecified, lymph nodes of inguinal region and lower limb</td>\n <td/>\n </tr>\n <tr>\n <td>C81.96</td>\n <td>Hodgkin lymphoma, unspecified, intrapelvic lymph nodes</td>\n <td/>\n </tr>\n <tr>\n <td>C81.97</td>\n <td>Hodgkin lymphoma, unspecified, spleen</td>\n <td/>\n </tr>\n <tr>\n <td>C81.98</td>\n <td>Hodgkin lymphoma, unspecified, lymph nodes of multiple sites</td>\n <td/>\n </tr>\n <tr>\n <td>C81.99</td>\n <td>Hodgkin lymphoma, unspecified, extranodal and solid organ sites</td>\n <td/>\n </tr>\n <tr>\n <td>C82.00</td>\n <td>Follicular lymphoma grade I, unspecified site</td>\n <td/>\n </tr>\n <tr>\n <td>C82.01</td>\n <td>Follicular lymphoma grade I, lymph nodes of head, face, and neck</td>\n <td/>\n </tr>\n <tr>\n <td>C82.02</td>\n <td>Follicular lymphoma grade I, intrathoracic lymph nodes</td>\n <td/>\n </tr>\n <tr>\n <td>C82.03</td>\n <td>Follicular lymphoma grade I, intra-abdominal lymph nodes</td>\n <td/>\n </tr>\n <tr>\n <td>C82.04</td>\n <td>Follicular lymphoma grade I, lymph nodes of axilla and upper limb</td>\n <td/>\n </tr>\n <tr>\n <td>C82.05</td>\n <td>Follicular lymphoma grade I, lymph nodes of inguinal region and lower limb</td>\n <td/>\n </tr>\n <tr>\n <td>C82.06</td>\n <td>Follicular lymphoma grade I, intrapelvic lymph nodes</td>\n <td/>\n </tr>\n <tr>\n <td>C82.07</td>\n <td>Follicular lymphoma grade I, spleen</td>\n <td/>\n </tr>\n <tr>\n <td>C82.08</td>\n <td>Follicular lymphoma grade I, lymph nodes of multiple sites</td>\n <td/>\n </tr>\n <tr>\n <td>C82.09</td>\n <td>Follicular lymphoma grade I, extranodal and solid organ sites</td>\n <td/>\n </tr>\n <tr>\n <td>C82.10</td>\n <td>Follicular lymphoma grade II, unspecified site</td>\n <td/>\n </tr>\n <tr>\n <td>C82.11</td>\n <td>Follicular lymphoma grade II, lymph nodes of head, face, and neck</td>\n <td/>\n </tr>\n <tr>\n <td>C82.12</td>\n <td>Follicular lymphoma grade II, intrathoracic lymph nodes</td>\n <td/>\n </tr>\n <tr>\n <td>C82.13</td>\n <td>Follicular lymphoma grade II, intra-abdominal lymph nodes</td>\n <td/>\n </tr>\n <tr>\n <td>C82.14</td>\n <td>Follicular lymphoma grade II, lymph nodes of axilla and upper limb</td>\n <td/>\n </tr>\n <tr>\n <td>C82.15</td>\n <td>Follicular lymphoma grade II, lymph nodes of inguinal region and lower limb</td>\n <td/>\n </tr>\n <tr>\n <td>C82.16</td>\n <td>Follicular lymphoma grade II, intrapelvic lymph nodes</td>\n <td/>\n </tr>\n <tr>\n <td>C82.17</td>\n <td>Follicular lymphoma grade II, spleen</td>\n <td/>\n </tr>\n <tr>\n <td>C82.18</td>\n <td>Follicular lymphoma grade II, lymph nodes of multiple sites</td>\n <td/>\n </tr>\n <tr>\n <td>C82.19</td>\n <td>Follicular lymphoma grade II, extranodal and solid organ sites</td>\n <td/>\n </tr>\n <tr>\n <td>C82.20</td>\n <td>Follicular lymphoma grade III, unspecified, unspecified site</td>\n <td/>\n </tr>\n <tr>\n <td>C82.21</td>\n <td>Follicular lymphoma grade III, unspecified, lymph nodes of head, face, and neck</td>\n <td/>\n </tr>\n <tr>\n <td>C82.22</td>\n <td>Follicular lymphoma grade III, unspecified, intrathoracic lymph nodes</td>\n <td/>\n </tr>\n <tr>\n <td>C82.23</td>\n <td>Follicular lymphoma grade III, unspecified, intra-abdominal lymph nodes</td>\n <td/>\n </tr>\n <tr>\n <td>C82.24</td>\n <td>Follicular lymphoma grade III, unspecified, lymph nodes of axilla and upper limb</td>\n <td/>\n </tr>\n <tr>\n <td>C82.25</td>\n <td>Follicular lymphoma grade III, unspecified, lymph nodes of inguinal region and lower limb</td>\n <td/>\n </tr>\n <tr>\n <td>C82.26</td>\n <td>Follicular lymphoma grade III, unspecified, intrapelvic lymph nodes</td>\n <td/>\n </tr>\n <tr>\n <td>C82.27</td>\n <td>Follicular lymphoma grade III, unspecified, spleen</td>\n <td/>\n </tr>\n <tr>\n <td>C82.28</td>\n <td>Follicular lymphoma grade III, unspecified, lymph nodes of multiple sites</td>\n <td/>\n </tr>\n <tr>\n <td>C82.29</td>\n <td>Follicular lymphoma grade III, unspecified, extranodal and solid organ sites</td>\n <td/>\n </tr>\n <tr>\n <td>C82.30</td>\n <td>Follicular lymphoma grade IIIa, unspecified site</td>\n <td/>\n </tr>\n <tr>\n <td>C82.31</td>\n <td>Follicular lymphoma grade IIIa, lymph nodes of head, face, and neck</td>\n <td/>\n </tr>\n <tr>\n <td>C82.32</td>\n <td>Follicular lymphoma grade IIIa, intrathoracic lymph nodes</td>\n <td/>\n </tr>\n <tr>\n <td>C82.33</td>\n <td>Follicular lymphoma grade IIIa, intra-abdominal lymph nodes</td>\n <td/>\n </tr>\n <tr>\n <td>C82.34</td>\n <td>Follicular lymphoma grade IIIa, lymph nodes of axilla and upper limb</td>\n <td/>\n </tr>\n <tr>\n <td>C82.35</td>\n <td>Follicular lymphoma grade IIIa, lymph nodes of inguinal region and lower limb</td>\n <td/>\n </tr>\n <tr>\n <td>C82.36</td>\n <td>Follicular lymphoma grade IIIa, intrapelvic lymph nodes</td>\n <td/>\n </tr>\n <tr>\n <td>C82.37</td>\n <td>Follicular lymphoma grade IIIa, spleen</td>\n <td/>\n </tr>\n <tr>\n <td>C82.38</td>\n <td>Follicular lymphoma grade IIIa, lymph nodes of multiple sites</td>\n <td/>\n </tr>\n <tr>\n <td>C82.39</td>\n <td>Follicular lymphoma grade IIIa, extranodal and solid organ sites</td>\n <td/>\n </tr>\n <tr>\n <td>C82.40</td>\n <td>Follicular lymphoma grade IIIb, unspecified site</td>\n <td/>\n </tr>\n <tr>\n <td>C82.41</td>\n <td>Follicular lymphoma grade IIIb, lymph nodes of head, face, and neck</td>\n <td/>\n </tr>\n <tr>\n <td>C82.42</td>\n <td>Follicular lymphoma grade IIIb, intrathoracic lymph nodes</td>\n <td/>\n </tr>\n <tr>\n <td>C82.43</td>\n <td>Follicular lymphoma grade IIIb, intra-abdominal lymph nodes</td>\n <td/>\n </tr>\n <tr>\n <td>C82.44</td>\n <td>Follicular lymphoma grade IIIb, lymph nodes of axilla and upper limb</td>\n <td/>\n </tr>\n <tr>\n <td>C82.45</td>\n <td>Follicular lymphoma grade IIIb, lymph nodes of inguinal region and lower limb</td>\n <td/>\n </tr>\n <tr>\n <td>C82.46</td>\n <td>Follicular lymphoma grade IIIb, intrapelvic lymph nodes</td>\n <td/>\n </tr>\n <tr>\n <td>C82.47</td>\n <td>Follicular lymphoma grade IIIb, spleen</td>\n <td/>\n </tr>\n <tr>\n <td>C82.48</td>\n <td>Follicular lymphoma grade IIIb, lymph nodes of multiple sites</td>\n <td/>\n </tr>\n <tr>\n <td>C82.49</td>\n <td>Follicular lymphoma grade IIIb, extranodal and solid organ sites</td>\n <td/>\n </tr>\n <tr>\n <td>C82.50</td>\n <td>Diffuse follicle center lymphoma, unspecified site</td>\n <td/>\n </tr>\n <tr>\n <td>C82.51</td>\n <td>Diffuse follicle center lymphoma, lymph nodes of head, face, and neck</td>\n <td/>\n </tr>\n <tr>\n <td>C82.52</td>\n <td>Diffuse follicle center lymphoma, intrathoracic lymph nodes</td>\n <td/>\n </tr>\n <tr>\n <td>C82.53</td>\n <td>Diffuse follicle center lymphoma, intra-abdominal lymph nodes</td>\n <td/>\n </tr>\n <tr>\n <td>C82.54</td>\n <td>Diffuse follicle center lymphoma, lymph nodes of axilla and upper limb</td>\n <td/>\n </tr>\n <tr>\n <td>C82.55</td>\n <td>Diffuse follicle center lymphoma, lymph nodes of inguinal region and lower limb</td>\n <td/>\n </tr>\n <tr>\n <td>C82.56</td>\n <td>Diffuse follicle center lymphoma, intrapelvic lymph nodes</td>\n <td/>\n </tr>\n <tr>\n <td>C82.57</td>\n <td>Diffuse follicle center lymphoma, spleen</td>\n <td/>\n </tr>\n <tr>\n <td>C82.58</td>\n <td>Diffuse follicle center lymphoma, lymph nodes of multiple sites</td>\n <td/>\n </tr>\n <tr>\n <td>C82.59</td>\n <td>Diffuse follicle center lymphoma, extranodal and solid organ sites</td>\n <td/>\n </tr>\n <tr>\n <td>C82.60</td>\n <td>Cutaneous follicle center lymphoma, unspecified site</td>\n <td/>\n </tr>\n <tr>\n <td>C82.61</td>\n <td>Cutaneous follicle center lymphoma, lymph nodes of head, face, and neck</td>\n <td/>\n </tr>\n <tr>\n <td>C82.62</td>\n <td>Cutaneous follicle center lymphoma, intrathoracic lymph nodes</td>\n <td/>\n </tr>\n <tr>\n <td>C82.63</td>\n <td>Cutaneous follicle center lymphoma, intra-abdominal lymph nodes</td>\n <td/>\n </tr>\n <tr>\n <td>C82.64</td>\n <td>Cutaneous follicle center lymphoma, lymph nodes of axilla and upper limb</td>\n <td/>\n </tr>\n <tr>\n <td>C82.65</td>\n <td>Cutaneous follicle center lymphoma, lymph nodes of inguinal region and lower limb</td>\n <td/>\n </tr>\n <tr>\n <td>C82.66</td>\n <td>Cutaneous follicle center lymphoma, intrapelvic lymph nodes</td>\n <td/>\n </tr>\n <tr>\n <td>C82.67</td>\n <td>Cutaneous follicle center lymphoma, spleen</td>\n <td/>\n </tr>\n <tr>\n <td>C82.68</td>\n <td>Cutaneous follicle center lymphoma, lymph nodes of multiple sites</td>\n <td/>\n </tr>\n <tr>\n <td>C82.69</td>\n <td>Cutaneous follicle center lymphoma, extranodal and solid organ sites</td>\n <td/>\n </tr>\n <tr>\n <td>C82.80</td>\n <td>Other types of follicular lymphoma, unspecified site</td>\n <td/>\n </tr>\n <tr>\n <td>C82.81</td>\n <td>Other types of follicular lymphoma, lymph nodes of head, face, and neck</td>\n <td/>\n </tr>\n <tr>\n <td>C82.82</td>\n <td>Other types of follicular lymphoma, intrathoracic lymph nodes</td>\n <td/>\n </tr>\n <tr>\n <td>C82.83</td>\n <td>Other types of follicular lymphoma, intra-abdominal lymph nodes</td>\n <td/>\n </tr>\n <tr>\n <td>C82.84</td>\n <td>Other types of follicular lymphoma, lymph nodes of axilla and upper limb</td>\n <td/>\n </tr>\n <tr>\n <td>C82.85</td>\n <td>Other types of follicular lymphoma, lymph nodes of inguinal region and lower limb</td>\n <td/>\n </tr>\n <tr>\n <td>C82.86</td>\n <td>Other types of follicular lymphoma, intrapelvic lymph nodes</td>\n <td/>\n </tr>\n <tr>\n <td>C82.87</td>\n <td>Other types of follicular lymphoma, spleen</td>\n <td/>\n </tr>\n <tr>\n <td>C82.88</td>\n <td>Other types of follicular lymphoma, lymph nodes of multiple sites</td>\n <td/>\n </tr>\n <tr>\n <td>C82.89</td>\n <td>Other types of follicular lymphoma, extranodal and solid organ sites</td>\n <td/>\n </tr>\n <tr>\n <td>C82.90</td>\n <td>Follicular lymphoma, unspecified, unspecified site</td>\n <td/>\n </tr>\n <tr>\n <td>C82.91</td>\n <td>Follicular lymphoma, unspecified, lymph nodes of head, face, and neck</td>\n <td/>\n </tr>\n <tr>\n <td>C82.92</td>\n <td>Follicular lymphoma, unspecified, intrathoracic lymph nodes</td>\n <td/>\n </tr>\n <tr>\n <td>C82.93</td>\n <td>Follicular lymphoma, unspecified, intra-abdominal lymph nodes</td>\n <td/>\n </tr>\n <tr>\n <td>C82.94</td>\n <td>Follicular lymphoma, unspecified, lymph nodes of axilla and upper limb</td>\n <td/>\n </tr>\n <tr>\n <td>C82.95</td>\n <td>Follicular lymphoma, unspecified, lymph nodes of inguinal region and lower limb</td>\n <td/>\n </tr>\n <tr>\n <td>C82.96</td>\n <td>Follicular lymphoma, unspecified, intrapelvic lymph nodes</td>\n <td/>\n </tr>\n <tr>\n <td>C82.97</td>\n <td>Follicular lymphoma, unspecified, spleen</td>\n <td/>\n </tr>\n <tr>\n <td>C82.98</td>\n <td>Follicular lymphoma, unspecified, lymph nodes of multiple sites</td>\n <td/>\n </tr>\n <tr>\n <td>C82.99</td>\n <td>Follicular lymphoma, unspecified, extranodal and solid organ sites</td>\n <td/>\n </tr>\n <tr>\n <td>C83.00</td>\n <td>Small cell B-cell lymphoma, unspecified site</td>\n <td/>\n </tr>\n <tr>\n <td>C83.01</td>\n <td>Small cell B-cell lymphoma, lymph nodes of head, face, and neck</td>\n <td/>\n </tr>\n <tr>\n <td>C83.02</td>\n <td>Small cell B-cell lymphoma, intrathoracic lymph nodes</td>\n <td/>\n </tr>\n <tr>\n <td>C83.03</td>\n <td>Small cell B-cell lymphoma, intra-abdominal lymph nodes</td>\n <td/>\n </tr>\n <tr>\n <td>C83.04</td>\n <td>Small cell B-cell lymphoma, lymph nodes of axilla and upper limb</td>\n <td/>\n </tr>\n <tr>\n <td>C83.05</td>\n <td>Small cell B-cell lymphoma, lymph nodes of inguinal region and lower limb</td>\n <td/>\n </tr>\n <tr>\n <td>C83.06</td>\n <td>Small cell B-cell lymphoma, intrapelvic lymph nodes</td>\n <td/>\n </tr>\n <tr>\n <td>C83.07</td>\n <td>Small cell B-cell lymphoma, spleen</td>\n <td/>\n </tr>\n <tr>\n <td>C83.08</td>\n <td>Small cell B-cell lymphoma, lymph nodes of multiple sites</td>\n <td/>\n </tr>\n <tr>\n <td>C83.09</td>\n <td>Small cell B-cell lymphoma, extranodal and solid organ sites</td>\n <td/>\n </tr>\n <tr>\n <td>C83.10</td>\n <td>Mantle cell lymphoma, unspecified site</td>\n <td/>\n </tr>\n <tr>\n <td>C83.11</td>\n <td>Mantle cell lymphoma, lymph nodes of head, face, and neck</td>\n <td/>\n </tr>\n <tr>\n <td>C83.12</td>\n <td>Mantle cell lymphoma, intrathoracic lymph nodes</td>\n <td/>\n </tr>\n <tr>\n <td>C83.13</td>\n <td>Mantle cell lymphoma, intra-abdominal lymph nodes</td>\n <td/>\n </tr>\n <tr>\n <td>C83.14</td>\n <td>Mantle cell lymphoma, lymph nodes of axilla and upper limb</td>\n <td/>\n </tr>\n <tr>\n <td>C83.15</td>\n <td>Mantle cell lymphoma, lymph nodes of inguinal region and lower limb</td>\n <td/>\n </tr>\n <tr>\n <td>C83.16</td>\n <td>Mantle cell lymphoma, intrapelvic lymph nodes</td>\n <td/>\n </tr>\n <tr>\n <td>C83.17</td>\n <td>Mantle cell lymphoma, spleen</td>\n <td/>\n </tr>\n <tr>\n <td>C83.18</td>\n <td>Mantle cell lymphoma, lymph nodes of multiple sites</td>\n <td/>\n </tr>\n <tr>\n <td>C83.19</td>\n <td>Mantle cell lymphoma, extranodal and solid organ sites</td>\n <td/>\n </tr>\n <tr>\n <td>C83.30</td>\n <td>Diffuse large B-cell lymphoma, unspecified site</td>\n <td/>\n </tr>\n <tr>\n <td>C83.31</td>\n <td>Diffuse large B-cell lymphoma, lymph nodes of head, face, and neck</td>\n <td/>\n </tr>\n <tr>\n <td>C83.32</td>\n <td>Diffuse large B-cell lymphoma, intrathoracic lymph nodes</td>\n <td/>\n </tr>\n <tr>\n <td>C83.33</td>\n <td>Diffuse large B-cell lymphoma, intra-abdominal lymph nodes</td>\n <td/>\n </tr>\n <tr>\n <td>C83.34</td>\n <td>Diffuse large B-cell lymphoma, lymph nodes of axilla and upper limb</td>\n <td/>\n </tr>\n <tr>\n <td>C83.35</td>\n <td>Diffuse large B-cell lymphoma, lymph nodes of inguinal region and lower limb</td>\n <td/>\n </tr>\n <tr>\n <td>C83.36</td>\n <td>Diffuse large B-cell lymphoma, intrapelvic lymph nodes</td>\n <td/>\n </tr>\n <tr>\n <td>C83.37</td>\n <td>Diffuse large B-cell lymphoma, spleen</td>\n <td/>\n </tr>\n <tr>\n <td>C83.38</td>\n <td>Diffuse large B-cell lymphoma, lymph nodes of multiple sites</td>\n <td/>\n </tr>\n <tr>\n <td>C83.39</td>\n <td>Diffuse large B-cell lymphoma, extranodal and solid organ sites</td>\n <td/>\n </tr>\n <tr>\n <td>C83.50</td>\n <td>Lymphoblastic (diffuse) lymphoma, unspecified site</td>\n <td/>\n </tr>\n <tr>\n <td>C83.51</td>\n <td>Lymphoblastic (diffuse) lymphoma, lymph nodes of head, face, and neck</td>\n <td/>\n </tr>\n <tr>\n <td>C83.52</td>\n <td>Lymphoblastic (diffuse) lymphoma, intrathoracic lymph nodes</td>\n <td/>\n </tr>\n <tr>\n <td>C83.53</td>\n <td>Lymphoblastic (diffuse) lymphoma, intra-abdominal lymph nodes</td>\n <td/>\n </tr>\n <tr>\n <td>C83.54</td>\n <td>Lymphoblastic (diffuse) lymphoma, lymph nodes of axilla and upper limb</td>\n <td/>\n </tr>\n <tr>\n <td>C83.55</td>\n <td>Lymphoblastic (diffuse) lymphoma, lymph nodes of inguinal region and lower limb</td>\n <td/>\n </tr>\n <tr>\n <td>C83.56</td>\n <td>Lymphoblastic (diffuse) lymphoma, intrapelvic lymph nodes</td>\n <td/>\n </tr>\n <tr>\n <td>C83.57</td>\n <td>Lymphoblastic (diffuse) lymphoma, spleen</td>\n <td/>\n </tr>\n <tr>\n <td>C83.58</td>\n <td>Lymphoblastic (diffuse) lymphoma, lymph nodes of multiple sites</td>\n <td/>\n </tr>\n <tr>\n <td>C83.59</td>\n <td>Lymphoblastic (diffuse) lymphoma, extranodal and solid organ sites</td>\n <td/>\n </tr>\n <tr>\n <td>C83.70</td>\n <td>Burkitt lymphoma, unspecified site</td>\n <td/>\n </tr>\n <tr>\n <td>C83.71</td>\n <td>Burkitt lymphoma, lymph nodes of head, face, and neck</td>\n <td/>\n </tr>\n <tr>\n <td>C83.72</td>\n <td>Burkitt lymphoma, intrathoracic lymph nodes</td>\n <td/>\n </tr>\n <tr>\n <td>C83.73</td>\n <td>Burkitt lymphoma, intra-abdominal lymph nodes</td>\n <td/>\n </tr>\n <tr>\n <td>C83.74</td>\n <td>Burkitt lymphoma, lymph nodes of axilla and upper limb</td>\n <td/>\n </tr>\n <tr>\n <td>C83.75</td>\n <td>Burkitt lymphoma, lymph nodes of inguinal region and lower limb</td>\n <td/>\n </tr>\n <tr>\n <td>C83.76</td>\n <td>Burkitt lymphoma, intrapelvic lymph nodes</td>\n <td/>\n </tr>\n <tr>\n <td>C83.77</td>\n <td>Burkitt lymphoma, spleen</td>\n <td/>\n </tr>\n <tr>\n <td>C83.78</td>\n <td>Burkitt lymphoma, lymph nodes of multiple sites</td>\n <td/>\n </tr>\n <tr>\n <td>C83.79</td>\n <td>Burkitt lymphoma, extranodal and solid organ sites</td>\n <td/>\n </tr>\n <tr>\n <td>C83.80</td>\n <td>Other non-follicular lymphoma, unspecified site</td>\n <td/>\n </tr>\n <tr>\n <td>C83.81</td>\n <td>Other non-follicular lymphoma, lymph nodes of head, face, and neck</td>\n <td/>\n </tr>\n <tr>\n <td>C83.82</td>\n <td>Other non-follicular lymphoma, intrathoracic lymph nodes</td>\n <td/>\n </tr>\n <tr>\n <td>C83.83</td>\n <td>Other non-follicular lymphoma, intra-abdominal lymph nodes</td>\n <td/>\n </tr>\n <tr>\n <td>C83.84</td>\n <td>Other non-follicular lymphoma, lymph nodes of axilla and upper limb</td>\n <td/>\n </tr>\n <tr>\n <td>C83.85</td>\n <td>Other non-follicular lymphoma, lymph nodes of inguinal region and lower limb</td>\n <td/>\n </tr>\n <tr>\n <td>C83.86</td>\n <td>Other non-follicular lymphoma, intrapelvic lymph nodes</td>\n <td/>\n </tr>\n <tr>\n <td>C83.87</td>\n <td>Other non-follicular lymphoma, spleen</td>\n <td/>\n </tr>\n <tr>\n <td>C83.88</td>\n <td>Other non-follicular lymphoma, lymph nodes of multiple sites</td>\n <td/>\n </tr>\n <tr>\n <td>C83.89</td>\n <td>Other non-follicular lymphoma, extranodal and solid organ sites</td>\n <td/>\n </tr>\n <tr>\n <td>C83.90</td>\n <td>Non-follicular (diffuse) lymphoma, unspecified, unspecified site</td>\n <td/>\n </tr>\n <tr>\n <td>C83.91</td>\n <td>Non-follicular (diffuse) lymphoma, unspecified, lymph nodes of head, face, and neck</td>\n <td/>\n </tr>\n <tr>\n <td>C83.92</td>\n <td>Non-follicular (diffuse) lymphoma, unspecified, intrathoracic lymph nodes</td>\n <td/>\n </tr>\n <tr>\n <td>C83.93</td>\n <td>Non-follicular (diffuse) lymphoma, unspecified, intra-abdominal lymph nodes</td>\n <td/>\n </tr>\n <tr>\n <td>C83.94</td>\n <td>Non-follicular (diffuse) lymphoma, unspecified, lymph nodes of axilla and upper limb</td>\n <td/>\n </tr>\n <tr>\n <td>C83.95</td>\n <td>Non-follicular (diffuse) lymphoma, unspecified, lymph nodes of inguinal region and lower limb</td>\n <td/>\n </tr>\n <tr>\n <td>C83.96</td>\n <td>Non-follicular (diffuse) lymphoma, unspecified, intrapelvic lymph nodes</td>\n <td/>\n </tr>\n <tr>\n <td>C83.97</td>\n <td>Non-follicular (diffuse) lymphoma, unspecified, spleen</td>\n <td/>\n </tr>\n <tr>\n <td>C83.98</td>\n <td>Non-follicular (diffuse) lymphoma, unspecified, lymph nodes of multiple sites</td>\n <td/>\n </tr>\n <tr>\n <td>C83.99</td>\n <td>Non-follicular (diffuse) lymphoma, unspecified, extranodal and solid organ sites</td>\n <td/>\n </tr>\n <tr>\n <td>C84.00</td>\n <td>Mycosis fungoides, unspecified site</td>\n <td/>\n </tr>\n <tr>\n <td>C84.01</td>\n <td>Mycosis fungoides, lymph nodes of head, face, and neck</td>\n <td/>\n </tr>\n <tr>\n <td>C84.02</td>\n <td>Mycosis fungoides, intrathoracic lymph nodes</td>\n <td/>\n </tr>\n <tr>\n <td>C84.03</td>\n <td>Mycosis fungoides, intra-abdominal lymph nodes</td>\n <td/>\n </tr>\n <tr>\n <td>C84.04</td>\n <td>Mycosis fungoides, lymph nodes of axilla and upper limb</td>\n <td/>\n </tr>\n <tr>\n <td>C84.05</td>\n <td>Mycosis fungoides, lymph nodes of inguinal region and lower limb</td>\n <td/>\n </tr>\n <tr>\n <td>C84.06</td>\n <td>Mycosis fungoides, intrapelvic lymph nodes</td>\n <td/>\n </tr>\n <tr>\n <td>C84.07</td>\n <td>Mycosis fungoides, spleen</td>\n <td/>\n </tr>\n <tr>\n <td>C84.08</td>\n <td>Mycosis fungoides, lymph nodes of multiple sites</td>\n <td/>\n </tr>\n <tr>\n <td>C84.09</td>\n <td>Mycosis fungoides, extranodal and solid organ sites</td>\n <td/>\n </tr>\n <tr>\n <td>C84.10</td>\n <td>Sézary disease, unspecified site</td>\n <td/>\n </tr>\n <tr>\n <td>C84.11</td>\n <td>Sézary disease, lymph nodes of head, face, and neck</td>\n <td/>\n </tr>\n <tr>\n <td>C84.12</td>\n <td>Sézary disease, intrathoracic lymph nodes</td>\n <td/>\n </tr>\n <tr>\n <td>C84.13</td>\n <td>Sézary disease, intra-abdominal lymph nodes</td>\n <td/>\n </tr>\n <tr>\n <td>C84.14</td>\n <td>Sézary disease, lymph nodes of axilla and upper limb</td>\n <td/>\n </tr>\n <tr>\n <td>C84.15</td>\n <td>Sézary disease, lymph nodes of inguinal region and lower limb</td>\n <td/>\n </tr>\n <tr>\n <td>C84.16</td>\n <td>Sézary disease, intrapelvic lymph nodes</td>\n <td/>\n </tr>\n <tr>\n <td>C84.17</td>\n <td>Sézary disease, spleen</td>\n <td/>\n </tr>\n <tr>\n <td>C84.18</td>\n <td>Sézary disease, lymph nodes of multiple sites</td>\n <td/>\n </tr>\n <tr>\n <td>C84.19</td>\n <td>Sézary disease, extranodal and solid organ sites</td>\n <td/>\n </tr>\n <tr>\n <td>C84.40</td>\n <td>Peripheral T-cell lymphoma, not classified, unspecified site</td>\n <td/>\n </tr>\n <tr>\n <td>C84.41</td>\n <td>Peripheral T-cell lymphoma, not classified, lymph nodes of head, face, and neck</td>\n <td/>\n </tr>\n <tr>\n <td>C84.42</td>\n <td>Peripheral T-cell lymphoma, not classified, intrathoracic lymph nodes</td>\n <td/>\n </tr>\n <tr>\n <td>C84.43</td>\n <td>Peripheral T-cell lymphoma, not classified, intra-abdominal lymph nodes</td>\n <td/>\n </tr>\n <tr>\n <td>C84.44</td>\n <td>Peripheral T-cell lymphoma, not classified, lymph nodes of axilla and upper limb</td>\n <td/>\n </tr>\n <tr>\n <td>C84.45</td>\n <td>Peripheral T-cell lymphoma, not classified, lymph nodes of inguinal region and lower limb</td>\n <td/>\n </tr>\n <tr>\n <td>C84.46</td>\n <td>Peripheral T-cell lymphoma, not classified, intrapelvic lymph nodes</td>\n <td/>\n </tr>\n <tr>\n <td>C84.47</td>\n <td>Peripheral T-cell lymphoma, not classified, spleen</td>\n <td/>\n </tr>\n <tr>\n <td>C84.48</td>\n <td>Peripheral T-cell lymphoma, not classified, lymph nodes of multiple sites</td>\n <td/>\n </tr>\n <tr>\n <td>C84.49</td>\n <td>Peripheral T-cell lymphoma, not classified, extranodal and solid organ sites</td>\n <td/>\n </tr>\n <tr>\n <td>C84.60</td>\n <td>Anaplastic large cell lymphoma, ALK-positive, unspecified site</td>\n <td/>\n </tr>\n <tr>\n <td>C84.61</td>\n <td>Anaplastic large cell lymphoma, ALK-positive, lymph nodes of head, face, and neck</td>\n <td/>\n </tr>\n <tr>\n <td>C84.62</td>\n <td>Anaplastic large cell lymphoma, ALK-positive, intrathoracic lymph nodes</td>\n <td/>\n </tr>\n <tr>\n <td>C84.63</td>\n <td>Anaplastic large cell lymphoma, ALK-positive, intra-abdominal lymph nodes</td>\n <td/>\n </tr>\n <tr>\n <td>C84.64</td>\n <td>Anaplastic large cell lymphoma, ALK-positive, lymph nodes of axilla and upper limb</td>\n <td/>\n </tr>\n <tr>\n <td>C84.65</td>\n <td>Anaplastic large cell lymphoma, ALK-positive, lymph nodes of inguinal region and lower limb</td>\n <td/>\n </tr>\n <tr>\n <td>C84.66</td>\n <td>Anaplastic large cell lymphoma, ALK-positive, intrapelvic lymph nodes</td>\n <td/>\n </tr>\n <tr>\n <td>C84.67</td>\n <td>Anaplastic large cell lymphoma, ALK-positive, spleen</td>\n <td/>\n </tr>\n <tr>\n <td>C84.68</td>\n <td>Anaplastic large cell lymphoma, ALK-positive, lymph nodes of multiple sites</td>\n <td/>\n </tr>\n <tr>\n <td>C84.69</td>\n <td>Anaplastic large cell lymphoma, ALK-positive, extranodal and solid organ sites</td>\n <td/>\n </tr>\n <tr>\n <td>C84.70</td>\n <td>Anaplastic large cell lymphoma, ALK-negative, unspecified site</td>\n <td/>\n </tr>\n <tr>\n <td>C84.71</td>\n <td>Anaplastic large cell lymphoma, ALK-negative, lymph nodes of head, face, and neck</td>\n <td/>\n </tr>\n <tr>\n <td>C84.72</td>\n <td>Anaplastic large cell lymphoma, ALK-negative, intrathoracic lymph nodes</td>\n <td/>\n </tr>\n <tr>\n <td>C84.73</td>\n <td>Anaplastic large cell lymphoma, ALK-negative, intra-abdominal lymph nodes</td>\n <td/>\n </tr>\n <tr>\n <td>C84.74</td>\n <td>Anaplastic large cell lymphoma, ALK-negative, lymph nodes of axilla and upper limb</td>\n <td/>\n </tr>\n <tr>\n <td>C84.75</td>\n <td>Anaplastic large cell lymphoma, ALK-negative, lymph nodes of inguinal region and lower limb</td>\n <td/>\n </tr>\n <tr>\n <td>C84.76</td>\n <td>Anaplastic large cell lymphoma, ALK-negative, intrapelvic lymph nodes</td>\n <td/>\n </tr>\n <tr>\n <td>C84.77</td>\n <td>Anaplastic large cell lymphoma, ALK-negative, spleen</td>\n <td/>\n </tr>\n <tr>\n <td>C84.78</td>\n <td>Anaplastic large cell lymphoma, ALK-negative, lymph nodes of multiple sites</td>\n <td/>\n </tr>\n <tr>\n <td>C84.79</td>\n <td>Anaplastic large cell lymphoma, ALK-negative, extranodal and solid organ sites</td>\n <td/>\n </tr>\n <tr>\n <td>C84.90</td>\n <td>Mature T/NK-cell lymphomas, unspecified, unspecified site</td>\n <td/>\n </tr>\n <tr>\n <td>C84.91</td>\n <td>Mature T/NK-cell lymphomas, unspecified, lymph nodes of head, face, and neck</td>\n <td/>\n </tr>\n <tr>\n <td>C84.92</td>\n <td>Mature T/NK-cell lymphomas, unspecified, intrathoracic lymph nodes</td>\n <td/>\n </tr>\n <tr>\n <td>C84.93</td>\n <td>Mature T/NK-cell lymphomas, unspecified, intra-abdominal lymph nodes</td>\n <td/>\n </tr>\n <tr>\n <td>C84.94</td>\n <td>Mature T/NK-cell lymphomas, unspecified, lymph nodes of axilla and upper limb</td>\n <td/>\n </tr>\n <tr>\n <td>C84.95</td>\n <td>Mature T/NK-cell lymphomas, unspecified, lymph nodes of inguinal region and lower limb</td>\n <td/>\n </tr>\n <tr>\n <td>C84.96</td>\n <td>Mature T/NK-cell lymphomas, unspecified, intrapelvic lymph nodes</td>\n <td/>\n </tr>\n <tr>\n <td>C84.97</td>\n <td>Mature T/NK-cell lymphomas, unspecified, spleen</td>\n <td/>\n </tr>\n <tr>\n <td>C84.98</td>\n <td>Mature T/NK-cell lymphomas, unspecified, lymph nodes of multiple sites</td>\n <td/>\n </tr>\n <tr>\n <td>C84.99</td>\n <td>Mature T/NK-cell lymphomas, unspecified, extranodal and solid organ sites</td>\n <td/>\n </tr>\n <tr>\n <td>C84.A0</td>\n <td>Cutaneous T-cell lymphoma, unspecified, unspecified site</td>\n <td/>\n </tr>\n <tr>\n <td>C84.A1</td>\n <td>Cutaneous T-cell lymphoma, unspecified lymph nodes of head, face, and neck</td>\n <td/>\n </tr>\n <tr>\n <td>C84.A2</td>\n <td>Cutaneous T-cell lymphoma, unspecified, intrathoracic lymph nodes</td>\n <td/>\n </tr>\n <tr>\n <td>C84.A3</td>\n <td>Cutaneous T-cell lymphoma, unspecified, intra-abdominal lymph nodes</td>\n <td/>\n </tr>\n <tr>\n <td>C84.A4</td>\n <td>Cutaneous T-cell lymphoma, unspecified, lymph nodes of axilla and upper limb</td>\n <td/>\n </tr>\n <tr>\n <td>C84.A5</td>\n <td>Cutaneous T-cell lymphoma, unspecified, lymph nodes of inguinal region and lower limb</td>\n <td/>\n </tr>\n <tr>\n <td>C84.A6</td>\n <td>Cutaneous T-cell lymphoma, unspecified, intrapelvic lymph nodes</td>\n <td/>\n </tr>\n <tr>\n <td>C84.A7</td>\n <td>Cutaneous T-cell lymphoma, unspecified, spleen</td>\n <td/>\n </tr>\n <tr>\n <td>C84.A8</td>\n <td>Cutaneous T-cell lymphoma, unspecified, lymph nodes of multiple sites</td>\n <td/>\n </tr>\n <tr>\n <td>C84.A9</td>\n <td>Cutaneous T-cell lymphoma, unspecified, extranodal and solid organ sites</td>\n <td/>\n </tr>\n <tr>\n <td>C84.Z0</td>\n <td>Other mature T/NK-cell lymphomas, unspecified site</td>\n <td/>\n </tr>\n <tr>\n <td>C84.Z1</td>\n <td>Other mature T/NK-cell lymphomas, lymph nodes of head, face, and neck</td>\n <td/>\n </tr>\n <tr>\n <td>C84.Z2</td>\n <td>Other mature T/NK-cell lymphomas, intrathoracic lymph nodes</td>\n <td/>\n </tr>\n <tr>\n <td>C84.Z3</td>\n <td>Other mature T/NK-cell lymphomas, intra-abdominal lymph nodes</td>\n <td/>\n </tr>\n <tr>\n <td>C84.Z4</td>\n <td>Other mature T/NK-cell lymphomas, lymph nodes of axilla and upper limb</td>\n <td/>\n </tr>\n <tr>\n <td>C84.Z5</td>\n <td>Other mature T/NK-cell lymphomas, lymph nodes of inguinal region and lower limb</td>\n <td/>\n </tr>\n <tr>\n <td>C84.Z6</td>\n <td>Other mature T/NK-cell lymphomas, intrapelvic lymph nodes</td>\n <td/>\n </tr>\n <tr>\n <td>C84.Z7</td>\n <td>Other mature T/NK-cell lymphomas, spleen</td>\n <td/>\n </tr>\n <tr>\n <td>C84.Z8</td>\n <td>Other mature T/NK-cell lymphomas, lymph nodes of multiple sites</td>\n <td/>\n </tr>\n <tr>\n <td>C84.Z9</td>\n <td>Other mature T/NK-cell lymphomas, extranodal and solid organ sites</td>\n <td/>\n </tr>\n <tr>\n <td>C85.10</td>\n <td>Unspecified B-cell lymphoma, unspecified site</td>\n <td/>\n </tr>\n <tr>\n <td>C85.11</td>\n <td>Unspecified B-cell lymphoma, lymph nodes of head, face, and neck</td>\n <td/>\n </tr>\n <tr>\n <td>C85.12</td>\n <td>Unspecified B-cell lymphoma, intrathoracic lymph nodes</td>\n <td/>\n </tr>\n <tr>\n <td>C85.13</td>\n <td>Unspecified B-cell lymphoma, intra-abdominal lymph nodes</td>\n <td/>\n </tr>\n <tr>\n <td>C85.14</td>\n <td>Unspecified B-cell lymphoma, lymph nodes of axilla and upper limb</td>\n <td/>\n </tr>\n <tr>\n <td>C85.15</td>\n <td>Unspecified B-cell lymphoma, lymph nodes of inguinal region and lower limb</td>\n <td/>\n </tr>\n <tr>\n <td>C85.16</td>\n <td>Unspecified B-cell lymphoma, intrapelvic lymph nodes</td>\n <td/>\n </tr>\n <tr>\n <td>C85.17</td>\n <td>Unspecified B-cell lymphoma, spleen</td>\n <td/>\n </tr>\n <tr>\n <td>C85.18</td>\n <td>Unspecified B-cell lymphoma, lymph nodes of multiple sites</td>\n <td/>\n </tr>\n <tr>\n <td>C85.19</td>\n <td>Unspecified B-cell lymphoma, extranodal and solid organ sites</td>\n <td/>\n </tr>\n <tr>\n <td>C85.20</td>\n <td>Mediastinal (thymic) large B-cell lymphoma, unspecified site</td>\n <td/>\n </tr>\n <tr>\n <td>C85.21</td>\n <td>Mediastinal (thymic) large B-cell lymphoma, lymph nodes of head, face, and neck</td>\n <td/>\n </tr>\n <tr>\n <td>C85.22</td>\n <td>Mediastinal (thymic) large B-cell lymphoma, intrathoracic lymph nodes</td>\n <td/>\n </tr>\n <tr>\n <td>C85.23</td>\n <td>Mediastinal (thymic) large B-cell lymphoma, intra-abdominal lymph nodes</td>\n <td/>\n </tr>\n <tr>\n <td>C85.24</td>\n <td>Mediastinal (thymic) large B-cell lymphoma, lymph nodes of axilla and upper limb</td>\n <td/>\n </tr>\n <tr>\n <td>C85.25</td>\n <td>Mediastinal (thymic) large B-cell lymphoma, lymph nodes of inguinal region and lower limb</td>\n <td/>\n </tr>\n <tr>\n <td>C85.26</td>\n <td>Mediastinal (thymic) large B-cell lymphoma, intrapelvic lymph nodes</td>\n <td/>\n </tr>\n <tr>\n <td>C85.27</td>\n <td>Mediastinal (thymic) large B-cell lymphoma, spleen</td>\n <td/>\n </tr>\n <tr>\n <td>C85.28</td>\n <td>Mediastinal (thymic) large B-cell lymphoma, lymph nodes of multiple sites</td>\n <td/>\n </tr>\n <tr>\n <td>C85.29</td>\n <td>Mediastinal (thymic) large B-cell lymphoma, extranodal and solid organ sites</td>\n <td/>\n </tr>\n <tr>\n <td>C85.80</td>\n <td>Other specified types of non-Hodgkin lymphoma, unspecified site</td>\n <td/>\n </tr>\n <tr>\n <td>C85.81</td>\n <td>Other specified types of non-Hodgkin lymphoma, lymph nodes of head, face, and neck</td>\n <td/>\n </tr>\n <tr>\n <td>C85.82</td>\n <td>Other specified types of non-Hodgkin lymphoma, intrathoracic lymph nodes</td>\n <td/>\n </tr>\n <tr>\n <td>C85.83</td>\n <td>Other specified types of non-Hodgkin lymphoma, intra-abdominal lymph nodes</td>\n <td/>\n </tr>\n <tr>\n <td>C85.84</td>\n <td>Other specified types of non-Hodgkin lymphoma, lymph nodes of axilla and upper limb</td>\n <td/>\n </tr>\n <tr>\n <td>C85.85</td>\n <td>Other specified types of non-Hodgkin lymphoma, lymph nodes of inguinal region and lower limb</td>\n <td/>\n </tr>\n <tr>\n <td>C85.86</td>\n <td>Other specified types of non-Hodgkin lymphoma, intrapelvic lymph nodes</td>\n <td/>\n </tr>\n <tr>\n <td>C85.87</td>\n <td>Other specified types of non-Hodgkin lymphoma, spleen</td>\n <td/>\n </tr>\n <tr>\n <td>C85.88</td>\n <td>Other specified types of non-Hodgkin lymphoma, lymph nodes of multiple sites</td>\n <td/>\n </tr>\n <tr>\n <td>C85.89</td>\n <td>Other specified types of non-Hodgkin lymphoma, extranodal and solid organ sites</td>\n <td/>\n </tr>\n <tr>\n <td>C85.90</td>\n <td>Non-Hodgkin lymphoma, unspecified, unspecified site</td>\n <td/>\n </tr>\n <tr>\n <td>C85.91</td>\n <td>Non-Hodgkin lymphoma, unspecified, lymph nodes of head, face, and neck</td>\n <td/>\n </tr>\n <tr>\n <td>C85.92</td>\n <td>Non-Hodgkin lymphoma, unspecified, intrathoracic lymph nodes</td>\n <td/>\n </tr>\n <tr>\n <td>C85.93</td>\n <td>Non-Hodgkin lymphoma, unspecified, intra-abdominal lymph nodes</td>\n <td/>\n </tr>\n <tr>\n <td>C85.94</td>\n <td>Non-Hodgkin lymphoma, unspecified, lymph nodes of axilla and upper limb</td>\n <td/>\n </tr>\n <tr>\n <td>C85.95</td>\n <td>Non-Hodgkin lymphoma, unspecified, lymph nodes of inguinal region and lower limb</td>\n <td/>\n </tr>\n <tr>\n <td>C85.96</td>\n <td>Non-Hodgkin lymphoma, unspecified, intrapelvic lymph nodes</td>\n <td/>\n </tr>\n <tr>\n <td>C85.97</td>\n <td>Non-Hodgkin lymphoma, unspecified, spleen</td>\n <td/>\n </tr>\n <tr>\n <td>C85.98</td>\n <td>Non-Hodgkin lymphoma, unspecified, lymph nodes of multiple sites</td>\n <td/>\n </tr>\n <tr>\n <td>C85.99</td>\n <td>Non-Hodgkin lymphoma, unspecified, extranodal and solid organ sites</td>\n <td/>\n </tr>\n <tr>\n <td>C86.0</td>\n <td>Extranodal NK/T-cell lymphoma, nasal type</td>\n <td/>\n </tr>\n <tr>\n <td>C86.1</td>\n <td>Hepatosplenic T-cell lymphoma</td>\n <td/>\n </tr>\n <tr>\n <td>C86.2</td>\n <td>Enteropathy-type (intestinal) T-cell lymphoma</td>\n <td/>\n </tr>\n <tr>\n <td>C86.3</td>\n <td>Subcutaneous panniculitis-like T-cell lymphoma</td>\n <td/>\n </tr>\n <tr>\n <td>C86.4</td>\n <td>Blastic NK-cell lymphoma</td>\n <td/>\n </tr>\n <tr>\n <td>C86.5</td>\n <td>Angioimmunoblastic T-cell lymphoma</td>\n <td/>\n </tr>\n <tr>\n <td>C86.6</td>\n <td>Primary cutaneous CD30-positive T-cell proliferations</td>\n <td/>\n </tr>\n <tr>\n <td>C88.0</td>\n <td>Waldenström macroglobulinemia</td>\n <td/>\n </tr>\n <tr>\n <td>C88.2</td>\n <td>Heavy chain disease</td>\n <td/>\n </tr>\n <tr>\n <td>C88.3</td>\n <td>Immunoproliferative small intestinal disease</td>\n <td/>\n </tr>\n <tr>\n <td>C88.4</td>\n <td>Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma]</td>\n <td/>\n </tr>\n <tr>\n <td>C88.8</td>\n <td>Other malignant immunoproliferative diseases</td>\n <td/>\n </tr>\n <tr>\n <td>C88.9</td>\n <td>Malignant immunoproliferative disease, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>C90.00</td>\n <td>Multiple myeloma not having achieved remission</td>\n <td/>\n </tr>\n <tr>\n <td>C90.01</td>\n <td>Multiple myeloma in remission</td>\n <td/>\n </tr>\n <tr>\n <td>C90.02</td>\n <td>Multiple myeloma in relapse</td>\n <td/>\n </tr>\n <tr>\n <td>C90.10</td>\n <td>Plasma cell leukemia not having achieved remission</td>\n <td/>\n </tr>\n <tr>\n <td>C90.11</td>\n <td>Plasma cell leukemia in remission</td>\n <td/>\n </tr>\n <tr>\n <td>C90.12</td>\n <td>Plasma cell leukemia in relapse</td>\n <td/>\n </tr>\n <tr>\n <td>C90.20</td>\n <td>Extramedullary plasmacytoma not having achieved remission</td>\n <td/>\n </tr>\n <tr>\n <td>C90.21</td>\n <td>Extramedullary plasmacytoma in remission</td>\n <td/>\n </tr>\n <tr>\n <td>C90.22</td>\n <td>Extramedullary plasmacytoma in relapse</td>\n <td/>\n </tr>\n <tr>\n <td>C90.30</td>\n <td>Solitary plasmacytoma not having achieved remission</td>\n <td/>\n </tr>\n <tr>\n <td>C90.31</td>\n <td>Solitary plasmacytoma in remission</td>\n <td/>\n </tr>\n <tr>\n <td>C90.32</td>\n <td>Solitary plasmacytoma in relapse</td>\n <td/>\n </tr>\n <tr>\n <td>C91.00</td>\n <td>Acute lymphoblastic leukemia not having achieved remission</td>\n <td/>\n </tr>\n <tr>\n <td>C91.01</td>\n <td>Acute lymphoblastic leukemia, in remission</td>\n <td/>\n </tr>\n <tr>\n <td>C91.02</td>\n <td>Acute lymphoblastic leukemia, in relapse</td>\n <td/>\n </tr>\n <tr>\n <td>C91.10</td>\n <td>Chronic lymphocytic leukemia of B-cell type not having achieved remission</td>\n <td/>\n </tr>\n <tr>\n <td>C91.11</td>\n <td>Chronic lymphocytic leukemia of B-cell type in remission</td>\n <td/>\n </tr>\n <tr>\n <td>C91.12</td>\n <td>Chronic lymphocytic leukemia of B-cell type in relapse</td>\n <td/>\n </tr>\n <tr>\n <td>C91.30</td>\n <td>Prolymphocytic leukemia of B-cell type not having achieved remission</td>\n <td/>\n </tr>\n <tr>\n <td>C91.31</td>\n <td>Prolymphocytic leukemia of B-cell type, in remission</td>\n <td/>\n </tr>\n <tr>\n <td>C91.32</td>\n <td>Prolymphocytic leukemia of B-cell type, in relapse</td>\n <td/>\n </tr>\n <tr>\n <td>C91.40</td>\n <td>Hairy cell leukemia not having achieved remission</td>\n <td/>\n </tr>\n <tr>\n <td>C91.41</td>\n <td>Hairy cell leukemia, in remission</td>\n <td/>\n </tr>\n <tr>\n <td>C91.42</td>\n <td>Hairy cell leukemia, in relapse</td>\n <td/>\n </tr>\n <tr>\n <td>C91.50</td>\n <td>Adult T-cell lymphoma/leukemia (HTLV-1-associated) not having achieved remission</td>\n <td/>\n </tr>\n <tr>\n <td>C91.51</td>\n <td>Adult T-cell lymphoma/leukemia (HTLV-1-associated), in remission</td>\n <td/>\n </tr>\n <tr>\n <td>C91.52</td>\n <td>Adult T-cell lymphoma/leukemia (HTLV-1-associated), in relapse</td>\n <td/>\n </tr>\n <tr>\n <td>C91.60</td>\n <td>Prolymphocytic leukemia of T-cell type not having achieved remission</td>\n <td/>\n </tr>\n <tr>\n <td>C91.61</td>\n <td>Prolymphocytic leukemia of T-cell type, in remission</td>\n <td/>\n </tr>\n <tr>\n <td>C91.62</td>\n <td>Prolymphocytic leukemia of T-cell type, in relapse</td>\n <td/>\n </tr>\n <tr>\n <td>C91.90</td>\n <td>Lymphoid leukemia, unspecified not having achieved remission</td>\n <td/>\n </tr>\n <tr>\n <td>C91.91</td>\n <td>Lymphoid leukemia, unspecified, in remission</td>\n <td/>\n </tr>\n <tr>\n <td>C91.92</td>\n <td>Lymphoid leukemia, unspecified, in relapse</td>\n <td/>\n </tr>\n <tr>\n <td>C91.A0</td>\n <td>Mature B-cell leukemia Burkitt-type not having achieved remission</td>\n <td/>\n </tr>\n <tr>\n <td>C91.A1</td>\n <td>Mature B-cell leukemia Burkitt-type, in remission</td>\n <td/>\n </tr>\n <tr>\n <td>C91.A2</td>\n <td>Mature B-cell leukemia Burkitt-type, in relapse</td>\n <td/>\n </tr>\n <tr>\n <td>C91.Z0</td>\n <td>Other lymphoid leukemia not having achieved remission</td>\n <td/>\n </tr>\n <tr>\n <td>C91.Z1</td>\n <td>Other lymphoid leukemia, in remission</td>\n <td/>\n </tr>\n <tr>\n <td>C91.Z2</td>\n <td>Other lymphoid leukemia, in relapse</td>\n <td/>\n </tr>\n <tr>\n <td>C92.00</td>\n <td>Acute myeloblastic leukemia, not having achieved remission</td>\n <td/>\n </tr>\n <tr>\n <td>C92.01</td>\n <td>Acute myeloblastic leukemia, in remission</td>\n <td/>\n </tr>\n <tr>\n <td>C92.02</td>\n <td>Acute myeloblastic leukemia, in relapse</td>\n <td/>\n </tr>\n <tr>\n <td>C92.10</td>\n <td>Chronic myeloid leukemia, BCR/ABL-positive, not having achieved remission</td>\n <td/>\n </tr>\n <tr>\n <td>C92.11</td>\n <td>Chronic myeloid leukemia, BCR/ABL-positive, in remission</td>\n <td/>\n </tr>\n <tr>\n <td>C92.12</td>\n <td>Chronic myeloid leukemia, BCR/ABL-positive, in relapse</td>\n <td/>\n </tr>\n <tr>\n <td>C92.20</td>\n <td>Atypical chronic myeloid leukemia, BCR/ABL-negative, not having achieved remission</td>\n <td/>\n </tr>\n <tr>\n <td>C92.21</td>\n <td>Atypical chronic myeloid leukemia, BCR/ABL-negative, in remission</td>\n <td/>\n </tr>\n <tr>\n <td>C92.22</td>\n <td>Atypical chronic myeloid leukemia, BCR/ABL-negative, in relapse</td>\n <td/>\n </tr>\n <tr>\n <td>C92.30</td>\n <td>Myeloid sarcoma, not having achieved remission</td>\n <td/>\n </tr>\n <tr>\n <td>C92.31</td>\n <td>Myeloid sarcoma, in remission</td>\n <td/>\n </tr>\n <tr>\n <td>C92.32</td>\n <td>Myeloid sarcoma, in relapse</td>\n <td/>\n </tr>\n <tr>\n <td>C92.40</td>\n <td>Acute promyelocytic leukemia, not having achieved remission</td>\n <td/>\n </tr>\n <tr>\n <td>C92.41</td>\n <td>Acute promyelocytic leukemia, in remission</td>\n <td/>\n </tr>\n <tr>\n <td>C92.42</td>\n <td>Acute promyelocytic leukemia, in relapse</td>\n <td/>\n </tr>\n <tr>\n <td>C92.50</td>\n <td>Acute myelomonocytic leukemia, not having achieved remission</td>\n <td/>\n </tr>\n <tr>\n <td>C92.51</td>\n <td>Acute myelomonocytic leukemia, in remission</td>\n <td/>\n </tr>\n <tr>\n <td>C92.52</td>\n <td>Acute myelomonocytic leukemia, in relapse</td>\n <td/>\n </tr>\n <tr>\n <td>C92.60</td>\n <td>Acute myeloid leukemia with 11q23-abnormality not having achieved remission</td>\n <td/>\n </tr>\n <tr>\n <td>C92.61</td>\n <td>Acute myeloid leukemia with 11q23-abnormality in remission</td>\n <td/>\n </tr>\n <tr>\n <td>C92.62</td>\n <td>Acute myeloid leukemia with 11q23-abnormality in relapse</td>\n <td/>\n </tr>\n <tr>\n <td>C92.90</td>\n <td>Myeloid leukemia, unspecified, not having achieved remission</td>\n <td/>\n </tr>\n <tr>\n <td>C92.91</td>\n <td>Myeloid leukemia, unspecified in remission</td>\n <td/>\n </tr>\n <tr>\n <td>C92.92</td>\n <td>Myeloid leukemia, unspecified in relapse</td>\n <td/>\n </tr>\n <tr>\n <td>C92.A0</td>\n <td>Acute myeloid leukemia with multilineage dysplasia, not having achieved remission</td>\n <td/>\n </tr>\n <tr>\n <td>C92.A1</td>\n <td>Acute myeloid leukemia with multilineage dysplasia, in remission</td>\n <td/>\n </tr>\n <tr>\n <td>C92.A2</td>\n <td>Acute myeloid leukemia with multilineage dysplasia, in relapse</td>\n <td/>\n </tr>\n <tr>\n <td>C92.Z0</td>\n <td>Other myeloid leukemia not having achieved remission</td>\n <td/>\n </tr>\n <tr>\n <td>C92.Z1</td>\n <td>Other myeloid leukemia, in remission</td>\n <td/>\n </tr>\n <tr>\n <td>C92.Z2</td>\n <td>Other myeloid leukemia, in relapse</td>\n <td/>\n </tr>\n <tr>\n <td>C93.00</td>\n <td>Acute monoblastic/monocytic leukemia, not having achieved remission</td>\n <td/>\n </tr>\n <tr>\n <td>C93.01</td>\n <td>Acute monoblastic/monocytic leukemia, in remission</td>\n <td/>\n </tr>\n <tr>\n <td>C93.02</td>\n <td>Acute monoblastic/monocytic leukemia, in relapse</td>\n <td/>\n </tr>\n <tr>\n <td>C93.10</td>\n <td>Chronic myelomonocytic leukemia not having achieved remission</td>\n <td/>\n </tr>\n <tr>\n <td>C93.11</td>\n <td>Chronic myelomonocytic leukemia, in remission</td>\n <td/>\n </tr>\n <tr>\n <td>C93.12</td>\n <td>Chronic myelomonocytic leukemia, in relapse</td>\n <td/>\n </tr>\n <tr>\n <td>C93.30</td>\n <td>Juvenile myelomonocytic leukemia, not having achieved remission</td>\n <td/>\n </tr>\n <tr>\n <td>C93.31</td>\n <td>Juvenile myelomonocytic leukemia, in remission</td>\n <td/>\n </tr>\n <tr>\n <td>C93.32</td>\n <td>Juvenile myelomonocytic leukemia, in relapse</td>\n <td/>\n </tr>\n <tr>\n <td>C93.90</td>\n <td>Monocytic leukemia, unspecified, not having achieved remission</td>\n <td/>\n </tr>\n <tr>\n <td>C93.91</td>\n <td>Monocytic leukemia, unspecified in remission</td>\n <td/>\n </tr>\n <tr>\n <td>C93.92</td>\n <td>Monocytic leukemia, unspecified in relapse</td>\n <td/>\n </tr>\n <tr>\n <td>C93.Z0</td>\n <td>Other monocytic leukemia, not having achieved remission</td>\n <td/>\n </tr>\n <tr>\n <td>C93.Z1</td>\n <td>Other monocytic leukemia, in remission</td>\n <td/>\n </tr>\n <tr>\n <td>C93.Z2</td>\n <td>Other monocytic leukemia, in relapse</td>\n <td/>\n </tr>\n <tr>\n <td>C94.00</td>\n <td>Acute erythroid leukemia, not having achieved remission</td>\n <td/>\n </tr>\n <tr>\n <td>C94.01</td>\n <td>Acute erythroid leukemia, in remission</td>\n <td/>\n </tr>\n <tr>\n <td>C94.02</td>\n <td>Acute erythroid leukemia, in relapse</td>\n <td/>\n </tr>\n <tr>\n <td>C94.20</td>\n <td>Acute megakaryoblastic leukemia not having achieved remission</td>\n <td/>\n </tr>\n <tr>\n <td>C94.21</td>\n <td>Acute megakaryoblastic leukemia, in remission</td>\n <td/>\n </tr>\n <tr>\n <td>C94.22</td>\n <td>Acute megakaryoblastic leukemia, in relapse</td>\n <td/>\n </tr>\n <tr>\n <td>C94.30</td>\n <td>Mast cell leukemia not having achieved remission</td>\n <td/>\n </tr>\n <tr>\n <td>C94.31</td>\n <td>Mast cell leukemia, in remission</td>\n <td/>\n </tr>\n <tr>\n <td>C94.32</td>\n <td>Mast cell leukemia, in relapse</td>\n <td/>\n </tr>\n <tr>\n <td>C94.40</td>\n <td>Acute panmyelosis with myelofibrosis not having achieved remission</td>\n <td/>\n </tr>\n <tr>\n <td>C94.41</td>\n <td>Acute panmyelosis with myelofibrosis, in remission</td>\n <td/>\n </tr>\n <tr>\n <td>C94.42</td>\n <td>Acute panmyelosis with myelofibrosis, in relapse</td>\n <td/>\n </tr>\n <tr>\n <td>C94.6</td>\n <td>Myelodysplastic disease, not classified</td>\n <td/>\n </tr>\n <tr>\n <td>C94.80</td>\n <td>Other specified leukemias not having achieved remission</td>\n <td/>\n </tr>\n <tr>\n <td>C94.81</td>\n <td>Other specified leukemias, in remission</td>\n <td/>\n </tr>\n <tr>\n <td>C94.82</td>\n <td>Other specified leukemias, in relapse</td>\n <td/>\n </tr>\n <tr>\n <td>C95.00</td>\n <td>Acute leukemia of unspecified cell type not having achieved remission</td>\n <td/>\n </tr>\n <tr>\n <td>C95.01</td>\n <td>Acute leukemia of unspecified cell type, in remission</td>\n <td/>\n </tr>\n <tr>\n <td>C95.02</td>\n <td>Acute leukemia of unspecified cell type, in relapse</td>\n <td/>\n </tr>\n <tr>\n <td>C95.10</td>\n <td>Chronic leukemia of unspecified cell type not having achieved remission</td>\n <td/>\n </tr>\n <tr>\n <td>C95.11</td>\n <td>Chronic leukemia of unspecified cell type, in remission</td>\n <td/>\n </tr>\n <tr>\n <td>C95.12</td>\n <td>Chronic leukemia of unspecified cell type, in relapse</td>\n <td/>\n </tr>\n <tr>\n <td>C95.90</td>\n <td>Leukemia, unspecified not having achieved remission</td>\n <td/>\n </tr>\n <tr>\n <td>C95.91</td>\n <td>Leukemia, unspecified, in remission</td>\n <td/>\n </tr>\n <tr>\n <td>C95.92</td>\n <td>Leukemia, unspecified, in relapse</td>\n <td/>\n </tr>\n <tr>\n <td>C96.0</td>\n <td>Multifocal and multisystemic (disseminated) Langerhans-cell histiocytosis</td>\n <td/>\n </tr>\n <tr>\n <td>C96.2</td>\n <td>Malignant mast cell neoplasm</td>\n <td/>\n </tr>\n <tr>\n <td>C96.20</td>\n <td>Malignant mast cell neoplasm, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>C96.21</td>\n <td>Aggressive systemic mastocytosis</td>\n <td/>\n </tr>\n <tr>\n <td>C96.22</td>\n <td>Mast cell sarcoma</td>\n <td/>\n </tr>\n <tr>\n <td>C96.29</td>\n <td>Other malignant mast cell neoplasm</td>\n <td/>\n </tr>\n <tr>\n <td>C96.4</td>\n <td>Sarcoma of dendritic cells (accessory cells)</td>\n <td/>\n </tr>\n <tr>\n <td>C96.5</td>\n <td>Multifocal and unisystemic Langerhans-cell histiocytosis</td>\n <td/>\n </tr>\n <tr>\n <td>C96.6</td>\n <td>Unifocal Langerhans-cell histiocytosis</td>\n <td/>\n </tr>\n <tr>\n <td>C96.9</td>\n <td>Malignant neoplasm of lymphoid, hematopoietic and related tissue, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>C96.A</td>\n <td>Histiocytic sarcoma</td>\n <td/>\n </tr>\n <tr>\n <td>C96.Z</td>\n <td>Other specified malignant neoplasms of lymphoid, hematopoietic and related tissue</td>\n <td/>\n </tr>\n <tr>\n <td>D00.00</td>\n <td>Carcinoma in situ of oral cavity, unspecified site</td>\n <td/>\n </tr>\n <tr>\n <td>D00.01</td>\n <td>Carcinoma in situ of labial mucosa and vermilion border</td>\n <td/>\n </tr>\n <tr>\n <td>D00.02</td>\n <td>Carcinoma in situ of buccal mucosa</td>\n <td/>\n </tr>\n <tr>\n <td>D00.03</td>\n <td>Carcinoma in situ of gingiva and edentulous alveolar ridge</td>\n <td/>\n </tr>\n <tr>\n <td>D00.04</td>\n <td>Carcinoma in situ of soft palate</td>\n <td/>\n </tr>\n <tr>\n <td>D00.05</td>\n <td>Carcinoma in situ of hard palate</td>\n <td/>\n </tr>\n <tr>\n <td>D00.06</td>\n <td>Carcinoma in situ of floor of mouth</td>\n <td/>\n </tr>\n <tr>\n <td>D00.07</td>\n <td>Carcinoma in situ of tongue</td>\n <td/>\n </tr>\n <tr>\n <td>D00.08</td>\n <td>Carcinoma in situ of pharynx</td>\n <td/>\n </tr>\n <tr>\n <td>D00.1</td>\n <td>Carcinoma in situ of esophagus</td>\n <td/>\n </tr>\n <tr>\n <td>D00.2</td>\n <td>Carcinoma in situ of stomach</td>\n <td/>\n </tr>\n <tr>\n <td>D01.0</td>\n <td>Carcinoma in situ of colon</td>\n <td/>\n </tr>\n <tr>\n <td>D01.1</td>\n <td>Carcinoma in situ of rectosigmoid junction</td>\n <td/>\n </tr>\n <tr>\n <td>D01.2</td>\n <td>Carcinoma in situ of rectum</td>\n <td/>\n </tr>\n <tr>\n <td>D01.3</td>\n <td>Carcinoma in situ of anus and anal canal</td>\n <td/>\n </tr>\n <tr>\n <td>D01.40</td>\n <td>Carcinoma in situ of unspecified part of intestine</td>\n <td/>\n </tr>\n <tr>\n <td>D01.49</td>\n <td>Carcinoma in situ of other parts of intestine</td>\n <td/>\n </tr>\n <tr>\n <td>D01.5</td>\n <td>Carcinoma in situ of liver, gallbladder and bile ducts</td>\n <td/>\n </tr>\n <tr>\n <td>D01.7</td>\n <td>Carcinoma in situ of other specified digestive organs</td>\n <td/>\n </tr>\n <tr>\n <td>D01.9</td>\n <td>Carcinoma in situ of digestive organ, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>D02.0</td>\n <td>Carcinoma in situ of larynx</td>\n <td/>\n </tr>\n <tr>\n <td>D02.1</td>\n <td>Carcinoma in situ of trachea</td>\n <td/>\n </tr>\n <tr>\n <td>D02.20</td>\n <td>Carcinoma in situ of unspecified bronchus and lung</td>\n <td/>\n </tr>\n <tr>\n <td>D02.21</td>\n <td>Carcinoma in situ of right bronchus and lung</td>\n <td/>\n </tr>\n <tr>\n <td>D02.22</td>\n <td>Carcinoma in situ of left bronchus and lung</td>\n <td/>\n </tr>\n <tr>\n <td>D02.3</td>\n <td>Carcinoma in situ of other parts of respiratory system</td>\n <td/>\n </tr>\n <tr>\n <td>D02.4</td>\n <td>Carcinoma in situ of respiratory system, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>D03.0</td>\n <td>Melanoma in situ of lip</td>\n <td/>\n </tr>\n <tr>\n <td>D03.10</td>\n <td>Melanoma in situ of unspecified eyelid, including canthus</td>\n <td/>\n </tr>\n <tr>\n <td>D03.11</td>\n <td>Melanoma in situ of right eyelid, including canthus</td>\n <td/>\n </tr>\n <tr>\n <td>D03.111</td>\n <td>Melanoma in situ of right upper eyelid, including canthus</td>\n <td/>\n </tr>\n <tr>\n <td>D03.112</td>\n <td>Melanoma in situ of right lower eyelid, including canthus</td>\n <td/>\n </tr>\n <tr>\n <td>D03.12</td>\n <td>Melanoma in situ of left eyelid, including canthus</td>\n <td/>\n </tr>\n <tr>\n <td>D03.121</td>\n <td>Melanoma in situ of left upper eyelid, including canthus</td>\n <td/>\n </tr>\n <tr>\n <td>D03.122</td>\n <td>Melanoma in situ of left lower eyelid, including canthus</td>\n <td/>\n </tr>\n <tr>\n <td>D03.20</td>\n <td>Melanoma in situ of unspecified ear and external auricular canal</td>\n <td/>\n </tr>\n <tr>\n <td>D03.21</td>\n <td>Melanoma in situ of right ear and external auricular canal</td>\n <td/>\n </tr>\n <tr>\n <td>D03.22</td>\n <td>Melanoma in situ of left ear and external auricular canal</td>\n <td/>\n </tr>\n <tr>\n <td>D03.30</td>\n <td>Melanoma in situ of unspecified part of face</td>\n <td/>\n </tr>\n <tr>\n <td>D03.39</td>\n <td>Melanoma in situ of other parts of face</td>\n <td/>\n </tr>\n <tr>\n <td>D03.4</td>\n <td>Melanoma in situ of scalp and neck</td>\n <td/>\n </tr>\n <tr>\n <td>D03.51</td>\n <td>Melanoma in situ of anal skin</td>\n <td/>\n </tr>\n <tr>\n <td>D03.52</td>\n <td>Melanoma in situ of breast (skin) (soft tissue)</td>\n <td/>\n </tr>\n <tr>\n <td>D03.59</td>\n <td>Melanoma in situ of other part of trunk</td>\n <td/>\n </tr>\n <tr>\n <td>D03.60</td>\n <td>Melanoma in situ of unspecified upper limb, including shoulder</td>\n <td/>\n </tr>\n <tr>\n <td>D03.61</td>\n <td>Melanoma in situ of right upper limb, including shoulder</td>\n <td/>\n </tr>\n <tr>\n <td>D03.62</td>\n <td>Melanoma in situ of left upper limb, including shoulder</td>\n <td/>\n </tr>\n <tr>\n <td>D03.70</td>\n <td>Melanoma in situ of unspecified lower limb, including hip</td>\n <td/>\n </tr>\n <tr>\n <td>D03.71</td>\n <td>Melanoma in situ of right lower limb, including hip</td>\n <td/>\n </tr>\n <tr>\n <td>D03.72</td>\n <td>Melanoma in situ of left lower limb, including hip</td>\n <td/>\n </tr>\n <tr>\n <td>D03.8</td>\n <td>Melanoma in situ of other sites</td>\n <td/>\n </tr>\n <tr>\n <td>D03.9</td>\n <td>Melanoma in situ, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>D04.0</td>\n <td>Carcinoma in situ of skin of lip</td>\n <td/>\n </tr>\n <tr>\n <td>D04.10</td>\n <td>Carcinoma in situ of skin of unspecified eyelid, including canthus</td>\n <td/>\n </tr>\n <tr>\n <td>D04.11</td>\n <td>Carcinoma in situ of skin of right eyelid, including canthus</td>\n <td/>\n </tr>\n <tr>\n <td>D04.111</td>\n <td>Carcinoma in situ of skin of right upper eyelid, including canthus</td>\n <td/>\n </tr>\n <tr>\n <td>D04.112</td>\n <td>Carcinoma in situ of skin of right lower eyelid, including canthus</td>\n <td/>\n </tr>\n <tr>\n <td>D04.12</td>\n <td>Carcinoma in situ of skin of left eyelid, including canthus</td>\n <td/>\n </tr>\n <tr>\n <td>D04.121</td>\n <td>Carcinoma in situ of skin of left upper eyelid, including canthus</td>\n <td/>\n </tr>\n <tr>\n <td>D04.122</td>\n <td>Carcinoma in situ of skin of left lower eyelid, including canthus</td>\n <td/>\n </tr>\n <tr>\n <td>D04.20</td>\n <td>Carcinoma in situ of skin of unspecified ear and external auricular canal</td>\n <td/>\n </tr>\n <tr>\n <td>D04.21</td>\n <td>Carcinoma in situ of skin of right ear and external auricular canal</td>\n <td/>\n </tr>\n <tr>\n <td>D04.22</td>\n <td>Carcinoma in situ of skin of left ear and external auricular canal</td>\n <td/>\n </tr>\n <tr>\n <td>D04.30</td>\n <td>Carcinoma in situ of skin of unspecified part of face</td>\n <td/>\n </tr>\n <tr>\n <td>D04.39</td>\n <td>Carcinoma in situ of skin of other parts of face</td>\n <td/>\n </tr>\n <tr>\n <td>D04.4</td>\n <td>Carcinoma in situ of skin of scalp and neck</td>\n <td/>\n </tr>\n <tr>\n <td>D04.5</td>\n <td>Carcinoma in situ of skin of trunk</td>\n <td/>\n </tr>\n <tr>\n <td>D04.60</td>\n <td>Carcinoma in situ of skin of unspecified upper limb, including shoulder</td>\n <td/>\n </tr>\n <tr>\n <td>D04.61</td>\n <td>Carcinoma in situ of skin of right upper limb, including shoulder</td>\n <td/>\n </tr>\n <tr>\n <td>D04.62</td>\n <td>Carcinoma in situ of skin of left upper limb, including shoulder</td>\n <td/>\n </tr>\n <tr>\n <td>D04.70</td>\n <td>Carcinoma in situ of skin of unspecified lower limb, including hip</td>\n <td/>\n </tr>\n <tr>\n <td>D04.71</td>\n <td>Carcinoma in situ of skin of right lower limb, including hip</td>\n <td/>\n </tr>\n <tr>\n <td>D04.72</td>\n <td>Carcinoma in situ of skin of left lower limb, including hip</td>\n <td/>\n </tr>\n <tr>\n <td>D04.8</td>\n <td>Carcinoma in situ of skin of other sites</td>\n <td/>\n </tr>\n <tr>\n <td>D04.9</td>\n <td>Carcinoma in situ of skin, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>D05.00</td>\n <td>Lobular carcinoma in situ of unspecified breast</td>\n <td/>\n </tr>\n <tr>\n <td>D05.01</td>\n <td>Lobular carcinoma in situ of right breast</td>\n <td/>\n </tr>\n <tr>\n <td>D05.02</td>\n <td>Lobular carcinoma in situ of left breast</td>\n <td/>\n </tr>\n <tr>\n <td>D05.10</td>\n <td>Intraductal carcinoma in situ of unspecified breast</td>\n <td/>\n </tr>\n <tr>\n <td>D05.11</td>\n <td>Intraductal carcinoma in situ of right breast</td>\n <td/>\n </tr>\n <tr>\n <td>D05.12</td>\n <td>Intraductal carcinoma in situ of left breast</td>\n <td/>\n </tr>\n <tr>\n <td>D05.80</td>\n <td>Other specified type of carcinoma in situ of unspecified breast</td>\n <td/>\n </tr>\n <tr>\n <td>D05.81</td>\n <td>Other specified type of carcinoma in situ of right breast</td>\n <td/>\n </tr>\n <tr>\n <td>D05.82</td>\n <td>Other specified type of carcinoma in situ of left breast</td>\n <td/>\n </tr>\n <tr>\n <td>D05.90</td>\n <td>Unspecified type of carcinoma in situ of unspecified breast</td>\n <td/>\n </tr>\n <tr>\n <td>D05.91</td>\n <td>Unspecified type of carcinoma in situ of right breast</td>\n <td/>\n </tr>\n <tr>\n <td>D05.92</td>\n <td>Unspecified type of carcinoma in situ of left breast</td>\n <td/>\n </tr>\n <tr>\n <td>D06.0</td>\n <td>Carcinoma in situ of endocervix</td>\n <td/>\n </tr>\n <tr>\n <td>D06.1</td>\n <td>Carcinoma in situ of exocervix</td>\n <td/>\n </tr>\n <tr>\n <td>D06.7</td>\n <td>Carcinoma in situ of other parts of cervix</td>\n <td/>\n </tr>\n <tr>\n <td>D06.9</td>\n <td>Carcinoma in situ of cervix, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>D07.0</td>\n <td>Carcinoma in situ of endometrium</td>\n <td/>\n </tr>\n <tr>\n <td>D07.1</td>\n <td>Carcinoma in situ of vulva</td>\n <td/>\n </tr>\n <tr>\n <td>D07.2</td>\n <td>Carcinoma in situ of vagina</td>\n <td/>\n </tr>\n <tr>\n <td>D07.30</td>\n <td>Carcinoma in situ of unspecified female genital organs</td>\n <td/>\n </tr>\n <tr>\n <td>D07.39</td>\n <td>Carcinoma in situ of other female genital organs</td>\n <td/>\n </tr>\n <tr>\n <td>D07.4</td>\n <td>Carcinoma in situ of penis</td>\n <td/>\n </tr>\n <tr>\n <td>D07.5</td>\n <td>Carcinoma in situ of prostate</td>\n <td/>\n </tr>\n <tr>\n <td>D07.60</td>\n <td>Carcinoma in situ of unspecified male genital organs</td>\n <td/>\n </tr>\n <tr>\n <td>D07.61</td>\n <td>Carcinoma in situ of scrotum</td>\n <td/>\n </tr>\n <tr>\n <td>D07.69</td>\n <td>Carcinoma in situ of other male genital organs</td>\n <td/>\n </tr>\n <tr>\n <td>D09.0</td>\n <td>Carcinoma in situ of bladder</td>\n <td/>\n </tr>\n <tr>\n <td>D09.10</td>\n <td>Carcinoma in situ of unspecified urinary organ</td>\n <td/>\n </tr>\n <tr>\n <td>D09.19</td>\n <td>Carcinoma in situ of other urinary organs</td>\n <td/>\n </tr>\n <tr>\n <td>D09.20</td>\n <td>Carcinoma in situ of unspecified eye</td>\n <td/>\n </tr>\n <tr>\n <td>D09.21</td>\n <td>Carcinoma in situ of right eye</td>\n <td/>\n </tr>\n <tr>\n <td>D09.22</td>\n <td>Carcinoma in situ of left eye</td>\n <td/>\n </tr>\n <tr>\n <td>D09.3</td>\n <td>Carcinoma in situ of thyroid and other endocrine glands</td>\n <td/>\n </tr>\n <tr>\n <td>D09.8</td>\n <td>Carcinoma in situ of other specified sites</td>\n <td/>\n </tr>\n <tr>\n <td>D09.9</td>\n <td>Carcinoma in situ, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>D10.0</td>\n <td>Benign neoplasm of lip</td>\n <td/>\n </tr>\n <tr>\n <td>D10.1</td>\n <td>Benign neoplasm of tongue</td>\n <td/>\n </tr>\n <tr>\n <td>D10.2</td>\n <td>Benign neoplasm of floor of mouth</td>\n <td/>\n </tr>\n <tr>\n <td>D10.30</td>\n <td>Benign neoplasm of unspecified part of mouth</td>\n <td/>\n </tr>\n <tr>\n <td>D10.39</td>\n <td>Benign neoplasm of other parts of mouth</td>\n <td/>\n </tr>\n <tr>\n <td>D10.4</td>\n <td>Benign neoplasm of tonsil</td>\n <td/>\n </tr>\n <tr>\n <td>D10.5</td>\n <td>Benign neoplasm of other parts of oropharynx</td>\n <td/>\n </tr>\n <tr>\n <td>D10.6</td>\n <td>Benign neoplasm of nasopharynx</td>\n <td/>\n </tr>\n <tr>\n <td>D10.7</td>\n <td>Benign neoplasm of hypopharynx</td>\n <td/>\n </tr>\n <tr>\n <td>D10.9</td>\n <td>Benign neoplasm of pharynx, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>D11.0</td>\n <td>Benign neoplasm of parotid gland</td>\n <td/>\n </tr>\n <tr>\n <td>D11.7</td>\n <td>Benign neoplasm of other major salivary glands</td>\n <td/>\n </tr>\n <tr>\n <td>D11.9</td>\n <td>Benign neoplasm of major salivary gland, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>D12.0</td>\n <td>Benign neoplasm of cecum</td>\n <td/>\n </tr>\n <tr>\n <td>D12.1</td>\n <td>Benign neoplasm of appendix</td>\n <td/>\n </tr>\n <tr>\n <td>D12.2</td>\n <td>Benign neoplasm of ascending colon</td>\n <td/>\n </tr>\n <tr>\n <td>D12.3</td>\n <td>Benign neoplasm of transverse colon</td>\n <td/>\n </tr>\n <tr>\n <td>D12.4</td>\n <td>Benign neoplasm of descending colon</td>\n <td/>\n </tr>\n <tr>\n <td>D12.5</td>\n <td>Benign neoplasm of sigmoid colon</td>\n <td/>\n </tr>\n <tr>\n <td>D12.6</td>\n <td>Benign neoplasm of colon, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>D12.7</td>\n <td>Benign neoplasm of rectosigmoid junction</td>\n <td/>\n </tr>\n <tr>\n <td>D12.8</td>\n <td>Benign neoplasm of rectum</td>\n <td/>\n </tr>\n <tr>\n <td>D12.9</td>\n <td>Benign neoplasm of anus and anal canal</td>\n <td/>\n </tr>\n <tr>\n <td>D13.0</td>\n <td>Benign neoplasm of esophagus</td>\n <td/>\n </tr>\n <tr>\n <td>D13.1</td>\n <td>Benign neoplasm of stomach</td>\n <td/>\n </tr>\n <tr>\n <td>D13.2</td>\n <td>Benign neoplasm of duodenum</td>\n <td/>\n </tr>\n <tr>\n <td>D13.30</td>\n <td>Benign neoplasm of unspecified part of small intestine</td>\n <td/>\n </tr>\n <tr>\n <td>D13.39</td>\n <td>Benign neoplasm of other parts of small intestine</td>\n <td/>\n </tr>\n <tr>\n <td>D13.4</td>\n <td>Benign neoplasm of liver</td>\n <td/>\n </tr>\n <tr>\n <td>D13.5</td>\n <td>Benign neoplasm of extrahepatic bile ducts</td>\n <td/>\n </tr>\n <tr>\n <td>D13.6</td>\n <td>Benign neoplasm of pancreas</td>\n <td/>\n </tr>\n <tr>\n <td>D13.7</td>\n <td>Benign neoplasm of endocrine pancreas</td>\n <td/>\n </tr>\n <tr>\n <td>D13.9</td>\n <td>Benign neoplasm of ill-defined sites within the digestive system</td>\n <td/>\n </tr>\n <tr>\n <td>D14.0</td>\n <td>Benign neoplasm of middle ear, nasal cavity and accessory sinuses</td>\n <td/>\n </tr>\n <tr>\n <td>D14.1</td>\n <td>Benign neoplasm of larynx</td>\n <td/>\n </tr>\n <tr>\n <td>D14.2</td>\n <td>Benign neoplasm of trachea</td>\n <td/>\n </tr>\n <tr>\n <td>D14.30</td>\n <td>Benign neoplasm of unspecified bronchus and lung</td>\n <td/>\n </tr>\n <tr>\n <td>D14.31</td>\n <td>Benign neoplasm of right bronchus and lung</td>\n <td/>\n </tr>\n <tr>\n <td>D14.32</td>\n <td>Benign neoplasm of left bronchus and lung</td>\n <td/>\n </tr>\n <tr>\n <td>D14.4</td>\n <td>Benign neoplasm of respiratory system, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>D15.0</td>\n <td>Benign neoplasm of thymus</td>\n <td/>\n </tr>\n <tr>\n <td>D15.1</td>\n <td>Benign neoplasm of heart</td>\n <td/>\n </tr>\n <tr>\n <td>D15.2</td>\n <td>Benign neoplasm of mediastinum</td>\n <td/>\n </tr>\n <tr>\n <td>D15.7</td>\n <td>Benign neoplasm of other specified intrathoracic organs</td>\n <td/>\n </tr>\n <tr>\n <td>D15.9</td>\n <td>Benign neoplasm of intrathoracic organ, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>D16.00</td>\n <td>Benign neoplasm of scapula and long bones of unspecified upper limb</td>\n <td/>\n </tr>\n <tr>\n <td>D16.01</td>\n <td>Benign neoplasm of scapula and long bones of right upper limb</td>\n <td/>\n </tr>\n <tr>\n <td>D16.02</td>\n <td>Benign neoplasm of scapula and long bones of left upper limb</td>\n <td/>\n </tr>\n <tr>\n <td>D16.10</td>\n <td>Benign neoplasm of short bones of unspecified upper limb</td>\n <td/>\n </tr>\n <tr>\n <td>D16.11</td>\n <td>Benign neoplasm of short bones of right upper limb</td>\n <td/>\n </tr>\n <tr>\n <td>D16.12</td>\n <td>Benign neoplasm of short bones of left upper limb</td>\n <td/>\n </tr>\n <tr>\n <td>D16.20</td>\n <td>Benign neoplasm of long bones of unspecified lower limb</td>\n <td/>\n </tr>\n <tr>\n <td>D16.21</td>\n <td>Benign neoplasm of long bones of right lower limb</td>\n <td/>\n </tr>\n <tr>\n <td>D16.22</td>\n <td>Benign neoplasm of long bones of left lower limb</td>\n <td/>\n </tr>\n <tr>\n <td>D16.30</td>\n <td>Benign neoplasm of short bones of unspecified lower limb</td>\n <td/>\n </tr>\n <tr>\n <td>D16.31</td>\n <td>Benign neoplasm of short bones of right lower limb</td>\n <td/>\n </tr>\n <tr>\n <td>D16.32</td>\n <td>Benign neoplasm of short bones of left lower limb</td>\n <td/>\n </tr>\n <tr>\n <td>D16.4</td>\n <td>Benign neoplasm of bones of skull and face</td>\n <td/>\n </tr>\n <tr>\n <td>D16.5</td>\n <td>Benign neoplasm of lower jaw bone</td>\n <td/>\n </tr>\n <tr>\n <td>D16.6</td>\n <td>Benign neoplasm of vertebral column</td>\n <td/>\n </tr>\n <tr>\n <td>D16.7</td>\n <td>Benign neoplasm of ribs, sternum and clavicle</td>\n <td/>\n </tr>\n <tr>\n <td>D16.8</td>\n <td>Benign neoplasm of pelvic bones, sacrum and coccyx</td>\n <td/>\n </tr>\n <tr>\n <td>D16.9</td>\n <td>Benign neoplasm of bone and articular cartilage, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>D17.0</td>\n <td>Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck</td>\n <td/>\n </tr>\n <tr>\n <td>D17.1</td>\n <td>Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk</td>\n <td/>\n </tr>\n <tr>\n <td>D17.20</td>\n <td>Benign lipomatous neoplasm of skin and subcutaneous tissue of unspecified limb</td>\n <td/>\n </tr>\n <tr>\n <td>D17.21</td>\n <td>Benign lipomatous neoplasm of skin and subcutaneous tissue of right arm</td>\n <td/>\n </tr>\n <tr>\n <td>D17.22</td>\n <td>Benign lipomatous neoplasm of skin and subcutaneous tissue of left arm</td>\n <td/>\n </tr>\n <tr>\n <td>D17.23</td>\n <td>Benign lipomatous neoplasm of skin and subcutaneous tissue of right leg</td>\n <td/>\n </tr>\n <tr>\n <td>D17.24</td>\n <td>Benign lipomatous neoplasm of skin and subcutaneous tissue of left leg</td>\n <td/>\n </tr>\n <tr>\n <td>D17.30</td>\n <td>Benign lipomatous neoplasm of skin and subcutaneous tissue of unspecified sites</td>\n <td/>\n </tr>\n <tr>\n <td>D17.39</td>\n <td>Benign lipomatous neoplasm of skin and subcutaneous tissue of other sites</td>\n <td/>\n </tr>\n <tr>\n <td>D17.4</td>\n <td>Benign lipomatous neoplasm of intrathoracic organs</td>\n <td/>\n </tr>\n <tr>\n <td>D17.5</td>\n <td>Benign lipomatous neoplasm of intra-abdominal organs</td>\n <td/>\n </tr>\n <tr>\n <td>D17.6</td>\n <td>Benign lipomatous neoplasm of spermatic cord</td>\n <td/>\n </tr>\n <tr>\n <td>D17.71</td>\n <td>Benign lipomatous neoplasm of kidney</td>\n <td/>\n </tr>\n <tr>\n <td>D17.72</td>\n <td>Benign lipomatous neoplasm of other genitourinary organ</td>\n <td/>\n </tr>\n <tr>\n <td>D17.79</td>\n <td>Benign lipomatous neoplasm of other sites</td>\n <td/>\n </tr>\n <tr>\n <td>D17.9</td>\n <td>Benign lipomatous neoplasm, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>D18.00</td>\n <td>Hemangioma unspecified site</td>\n <td/>\n </tr>\n <tr>\n <td>D18.01</td>\n <td>Hemangioma of skin and subcutaneous tissue</td>\n <td/>\n </tr>\n <tr>\n <td>D18.02</td>\n <td>Hemangioma of intracranial structures</td>\n <td/>\n </tr>\n <tr>\n <td>D18.03</td>\n <td>Hemangioma of intra-abdominal structures</td>\n <td/>\n </tr>\n <tr>\n <td>D18.09</td>\n <td>Hemangioma of other sites</td>\n <td/>\n </tr>\n <tr>\n <td>D18.1</td>\n <td>Lymphangioma, any site</td>\n <td/>\n </tr>\n <tr>\n <td>D19.0</td>\n <td>Benign neoplasm of mesothelial tissue of pleura</td>\n <td/>\n </tr>\n <tr>\n <td>D19.1</td>\n <td>Benign neoplasm of mesothelial tissue of peritoneum</td>\n <td/>\n </tr>\n <tr>\n <td>D19.7</td>\n <td>Benign neoplasm of mesothelial tissue of other sites</td>\n <td/>\n </tr>\n <tr>\n <td>D19.9</td>\n <td>Benign neoplasm of mesothelial tissue, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>D20.0</td>\n <td>Benign neoplasm of soft tissue of retroperitoneum</td>\n <td/>\n </tr>\n <tr>\n <td>D20.1</td>\n <td>Benign neoplasm of soft tissue of peritoneum</td>\n <td/>\n </tr>\n <tr>\n <td>D21.0</td>\n <td>Benign neoplasm of connective and other soft tissue of head, face and neck</td>\n <td/>\n </tr>\n <tr>\n <td>D21.10</td>\n <td>Benign neoplasm of connective and other soft tissue of unspecified upper limb, including shoulder</td>\n <td/>\n </tr>\n <tr>\n <td>D21.11</td>\n <td>Benign neoplasm of connective and other soft tissue of right upper limb, including shoulder</td>\n <td/>\n </tr>\n <tr>\n <td>D21.12</td>\n <td>Benign neoplasm of connective and other soft tissue of left upper limb, including shoulder</td>\n <td/>\n </tr>\n <tr>\n <td>D21.20</td>\n <td>Benign neoplasm of connective and other soft tissue of unspecified lower limb, including hip</td>\n <td/>\n </tr>\n <tr>\n <td>D21.21</td>\n <td>Benign neoplasm of connective and other soft tissue of right lower limb, including hip</td>\n <td/>\n </tr>\n <tr>\n <td>D21.22</td>\n <td>Benign neoplasm of connective and other soft tissue of left lower limb, including hip</td>\n <td/>\n </tr>\n <tr>\n <td>D21.3</td>\n <td>Benign neoplasm of connective and other soft tissue of thorax</td>\n <td/>\n </tr>\n <tr>\n <td>D21.4</td>\n <td>Benign neoplasm of connective and other soft tissue of abdomen</td>\n <td/>\n </tr>\n <tr>\n <td>D21.5</td>\n <td>Benign neoplasm of connective and other soft tissue of pelvis</td>\n <td/>\n </tr>\n <tr>\n <td>D21.6</td>\n <td>Benign neoplasm of connective and other soft tissue of trunk, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>D21.9</td>\n <td>Benign neoplasm of connective and other soft tissue, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>D22.0</td>\n <td>Melanocytic nevi of lip</td>\n <td/>\n </tr>\n <tr>\n <td>D22.10</td>\n <td>Melanocytic nevi of unspecified eyelid, including canthus</td>\n <td/>\n </tr>\n <tr>\n <td>D22.11</td>\n <td>Melanocytic nevi of right eyelid, including canthus</td>\n <td/>\n </tr>\n <tr>\n <td>D22.111</td>\n <td>Melanocytic nevi of right upper eyelid, including canthus</td>\n <td/>\n </tr>\n <tr>\n <td>D22.112</td>\n <td>Melanocytic nevi of right lower eyelid, including canthus</td>\n <td/>\n </tr>\n <tr>\n <td>D22.12</td>\n <td>Melanocytic nevi of left eyelid, including canthus</td>\n <td/>\n </tr>\n <tr>\n <td>D22.121</td>\n <td>Melanocytic nevi of left upper eyelid, including canthus</td>\n <td/>\n </tr>\n <tr>\n <td>D22.122</td>\n <td>Melanocytic nevi of left lower eyelid, including canthus</td>\n <td/>\n </tr>\n <tr>\n <td>D22.20</td>\n <td>Melanocytic nevi of unspecified ear and external auricular canal</td>\n <td/>\n </tr>\n <tr>\n <td>D22.21</td>\n <td>Melanocytic nevi of right ear and external auricular canal</td>\n <td/>\n </tr>\n <tr>\n <td>D22.22</td>\n <td>Melanocytic nevi of left ear and external auricular canal</td>\n <td/>\n </tr>\n <tr>\n <td>D22.30</td>\n <td>Melanocytic nevi of unspecified part of face</td>\n <td/>\n </tr>\n <tr>\n <td>D22.39</td>\n <td>Melanocytic nevi of other parts of face</td>\n <td/>\n </tr>\n <tr>\n <td>D22.4</td>\n <td>Melanocytic nevi of scalp and neck</td>\n <td/>\n </tr>\n <tr>\n <td>D22.5</td>\n <td>Melanocytic nevi of trunk</td>\n <td/>\n </tr>\n <tr>\n <td>D22.60</td>\n <td>Melanocytic nevi of unspecified upper limb, including shoulder</td>\n <td/>\n </tr>\n <tr>\n <td>D22.61</td>\n <td>Melanocytic nevi of right upper limb, including shoulder</td>\n <td/>\n </tr>\n <tr>\n <td>D22.62</td>\n <td>Melanocytic nevi of left upper limb, including shoulder</td>\n <td/>\n </tr>\n <tr>\n <td>D22.70</td>\n <td>Melanocytic nevi of unspecified lower limb, including hip</td>\n <td/>\n </tr>\n <tr>\n <td>D22.71</td>\n <td>Melanocytic nevi of right lower limb, including hip</td>\n <td/>\n </tr>\n <tr>\n <td>D22.72</td>\n <td>Melanocytic nevi of left lower limb, including hip</td>\n <td/>\n </tr>\n <tr>\n <td>D22.9</td>\n <td>Melanocytic nevi, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>D23.0</td>\n <td>Other benign neoplasm of skin of lip</td>\n <td/>\n </tr>\n <tr>\n <td>D23.10</td>\n <td>Other benign neoplasm of skin of unspecified eyelid, including canthus</td>\n <td/>\n </tr>\n <tr>\n <td>D23.11</td>\n <td>Other benign neoplasm of skin of right eyelid, including canthus</td>\n <td/>\n </tr>\n <tr>\n <td>D23.111</td>\n <td>Other benign neoplasm of skin of right upper eyelid, including canthus</td>\n <td/>\n </tr>\n <tr>\n <td>D23.112</td>\n <td>Other benign neoplasm of skin of right lower eyelid, including canthus</td>\n <td/>\n </tr>\n <tr>\n <td>D23.12</td>\n <td>Other benign neoplasm of skin of left eyelid, including canthus</td>\n <td/>\n </tr>\n <tr>\n <td>D23.121</td>\n <td>Other benign neoplasm of skin of left upper eyelid, including canthus</td>\n <td/>\n </tr>\n <tr>\n <td>D23.122</td>\n <td>Other benign neoplasm of skin of left lower eyelid, including canthus</td>\n <td/>\n </tr>\n <tr>\n <td>D23.20</td>\n <td>Other benign neoplasm of skin of unspecified ear and external auricular canal</td>\n <td/>\n </tr>\n <tr>\n <td>D23.21</td>\n <td>Other benign neoplasm of skin of right ear and external auricular canal</td>\n <td/>\n </tr>\n <tr>\n <td>D23.22</td>\n <td>Other benign neoplasm of skin of left ear and external auricular canal</td>\n <td/>\n </tr>\n <tr>\n <td>D23.30</td>\n <td>Other benign neoplasm of skin of unspecified part of face</td>\n <td/>\n </tr>\n <tr>\n <td>D23.39</td>\n <td>Other benign neoplasm of skin of other parts of face</td>\n <td/>\n </tr>\n <tr>\n <td>D23.4</td>\n <td>Other benign neoplasm of skin of scalp and neck</td>\n <td/>\n </tr>\n <tr>\n <td>D23.5</td>\n <td>Other benign neoplasm of skin of trunk</td>\n <td/>\n </tr>\n <tr>\n <td>D23.60</td>\n <td>Other benign neoplasm of skin of unspecified upper limb, including shoulder</td>\n <td/>\n </tr>\n <tr>\n <td>D23.61</td>\n <td>Other benign neoplasm of skin of right upper limb, including shoulder</td>\n <td/>\n </tr>\n <tr>\n <td>D23.62</td>\n <td>Other benign neoplasm of skin of left upper limb, including shoulder</td>\n <td/>\n </tr>\n <tr>\n <td>D23.70</td>\n <td>Other benign neoplasm of skin of unspecified lower limb, including hip</td>\n <td/>\n </tr>\n <tr>\n <td>D23.71</td>\n <td>Other benign neoplasm of skin of right lower limb, including hip</td>\n <td/>\n </tr>\n <tr>\n <td>D23.72</td>\n <td>Other benign neoplasm of skin of left lower limb, including hip</td>\n <td/>\n </tr>\n <tr>\n <td>D23.9</td>\n <td>Other benign neoplasm of skin, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>D24.1</td>\n <td>Benign neoplasm of right breast</td>\n <td/>\n </tr>\n <tr>\n <td>D24.2</td>\n <td>Benign neoplasm of left breast</td>\n <td/>\n </tr>\n <tr>\n <td>D24.9</td>\n <td>Benign neoplasm of unspecified breast</td>\n <td/>\n </tr>\n <tr>\n <td>D25.0</td>\n <td>Submucous leiomyoma of uterus</td>\n <td/>\n </tr>\n <tr>\n <td>D25.1</td>\n <td>Intramural leiomyoma of uterus</td>\n <td/>\n </tr>\n <tr>\n <td>D25.2</td>\n <td>Subserosal leiomyoma of uterus</td>\n <td/>\n </tr>\n <tr>\n <td>D25.9</td>\n <td>Leiomyoma of uterus, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>D26.0</td>\n <td>Other benign neoplasm of cervix uteri</td>\n <td/>\n </tr>\n <tr>\n <td>D26.1</td>\n <td>Other benign neoplasm of corpus uteri</td>\n <td/>\n </tr>\n <tr>\n <td>D26.7</td>\n <td>Other benign neoplasm of other parts of uterus</td>\n <td/>\n </tr>\n <tr>\n <td>D26.9</td>\n <td>Other benign neoplasm of uterus, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>D27.0</td>\n <td>Benign neoplasm of right ovary</td>\n <td/>\n </tr>\n <tr>\n <td>D27.1</td>\n <td>Benign neoplasm of left ovary</td>\n <td/>\n </tr>\n <tr>\n <td>D27.9</td>\n <td>Benign neoplasm of unspecified ovary</td>\n <td/>\n </tr>\n <tr>\n <td>D28.0</td>\n <td>Benign neoplasm of vulva</td>\n <td/>\n </tr>\n <tr>\n <td>D28.1</td>\n <td>Benign neoplasm of vagina</td>\n <td/>\n </tr>\n <tr>\n <td>D28.2</td>\n <td>Benign neoplasm of uterine tubes and ligaments</td>\n <td/>\n </tr>\n <tr>\n <td>D28.7</td>\n <td>Benign neoplasm of other specified female genital organs</td>\n <td/>\n </tr>\n <tr>\n <td>D28.9</td>\n <td>Benign neoplasm of female genital organ, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>D29.0</td>\n <td>Benign neoplasm of penis</td>\n <td/>\n </tr>\n <tr>\n <td>D29.1</td>\n <td>Benign neoplasm of prostate</td>\n <td/>\n </tr>\n <tr>\n <td>D29.20</td>\n <td>Benign neoplasm of unspecified testis</td>\n <td/>\n </tr>\n <tr>\n <td>D29.21</td>\n <td>Benign neoplasm of right testis</td>\n <td/>\n </tr>\n <tr>\n <td>D29.22</td>\n <td>Benign neoplasm of left testis</td>\n <td/>\n </tr>\n <tr>\n <td>D29.30</td>\n <td>Benign neoplasm of unspecified epididymis</td>\n <td/>\n </tr>\n <tr>\n <td>D29.31</td>\n <td>Benign neoplasm of right epididymis</td>\n <td/>\n </tr>\n <tr>\n <td>D29.32</td>\n <td>Benign neoplasm of left epididymis</td>\n <td/>\n </tr>\n <tr>\n <td>D29.4</td>\n <td>Benign neoplasm of scrotum</td>\n <td/>\n </tr>\n <tr>\n <td>D29.8</td>\n <td>Benign neoplasm of other specified male genital organs</td>\n <td/>\n </tr>\n <tr>\n <td>D29.9</td>\n <td>Benign neoplasm of male genital organ, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>D30.00</td>\n <td>Benign neoplasm of unspecified kidney</td>\n <td/>\n </tr>\n <tr>\n <td>D30.01</td>\n <td>Benign neoplasm of right kidney</td>\n <td/>\n </tr>\n <tr>\n <td>D30.02</td>\n <td>Benign neoplasm of left kidney</td>\n <td/>\n </tr>\n <tr>\n <td>D30.10</td>\n <td>Benign neoplasm of unspecified renal pelvis</td>\n <td/>\n </tr>\n <tr>\n <td>D30.11</td>\n <td>Benign neoplasm of right renal pelvis</td>\n <td/>\n </tr>\n <tr>\n <td>D30.12</td>\n <td>Benign neoplasm of left renal pelvis</td>\n <td/>\n </tr>\n <tr>\n <td>D30.20</td>\n <td>Benign neoplasm of unspecified ureter</td>\n <td/>\n </tr>\n <tr>\n <td>D30.21</td>\n <td>Benign neoplasm of right ureter</td>\n <td/>\n </tr>\n <tr>\n <td>D30.22</td>\n <td>Benign neoplasm of left ureter</td>\n <td/>\n </tr>\n <tr>\n <td>D30.3</td>\n <td>Benign neoplasm of bladder</td>\n <td/>\n </tr>\n <tr>\n <td>D30.4</td>\n <td>Benign neoplasm of urethra</td>\n <td/>\n </tr>\n <tr>\n <td>D30.8</td>\n <td>Benign neoplasm of other specified urinary organs</td>\n <td/>\n </tr>\n <tr>\n <td>D30.9</td>\n <td>Benign neoplasm of urinary organ, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>D31.00</td>\n <td>Benign neoplasm of unspecified conjunctiva</td>\n <td/>\n </tr>\n <tr>\n <td>D31.01</td>\n <td>Benign neoplasm of right conjunctiva</td>\n <td/>\n </tr>\n <tr>\n <td>D31.02</td>\n <td>Benign neoplasm of left conjunctiva</td>\n <td/>\n </tr>\n <tr>\n <td>D31.10</td>\n <td>Benign neoplasm of unspecified cornea</td>\n <td/>\n </tr>\n <tr>\n <td>D31.11</td>\n <td>Benign neoplasm of right cornea</td>\n <td/>\n </tr>\n <tr>\n <td>D31.12</td>\n <td>Benign neoplasm of left cornea</td>\n <td/>\n </tr>\n <tr>\n <td>D31.20</td>\n <td>Benign neoplasm of unspecified retina</td>\n <td/>\n </tr>\n <tr>\n <td>D31.21</td>\n <td>Benign neoplasm of right retina</td>\n <td/>\n </tr>\n <tr>\n <td>D31.22</td>\n <td>Benign neoplasm of left retina</td>\n <td/>\n </tr>\n <tr>\n <td>D31.30</td>\n <td>Benign neoplasm of unspecified choroid</td>\n <td/>\n </tr>\n <tr>\n <td>D31.31</td>\n <td>Benign neoplasm of right choroid</td>\n <td/>\n </tr>\n <tr>\n <td>D31.32</td>\n <td>Benign neoplasm of left choroid</td>\n <td/>\n </tr>\n <tr>\n <td>D31.40</td>\n <td>Benign neoplasm of unspecified ciliary body</td>\n <td/>\n </tr>\n <tr>\n <td>D31.41</td>\n <td>Benign neoplasm of right ciliary body</td>\n <td/>\n </tr>\n <tr>\n <td>D31.42</td>\n <td>Benign neoplasm of left ciliary body</td>\n <td/>\n </tr>\n <tr>\n <td>D31.50</td>\n <td>Benign neoplasm of unspecified lacrimal gland and duct</td>\n <td/>\n </tr>\n <tr>\n <td>D31.51</td>\n <td>Benign neoplasm of right lacrimal gland and duct</td>\n <td/>\n </tr>\n <tr>\n <td>D31.52</td>\n <td>Benign neoplasm of left lacrimal gland and duct</td>\n <td/>\n </tr>\n <tr>\n <td>D31.60</td>\n <td>Benign neoplasm of unspecified site of unspecified orbit</td>\n <td/>\n </tr>\n <tr>\n <td>D31.61</td>\n <td>Benign neoplasm of unspecified site of right orbit</td>\n <td/>\n </tr>\n <tr>\n <td>D31.62</td>\n <td>Benign neoplasm of unspecified site of left orbit</td>\n <td/>\n </tr>\n <tr>\n <td>D31.90</td>\n <td>Benign neoplasm of unspecified part of unspecified eye</td>\n <td/>\n </tr>\n <tr>\n <td>D31.91</td>\n <td>Benign neoplasm of unspecified part of right eye</td>\n <td/>\n </tr>\n <tr>\n <td>D31.92</td>\n <td>Benign neoplasm of unspecified part of left eye</td>\n <td/>\n </tr>\n <tr>\n <td>D32.0</td>\n <td>Benign neoplasm of cerebral meninges</td>\n <td/>\n </tr>\n <tr>\n <td>D32.1</td>\n <td>Benign neoplasm of spinal meninges</td>\n <td/>\n </tr>\n <tr>\n <td>D32.9</td>\n <td>Benign neoplasm of meninges, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>D33.0</td>\n <td>Benign neoplasm of brain, supratentorial</td>\n <td/>\n </tr>\n <tr>\n <td>D33.1</td>\n <td>Benign neoplasm of brain, infratentorial</td>\n <td/>\n </tr>\n <tr>\n <td>D33.2</td>\n <td>Benign neoplasm of brain, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>D33.3</td>\n <td>Benign neoplasm of cranial nerves</td>\n <td/>\n </tr>\n <tr>\n <td>D33.4</td>\n <td>Benign neoplasm of spinal cord</td>\n <td/>\n </tr>\n <tr>\n <td>D33.7</td>\n <td>Benign neoplasm of other specified parts of central nervous system</td>\n <td/>\n </tr>\n <tr>\n <td>D33.9</td>\n <td>Benign neoplasm of central nervous system, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>D34</td>\n <td>Benign neoplasm of thyroid gland</td>\n <td/>\n </tr>\n <tr>\n <td>D35.00</td>\n <td>Benign neoplasm of unspecified adrenal gland</td>\n <td/>\n </tr>\n <tr>\n <td>D35.01</td>\n <td>Benign neoplasm of right adrenal gland</td>\n <td/>\n </tr>\n <tr>\n <td>D35.02</td>\n <td>Benign neoplasm of left adrenal gland</td>\n <td/>\n </tr>\n <tr>\n <td>D35.1</td>\n <td>Benign neoplasm of parathyroid gland</td>\n <td/>\n </tr>\n <tr>\n <td>D35.2</td>\n <td>Benign neoplasm of pituitary gland</td>\n <td/>\n </tr>\n <tr>\n <td>D35.3</td>\n <td>Benign neoplasm of craniopharyngeal duct</td>\n <td/>\n </tr>\n <tr>\n <td>D35.4</td>\n <td>Benign neoplasm of pineal gland</td>\n <td/>\n </tr>\n <tr>\n <td>D35.5</td>\n <td>Benign neoplasm of carotid body</td>\n <td/>\n </tr>\n <tr>\n <td>D35.6</td>\n <td>Benign neoplasm of aortic body and other paraganglia</td>\n <td/>\n </tr>\n <tr>\n <td>D35.7</td>\n <td>Benign neoplasm of other specified endocrine glands</td>\n <td/>\n </tr>\n <tr>\n <td>D35.9</td>\n <td>Benign neoplasm of endocrine gland, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>D36.0</td>\n <td>Benign neoplasm of lymph nodes</td>\n <td/>\n </tr>\n <tr>\n <td>D36.10</td>\n <td>Benign neoplasm of peripheral nerves and autonomic nervous system, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>D36.11</td>\n <td>Benign neoplasm of peripheral nerves and autonomic nervous system of face, head, and neck</td>\n <td/>\n </tr>\n <tr>\n <td>D36.12</td>\n <td>Benign neoplasm of peripheral nerves and autonomic nervous system, upper limb, including shoulder</td>\n <td/>\n </tr>\n <tr>\n <td>D36.13</td>\n <td>Benign neoplasm of peripheral nerves and autonomic nervous system of lower limb, including hip</td>\n <td/>\n </tr>\n <tr>\n <td>D36.14</td>\n <td>Benign neoplasm of peripheral nerves and autonomic nervous system of thorax</td>\n <td/>\n </tr>\n <tr>\n <td>D36.15</td>\n <td>Benign neoplasm of peripheral nerves and autonomic nervous system of abdomen</td>\n <td/>\n </tr>\n <tr>\n <td>D36.16</td>\n <td>Benign neoplasm of peripheral nerves and autonomic nervous system of pelvis</td>\n <td/>\n </tr>\n <tr>\n <td>D36.17</td>\n <td>Benign neoplasm of peripheral nerves and autonomic nervous system of trunk, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>D36.7</td>\n <td>Benign neoplasm of other specified sites</td>\n <td/>\n </tr>\n <tr>\n <td>D36.9</td>\n <td>Benign neoplasm, unspecified site</td>\n <td/>\n </tr>\n <tr>\n <td>D37.01</td>\n <td>Neoplasm of uncertain behavior of lip</td>\n <td/>\n </tr>\n <tr>\n <td>D37.02</td>\n <td>Neoplasm of uncertain behavior of tongue</td>\n <td/>\n </tr>\n <tr>\n <td>D37.030</td>\n <td>Neoplasm of uncertain behavior of the parotid salivary glands</td>\n <td/>\n </tr>\n <tr>\n <td>D37.031</td>\n <td>Neoplasm of uncertain behavior of the sublingual salivary glands</td>\n <td/>\n </tr>\n <tr>\n <td>D37.032</td>\n <td>Neoplasm of uncertain behavior of the submandibular salivary glands</td>\n <td/>\n </tr>\n <tr>\n <td>D37.039</td>\n <td>Neoplasm of uncertain behavior of the major salivary glands, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>D37.04</td>\n <td>Neoplasm of uncertain behavior of the minor salivary glands</td>\n <td/>\n </tr>\n <tr>\n <td>D37.05</td>\n <td>Neoplasm of uncertain behavior of pharynx</td>\n <td/>\n </tr>\n <tr>\n <td>D37.09</td>\n <td>Neoplasm of uncertain behavior of other specified sites of the oral cavity</td>\n <td/>\n </tr>\n <tr>\n <td>D37.1</td>\n <td>Neoplasm of uncertain behavior of stomach</td>\n <td/>\n </tr>\n <tr>\n <td>D37.2</td>\n <td>Neoplasm of uncertain behavior of small intestine</td>\n <td/>\n </tr>\n <tr>\n <td>D37.3</td>\n <td>Neoplasm of uncertain behavior of appendix</td>\n <td/>\n </tr>\n <tr>\n <td>D37.4</td>\n <td>Neoplasm of uncertain behavior of colon</td>\n <td/>\n </tr>\n <tr>\n <td>D37.5</td>\n <td>Neoplasm of uncertain behavior of rectum</td>\n <td/>\n </tr>\n <tr>\n <td>D37.6</td>\n <td>Neoplasm of uncertain behavior of liver, gallbladder and bile ducts</td>\n <td/>\n </tr>\n <tr>\n <td>D37.8</td>\n <td>Neoplasm of uncertain behavior of other specified digestive organs</td>\n <td/>\n </tr>\n <tr>\n <td>D37.9</td>\n <td>Neoplasm of uncertain behavior of digestive organ, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>D38.0</td>\n <td>Neoplasm of uncertain behavior of larynx</td>\n <td/>\n </tr>\n <tr>\n <td>D38.1</td>\n <td>Neoplasm of uncertain behavior of trachea, bronchus and lung</td>\n <td/>\n </tr>\n <tr>\n <td>D38.2</td>\n <td>Neoplasm of uncertain behavior of pleura</td>\n <td/>\n </tr>\n <tr>\n <td>D38.3</td>\n <td>Neoplasm of uncertain behavior of mediastinum</td>\n <td/>\n </tr>\n <tr>\n <td>D38.4</td>\n <td>Neoplasm of uncertain behavior of thymus</td>\n <td/>\n </tr>\n <tr>\n <td>D38.5</td>\n <td>Neoplasm of uncertain behavior of other respiratory organs</td>\n <td/>\n </tr>\n <tr>\n <td>D38.6</td>\n <td>Neoplasm of uncertain behavior of respiratory organ, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>D39.0</td>\n <td>Neoplasm of uncertain behavior of uterus</td>\n <td/>\n </tr>\n <tr>\n <td>D39.10</td>\n <td>Neoplasm of uncertain behavior of unspecified ovary</td>\n <td/>\n </tr>\n <tr>\n <td>D39.11</td>\n <td>Neoplasm of uncertain behavior of right ovary</td>\n <td/>\n </tr>\n <tr>\n <td>D39.12</td>\n <td>Neoplasm of uncertain behavior of left ovary</td>\n <td/>\n </tr>\n <tr>\n <td>D39.2</td>\n <td>Neoplasm of uncertain behavior of placenta</td>\n <td/>\n </tr>\n <tr>\n <td>D39.8</td>\n <td>Neoplasm of uncertain behavior of other specified female genital organs</td>\n <td/>\n </tr>\n <tr>\n <td>D39.9</td>\n <td>Neoplasm of uncertain behavior of female genital organ, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>D3A.00</td>\n <td>Benign carcinoid tumor of unspecified site</td>\n <td/>\n </tr>\n <tr>\n <td>D3A.010</td>\n <td>Benign carcinoid tumor of the duodenum</td>\n <td/>\n </tr>\n <tr>\n <td>D3A.011</td>\n <td>Benign carcinoid tumor of the jejunum</td>\n <td/>\n </tr>\n <tr>\n <td>D3A.012</td>\n <td>Benign carcinoid tumor of the ileum</td>\n <td/>\n </tr>\n <tr>\n <td>D3A.019</td>\n <td>Benign carcinoid tumor of the small intestine, unspecified portion</td>\n <td/>\n </tr>\n <tr>\n <td>D3A.020</td>\n <td>Benign carcinoid tumor of the appendix</td>\n <td/>\n </tr>\n <tr>\n <td>D3A.021</td>\n <td>Benign carcinoid tumor of the cecum</td>\n <td/>\n </tr>\n <tr>\n <td>D3A.022</td>\n <td>Benign carcinoid tumor of the ascending colon</td>\n <td/>\n </tr>\n <tr>\n <td>D3A.023</td>\n <td>Benign carcinoid tumor of the transverse colon</td>\n <td/>\n </tr>\n <tr>\n <td>D3A.024</td>\n <td>Benign carcinoid tumor of the descending colon</td>\n <td/>\n </tr>\n <tr>\n <td>D3A.025</td>\n <td>Benign carcinoid tumor of the sigmoid colon</td>\n <td/>\n </tr>\n <tr>\n <td>D3A.026</td>\n <td>Benign carcinoid tumor of the rectum</td>\n <td/>\n </tr>\n <tr>\n <td>D3A.029</td>\n <td>Benign carcinoid tumor of the large intestine, unspecified portion</td>\n <td/>\n </tr>\n <tr>\n <td>D3A.090</td>\n <td>Benign carcinoid tumor of the bronchus and lung</td>\n <td/>\n </tr>\n <tr>\n <td>D3A.091</td>\n <td>Benign carcinoid tumor of the thymus</td>\n <td/>\n </tr>\n <tr>\n <td>D3A.092</td>\n <td>Benign carcinoid tumor of the stomach</td>\n <td/>\n </tr>\n <tr>\n <td>D3A.093</td>\n <td>Benign carcinoid tumor of the kidney</td>\n <td/>\n </tr>\n <tr>\n <td>D3A.094</td>\n <td>Benign carcinoid tumor of the foregut, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>D3A.095</td>\n <td>Benign carcinoid tumor of the midgut, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>D3A.096</td>\n <td>Benign carcinoid tumor of the hindgut, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>D3A.098</td>\n <td>Benign carcinoid tumors of other sites</td>\n <td/>\n </tr>\n <tr>\n <td>D3A.8</td>\n <td>Other benign neuroendocrine tumors</td>\n <td/>\n </tr>\n <tr>\n <td>D40.0</td>\n <td>Neoplasm of uncertain behavior of prostate</td>\n <td/>\n </tr>\n <tr>\n <td>D40.10</td>\n <td>Neoplasm of uncertain behavior of unspecified testis</td>\n <td/>\n </tr>\n <tr>\n <td>D40.11</td>\n <td>Neoplasm of uncertain behavior of right testis</td>\n <td/>\n </tr>\n <tr>\n <td>D40.12</td>\n <td>Neoplasm of uncertain behavior of left testis</td>\n <td/>\n </tr>\n <tr>\n <td>D40.8</td>\n <td>Neoplasm of uncertain behavior of other specified male genital organs</td>\n <td/>\n </tr>\n <tr>\n <td>D40.9</td>\n <td>Neoplasm of uncertain behavior of male genital organ, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>D41.00</td>\n <td>Neoplasm of uncertain behavior of unspecified kidney</td>\n <td/>\n </tr>\n <tr>\n <td>D41.01</td>\n <td>Neoplasm of uncertain behavior of right kidney</td>\n <td/>\n </tr>\n <tr>\n <td>D41.02</td>\n <td>Neoplasm of uncertain behavior of left kidney</td>\n <td/>\n </tr>\n <tr>\n <td>D41.10</td>\n <td>Neoplasm of uncertain behavior of unspecified renal pelvis</td>\n <td/>\n </tr>\n <tr>\n <td>D41.11</td>\n <td>Neoplasm of uncertain behavior of right renal pelvis</td>\n <td/>\n </tr>\n <tr>\n <td>D41.12</td>\n <td>Neoplasm of uncertain behavior of left renal pelvis</td>\n <td/>\n </tr>\n <tr>\n <td>D41.20</td>\n <td>Neoplasm of uncertain behavior of unspecified ureter</td>\n <td/>\n </tr>\n <tr>\n <td>D41.21</td>\n <td>Neoplasm of uncertain behavior of right ureter</td>\n <td/>\n </tr>\n <tr>\n <td>D41.22</td>\n <td>Neoplasm of uncertain behavior of left ureter</td>\n <td/>\n </tr>\n <tr>\n <td>D41.3</td>\n <td>Neoplasm of uncertain behavior of urethra</td>\n <td/>\n </tr>\n <tr>\n <td>D41.4</td>\n <td>Neoplasm of uncertain behavior of bladder</td>\n <td/>\n </tr>\n <tr>\n <td>D41.8</td>\n <td>Neoplasm of uncertain behavior of other specified urinary organs</td>\n <td/>\n </tr>\n <tr>\n <td>D41.9</td>\n <td>Neoplasm of uncertain behavior of unspecified urinary organ</td>\n <td/>\n </tr>\n <tr>\n <td>D42.0</td>\n <td>Neoplasm of uncertain behavior of cerebral meninges</td>\n <td/>\n </tr>\n <tr>\n <td>D42.1</td>\n <td>Neoplasm of uncertain behavior of spinal meninges</td>\n <td/>\n </tr>\n <tr>\n <td>D42.9</td>\n <td>Neoplasm of uncertain behavior of meninges, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>D43.0</td>\n <td>Neoplasm of uncertain behavior of brain, supratentorial</td>\n <td/>\n </tr>\n <tr>\n <td>D43.1</td>\n <td>Neoplasm of uncertain behavior of brain, infratentorial</td>\n <td/>\n </tr>\n <tr>\n <td>D43.2</td>\n <td>Neoplasm of uncertain behavior of brain, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>D43.3</td>\n <td>Neoplasm of uncertain behavior of cranial nerves</td>\n <td/>\n </tr>\n <tr>\n <td>D43.4</td>\n <td>Neoplasm of uncertain behavior of spinal cord</td>\n <td/>\n </tr>\n <tr>\n <td>D43.8</td>\n <td>Neoplasm of uncertain behavior of other specified parts of central nervous system</td>\n <td/>\n </tr>\n <tr>\n <td>D43.9</td>\n <td>Neoplasm of uncertain behavior of central nervous system, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>D44.0</td>\n <td>Neoplasm of uncertain behavior of thyroid gland</td>\n <td/>\n </tr>\n <tr>\n <td>D44.10</td>\n <td>Neoplasm of uncertain behavior of unspecified adrenal gland</td>\n <td/>\n </tr>\n <tr>\n <td>D44.11</td>\n <td>Neoplasm of uncertain behavior of right adrenal gland</td>\n <td/>\n </tr>\n <tr>\n <td>D44.12</td>\n <td>Neoplasm of uncertain behavior of left adrenal gland</td>\n <td/>\n </tr>\n <tr>\n <td>D44.2</td>\n <td>Neoplasm of uncertain behavior of parathyroid gland</td>\n <td/>\n </tr>\n <tr>\n <td>D44.3</td>\n <td>Neoplasm of uncertain behavior of pituitary gland</td>\n <td/>\n </tr>\n <tr>\n <td>D44.4</td>\n <td>Neoplasm of uncertain behavior of craniopharyngeal duct</td>\n <td/>\n </tr>\n <tr>\n <td>D44.5</td>\n <td>Neoplasm of uncertain behavior of pineal gland</td>\n <td/>\n </tr>\n <tr>\n <td>D44.6</td>\n <td>Neoplasm of uncertain behavior of carotid body</td>\n <td/>\n </tr>\n <tr>\n <td>D44.7</td>\n <td>Neoplasm of uncertain behavior of aortic body and other paraganglia</td>\n <td/>\n </tr>\n <tr>\n <td>D44.9</td>\n <td>Neoplasm of uncertain behavior of unspecified endocrine gland</td>\n <td/>\n </tr>\n <tr>\n <td>D45</td>\n <td>Polycythemia vera</td>\n <td/>\n </tr>\n <tr>\n <td>D46.0</td>\n <td>Refractory anemia without ring sideroblasts, so stated</td>\n <td/>\n </tr>\n <tr>\n <td>D46.1</td>\n <td>Refractory anemia with ring sideroblasts</td>\n <td/>\n </tr>\n <tr>\n <td>D46.20</td>\n <td>Refractory anemia with excess of blasts, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>D46.21</td>\n <td>Refractory anemia with excess of blasts 1</td>\n <td/>\n </tr>\n <tr>\n <td>D46.22</td>\n <td>Refractory anemia with excess of blasts 2</td>\n <td/>\n </tr>\n <tr>\n <td>D46.4</td>\n <td>Refractory anemia, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>D46.9</td>\n <td>Myelodysplastic syndrome, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>D46.A</td>\n <td>Refractory cytopenia with multilineage dysplasia</td>\n <td/>\n </tr>\n <tr>\n <td>D46.B</td>\n <td>Refractory cytopenia with multilineage dysplasia and ring sideroblasts</td>\n <td/>\n </tr>\n <tr>\n <td>D46.C</td>\n <td>Myelodysplastic syndrome with isolated del(5q) chromosomal abnormality</td>\n <td/>\n </tr>\n <tr>\n <td>D46.Z</td>\n <td>Other myelodysplastic syndromes</td>\n <td/>\n </tr>\n <tr>\n <td>D47.0</td>\n <td>Mast cell neoplasms of uncertain behavior</td>\n <td/>\n </tr>\n <tr>\n <td>D47.01</td>\n <td>Cutaneous mastocytosis</td>\n <td/>\n </tr>\n <tr>\n <td>D47.02</td>\n <td>Systemic mastocytosis</td>\n <td/>\n </tr>\n <tr>\n <td>D47.09</td>\n <td>Other mast cell neoplasms of uncertain behavior</td>\n <td/>\n </tr>\n <tr>\n <td>D47.1</td>\n <td>Chronic myeloproliferative disease</td>\n <td/>\n </tr>\n <tr>\n <td>D47.2</td>\n <td>Monoclonal gammopathy</td>\n <td/>\n </tr>\n <tr>\n <td>D47.3</td>\n <td>Essential (hemorrhagic) thrombocythemia</td>\n <td/>\n </tr>\n <tr>\n <td>D47.4</td>\n <td>Osteomyelofibrosis</td>\n <td/>\n </tr>\n <tr>\n <td>D47.9</td>\n <td>Neoplasm of uncertain behavior of lymphoid, hematopoietic and related tissue, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>D47.Z1</td>\n <td>Post-transplant lymphoproliferative disorder (PTLD)</td>\n <td/>\n </tr>\n <tr>\n <td>D47.Z2</td>\n <td>Castleman disease</td>\n <td/>\n </tr>\n <tr>\n <td>D47.Z9</td>\n <td>Other specified neoplasms of uncertain behavior of lymphoid, hematopoietic and related tissue</td>\n <td/>\n </tr>\n <tr>\n <td>D48.0</td>\n <td>Neoplasm of uncertain behavior of bone and articular cartilage</td>\n <td/>\n </tr>\n <tr>\n <td>D48.1</td>\n <td>Neoplasm of uncertain behavior of connective and other soft tissue</td>\n <td/>\n </tr>\n <tr>\n <td>D48.2</td>\n <td>Neoplasm of uncertain behavior of peripheral nerves and autonomic nervous system</td>\n <td/>\n </tr>\n <tr>\n <td>D48.3</td>\n <td>Neoplasm of uncertain behavior of retroperitoneum</td>\n <td/>\n </tr>\n <tr>\n <td>D48.4</td>\n <td>Neoplasm of uncertain behavior of peritoneum</td>\n <td/>\n </tr>\n <tr>\n <td>D48.5</td>\n <td>Neoplasm of uncertain behavior of skin</td>\n <td/>\n </tr>\n <tr>\n <td>D48.60</td>\n <td>Neoplasm of uncertain behavior of unspecified breast</td>\n <td/>\n </tr>\n <tr>\n <td>D48.61</td>\n <td>Neoplasm of uncertain behavior of right breast</td>\n <td/>\n </tr>\n <tr>\n <td>D48.62</td>\n <td>Neoplasm of uncertain behavior of left breast</td>\n <td/>\n </tr>\n <tr>\n <td>D48.7</td>\n <td>Neoplasm of uncertain behavior of other specified sites</td>\n <td/>\n </tr>\n <tr>\n <td>D48.9</td>\n <td>Neoplasm of uncertain behavior, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>D49.0</td>\n <td>Neoplasm of unspecified behavior of digestive system</td>\n <td/>\n </tr>\n <tr>\n <td>D49.1</td>\n <td>Neoplasm of unspecified behavior of respiratory system</td>\n <td/>\n </tr>\n <tr>\n <td>D49.2</td>\n <td>Neoplasm of unspecified behavior of bone, soft tissue, and skin</td>\n <td/>\n </tr>\n <tr>\n <td>D49.3</td>\n <td>Neoplasm of unspecified behavior of breast</td>\n <td/>\n </tr>\n <tr>\n <td>D49.4</td>\n <td>Neoplasm of unspecified behavior of bladder</td>\n <td/>\n </tr>\n <tr>\n <td>D49.5</td>\n <td>Neoplasm of unspecified behavior of other genitourinary organs</td>\n <td/>\n </tr>\n <tr>\n <td>D49.511</td>\n <td>Neoplasm of unspecified behavior of right kidney</td>\n <td/>\n </tr>\n <tr>\n <td>D49.512</td>\n <td>Neoplasm of unspecified behavior of left kidney</td>\n <td/>\n </tr>\n <tr>\n <td>D49.519</td>\n <td>Neoplasm of unspecified behavior of unspecified kidney</td>\n <td/>\n </tr>\n <tr>\n <td>D49.59</td>\n <td>Neoplasm of unspecified behavior of other genitourinary organ</td>\n <td/>\n </tr>\n <tr>\n <td>D49.6</td>\n <td>Neoplasm of unspecified behavior of brain</td>\n <td/>\n </tr>\n <tr>\n <td>D49.7</td>\n <td>Neoplasm of unspecified behavior of endocrine glands and other parts of nervous system</td>\n <td/>\n </tr>\n <tr>\n <td>D49.81</td>\n <td>Neoplasm of unspecified behavior of retina and choroid</td>\n <td/>\n </tr>\n <tr>\n <td>D49.89</td>\n <td>Neoplasm of unspecified behavior of other specified sites</td>\n <td/>\n </tr>\n <tr>\n <td>D49.9</td>\n <td>Neoplasm of unspecified behavior of unspecified site</td>\n <td/>\n </tr>\n <tr>\n <td>E31.22</td>\n <td>Multiple endocrine neoplasia [MEN] type IIA</td>\n <td/>\n </tr>\n <tr>\n <td>E31.23</td>\n <td>Multiple endocrine neoplasia [MEN] type IIB</td>\n <td/>\n </tr>\n <tr>\n <td>G43.601</td>\n <td>Persistent migraine aura with cerebral infarction, not intractable, with status migrainosus</td>\n <td/>\n </tr>\n <tr>\n <td>G43.609</td>\n <td>Persistent migraine aura with cerebral infarction, not intractable, without status migrainosus</td>\n <td/>\n </tr>\n <tr>\n <td>G43.611</td>\n <td>Persistent migraine aura with cerebral infarction, intractable, with status migrainosus</td>\n <td/>\n </tr>\n <tr>\n <td>G43.619</td>\n <td>Persistent migraine aura with cerebral infarction, intractable, without status migrainosus</td>\n <td/>\n </tr>\n <tr>\n <td>G45.0</td>\n <td>Vertebro-basilar artery syndrome</td>\n <td/>\n </tr>\n <tr>\n <td>G45.1</td>\n <td>Carotid artery syndrome (hemispheric)</td>\n <td/>\n </tr>\n <tr>\n <td>G45.2</td>\n <td>Multiple and bilateral precerebral artery syndromes</td>\n <td/>\n </tr>\n <tr>\n <td>G45.3</td>\n <td>Amaurosis fugax</td>\n <td/>\n </tr>\n <tr>\n <td>G45.4</td>\n <td>Transient global amnesia</td>\n <td/>\n </tr>\n <tr>\n <td>G45.8</td>\n <td>Other transient cerebral ischemic attacks and related syndromes</td>\n <td/>\n </tr>\n <tr>\n <td>G45.9</td>\n <td>Transient cerebral ischemic attack, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>G46.0</td>\n <td>Middle cerebral artery syndrome</td>\n <td/>\n </tr>\n <tr>\n <td>G46.1</td>\n <td>Anterior cerebral artery syndrome</td>\n <td/>\n </tr>\n <tr>\n <td>G46.2</td>\n <td>Posterior cerebral artery syndrome</td>\n <td/>\n </tr>\n <tr>\n <td>G46.3</td>\n <td>Brain stem stroke syndrome</td>\n <td/>\n </tr>\n <tr>\n <td>G46.4</td>\n <td>Cerebellar stroke syndrome</td>\n <td/>\n </tr>\n <tr>\n <td>G46.5</td>\n <td>Pure motor lacunar syndrome</td>\n <td/>\n </tr>\n <tr>\n <td>G46.6</td>\n <td>Pure sensory lacunar syndrome</td>\n <td/>\n </tr>\n <tr>\n <td>G46.7</td>\n <td>Other lacunar syndromes</td>\n <td/>\n </tr>\n <tr>\n <td>G46.8</td>\n <td>Other vascular syndromes of brain in cerebrovascular diseases</td>\n <td/>\n </tr>\n <tr>\n <td>G93.3</td>\n <td>Postviral fatigue syndrome</td>\n <td/>\n </tr>\n <tr>\n <td>I01.0</td>\n <td>Acute rheumatic pericarditis</td>\n <td/>\n </tr>\n <tr>\n <td>I01.1</td>\n <td>Acute rheumatic endocarditis</td>\n <td/>\n </tr>\n <tr>\n <td>I01.2</td>\n <td>Acute rheumatic myocarditis</td>\n <td/>\n </tr>\n <tr>\n <td>I01.8</td>\n <td>Other acute rheumatic heart disease</td>\n <td/>\n </tr>\n <tr>\n <td>I01.9</td>\n <td>Acute rheumatic heart disease, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>I02.0</td>\n <td>Rheumatic chorea with heart involvement</td>\n <td/>\n </tr>\n <tr>\n <td>I05.0</td>\n <td>Rheumatic mitral stenosis</td>\n <td/>\n </tr>\n <tr>\n <td>I05.1</td>\n <td>Rheumatic mitral insufficiency</td>\n <td/>\n </tr>\n <tr>\n <td>I05.2</td>\n <td>Rheumatic mitral stenosis with insufficiency</td>\n <td/>\n </tr>\n <tr>\n <td>I05.8</td>\n <td>Other rheumatic mitral valve diseases</td>\n <td/>\n </tr>\n <tr>\n <td>I05.9</td>\n <td>Rheumatic mitral valve disease, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>I06.0</td>\n <td>Rheumatic aortic stenosis</td>\n <td/>\n </tr>\n <tr>\n <td>I06.1</td>\n <td>Rheumatic aortic insufficiency</td>\n <td/>\n </tr>\n <tr>\n <td>I06.2</td>\n <td>Rheumatic aortic stenosis with insufficiency</td>\n <td/>\n </tr>\n <tr>\n <td>I06.8</td>\n <td>Other rheumatic aortic valve diseases</td>\n <td/>\n </tr>\n <tr>\n <td>I06.9</td>\n <td>Rheumatic aortic valve disease, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>I07.0</td>\n <td>Rheumatic tricuspid stenosis</td>\n <td/>\n </tr>\n <tr>\n <td>I07.1</td>\n <td>Rheumatic tricuspid insufficiency</td>\n <td/>\n </tr>\n <tr>\n <td>I07.2</td>\n <td>Rheumatic tricuspid stenosis and insufficiency</td>\n <td/>\n </tr>\n <tr>\n <td>I07.8</td>\n <td>Other rheumatic tricuspid valve diseases</td>\n <td/>\n </tr>\n <tr>\n <td>I07.9</td>\n <td>Rheumatic tricuspid valve disease, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>I08.0</td>\n <td>Rheumatic disorders of both mitral and aortic valves</td>\n <td/>\n </tr>\n <tr>\n <td>I08.1</td>\n <td>Rheumatic disorders of both mitral and tricuspid valves</td>\n <td/>\n </tr>\n <tr>\n <td>I08.2</td>\n <td>Rheumatic disorders of both aortic and tricuspid valves</td>\n <td/>\n </tr>\n <tr>\n <td>I08.3</td>\n <td>Combined rheumatic disorders of mitral, aortic and tricuspid valves</td>\n <td/>\n </tr>\n <tr>\n <td>I08.8</td>\n <td>Other rheumatic multiple valve diseases</td>\n <td/>\n </tr>\n <tr>\n <td>I08.9</td>\n <td>Rheumatic multiple valve disease, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>I09.0</td>\n <td>Rheumatic myocarditis</td>\n <td/>\n </tr>\n <tr>\n <td>I09.1</td>\n <td>Rheumatic diseases of endocardium, valve unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>I09.2</td>\n <td>Chronic rheumatic pericarditis</td>\n <td/>\n </tr>\n <tr>\n <td>I09.81</td>\n <td>Rheumatic heart failure</td>\n <td/>\n </tr>\n <tr>\n <td>I09.89</td>\n <td>Other specified rheumatic heart diseases</td>\n <td/>\n </tr>\n <tr>\n <td>I09.9</td>\n <td>Rheumatic heart disease, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>I10</td>\n <td>Essential (primary) hypertension</td>\n <td/>\n </tr>\n <tr>\n <td>I11.0</td>\n <td>Hypertensive heart disease with heart failure</td>\n <td/>\n </tr>\n <tr>\n <td>I11.9</td>\n <td>Hypertensive heart disease without heart failure</td>\n <td/>\n </tr>\n <tr>\n <td>I12.0</td>\n <td>Hypertensive chronic kidney disease with stage 5 chronic kidney disease or end stage renal disease</td>\n <td/>\n </tr>\n <tr>\n <td>I12.9</td>\n <td>Hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease</td>\n <td/>\n </tr>\n <tr>\n <td>I13.0</td>\n <td>Hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease</td>\n <td/>\n </tr>\n <tr>\n <td>I13.10</td>\n <td>Hypertensive heart and chronic kidney disease without heart failure, with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease</td>\n <td/>\n </tr>\n <tr>\n <td>I13.11</td>\n <td>Hypertensive heart and chronic kidney disease without heart failure, with stage 5 chronic kidney disease, or end stage renal disease</td>\n <td/>\n </tr>\n <tr>\n <td>I13.2</td>\n <td>Hypertensive heart and chronic kidney disease with heart failure and with stage 5 chronic kidney disease, or end stage renal disease</td>\n <td/>\n </tr>\n <tr>\n <td>I15.0</td>\n <td>Renovascular hypertension</td>\n <td/>\n </tr>\n <tr>\n <td>I15.1</td>\n <td>Hypertension secondary to other renal disorders</td>\n <td/>\n </tr>\n <tr>\n <td>I15.2</td>\n <td>Hypertension secondary to endocrine disorders</td>\n <td/>\n </tr>\n <tr>\n <td>I15.8</td>\n <td>Other secondary hypertension</td>\n <td/>\n </tr>\n <tr>\n <td>I15.9</td>\n <td>Secondary hypertension, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>I16.0</td>\n <td>Hypertensive urgency</td>\n <td/>\n </tr>\n <tr>\n <td>I16.1</td>\n <td>Hypertensive emergency</td>\n <td/>\n </tr>\n <tr>\n <td>I16.9</td>\n <td>Hypertensive crisis, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>I20.0</td>\n <td>Unstable angina</td>\n <td/>\n </tr>\n <tr>\n <td>I20.1</td>\n <td>Angina pectoris with documented spasm</td>\n <td/>\n </tr>\n <tr>\n <td>I20.8</td>\n <td>Other forms of angina pectoris</td>\n <td/>\n </tr>\n <tr>\n <td>I20.9</td>\n <td>Angina pectoris, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>I21.01</td>\n <td>ST elevation (STEMI) myocardial infarction involving left main coronary artery</td>\n <td/>\n </tr>\n <tr>\n <td>I21.02</td>\n <td>ST elevation (STEMI) myocardial infarction involving left anterior descending coronary artery</td>\n <td/>\n </tr>\n <tr>\n <td>I21.09</td>\n <td>ST elevation (STEMI) myocardial infarction involving other coronary artery of anterior wall</td>\n <td/>\n </tr>\n <tr>\n <td>I21.11</td>\n <td>ST elevation (STEMI) myocardial infarction involving right coronary artery</td>\n <td/>\n </tr>\n <tr>\n <td>I21.19</td>\n <td>ST elevation (STEMI) myocardial infarction involving other coronary artery of inferior wall</td>\n <td/>\n </tr>\n <tr>\n <td>I21.21</td>\n <td>ST elevation (STEMI) myocardial infarction involving left circumflex coronary artery</td>\n <td/>\n </tr>\n <tr>\n <td>I21.29</td>\n <td>ST elevation (STEMI) myocardial infarction involving other sites</td>\n <td/>\n </tr>\n <tr>\n <td>I21.3</td>\n <td>ST elevation (STEMI) myocardial infarction of unspecified site</td>\n <td/>\n </tr>\n <tr>\n <td>I21.4</td>\n <td>Non-ST elevation (NSTEMI) myocardial infarction</td>\n <td/>\n </tr>\n <tr>\n <td>I21.9</td>\n <td>Acute myocardial infarction, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>I21.A1</td>\n <td>Myocardial infarction type 2</td>\n <td/>\n </tr>\n <tr>\n <td>I21.A9</td>\n <td>Other myocardial infarction type</td>\n <td/>\n </tr>\n <tr>\n <td>I22.0</td>\n <td>Subsequent ST elevation (STEMI) myocardial infarction of anterior wall</td>\n <td/>\n </tr>\n <tr>\n <td>I22.1</td>\n <td>Subsequent ST elevation (STEMI) myocardial infarction of inferior wall</td>\n <td/>\n </tr>\n <tr>\n <td>I22.2</td>\n <td>Subsequent non-ST elevation (NSTEMI) myocardial infarction</td>\n <td/>\n </tr>\n <tr>\n <td>I22.8</td>\n <td>Subsequent ST elevation (STEMI) myocardial infarction of other sites</td>\n <td/>\n </tr>\n <tr>\n <td>I22.9</td>\n <td>Subsequent ST elevation (STEMI) myocardial infarction of unspecified site</td>\n <td/>\n </tr>\n <tr>\n <td>I23.0</td>\n <td>Hemopericardium as current complication following acute myocardial infarction</td>\n <td/>\n </tr>\n <tr>\n <td>I23.1</td>\n <td>Atrial septal defect as current complication following acute myocardial infarction</td>\n <td/>\n </tr>\n <tr>\n <td>I23.2</td>\n <td>Ventricular septal defect as current complication following acute myocardial infarction</td>\n <td/>\n </tr>\n <tr>\n <td>I23.3</td>\n <td>Rupture of cardiac wall without hemopericardium as current complication following acute myocardial infarction</td>\n <td/>\n </tr>\n <tr>\n <td>I23.4</td>\n <td>Rupture of chordae tendineae as current complication following acute myocardial infarction</td>\n <td/>\n </tr>\n <tr>\n <td>I23.5</td>\n <td>Rupture of papillary muscle as current complication following acute myocardial infarction</td>\n <td/>\n </tr>\n <tr>\n <td>I23.6</td>\n <td>Thrombosis of atrium, auricular appendage, and ventricle as current complications following acute myocardial infarction</td>\n <td/>\n </tr>\n <tr>\n <td>I23.7</td>\n <td>Postinfarction angina</td>\n <td/>\n </tr>\n <tr>\n <td>I23.8</td>\n <td>Other current complications following acute myocardial infarction</td>\n <td/>\n </tr>\n <tr>\n <td>I24.0</td>\n <td>Acute coronary thrombosis not resulting in myocardial infarction</td>\n <td/>\n </tr>\n <tr>\n <td>I24.1</td>\n <td>Dressler's syndrome</td>\n <td/>\n </tr>\n <tr>\n <td>I24.8</td>\n <td>Other forms of acute ischemic heart disease</td>\n <td/>\n </tr>\n <tr>\n <td>I24.9</td>\n <td>Acute ischemic heart disease, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>I25.10</td>\n <td>Atherosclerotic heart disease of native coronary artery without angina pectoris</td>\n <td/>\n </tr>\n <tr>\n <td>I25.110</td>\n <td>Atherosclerotic heart disease of native coronary artery with unstable angina pectoris</td>\n <td/>\n </tr>\n <tr>\n <td>I25.111</td>\n <td>Atherosclerotic heart disease of native coronary artery with angina pectoris with documented spasm</td>\n <td/>\n </tr>\n <tr>\n <td>I25.118</td>\n <td>Atherosclerotic heart disease of native coronary artery with other forms of angina pectoris</td>\n <td/>\n </tr>\n <tr>\n <td>I25.119</td>\n <td>Atherosclerotic heart disease of native coronary artery with unspecified angina pectoris</td>\n <td/>\n </tr>\n <tr>\n <td>I25.2</td>\n <td>Old myocardial infarction</td>\n <td/>\n </tr>\n <tr>\n <td>I25.3</td>\n <td>Aneurysm of heart</td>\n <td/>\n </tr>\n <tr>\n <td>I25.41</td>\n <td>Coronary artery aneurysm</td>\n <td/>\n </tr>\n <tr>\n <td>I25.42</td>\n <td>Coronary artery dissection</td>\n <td/>\n </tr>\n <tr>\n <td>I25.5</td>\n <td>Ischemic cardiomyopathy</td>\n <td/>\n </tr>\n <tr>\n <td>I25.6</td>\n <td>Silent myocardial ischemia</td>\n <td/>\n </tr>\n <tr>\n <td>I25.750</td>\n <td>Atherosclerosis of native coronary artery of transplanted heart with unstable angina</td>\n <td/>\n </tr>\n <tr>\n <td>I25.751</td>\n <td>Atherosclerosis of native coronary artery of transplanted heart with angina pectoris with documented spasm</td>\n <td/>\n </tr>\n <tr>\n <td>I25.758</td>\n <td>Atherosclerosis of native coronary artery of transplanted heart with other forms of angina pectoris</td>\n <td/>\n </tr>\n <tr>\n <td>I25.759</td>\n <td>Atherosclerosis of native coronary artery of transplanted heart with unspecified angina pectoris</td>\n <td/>\n </tr>\n <tr>\n <td>I25.811</td>\n <td>Atherosclerosis of native coronary artery of transplanted heart without angina pectoris</td>\n <td/>\n </tr>\n <tr>\n <td>I25.82</td>\n <td>Chronic total occlusion of coronary artery</td>\n <td/>\n </tr>\n <tr>\n <td>I25.83</td>\n <td>Coronary atherosclerosis due to lipid rich plaque</td>\n <td/>\n </tr>\n <tr>\n <td>I25.84</td>\n <td>Coronary atherosclerosis due to calcified coronary lesion</td>\n <td/>\n </tr>\n <tr>\n <td>I25.89</td>\n <td>Other forms of chronic ischemic heart disease</td>\n <td/>\n </tr>\n <tr>\n <td>I25.9</td>\n <td>Chronic ischemic heart disease, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>I26.01</td>\n <td>Septic pulmonary embolism with acute cor pulmonale</td>\n <td/>\n </tr>\n <tr>\n <td>I26.02</td>\n <td>Saddle embolus of pulmonary artery with acute cor pulmonale</td>\n <td/>\n </tr>\n <tr>\n <td>I26.09</td>\n <td>Other pulmonary embolism with acute cor pulmonale</td>\n <td/>\n </tr>\n <tr>\n <td>I26.90</td>\n <td>Septic pulmonary embolism without acute cor pulmonale</td>\n <td/>\n </tr>\n <tr>\n <td>I26.92</td>\n <td>Saddle embolus of pulmonary artery without acute cor pulmonale</td>\n <td/>\n </tr>\n <tr>\n <td>I26.99</td>\n <td>Other pulmonary embolism without acute cor pulmonale</td>\n <td/>\n </tr>\n <tr>\n <td>I27.0</td>\n <td>Primary pulmonary hypertension</td>\n <td/>\n </tr>\n <tr>\n <td>I27.1</td>\n <td>Kyphoscoliotic heart disease</td>\n <td/>\n </tr>\n <tr>\n <td>I27.2</td>\n <td>Other secondary pulmonary hypertension</td>\n <td/>\n </tr>\n <tr>\n <td>I27.20</td>\n <td>Pulmonary hypertension, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>I27.21</td>\n <td>Secondary pulmonary arterial hypertension</td>\n <td/>\n </tr>\n <tr>\n <td>I27.22</td>\n <td>Pulmonary hypertension due to left heart disease</td>\n <td/>\n </tr>\n <tr>\n <td>I27.23</td>\n <td>Pulmonary hypertension due to lung diseases and hypoxia</td>\n <td/>\n </tr>\n <tr>\n <td>I27.24</td>\n <td>Chronic thromboembolic pulmonary hypertension</td>\n <td/>\n </tr>\n <tr>\n <td>I27.29</td>\n <td>Other secondary pulmonary hypertension</td>\n <td/>\n </tr>\n <tr>\n <td>I27.81</td>\n <td>Cor pulmonale (chronic)</td>\n <td/>\n </tr>\n <tr>\n <td>I27.82</td>\n <td>Chronic pulmonary embolism</td>\n <td/>\n </tr>\n <tr>\n <td>I27.83</td>\n <td>Eisenmenger's syndrome</td>\n <td/>\n </tr>\n <tr>\n <td>I27.89</td>\n <td>Other specified pulmonary heart diseases</td>\n <td/>\n </tr>\n <tr>\n <td>I27.9</td>\n <td>Pulmonary heart disease, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>I28.0</td>\n <td>Arteriovenous fistula of pulmonary vessels</td>\n <td/>\n </tr>\n <tr>\n <td>I28.1</td>\n <td>Aneurysm of pulmonary artery</td>\n <td/>\n </tr>\n <tr>\n <td>I28.8</td>\n <td>Other diseases of pulmonary vessels</td>\n <td/>\n </tr>\n <tr>\n <td>I28.9</td>\n <td>Disease of pulmonary vessels, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>I30.0</td>\n <td>Acute nonspecific idiopathic pericarditis</td>\n <td/>\n </tr>\n <tr>\n <td>I30.1</td>\n <td>Infective pericarditis</td>\n <td/>\n </tr>\n <tr>\n <td>I30.8</td>\n <td>Other forms of acute pericarditis</td>\n <td/>\n </tr>\n <tr>\n <td>I30.9</td>\n <td>Acute pericarditis, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>I31.0</td>\n <td>Chronic adhesive pericarditis</td>\n <td/>\n </tr>\n <tr>\n <td>I31.1</td>\n <td>Chronic constrictive pericarditis</td>\n <td/>\n </tr>\n <tr>\n <td>I31.2</td>\n <td>Hemopericardium, not elsewhere classified</td>\n <td/>\n </tr>\n <tr>\n <td>I31.3</td>\n <td>Pericardial effusion (noninflammatory)</td>\n <td/>\n </tr>\n <tr>\n <td>I31.4</td>\n <td>Cardiac tamponade</td>\n <td/>\n </tr>\n <tr>\n <td>I31.8</td>\n <td>Other specified diseases of pericardium</td>\n <td/>\n </tr>\n <tr>\n <td>I31.9</td>\n <td>Disease of pericardium, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>I32</td>\n <td>Pericarditis in diseases classified elsewhere</td>\n <td/>\n </tr>\n <tr>\n <td>I33.0</td>\n <td>Acute and subacute infective endocarditis</td>\n <td/>\n </tr>\n <tr>\n <td>I33.9</td>\n <td>Acute and subacute endocarditis, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>I34.0</td>\n <td>Nonrheumatic mitral (valve) insufficiency</td>\n <td/>\n </tr>\n <tr>\n <td>I34.1</td>\n <td>Nonrheumatic mitral (valve) prolapse</td>\n <td/>\n </tr>\n <tr>\n <td>I34.2</td>\n <td>Nonrheumatic mitral (valve) stenosis</td>\n <td/>\n </tr>\n <tr>\n <td>I34.8</td>\n <td>Other nonrheumatic mitral valve disorders</td>\n <td/>\n </tr>\n <tr>\n <td>I34.9</td>\n <td>Nonrheumatic mitral valve disorder, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>I35.0</td>\n <td>Nonrheumatic aortic (valve) stenosis</td>\n <td/>\n </tr>\n <tr>\n <td>I35.1</td>\n <td>Nonrheumatic aortic (valve) insufficiency</td>\n <td/>\n </tr>\n <tr>\n <td>I35.2</td>\n <td>Nonrheumatic aortic (valve) stenosis with insufficiency</td>\n <td/>\n </tr>\n <tr>\n <td>I35.8</td>\n <td>Other nonrheumatic aortic valve disorders</td>\n <td/>\n </tr>\n <tr>\n <td>I35.9</td>\n <td>Nonrheumatic aortic valve disorder, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>I36.0</td>\n <td>Nonrheumatic tricuspid (valve) stenosis</td>\n <td/>\n </tr>\n <tr>\n <td>I36.1</td>\n <td>Nonrheumatic tricuspid (valve) insufficiency</td>\n <td/>\n </tr>\n <tr>\n <td>I36.2</td>\n <td>Nonrheumatic tricuspid (valve) stenosis with insufficiency</td>\n <td/>\n </tr>\n <tr>\n <td>I36.8</td>\n <td>Other nonrheumatic tricuspid valve disorders</td>\n <td/>\n </tr>\n <tr>\n <td>I36.9</td>\n <td>Nonrheumatic tricuspid valve disorder, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>I37.0</td>\n <td>Nonrheumatic pulmonary valve stenosis</td>\n <td/>\n </tr>\n <tr>\n <td>I37.1</td>\n <td>Nonrheumatic pulmonary valve insufficiency</td>\n <td/>\n </tr>\n <tr>\n <td>I37.2</td>\n <td>Nonrheumatic pulmonary valve stenosis with insufficiency</td>\n <td/>\n </tr>\n <tr>\n <td>I37.8</td>\n <td>Other nonrheumatic pulmonary valve disorders</td>\n <td/>\n </tr>\n <tr>\n <td>I37.9</td>\n <td>Nonrheumatic pulmonary valve disorder, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>I38</td>\n <td>Endocarditis, valve unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>I39</td>\n <td>Endocarditis and heart valve disorders in diseases classified elsewhere</td>\n <td/>\n </tr>\n <tr>\n <td>I40.0</td>\n <td>Infective myocarditis</td>\n <td/>\n </tr>\n <tr>\n <td>I40.1</td>\n <td>Isolated myocarditis</td>\n <td/>\n </tr>\n <tr>\n <td>I40.8</td>\n <td>Other acute myocarditis</td>\n <td/>\n </tr>\n <tr>\n <td>I40.9</td>\n <td>Acute myocarditis, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>I41</td>\n <td>Myocarditis in diseases classified elsewhere</td>\n <td/>\n </tr>\n <tr>\n <td>I42.0</td>\n <td>Dilated cardiomyopathy</td>\n <td/>\n </tr>\n <tr>\n <td>I42.1</td>\n <td>Obstructive hypertrophic cardiomyopathy</td>\n <td/>\n </tr>\n <tr>\n <td>I42.2</td>\n <td>Other hypertrophic cardiomyopathy</td>\n <td/>\n </tr>\n <tr>\n <td>I42.3</td>\n <td>Endomyocardial (eosinophilic) disease</td>\n <td/>\n </tr>\n <tr>\n <td>I42.4</td>\n <td>Endocardial fibroelastosis</td>\n <td/>\n </tr>\n <tr>\n <td>I42.5</td>\n <td>Other restrictive cardiomyopathy</td>\n <td/>\n </tr>\n <tr>\n <td>I42.7</td>\n <td>Cardiomyopathy due to drug and external agent</td>\n <td/>\n </tr>\n <tr>\n <td>I42.8</td>\n <td>Other cardiomyopathies</td>\n <td/>\n </tr>\n <tr>\n <td>I42.9</td>\n <td>Cardiomyopathy, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>I43</td>\n <td>Cardiomyopathy in diseases classified elsewhere</td>\n <td/>\n </tr>\n <tr>\n <td>I44.0</td>\n <td>Atrioventricular block, first degree</td>\n <td/>\n </tr>\n <tr>\n <td>I44.1</td>\n <td>Atrioventricular block, second degree</td>\n <td/>\n </tr>\n <tr>\n <td>I44.2</td>\n <td>Atrioventricular block, complete</td>\n <td/>\n </tr>\n <tr>\n <td>I44.30</td>\n <td>Unspecified atrioventricular block</td>\n <td/>\n </tr>\n <tr>\n <td>I44.39</td>\n <td>Other atrioventricular block</td>\n <td/>\n </tr>\n <tr>\n <td>I44.4</td>\n <td>Left anterior fascicular block</td>\n <td/>\n </tr>\n <tr>\n <td>I44.5</td>\n <td>Left posterior fascicular block</td>\n <td/>\n </tr>\n <tr>\n <td>I44.60</td>\n <td>Unspecified fascicular block</td>\n <td/>\n </tr>\n <tr>\n <td>I44.69</td>\n <td>Other fascicular block</td>\n <td/>\n </tr>\n <tr>\n <td>I44.7</td>\n <td>Left bundle-branch block, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>I45.0</td>\n <td>Right fascicular block</td>\n <td/>\n </tr>\n <tr>\n <td>I45.10</td>\n <td>Unspecified right bundle-branch block</td>\n <td/>\n </tr>\n <tr>\n <td>I45.19</td>\n <td>Other right bundle-branch block</td>\n <td/>\n </tr>\n <tr>\n <td>I45.2</td>\n <td>Bifascicular block</td>\n <td/>\n </tr>\n <tr>\n <td>I45.3</td>\n <td>Trifascicular block</td>\n <td/>\n </tr>\n <tr>\n <td>I45.4</td>\n <td>Nonspecific intraventricular block</td>\n <td/>\n </tr>\n <tr>\n <td>I45.5</td>\n <td>Other specified heart block</td>\n <td/>\n </tr>\n <tr>\n <td>I45.6</td>\n <td>Pre-excitation syndrome</td>\n <td/>\n </tr>\n <tr>\n <td>I45.81</td>\n <td>Long QT syndrome</td>\n <td/>\n </tr>\n <tr>\n <td>I45.89</td>\n <td>Other specified conduction disorders</td>\n <td/>\n </tr>\n <tr>\n <td>I45.9</td>\n <td>Conduction disorder, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>I46.2</td>\n <td>Cardiac arrest due to underlying cardiac condition</td>\n <td/>\n </tr>\n <tr>\n <td>I46.8</td>\n <td>Cardiac arrest due to other underlying condition</td>\n <td/>\n </tr>\n <tr>\n <td>I46.9</td>\n <td>Cardiac arrest, cause unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>I47.0</td>\n <td>Re-entry ventricular arrhythmia</td>\n <td/>\n </tr>\n <tr>\n <td>I47.1</td>\n <td>Supraventricular tachycardia</td>\n <td/>\n </tr>\n <tr>\n <td>I47.2</td>\n <td>Ventricular tachycardia</td>\n <td/>\n </tr>\n <tr>\n <td>I47.9</td>\n <td>Paroxysmal tachycardia, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>I48.0</td>\n <td>Paroxysmal atrial fibrillation</td>\n <td/>\n </tr>\n <tr>\n <td>I48.1</td>\n <td>Persistent atrial fibrillation</td>\n <td/>\n </tr>\n <tr>\n <td>I48.2</td>\n <td>Chronic atrial fibrillation</td>\n <td/>\n </tr>\n <tr>\n <td>I48.3</td>\n <td>Typical atrial flutter</td>\n <td/>\n </tr>\n <tr>\n <td>I48.4</td>\n <td>Atypical atrial flutter</td>\n <td/>\n </tr>\n <tr>\n <td>I48.91</td>\n <td>Unspecified atrial fibrillation</td>\n <td/>\n </tr>\n <tr>\n <td>I48.92</td>\n <td>Unspecified atrial flutter</td>\n <td/>\n </tr>\n <tr>\n <td>I49.01</td>\n <td>Ventricular fibrillation</td>\n <td/>\n </tr>\n <tr>\n <td>I49.02</td>\n <td>Ventricular flutter</td>\n <td/>\n </tr>\n <tr>\n <td>I49.1</td>\n <td>Atrial premature depolarization</td>\n <td/>\n </tr>\n <tr>\n <td>I49.2</td>\n <td>Junctional premature depolarization</td>\n <td/>\n </tr>\n <tr>\n <td>I49.3</td>\n <td>Ventricular premature depolarization</td>\n <td/>\n </tr>\n <tr>\n <td>I49.40</td>\n <td>Unspecified premature depolarization</td>\n <td/>\n </tr>\n <tr>\n <td>I49.49</td>\n <td>Other premature depolarization</td>\n <td/>\n </tr>\n <tr>\n <td>I49.5</td>\n <td>Sick sinus syndrome</td>\n <td/>\n </tr>\n <tr>\n <td>I49.8</td>\n <td>Other specified cardiac arrhythmias</td>\n <td/>\n </tr>\n <tr>\n <td>I49.9</td>\n <td>Cardiac arrhythmia, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>I50.1</td>\n <td>Left ventricular failure, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>I50.20</td>\n <td>Unspecified systolic (congestive) heart failure</td>\n <td/>\n </tr>\n <tr>\n <td>I50.21</td>\n <td>Acute systolic (congestive) heart failure</td>\n <td/>\n </tr>\n <tr>\n <td>I50.22</td>\n <td>Chronic systolic (congestive) heart failure</td>\n <td/>\n </tr>\n <tr>\n <td>I50.23</td>\n <td>Acute on chronic systolic (congestive) heart failure</td>\n <td/>\n </tr>\n <tr>\n <td>I50.30</td>\n <td>Unspecified diastolic (congestive) heart failure</td>\n <td/>\n </tr>\n <tr>\n <td>I50.31</td>\n <td>Acute diastolic (congestive) heart failure</td>\n <td/>\n </tr>\n <tr>\n <td>I50.32</td>\n <td>Chronic diastolic (congestive) heart failure</td>\n <td/>\n </tr>\n <tr>\n <td>I50.33</td>\n <td>Acute on chronic diastolic (congestive) heart failure</td>\n <td/>\n </tr>\n <tr>\n <td>I50.40</td>\n <td>Unspecified combined systolic (congestive) and diastolic (congestive) heart failure</td>\n <td/>\n </tr>\n <tr>\n <td>I50.41</td>\n <td>Acute combined systolic (congestive) and diastolic (congestive) heart failure</td>\n <td/>\n </tr>\n <tr>\n <td>I50.42</td>\n <td>Chronic combined systolic (congestive) and diastolic (congestive) heart failure</td>\n <td/>\n </tr>\n <tr>\n <td>I50.43</td>\n <td>Acute on chronic combined systolic (congestive) and diastolic (congestive) heart failure</td>\n <td/>\n </tr>\n <tr>\n <td>I50.810</td>\n <td>Right heart failure, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>I50.811</td>\n <td>Acute right heart failure</td>\n <td/>\n </tr>\n <tr>\n <td>I50.812</td>\n <td>Chronic right heart failure</td>\n <td/>\n </tr>\n <tr>\n <td>I50.813</td>\n <td>Acute on chronic right heart failure</td>\n <td/>\n </tr>\n <tr>\n <td>I50.814</td>\n <td>Right heart failure due to left heart failure</td>\n <td/>\n </tr>\n <tr>\n <td>I50.82</td>\n <td>Biventricular heart failure</td>\n <td/>\n </tr>\n <tr>\n <td>I50.83</td>\n <td>High output heart failure</td>\n <td/>\n </tr>\n <tr>\n <td>I50.84</td>\n <td>End stage heart failure</td>\n <td/>\n </tr>\n <tr>\n <td>I50.89</td>\n <td>Other heart failure</td>\n <td/>\n </tr>\n <tr>\n <td>I50.9</td>\n <td>Heart failure, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>I51.0</td>\n <td>Cardiac septal defect, acquired</td>\n <td/>\n </tr>\n <tr>\n <td>I51.1</td>\n <td>Rupture of chordae tendineae, not elsewhere classified</td>\n <td/>\n </tr>\n <tr>\n <td>I51.2</td>\n <td>Rupture of papillary muscle, not elsewhere classified</td>\n <td/>\n </tr>\n <tr>\n <td>I51.3</td>\n <td>Intracardiac thrombosis, not elsewhere classified</td>\n <td/>\n </tr>\n <tr>\n <td>I51.4</td>\n <td>Myocarditis, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>I51.5</td>\n <td>Myocardial degeneration</td>\n <td/>\n </tr>\n <tr>\n <td>I51.7</td>\n <td>Cardiomegaly</td>\n <td/>\n </tr>\n <tr>\n <td>I51.81</td>\n <td>Takotsubo syndrome</td>\n <td/>\n </tr>\n <tr>\n <td>I51.89</td>\n <td>Other ill-defined heart diseases</td>\n <td/>\n </tr>\n <tr>\n <td>I51.9</td>\n <td>Heart disease, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>I52</td>\n <td>Other heart disorders in diseases classified elsewhere</td>\n <td/>\n </tr>\n <tr>\n <td>I60.00</td>\n <td>Nontraumatic subarachnoid hemorrhage from unspecified carotid siphon and bifurcation</td>\n <td/>\n </tr>\n <tr>\n <td>I60.01</td>\n <td>Nontraumatic subarachnoid hemorrhage from right carotid siphon and bifurcation</td>\n <td/>\n </tr>\n <tr>\n <td>I60.02</td>\n <td>Nontraumatic subarachnoid hemorrhage from left carotid siphon and bifurcation</td>\n <td/>\n </tr>\n <tr>\n <td>I60.10</td>\n <td>Nontraumatic subarachnoid hemorrhage from unspecified middle cerebral artery</td>\n <td/>\n </tr>\n <tr>\n <td>I60.11</td>\n <td>Nontraumatic subarachnoid hemorrhage from right middle cerebral artery</td>\n <td/>\n </tr>\n <tr>\n <td>I60.12</td>\n <td>Nontraumatic subarachnoid hemorrhage from left middle cerebral artery</td>\n <td/>\n </tr>\n <tr>\n <td>I60.2</td>\n <td>Nontraumatic subarachnoid hemorrhage from anterior communicating artery</td>\n <td/>\n </tr>\n <tr>\n <td>I60.30</td>\n <td>Nontraumatic subarachnoid hemorrhage from unspecified posterior communicating artery</td>\n <td/>\n </tr>\n <tr>\n <td>I60.31</td>\n <td>Nontraumatic subarachnoid hemorrhage from right posterior communicating artery</td>\n <td/>\n </tr>\n <tr>\n <td>I60.32</td>\n <td>Nontraumatic subarachnoid hemorrhage from left posterior communicating artery</td>\n <td/>\n </tr>\n <tr>\n <td>I60.4</td>\n <td>Nontraumatic subarachnoid hemorrhage from basilar artery</td>\n <td/>\n </tr>\n <tr>\n <td>I60.50</td>\n <td>Nontraumatic subarachnoid hemorrhage from unspecified vertebral artery</td>\n <td/>\n </tr>\n <tr>\n <td>I60.51</td>\n <td>Nontraumatic subarachnoid hemorrhage from right vertebral artery</td>\n <td/>\n </tr>\n <tr>\n <td>I60.52</td>\n <td>Nontraumatic subarachnoid hemorrhage from left vertebral artery</td>\n <td/>\n </tr>\n <tr>\n <td>I60.6</td>\n <td>Nontraumatic subarachnoid hemorrhage from other intracranial arteries</td>\n <td/>\n </tr>\n <tr>\n <td>I60.7</td>\n <td>Nontraumatic subarachnoid hemorrhage from unspecified intracranial artery</td>\n <td/>\n </tr>\n <tr>\n <td>I60.8</td>\n <td>Other nontraumatic subarachnoid hemorrhage</td>\n <td/>\n </tr>\n <tr>\n <td>I60.9</td>\n <td>Nontraumatic subarachnoid hemorrhage, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>I61.0</td>\n <td>Nontraumatic intracerebral hemorrhage in hemisphere, subcortical</td>\n <td/>\n </tr>\n <tr>\n <td>I61.1</td>\n <td>Nontraumatic intracerebral hemorrhage in hemisphere, cortical</td>\n <td/>\n </tr>\n <tr>\n <td>I61.2</td>\n <td>Nontraumatic intracerebral hemorrhage in hemisphere, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>I61.3</td>\n <td>Nontraumatic intracerebral hemorrhage in brain stem</td>\n <td/>\n </tr>\n <tr>\n <td>I61.4</td>\n <td>Nontraumatic intracerebral hemorrhage in cerebellum</td>\n <td/>\n </tr>\n <tr>\n <td>I61.5</td>\n <td>Nontraumatic intracerebral hemorrhage, intraventricular</td>\n <td/>\n </tr>\n <tr>\n <td>I61.6</td>\n <td>Nontraumatic intracerebral hemorrhage, multiple localized</td>\n <td/>\n </tr>\n <tr>\n <td>I61.8</td>\n <td>Other nontraumatic intracerebral hemorrhage</td>\n <td/>\n </tr>\n <tr>\n <td>I61.9</td>\n <td>Nontraumatic intracerebral hemorrhage, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>I62.00</td>\n <td>Nontraumatic subdural hemorrhage, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>I62.01</td>\n <td>Nontraumatic acute subdural hemorrhage</td>\n <td/>\n </tr>\n <tr>\n <td>I62.02</td>\n <td>Nontraumatic subacute subdural hemorrhage</td>\n <td/>\n </tr>\n <tr>\n <td>I62.03</td>\n <td>Nontraumatic chronic subdural hemorrhage</td>\n <td/>\n </tr>\n <tr>\n <td>I62.1</td>\n <td>Nontraumatic extradural hemorrhage</td>\n <td/>\n </tr>\n <tr>\n <td>I62.9</td>\n <td>Nontraumatic intracranial hemorrhage, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>I63.00</td>\n <td>Cerebral infarction due to thrombosis of unspecified precerebral artery</td>\n <td/>\n </tr>\n <tr>\n <td>I63.011</td>\n <td>Cerebral infarction due to thrombosis of right vertebral artery</td>\n <td/>\n </tr>\n <tr>\n <td>I63.012</td>\n <td>Cerebral infarction due to thrombosis of left vertebral artery</td>\n <td/>\n </tr>\n <tr>\n <td>I63.013</td>\n <td>Cerebral infarction due to thrombosis of bilateral vertebral arteries</td>\n <td/>\n </tr>\n <tr>\n <td>I63.019</td>\n <td>Cerebral infarction due to thrombosis of unspecified vertebral artery</td>\n <td/>\n </tr>\n <tr>\n <td>I63.02</td>\n <td>Cerebral infarction due to thrombosis of basilar artery</td>\n <td/>\n </tr>\n <tr>\n <td>I63.031</td>\n <td>Cerebral infarction due to thrombosis of right carotid artery</td>\n <td/>\n </tr>\n <tr>\n <td>I63.032</td>\n <td>Cerebral infarction due to thrombosis of left carotid artery</td>\n <td/>\n </tr>\n <tr>\n <td>I63.033</td>\n <td>Cerebral infarction due to thrombosis of bilateral carotid arteries</td>\n <td/>\n </tr>\n <tr>\n <td>I63.039</td>\n <td>Cerebral infarction due to thrombosis of unspecified carotid artery</td>\n <td/>\n </tr>\n <tr>\n <td>I63.09</td>\n <td>Cerebral infarction due to thrombosis of other precerebral artery</td>\n <td/>\n </tr>\n <tr>\n <td>I63.10</td>\n <td>Cerebral infarction due to embolism of unspecified precerebral artery</td>\n <td/>\n </tr>\n <tr>\n <td>I63.111</td>\n <td>Cerebral infarction due to embolism of right vertebral artery</td>\n <td/>\n </tr>\n <tr>\n <td>I63.112</td>\n <td>Cerebral infarction due to embolism of left vertebral artery</td>\n <td/>\n </tr>\n <tr>\n <td>I63.113</td>\n <td>Cerebral infarction due to embolism of bilateral vertebral arteries</td>\n <td/>\n </tr>\n <tr>\n <td>I63.119</td>\n <td>Cerebral infarction due to embolism of unspecified vertebral artery</td>\n <td/>\n </tr>\n <tr>\n <td>I63.12</td>\n <td>Cerebral infarction due to embolism of basilar artery</td>\n <td/>\n </tr>\n <tr>\n <td>I63.131</td>\n <td>Cerebral infarction due to embolism of right carotid artery</td>\n <td/>\n </tr>\n <tr>\n <td>I63.132</td>\n <td>Cerebral infarction due to embolism of left carotid artery</td>\n <td/>\n </tr>\n <tr>\n <td>I63.133</td>\n <td>Cerebral infarction due to embolism of bilateral carotid arteries</td>\n <td/>\n </tr>\n <tr>\n <td>I63.139</td>\n <td>Cerebral infarction due to embolism of unspecified carotid artery</td>\n <td/>\n </tr>\n <tr>\n <td>I63.19</td>\n <td>Cerebral infarction due to embolism of other precerebral artery</td>\n <td/>\n </tr>\n <tr>\n <td>I63.20</td>\n <td>Cerebral infarction due to unspecified occlusion or stenosis of unspecified precerebral arteries</td>\n <td/>\n </tr>\n <tr>\n <td>I63.211</td>\n <td>Cerebral infarction due to unspecified occlusion or stenosis of right vertebral artery</td>\n <td/>\n </tr>\n <tr>\n <td>I63.212</td>\n <td>Cerebral infarction due to unspecified occlusion or stenosis of left vertebral artery</td>\n <td/>\n </tr>\n <tr>\n <td>I63.213</td>\n <td>Cerebral infarction due to unspecified occlusion or stenosis of bilateral vertebral arteries</td>\n <td/>\n </tr>\n <tr>\n <td>I63.219</td>\n <td>Cerebral infarction due to unspecified occlusion or stenosis of unspecified vertebral artery</td>\n <td/>\n </tr>\n <tr>\n <td>I63.22</td>\n <td>Cerebral infarction due to unspecified occlusion or stenosis of basilar artery</td>\n <td/>\n </tr>\n <tr>\n <td>I63.231</td>\n <td>Cerebral infarction due to unspecified occlusion or stenosis of right carotid arteries</td>\n <td/>\n </tr>\n <tr>\n <td>I63.232</td>\n <td>Cerebral infarction due to unspecified occlusion or stenosis of left carotid arteries</td>\n <td/>\n </tr>\n <tr>\n <td>I63.233</td>\n <td>Cerebral infarction due to unspecified occlusion or stenosis of bilateral carotid arteries</td>\n <td/>\n </tr>\n <tr>\n <td>I63.239</td>\n <td>Cerebral infarction due to unspecified occlusion or stenosis of unspecified carotid artery</td>\n <td/>\n </tr>\n <tr>\n <td>I63.29</td>\n <td>Cerebral infarction due to unspecified occlusion or stenosis of other precerebral arteries</td>\n <td/>\n </tr>\n <tr>\n <td>I63.30</td>\n <td>Cerebral infarction due to thrombosis of unspecified cerebral artery</td>\n <td/>\n </tr>\n <tr>\n <td>I63.311</td>\n <td>Cerebral infarction due to thrombosis of right middle cerebral artery</td>\n <td/>\n </tr>\n <tr>\n <td>I63.312</td>\n <td>Cerebral infarction due to thrombosis of left middle cerebral artery</td>\n <td/>\n </tr>\n <tr>\n <td>I63.313</td>\n <td>Cerebral infarction due to thrombosis of bilateral middle cerebral arteries</td>\n <td/>\n </tr>\n <tr>\n <td>I63.319</td>\n <td>Cerebral infarction due to thrombosis of unspecified middle cerebral artery</td>\n <td/>\n </tr>\n <tr>\n <td>I63.321</td>\n <td>Cerebral infarction due to thrombosis of right anterior cerebral artery</td>\n <td/>\n </tr>\n <tr>\n <td>I63.322</td>\n <td>Cerebral infarction due to thrombosis of left anterior cerebral artery</td>\n <td/>\n </tr>\n <tr>\n <td>I63.323</td>\n <td>Cerebral infarction due to thrombosis of bilateral anterior cerebral arteries</td>\n <td/>\n </tr>\n <tr>\n <td>I63.329</td>\n <td>Cerebral infarction due to thrombosis of unspecified anterior cerebral artery</td>\n <td/>\n </tr>\n <tr>\n <td>I63.331</td>\n <td>Cerebral infarction due to thrombosis of right posterior cerebral artery</td>\n <td/>\n </tr>\n <tr>\n <td>I63.332</td>\n <td>Cerebral infarction due to thrombosis of left posterior cerebral artery</td>\n <td/>\n </tr>\n <tr>\n <td>I63.333</td>\n <td>Cerebral infarction due to thrombosis of bilateral posterior cerebral arteries</td>\n <td/>\n </tr>\n <tr>\n <td>I63.339</td>\n <td>Cerebral infarction due to thrombosis of unspecified posterior cerebral artery</td>\n <td/>\n </tr>\n <tr>\n <td>I63.341</td>\n <td>Cerebral infarction due to thrombosis of right cerebellar artery</td>\n <td/>\n </tr>\n <tr>\n <td>I63.342</td>\n <td>Cerebral infarction due to thrombosis of left cerebellar artery</td>\n <td/>\n </tr>\n <tr>\n <td>I63.343</td>\n <td>Cerebral infarction due to thrombosis of bilateral cerebellar arteries</td>\n <td/>\n </tr>\n <tr>\n <td>I63.349</td>\n <td>Cerebral infarction due to thrombosis of unspecified cerebellar artery</td>\n <td/>\n </tr>\n <tr>\n <td>I63.39</td>\n <td>Cerebral infarction due to thrombosis of other cerebral artery</td>\n <td/>\n </tr>\n <tr>\n <td>I63.40</td>\n <td>Cerebral infarction due to embolism of unspecified cerebral artery</td>\n <td/>\n </tr>\n <tr>\n <td>I63.411</td>\n <td>Cerebral infarction due to embolism of right middle cerebral artery</td>\n <td/>\n </tr>\n <tr>\n <td>I63.412</td>\n <td>Cerebral infarction due to embolism of left middle cerebral artery</td>\n <td/>\n </tr>\n <tr>\n <td>I63.413</td>\n <td>Cerebral infarction due to embolism of bilateral middle cerebral arteries</td>\n <td/>\n </tr>\n <tr>\n <td>I63.419</td>\n <td>Cerebral infarction due to embolism of unspecified middle cerebral artery</td>\n <td/>\n </tr>\n <tr>\n <td>I63.421</td>\n <td>Cerebral infarction due to embolism of right anterior cerebral artery</td>\n <td/>\n </tr>\n <tr>\n <td>I63.422</td>\n <td>Cerebral infarction due to embolism of left anterior cerebral artery</td>\n <td/>\n </tr>\n <tr>\n <td>I63.423</td>\n <td>Cerebral infarction due to embolism of bilateral anterior cerebral arteries</td>\n <td/>\n </tr>\n <tr>\n <td>I63.429</td>\n <td>Cerebral infarction due to embolism of unspecified anterior cerebral artery</td>\n <td/>\n </tr>\n <tr>\n <td>I63.431</td>\n <td>Cerebral infarction due to embolism of right posterior cerebral artery</td>\n <td/>\n </tr>\n <tr>\n <td>I63.432</td>\n <td>Cerebral infarction due to embolism of left posterior cerebral artery</td>\n <td/>\n </tr>\n <tr>\n <td>I63.433</td>\n <td>Cerebral infarction due to embolism of bilateral posterior cerebral arteries</td>\n <td/>\n </tr>\n <tr>\n <td>I63.439</td>\n <td>Cerebral infarction due to embolism of unspecified posterior cerebral artery</td>\n <td/>\n </tr>\n <tr>\n <td>I63.441</td>\n <td>Cerebral infarction due to embolism of right cerebellar artery</td>\n <td/>\n </tr>\n <tr>\n <td>I63.442</td>\n <td>Cerebral infarction due to embolism of left cerebellar artery</td>\n <td/>\n </tr>\n <tr>\n <td>I63.443</td>\n <td>Cerebral infarction due to embolism of bilateral cerebellar arteries</td>\n <td/>\n </tr>\n <tr>\n <td>I63.449</td>\n <td>Cerebral infarction due to embolism of unspecified cerebellar artery</td>\n <td/>\n </tr>\n <tr>\n <td>I63.49</td>\n <td>Cerebral infarction due to embolism of other cerebral artery</td>\n <td/>\n </tr>\n <tr>\n <td>I63.50</td>\n <td>Cerebral infarction due to unspecified occlusion or stenosis of unspecified cerebral artery</td>\n <td/>\n </tr>\n <tr>\n <td>I63.511</td>\n <td>Cerebral infarction due to unspecified occlusion or stenosis of right middle cerebral artery</td>\n <td/>\n </tr>\n <tr>\n <td>I63.512</td>\n <td>Cerebral infarction due to unspecified occlusion or stenosis of left middle cerebral artery</td>\n <td/>\n </tr>\n <tr>\n <td>I63.513</td>\n <td>Cerebral infarction due to unspecified occlusion or stenosis of bilateral middle cerebral arteries</td>\n <td/>\n </tr>\n <tr>\n <td>I63.519</td>\n <td>Cerebral infarction due to unspecified occlusion or stenosis of unspecified middle cerebral artery</td>\n <td/>\n </tr>\n <tr>\n <td>I63.521</td>\n <td>Cerebral infarction due to unspecified occlusion or stenosis of right anterior cerebral artery</td>\n <td/>\n </tr>\n <tr>\n <td>I63.522</td>\n <td>Cerebral infarction due to unspecified occlusion or stenosis of left anterior cerebral artery</td>\n <td/>\n </tr>\n <tr>\n <td>I63.523</td>\n <td>Cerebral infarction due to unspecified occlusion or stenosis of bilateral anterior cerebral arteries</td>\n <td/>\n </tr>\n <tr>\n <td>I63.529</td>\n <td>Cerebral infarction due to unspecified occlusion or stenosis of unspecified anterior cerebral artery</td>\n <td/>\n </tr>\n <tr>\n <td>I63.531</td>\n <td>Cerebral infarction due to unspecified occlusion or stenosis of right posterior cerebral artery</td>\n <td/>\n </tr>\n <tr>\n <td>I63.532</td>\n <td>Cerebral infarction due to unspecified occlusion or stenosis of left posterior cerebral artery</td>\n <td/>\n </tr>\n <tr>\n <td>I63.533</td>\n <td>Cerebral infarction due to unspecified occlusion or stenosis of bilateral posterior cerebral arteries</td>\n <td/>\n </tr>\n <tr>\n <td>I63.539</td>\n <td>Cerebral infarction due to unspecified occlusion or stenosis of unspecified posterior cerebral artery</td>\n <td/>\n </tr>\n <tr>\n <td>I63.541</td>\n <td>Cerebral infarction due to unspecified occlusion or stenosis of right cerebellar artery</td>\n <td/>\n </tr>\n <tr>\n <td>I63.542</td>\n <td>Cerebral infarction due to unspecified occlusion or stenosis of left cerebellar artery</td>\n <td/>\n </tr>\n <tr>\n <td>I63.543</td>\n <td>Cerebral infarction due to unspecified occlusion or stenosis of bilateral cerebellar arteries</td>\n <td/>\n </tr>\n <tr>\n <td>I63.549</td>\n <td>Cerebral infarction due to unspecified occlusion or stenosis of unspecified cerebellar artery</td>\n <td/>\n </tr>\n <tr>\n <td>I63.59</td>\n <td>Cerebral infarction due to unspecified occlusion or stenosis of other cerebral artery</td>\n <td/>\n </tr>\n <tr>\n <td>I63.6</td>\n <td>Cerebral infarction due to cerebral venous thrombosis, nonpyogenic</td>\n <td/>\n </tr>\n <tr>\n <td>I63.8</td>\n <td>Other cerebral infarction</td>\n <td/>\n </tr>\n <tr>\n <td>I63.81</td>\n <td>Other cerebral infarction due to occlusion or stenosis of small artery</td>\n <td/>\n </tr>\n <tr>\n <td>I63.89</td>\n <td>Other cerebral infarction</td>\n <td/>\n </tr>\n <tr>\n <td>I63.9</td>\n <td>Cerebral infarction, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>I65.01</td>\n <td>Occlusion and stenosis of right vertebral artery</td>\n <td/>\n </tr>\n <tr>\n <td>I65.02</td>\n <td>Occlusion and stenosis of left vertebral artery</td>\n <td/>\n </tr>\n <tr>\n <td>I65.03</td>\n <td>Occlusion and stenosis of bilateral vertebral arteries</td>\n <td/>\n </tr>\n <tr>\n <td>I65.09</td>\n <td>Occlusion and stenosis of unspecified vertebral artery</td>\n <td/>\n </tr>\n <tr>\n <td>I65.1</td>\n <td>Occlusion and stenosis of basilar artery</td>\n <td/>\n </tr>\n <tr>\n <td>I65.21</td>\n <td>Occlusion and stenosis of right carotid artery</td>\n <td/>\n </tr>\n <tr>\n <td>I65.22</td>\n <td>Occlusion and stenosis of left carotid artery</td>\n <td/>\n </tr>\n <tr>\n <td>I65.23</td>\n <td>Occlusion and stenosis of bilateral carotid arteries</td>\n <td/>\n </tr>\n <tr>\n <td>I65.29</td>\n <td>Occlusion and stenosis of unspecified carotid artery</td>\n <td/>\n </tr>\n <tr>\n <td>I65.8</td>\n <td>Occlusion and stenosis of other precerebral arteries</td>\n <td/>\n </tr>\n <tr>\n <td>I65.9</td>\n <td>Occlusion and stenosis of unspecified precerebral artery</td>\n <td/>\n </tr>\n <tr>\n <td>I66.01</td>\n <td>Occlusion and stenosis of right middle cerebral artery</td>\n <td/>\n </tr>\n <tr>\n <td>I66.02</td>\n <td>Occlusion and stenosis of left middle cerebral artery</td>\n <td/>\n </tr>\n <tr>\n <td>I66.03</td>\n <td>Occlusion and stenosis of bilateral middle cerebral arteries</td>\n <td/>\n </tr>\n <tr>\n <td>I66.09</td>\n <td>Occlusion and stenosis of unspecified middle cerebral artery</td>\n <td/>\n </tr>\n <tr>\n <td>I66.11</td>\n <td>Occlusion and stenosis of right anterior cerebral artery</td>\n <td/>\n </tr>\n <tr>\n <td>I66.12</td>\n <td>Occlusion and stenosis of left anterior cerebral artery</td>\n <td/>\n </tr>\n <tr>\n <td>I66.13</td>\n <td>Occlusion and stenosis of bilateral anterior cerebral arteries</td>\n <td/>\n </tr>\n <tr>\n <td>I66.19</td>\n <td>Occlusion and stenosis of unspecified anterior cerebral artery</td>\n <td/>\n </tr>\n <tr>\n <td>I66.21</td>\n <td>Occlusion and stenosis of right posterior cerebral artery</td>\n <td/>\n </tr>\n <tr>\n <td>I66.22</td>\n <td>Occlusion and stenosis of left posterior cerebral artery</td>\n <td/>\n </tr>\n <tr>\n <td>I66.23</td>\n <td>Occlusion and stenosis of bilateral posterior cerebral arteries</td>\n <td/>\n </tr>\n <tr>\n <td>I66.29</td>\n <td>Occlusion and stenosis of unspecified posterior cerebral artery</td>\n <td/>\n </tr>\n <tr>\n <td>I66.3</td>\n <td>Occlusion and stenosis of cerebellar arteries</td>\n <td/>\n </tr>\n <tr>\n <td>I66.8</td>\n <td>Occlusion and stenosis of other cerebral arteries</td>\n <td/>\n </tr>\n <tr>\n <td>I66.9</td>\n <td>Occlusion and stenosis of unspecified cerebral artery</td>\n <td/>\n </tr>\n <tr>\n <td>I67.0</td>\n <td>Dissection of cerebral arteries, nonruptured</td>\n <td/>\n </tr>\n <tr>\n <td>I67.1</td>\n <td>Cerebral aneurysm, nonruptured</td>\n <td/>\n </tr>\n <tr>\n <td>I67.2</td>\n <td>Cerebral atherosclerosis</td>\n <td/>\n </tr>\n <tr>\n <td>I67.4</td>\n <td>Hypertensive encephalopathy</td>\n <td/>\n </tr>\n <tr>\n <td>I67.5</td>\n <td>Moyamoya disease</td>\n <td/>\n </tr>\n <tr>\n <td>I67.6</td>\n <td>Nonpyogenic thrombosis of intracranial venous system</td>\n <td/>\n </tr>\n <tr>\n <td>I67.7</td>\n <td>Cerebral arteritis, not elsewhere classified</td>\n <td/>\n </tr>\n <tr>\n <td>I67.81</td>\n <td>Acute cerebrovascular insufficiency</td>\n <td/>\n </tr>\n <tr>\n <td>I67.82</td>\n <td>Cerebral ischemia</td>\n <td/>\n </tr>\n <tr>\n <td>I67.83</td>\n <td>Posterior reversible encephalopathy syndrome</td>\n <td/>\n </tr>\n <tr>\n <td>I67.841</td>\n <td>Reversible cerebrovascular vasoconstriction syndrome</td>\n <td/>\n </tr>\n <tr>\n <td>I67.848</td>\n <td>Other cerebrovascular vasospasm and vasoconstriction</td>\n <td/>\n </tr>\n <tr>\n <td>I67.850</td>\n <td>Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy</td>\n <td/>\n </tr>\n <tr>\n <td>I67.858</td>\n <td>Other hereditary cerebrovascular disease</td>\n <td/>\n </tr>\n <tr>\n <td>I67.89</td>\n <td>Other cerebrovascular disease</td>\n <td/>\n </tr>\n <tr>\n <td>I67.9</td>\n <td>Cerebrovascular disease, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>I68.0</td>\n <td>Cerebral amyloid angiopathy</td>\n <td/>\n </tr>\n <tr>\n <td>I68.2</td>\n <td>Cerebral arteritis in other diseases classified elsewhere</td>\n <td/>\n </tr>\n <tr>\n <td>I68.8</td>\n <td>Other cerebrovascular disorders in diseases classified elsewhere</td>\n <td/>\n </tr>\n <tr>\n <td>I69.00</td>\n <td>Unspecified sequelae of nontraumatic subarachnoid hemorrhage</td>\n <td/>\n </tr>\n <tr>\n <td>I69.01</td>\n <td>Cognitive deficits following nontraumatic subarachnoid hemorrhage</td>\n <td/>\n </tr>\n <tr>\n <td>I69.010</td>\n <td>Attention and concentration deficit following nontraumatic subarachnoid hemorrhage</td>\n <td/>\n </tr>\n <tr>\n <td>I69.011</td>\n <td>Memory deficit following nontraumatic subarachnoid hemorrhage</td>\n <td/>\n </tr>\n <tr>\n <td>I69.012</td>\n <td>Visuospatial deficit and spatial neglect following nontraumatic subarachnoid hemorrhage</td>\n <td/>\n </tr>\n <tr>\n <td>I69.013</td>\n <td>Psychomotor deficit following nontraumatic subarachnoid hemorrhage</td>\n <td/>\n </tr>\n <tr>\n <td>I69.014</td>\n <td>Frontal lobe and executive function deficit following nontraumatic subarachnoid hemorrhage</td>\n <td/>\n </tr>\n <tr>\n <td>I69.015</td>\n <td>Cognitive social or emotional deficit following nontraumatic subarachnoid hemorrhage</td>\n <td/>\n </tr>\n <tr>\n <td>I69.018</td>\n <td>Other symptoms and signs involving cognitive functions following nontraumatic subarachnoid hemorrhage</td>\n <td/>\n </tr>\n <tr>\n <td>I69.019</td>\n <td>Unspecified symptoms and signs involving cognitive functions following nontraumatic subarachnoid hemorrhage</td>\n <td/>\n </tr>\n <tr>\n <td>I69.020</td>\n <td>Aphasia following nontraumatic subarachnoid hemorrhage</td>\n <td/>\n </tr>\n <tr>\n <td>I69.021</td>\n <td>Dysphasia following nontraumatic subarachnoid hemorrhage</td>\n <td/>\n </tr>\n <tr>\n <td>I69.022</td>\n <td>Dysarthria following nontraumatic subarachnoid hemorrhage</td>\n <td/>\n </tr>\n <tr>\n <td>I69.023</td>\n <td>Fluency disorder following nontraumatic subarachnoid hemorrhage</td>\n <td/>\n </tr>\n <tr>\n <td>I69.028</td>\n <td>Other speech and language deficits following nontraumatic subarachnoid hemorrhage</td>\n <td/>\n </tr>\n <tr>\n <td>I69.031</td>\n <td>Monoplegia of upper limb following nontraumatic subarachnoid hemorrhage affecting right dominant side</td>\n <td/>\n </tr>\n <tr>\n <td>I69.032</td>\n <td>Monoplegia of upper limb following nontraumatic subarachnoid hemorrhage affecting left dominant side</td>\n <td/>\n </tr>\n <tr>\n <td>I69.033</td>\n <td>Monoplegia of upper limb following nontraumatic subarachnoid hemorrhage affecting right non-dominant side</td>\n <td/>\n </tr>\n <tr>\n <td>I69.034</td>\n <td>Monoplegia of upper limb following nontraumatic subarachnoid hemorrhage affecting left non-dominant side</td>\n <td/>\n </tr>\n <tr>\n <td>I69.039</td>\n <td>Monoplegia of upper limb following nontraumatic subarachnoid hemorrhage affecting unspecified side</td>\n <td/>\n </tr>\n <tr>\n <td>I69.041</td>\n <td>Monoplegia of lower limb following nontraumatic subarachnoid hemorrhage affecting right dominant side</td>\n <td/>\n </tr>\n <tr>\n <td>I69.042</td>\n <td>Monoplegia of lower limb following nontraumatic subarachnoid hemorrhage affecting left dominant side</td>\n <td/>\n </tr>\n <tr>\n <td>I69.043</td>\n <td>Monoplegia of lower limb following nontraumatic subarachnoid hemorrhage affecting right non-dominant side</td>\n <td/>\n </tr>\n <tr>\n <td>I69.044</td>\n <td>Monoplegia of lower limb following nontraumatic subarachnoid hemorrhage affecting left non-dominant side</td>\n <td/>\n </tr>\n <tr>\n <td>I69.049</td>\n <td>Monoplegia of lower limb following nontraumatic subarachnoid hemorrhage affecting unspecified side</td>\n <td/>\n </tr>\n <tr>\n <td>I69.051</td>\n <td>Hemiplegia and hemiparesis following nontraumatic subarachnoid hemorrhage affecting right dominant side</td>\n <td/>\n </tr>\n <tr>\n <td>I69.052</td>\n <td>Hemiplegia and hemiparesis following nontraumatic subarachnoid hemorrhage affecting left dominant side</td>\n <td/>\n </tr>\n <tr>\n <td>I69.053</td>\n <td>Hemiplegia and hemiparesis following nontraumatic subarachnoid hemorrhage affecting right non-dominant side</td>\n <td/>\n </tr>\n <tr>\n <td>I69.054</td>\n <td>Hemiplegia and hemiparesis following nontraumatic subarachnoid hemorrhage affecting left non-dominant side</td>\n <td/>\n </tr>\n <tr>\n <td>I69.059</td>\n <td>Hemiplegia and hemiparesis following nontraumatic subarachnoid hemorrhage affecting unspecified side</td>\n <td/>\n </tr>\n <tr>\n <td>I69.061</td>\n <td>Other paralytic syndrome following nontraumatic subarachnoid hemorrhage affecting right dominant side</td>\n <td/>\n </tr>\n <tr>\n <td>I69.062</td>\n <td>Other paralytic syndrome following nontraumatic subarachnoid hemorrhage affecting left dominant side</td>\n <td/>\n </tr>\n <tr>\n <td>I69.063</td>\n <td>Other paralytic syndrome following nontraumatic subarachnoid hemorrhage affecting right non-dominant side</td>\n <td/>\n </tr>\n <tr>\n <td>I69.064</td>\n <td>Other paralytic syndrome following nontraumatic subarachnoid hemorrhage affecting left non-dominant side</td>\n <td/>\n </tr>\n <tr>\n <td>I69.065</td>\n <td>Other paralytic syndrome following nontraumatic subarachnoid hemorrhage, bilateral</td>\n <td/>\n </tr>\n <tr>\n <td>I69.069</td>\n <td>Other paralytic syndrome following nontraumatic subarachnoid hemorrhage affecting unspecified side</td>\n <td/>\n </tr>\n <tr>\n <td>I69.090</td>\n <td>Apraxia following nontraumatic subarachnoid hemorrhage</td>\n <td/>\n </tr>\n <tr>\n <td>I69.091</td>\n <td>Dysphagia following nontraumatic subarachnoid hemorrhage</td>\n <td/>\n </tr>\n <tr>\n <td>I69.092</td>\n <td>Facial weakness following nontraumatic subarachnoid hemorrhage</td>\n <td/>\n </tr>\n <tr>\n <td>I69.093</td>\n <td>Ataxia following nontraumatic subarachnoid hemorrhage</td>\n <td/>\n </tr>\n <tr>\n <td>I69.098</td>\n <td>Other sequelae following nontraumatic subarachnoid hemorrhage</td>\n <td/>\n </tr>\n <tr>\n <td>I69.10</td>\n <td>Unspecified sequelae of nontraumatic intracerebral hemorrhage</td>\n <td/>\n </tr>\n <tr>\n <td>I69.11</td>\n <td>Cognitive deficits following nontraumatic intracerebral hemorrhage</td>\n <td/>\n </tr>\n <tr>\n <td>I69.110</td>\n <td>Attention and concentration deficit following nontraumatic intracerebral hemorrhage</td>\n <td/>\n </tr>\n <tr>\n <td>I69.111</td>\n <td>Memory deficit following nontraumatic intracerebral hemorrhage</td>\n <td/>\n </tr>\n <tr>\n <td>I69.112</td>\n <td>Visuospatial deficit and spatial neglect following nontraumatic intracerebral hemorrhage</td>\n <td/>\n </tr>\n <tr>\n <td>I69.113</td>\n <td>Psychomotor deficit following nontraumatic intracerebral hemorrhage</td>\n <td/>\n </tr>\n <tr>\n <td>I69.114</td>\n <td>Frontal lobe and executive function deficit following nontraumatic intracerebral hemorrhage</td>\n <td/>\n </tr>\n <tr>\n <td>I69.115</td>\n <td>Cognitive social or emotional deficit following nontraumatic intracerebral hemorrhage</td>\n <td/>\n </tr>\n <tr>\n <td>I69.118</td>\n <td>Other symptoms and signs involving cognitive functions following nontraumatic intracerebral hemorrhage</td>\n <td/>\n </tr>\n <tr>\n <td>I69.119</td>\n <td>Unspecified symptoms and signs involving cognitive functions following nontraumatic intracerebral hemorrhage</td>\n <td/>\n </tr>\n <tr>\n <td>I69.120</td>\n <td>Aphasia following nontraumatic intracerebral hemorrhage</td>\n <td/>\n </tr>\n <tr>\n <td>I69.121</td>\n <td>Dysphasia following nontraumatic intracerebral hemorrhage</td>\n <td/>\n </tr>\n <tr>\n <td>I69.122</td>\n <td>Dysarthria following nontraumatic intracerebral hemorrhage</td>\n <td/>\n </tr>\n <tr>\n <td>I69.123</td>\n <td>Fluency disorder following nontraumatic intracerebral hemorrhage</td>\n <td/>\n </tr>\n <tr>\n <td>I69.128</td>\n <td>Other speech and language deficits following nontraumatic intracerebral hemorrhage</td>\n <td/>\n </tr>\n <tr>\n <td>I69.131</td>\n <td>Monoplegia of upper limb following nontraumatic intracerebral hemorrhage affecting right dominant side</td>\n <td/>\n </tr>\n <tr>\n <td>I69.132</td>\n <td>Monoplegia of upper limb following nontraumatic intracerebral hemorrhage affecting left dominant side</td>\n <td/>\n </tr>\n <tr>\n <td>I69.133</td>\n <td>Monoplegia of upper limb following nontraumatic intracerebral hemorrhage affecting right non-dominant side</td>\n <td/>\n </tr>\n <tr>\n <td>I69.134</td>\n <td>Monoplegia of upper limb following nontraumatic intracerebral hemorrhage affecting left non-dominant side</td>\n <td/>\n </tr>\n <tr>\n <td>I69.139</td>\n <td>Monoplegia of upper limb following nontraumatic intracerebral hemorrhage affecting unspecified side</td>\n <td/>\n </tr>\n <tr>\n <td>I69.141</td>\n <td>Monoplegia of lower limb following nontraumatic intracerebral hemorrhage affecting right dominant side</td>\n <td/>\n </tr>\n <tr>\n <td>I69.142</td>\n <td>Monoplegia of lower limb following nontraumatic intracerebral hemorrhage affecting left dominant side</td>\n <td/>\n </tr>\n <tr>\n <td>I69.143</td>\n <td>Monoplegia of lower limb following nontraumatic intracerebral hemorrhage affecting right non-dominant side</td>\n <td/>\n </tr>\n <tr>\n <td>I69.144</td>\n <td>Monoplegia of lower limb following nontraumatic intracerebral hemorrhage affecting left non-dominant side</td>\n <td/>\n </tr>\n <tr>\n <td>I69.149</td>\n <td>Monoplegia of lower limb following nontraumatic intracerebral hemorrhage affecting unspecified side</td>\n <td/>\n </tr>\n <tr>\n <td>I69.151</td>\n <td>Hemiplegia and hemiparesis following nontraumatic intracerebral hemorrhage affecting right dominant side</td>\n <td/>\n </tr>\n <tr>\n <td>I69.152</td>\n <td>Hemiplegia and hemiparesis following nontraumatic intracerebral hemorrhage affecting left dominant side</td>\n <td/>\n </tr>\n <tr>\n <td>I69.153</td>\n <td>Hemiplegia and hemiparesis following nontraumatic intracerebral hemorrhage affecting right non-dominant side</td>\n <td/>\n </tr>\n <tr>\n <td>I69.154</td>\n <td>Hemiplegia and hemiparesis following nontraumatic intracerebral hemorrhage affecting left non-dominant side</td>\n <td/>\n </tr>\n <tr>\n <td>I69.159</td>\n <td>Hemiplegia and hemiparesis following nontraumatic intracerebral hemorrhage affecting unspecified side</td>\n <td/>\n </tr>\n <tr>\n <td>I69.161</td>\n <td>Other paralytic syndrome following nontraumatic intracerebral hemorrhage affecting right dominant side</td>\n <td/>\n </tr>\n <tr>\n <td>I69.162</td>\n <td>Other paralytic syndrome following nontraumatic intracerebral hemorrhage affecting left dominant side</td>\n <td/>\n </tr>\n <tr>\n <td>I69.163</td>\n <td>Other paralytic syndrome following nontraumatic intracerebral hemorrhage affecting right non-dominant side</td>\n <td/>\n </tr>\n <tr>\n <td>I69.164</td>\n <td>Other paralytic syndrome following nontraumatic intracerebral hemorrhage affecting left non-dominant side</td>\n <td/>\n </tr>\n <tr>\n <td>I69.165</td>\n <td>Other paralytic syndrome following nontraumatic intracerebral hemorrhage, bilateral</td>\n <td/>\n </tr>\n <tr>\n <td>I69.169</td>\n <td>Other paralytic syndrome following nontraumatic intracerebral hemorrhage affecting unspecified side</td>\n <td/>\n </tr>\n <tr>\n <td>I69.190</td>\n <td>Apraxia following nontraumatic intracerebral hemorrhage</td>\n <td/>\n </tr>\n <tr>\n <td>I69.191</td>\n <td>Dysphagia following nontraumatic intracerebral hemorrhage</td>\n <td/>\n </tr>\n <tr>\n <td>I69.192</td>\n <td>Facial weakness following nontraumatic intracerebral hemorrhage</td>\n <td/>\n </tr>\n <tr>\n <td>I69.193</td>\n <td>Ataxia following nontraumatic intracerebral hemorrhage</td>\n <td/>\n </tr>\n <tr>\n <td>I69.198</td>\n <td>Other sequelae of nontraumatic intracerebral hemorrhage</td>\n <td/>\n </tr>\n <tr>\n <td>I69.20</td>\n <td>Unspecified sequelae of other nontraumatic intracranial hemorrhage</td>\n <td/>\n </tr>\n <tr>\n <td>I69.21</td>\n <td>Cognitive deficits following other nontraumatic intracranial hemorrhage</td>\n <td/>\n </tr>\n <tr>\n <td>I69.210</td>\n <td>Attention and concentration deficit following other nontraumatic intracranial hemorrhage</td>\n <td/>\n </tr>\n <tr>\n <td>I69.211</td>\n <td>Memory deficit following other nontraumatic intracranial hemorrhage</td>\n <td/>\n </tr>\n <tr>\n <td>I69.212</td>\n <td>Visuospatial deficit and spatial neglect following other nontraumatic intracranial hemorrhage</td>\n <td/>\n </tr>\n <tr>\n <td>I69.213</td>\n <td>Psychomotor deficit following other nontraumatic intracranial hemorrhage</td>\n <td/>\n </tr>\n <tr>\n <td>I69.214</td>\n <td>Frontal lobe and executive function deficit following other nontraumatic intracranial hemorrhage</td>\n <td/>\n </tr>\n <tr>\n <td>I69.215</td>\n <td>Cognitive social or emotional deficit following other nontraumatic intracranial hemorrhage</td>\n <td/>\n </tr>\n <tr>\n <td>I69.218</td>\n <td>Other symptoms and signs involving cognitive functions following other nontraumatic intracranial hemorrhage</td>\n <td/>\n </tr>\n <tr>\n <td>I69.219</td>\n <td>Unspecified symptoms and signs involving cognitive functions following other nontraumatic intracranial hemorrhage</td>\n <td/>\n </tr>\n <tr>\n <td>I69.220</td>\n <td>Aphasia following other nontraumatic intracranial hemorrhage</td>\n <td/>\n </tr>\n <tr>\n <td>I69.221</td>\n <td>Dysphasia following other nontraumatic intracranial hemorrhage</td>\n <td/>\n </tr>\n <tr>\n <td>I69.222</td>\n <td>Dysarthria following other nontraumatic intracranial hemorrhage</td>\n <td/>\n </tr>\n <tr>\n <td>I69.223</td>\n <td>Fluency disorder following other nontraumatic intracranial hemorrhage</td>\n <td/>\n </tr>\n <tr>\n <td>I69.228</td>\n <td>Other speech and language deficits following other nontraumatic intracranial hemorrhage</td>\n <td/>\n </tr>\n <tr>\n <td>I69.231</td>\n <td>Monoplegia of upper limb following other nontraumatic intracranial hemorrhage affecting right dominant side</td>\n <td/>\n </tr>\n <tr>\n <td>I69.232</td>\n <td>Monoplegia of upper limb following other nontraumatic intracranial hemorrhage affecting left dominant side</td>\n <td/>\n </tr>\n <tr>\n <td>I69.233</td>\n <td>Monoplegia of upper limb following other nontraumatic intracranial hemorrhage affecting right non-dominant side</td>\n <td/>\n </tr>\n <tr>\n <td>I69.234</td>\n <td>Monoplegia of upper limb following other nontraumatic intracranial hemorrhage affecting left non-dominant side</td>\n <td/>\n </tr>\n <tr>\n <td>I69.239</td>\n <td>Monoplegia of upper limb following other nontraumatic intracranial hemorrhage affecting unspecified side</td>\n <td/>\n </tr>\n <tr>\n <td>I69.241</td>\n <td>Monoplegia of lower limb following other nontraumatic intracranial hemorrhage affecting right dominant side</td>\n <td/>\n </tr>\n <tr>\n <td>I69.242</td>\n <td>Monoplegia of lower limb following other nontraumatic intracranial hemorrhage affecting left dominant side</td>\n <td/>\n </tr>\n <tr>\n <td>I69.243</td>\n <td>Monoplegia of lower limb following other nontraumatic intracranial hemorrhage affecting right non-dominant side</td>\n <td/>\n </tr>\n <tr>\n <td>I69.244</td>\n <td>Monoplegia of lower limb following other nontraumatic intracranial hemorrhage affecting left non-dominant side</td>\n <td/>\n </tr>\n <tr>\n <td>I69.249</td>\n <td>Monoplegia of lower limb following other nontraumatic intracranial hemorrhage affecting unspecified side</td>\n <td/>\n </tr>\n <tr>\n <td>I69.251</td>\n <td>Hemiplegia and hemiparesis following other nontraumatic intracranial hemorrhage affecting right dominant side</td>\n <td/>\n </tr>\n <tr>\n <td>I69.252</td>\n <td>Hemiplegia and hemiparesis following other nontraumatic intracranial hemorrhage affecting left dominant side</td>\n <td/>\n </tr>\n <tr>\n <td>I69.253</td>\n <td>Hemiplegia and hemiparesis following other nontraumatic intracranial hemorrhage affecting right non-dominant side</td>\n <td/>\n </tr>\n <tr>\n <td>I69.254</td>\n <td>Hemiplegia and hemiparesis following other nontraumatic intracranial hemorrhage affecting left non-dominant side</td>\n <td/>\n </tr>\n <tr>\n <td>I69.259</td>\n <td>Hemiplegia and hemiparesis following other nontraumatic intracranial hemorrhage affecting unspecified side</td>\n <td/>\n </tr>\n <tr>\n <td>I69.261</td>\n <td>Other paralytic syndrome following other nontraumatic intracranial hemorrhage affecting right dominant side</td>\n <td/>\n </tr>\n <tr>\n <td>I69.262</td>\n <td>Other paralytic syndrome following other nontraumatic intracranial hemorrhage affecting left dominant side</td>\n <td/>\n </tr>\n <tr>\n <td>I69.263</td>\n <td>Other paralytic syndrome following other nontraumatic intracranial hemorrhage affecting right non-dominant side</td>\n <td/>\n </tr>\n <tr>\n <td>I69.264</td>\n <td>Other paralytic syndrome following other nontraumatic intracranial hemorrhage affecting left non-dominant side</td>\n <td/>\n </tr>\n <tr>\n <td>I69.265</td>\n <td>Other paralytic syndrome following other nontraumatic intracranial hemorrhage, bilateral</td>\n <td/>\n </tr>\n <tr>\n <td>I69.269</td>\n <td>Other paralytic syndrome following other nontraumatic intracranial hemorrhage affecting unspecified side</td>\n <td/>\n </tr>\n <tr>\n <td>I69.290</td>\n <td>Apraxia following other nontraumatic intracranial hemorrhage</td>\n <td/>\n </tr>\n <tr>\n <td>I69.291</td>\n <td>Dysphagia following other nontraumatic intracranial hemorrhage</td>\n <td/>\n </tr>\n <tr>\n <td>I69.292</td>\n <td>Facial weakness following other nontraumatic intracranial hemorrhage</td>\n <td/>\n </tr>\n <tr>\n <td>I69.293</td>\n <td>Ataxia following other nontraumatic intracranial hemorrhage</td>\n <td/>\n </tr>\n <tr>\n <td>I69.298</td>\n <td>Other sequelae of other nontraumatic intracranial hemorrhage</td>\n <td/>\n </tr>\n <tr>\n <td>I69.30</td>\n <td>Unspecified sequelae of cerebral infarction</td>\n <td/>\n </tr>\n <tr>\n <td>I69.31</td>\n <td>Cognitive deficits following cerebral infarction</td>\n <td/>\n </tr>\n <tr>\n <td>I69.310</td>\n <td>Attention and concentration deficit following cerebral infarction</td>\n <td/>\n </tr>\n <tr>\n <td>I69.311</td>\n <td>Memory deficit following cerebral infarction</td>\n <td/>\n </tr>\n <tr>\n <td>I69.312</td>\n <td>Visuospatial deficit and spatial neglect following cerebral infarction</td>\n <td/>\n </tr>\n <tr>\n <td>I69.313</td>\n <td>Psychomotor deficit following cerebral infarction</td>\n <td/>\n </tr>\n <tr>\n <td>I69.314</td>\n <td>Frontal lobe and executive function deficit following cerebral infarction</td>\n <td/>\n </tr>\n <tr>\n <td>I69.315</td>\n <td>Cognitive social or emotional deficit following cerebral infarction</td>\n <td/>\n </tr>\n <tr>\n <td>I69.318</td>\n <td>Other symptoms and signs involving cognitive functions following cerebral infarction</td>\n <td/>\n </tr>\n <tr>\n <td>I69.319</td>\n <td>Unspecified symptoms and signs involving cognitive functions following cerebral infarction</td>\n <td/>\n </tr>\n <tr>\n <td>I69.320</td>\n <td>Aphasia following cerebral infarction</td>\n <td/>\n </tr>\n <tr>\n <td>I69.321</td>\n <td>Dysphasia following cerebral infarction</td>\n <td/>\n </tr>\n <tr>\n <td>I69.322</td>\n <td>Dysarthria following cerebral infarction</td>\n <td/>\n </tr>\n <tr>\n <td>I69.323</td>\n <td>Fluency disorder following cerebral infarction</td>\n <td/>\n </tr>\n <tr>\n <td>I69.328</td>\n <td>Other speech and language deficits following cerebral infarction</td>\n <td/>\n </tr>\n <tr>\n <td>I69.331</td>\n <td>Monoplegia of upper limb following cerebral infarction affecting right dominant side</td>\n <td/>\n </tr>\n <tr>\n <td>I69.332</td>\n <td>Monoplegia of upper limb following cerebral infarction affecting left dominant side</td>\n <td/>\n </tr>\n <tr>\n <td>I69.333</td>\n <td>Monoplegia of upper limb following cerebral infarction affecting right non-dominant side</td>\n <td/>\n </tr>\n <tr>\n <td>I69.334</td>\n <td>Monoplegia of upper limb following cerebral infarction affecting left non-dominant side</td>\n <td/>\n </tr>\n <tr>\n <td>I69.339</td>\n <td>Monoplegia of upper limb following cerebral infarction affecting unspecified side</td>\n <td/>\n </tr>\n <tr>\n <td>I69.341</td>\n <td>Monoplegia of lower limb following cerebral infarction affecting right dominant side</td>\n <td/>\n </tr>\n <tr>\n <td>I69.342</td>\n <td>Monoplegia of lower limb following cerebral infarction affecting left dominant side</td>\n <td/>\n </tr>\n <tr>\n <td>I69.343</td>\n <td>Monoplegia of lower limb following cerebral infarction affecting right non-dominant side</td>\n <td/>\n </tr>\n <tr>\n <td>I69.344</td>\n <td>Monoplegia of lower limb following cerebral infarction affecting left non-dominant side</td>\n <td/>\n </tr>\n <tr>\n <td>I69.349</td>\n <td>Monoplegia of lower limb following cerebral infarction affecting unspecified side</td>\n <td/>\n </tr>\n <tr>\n <td>I69.351</td>\n <td>Hemiplegia and hemiparesis following cerebral infarction affecting right dominant side</td>\n <td/>\n </tr>\n <tr>\n <td>I69.352</td>\n <td>Hemiplegia and hemiparesis following cerebral infarction affecting left dominant side</td>\n <td/>\n </tr>\n <tr>\n <td>I69.353</td>\n <td>Hemiplegia and hemiparesis following cerebral infarction affecting right non-dominant side</td>\n <td/>\n </tr>\n <tr>\n <td>I69.354</td>\n <td>Hemiplegia and hemiparesis following cerebral infarction affecting left non-dominant side</td>\n <td/>\n </tr>\n <tr>\n <td>I69.359</td>\n <td>Hemiplegia and hemiparesis following cerebral infarction affecting unspecified side</td>\n <td/>\n </tr>\n <tr>\n <td>I69.361</td>\n <td>Other paralytic syndrome following cerebral infarction affecting right dominant side</td>\n <td/>\n </tr>\n <tr>\n <td>I69.362</td>\n <td>Other paralytic syndrome following cerebral infarction affecting left dominant side</td>\n <td/>\n </tr>\n <tr>\n <td>I69.363</td>\n <td>Other paralytic syndrome following cerebral infarction affecting right non-dominant side</td>\n <td/>\n </tr>\n <tr>\n <td>I69.364</td>\n <td>Other paralytic syndrome following cerebral infarction affecting left non-dominant side</td>\n <td/>\n </tr>\n <tr>\n <td>I69.365</td>\n <td>Other paralytic syndrome following cerebral infarction, bilateral</td>\n <td/>\n </tr>\n <tr>\n <td>I69.369</td>\n <td>Other paralytic syndrome following cerebral infarction affecting unspecified side</td>\n <td/>\n </tr>\n <tr>\n <td>I69.390</td>\n <td>Apraxia following cerebral infarction</td>\n <td/>\n </tr>\n <tr>\n <td>I69.391</td>\n <td>Dysphagia following cerebral infarction</td>\n <td/>\n </tr>\n <tr>\n <td>I69.392</td>\n <td>Facial weakness following cerebral infarction</td>\n <td/>\n </tr>\n <tr>\n <td>I69.393</td>\n <td>Ataxia following cerebral infarction</td>\n <td/>\n </tr>\n <tr>\n <td>I69.398</td>\n <td>Other sequelae of cerebral infarction</td>\n <td/>\n </tr>\n <tr>\n <td>I69.80</td>\n <td>Unspecified sequelae of other cerebrovascular disease</td>\n <td/>\n </tr>\n <tr>\n <td>I69.81</td>\n <td>Cognitive deficits following other cerebrovascular disease</td>\n <td/>\n </tr>\n <tr>\n <td>I69.810</td>\n <td>Attention and concentration deficit following other cerebrovascular disease</td>\n <td/>\n </tr>\n <tr>\n <td>I69.811</td>\n <td>Memory deficit following other cerebrovascular disease</td>\n <td/>\n </tr>\n <tr>\n <td>I69.812</td>\n <td>Visuospatial deficit and spatial neglect following other cerebrovascular disease</td>\n <td/>\n </tr>\n <tr>\n <td>I69.813</td>\n <td>Psychomotor deficit following other cerebrovascular disease</td>\n <td/>\n </tr>\n <tr>\n <td>I69.814</td>\n <td>Frontal lobe and executive function deficit following other cerebrovascular disease</td>\n <td/>\n </tr>\n <tr>\n <td>I69.815</td>\n <td>Cognitive social or emotional deficit following other cerebrovascular disease</td>\n <td/>\n </tr>\n <tr>\n <td>I69.818</td>\n <td>Other symptoms and signs involving cognitive functions following other cerebrovascular disease</td>\n <td/>\n </tr>\n <tr>\n <td>I69.819</td>\n <td>Unspecified symptoms and signs involving cognitive functions following other cerebrovascular disease</td>\n <td/>\n </tr>\n <tr>\n <td>I69.820</td>\n <td>Aphasia following other cerebrovascular disease</td>\n <td/>\n </tr>\n <tr>\n <td>I69.821</td>\n <td>Dysphasia following other cerebrovascular disease</td>\n <td/>\n </tr>\n <tr>\n <td>I69.822</td>\n <td>Dysarthria following other cerebrovascular disease</td>\n <td/>\n </tr>\n <tr>\n <td>I69.823</td>\n <td>Fluency disorder following other cerebrovascular disease</td>\n <td/>\n </tr>\n <tr>\n <td>I69.828</td>\n <td>Other speech and language deficits following other cerebrovascular disease</td>\n <td/>\n </tr>\n <tr>\n <td>I69.831</td>\n <td>Monoplegia of upper limb following other cerebrovascular disease affecting right dominant side</td>\n <td/>\n </tr>\n <tr>\n <td>I69.832</td>\n <td>Monoplegia of upper limb following other cerebrovascular disease affecting left dominant side</td>\n <td/>\n </tr>\n <tr>\n <td>I69.833</td>\n <td>Monoplegia of upper limb following other cerebrovascular disease affecting right non-dominant side</td>\n <td/>\n </tr>\n <tr>\n <td>I69.834</td>\n <td>Monoplegia of upper limb following other cerebrovascular disease affecting left non-dominant side</td>\n <td/>\n </tr>\n <tr>\n <td>I69.839</td>\n <td>Monoplegia of upper limb following other cerebrovascular disease affecting unspecified side</td>\n <td/>\n </tr>\n <tr>\n <td>I69.841</td>\n <td>Monoplegia of lower limb following other cerebrovascular disease affecting right dominant side</td>\n <td/>\n </tr>\n <tr>\n <td>I69.842</td>\n <td>Monoplegia of lower limb following other cerebrovascular disease affecting left dominant side</td>\n <td/>\n </tr>\n <tr>\n <td>I69.843</td>\n <td>Monoplegia of lower limb following other cerebrovascular disease affecting right non-dominant side</td>\n <td/>\n </tr>\n <tr>\n <td>I69.844</td>\n <td>Monoplegia of lower limb following other cerebrovascular disease affecting left non-dominant side</td>\n <td/>\n </tr>\n <tr>\n <td>I69.849</td>\n <td>Monoplegia of lower limb following other cerebrovascular disease affecting unspecified side</td>\n <td/>\n </tr>\n <tr>\n <td>I69.851</td>\n <td>Hemiplegia and hemiparesis following other cerebrovascular disease affecting right dominant side</td>\n <td/>\n </tr>\n <tr>\n <td>I69.852</td>\n <td>Hemiplegia and hemiparesis following other cerebrovascular disease affecting left dominant side</td>\n <td/>\n </tr>\n <tr>\n <td>I69.853</td>\n <td>Hemiplegia and hemiparesis following other cerebrovascular disease affecting right non-dominant side</td>\n <td/>\n </tr>\n <tr>\n <td>I69.854</td>\n <td>Hemiplegia and hemiparesis following other cerebrovascular disease affecting left non-dominant side</td>\n <td/>\n </tr>\n <tr>\n <td>I69.859</td>\n <td>Hemiplegia and hemiparesis following other cerebrovascular disease affecting unspecified side</td>\n <td/>\n </tr>\n <tr>\n <td>I69.861</td>\n <td>Other paralytic syndrome following other cerebrovascular disease affecting right dominant side</td>\n <td/>\n </tr>\n <tr>\n <td>I69.862</td>\n <td>Other paralytic syndrome following other cerebrovascular disease affecting left dominant side</td>\n <td/>\n </tr>\n <tr>\n <td>I69.863</td>\n <td>Other paralytic syndrome following other cerebrovascular disease affecting right non-dominant side</td>\n <td/>\n </tr>\n <tr>\n <td>I69.864</td>\n <td>Other paralytic syndrome following other cerebrovascular disease affecting left non-dominant side</td>\n <td/>\n </tr>\n <tr>\n <td>I69.865</td>\n <td>Other paralytic syndrome following other cerebrovascular disease, bilateral</td>\n <td/>\n </tr>\n <tr>\n <td>I69.869</td>\n <td>Other paralytic syndrome following other cerebrovascular disease affecting unspecified side</td>\n <td/>\n </tr>\n <tr>\n <td>I69.890</td>\n <td>Apraxia following other cerebrovascular disease</td>\n <td/>\n </tr>\n <tr>\n <td>I69.891</td>\n <td>Dysphagia following other cerebrovascular disease</td>\n <td/>\n </tr>\n <tr>\n <td>I69.892</td>\n <td>Facial weakness following other cerebrovascular disease</td>\n <td/>\n </tr>\n <tr>\n <td>I69.893</td>\n <td>Ataxia following other cerebrovascular disease</td>\n <td/>\n </tr>\n <tr>\n <td>I69.898</td>\n <td>Other sequelae of other cerebrovascular disease</td>\n <td/>\n </tr>\n <tr>\n <td>I69.90</td>\n <td>Unspecified sequelae of unspecified cerebrovascular disease</td>\n <td/>\n </tr>\n <tr>\n <td>I69.91</td>\n <td>Cognitive deficits following unspecified cerebrovascular disease</td>\n <td/>\n </tr>\n <tr>\n <td>I69.910</td>\n <td>Attention and concentration deficit following unspecified cerebrovascular disease</td>\n <td/>\n </tr>\n <tr>\n <td>I69.911</td>\n <td>Memory deficit following unspecified cerebrovascular disease</td>\n <td/>\n </tr>\n <tr>\n <td>I69.912</td>\n <td>Visuospatial deficit and spatial neglect following unspecified cerebrovascular disease</td>\n <td/>\n </tr>\n <tr>\n <td>I69.913</td>\n <td>Psychomotor deficit following unspecified cerebrovascular disease</td>\n <td/>\n </tr>\n <tr>\n <td>I69.914</td>\n <td>Frontal lobe and executive function deficit following unspecified cerebrovascular disease</td>\n <td/>\n </tr>\n <tr>\n <td>I69.915</td>\n <td>Cognitive social or emotional deficit following unspecified cerebrovascular disease</td>\n <td/>\n </tr>\n <tr>\n <td>I69.918</td>\n <td>Other symptoms and signs involving cognitive functions following unspecified cerebrovascular disease</td>\n <td/>\n </tr>\n <tr>\n <td>I69.919</td>\n <td>Unspecified symptoms and signs involving cognitive functions following unspecified cerebrovascular disease</td>\n <td/>\n </tr>\n <tr>\n <td>I69.920</td>\n <td>Aphasia following unspecified cerebrovascular disease</td>\n <td/>\n </tr>\n <tr>\n <td>I69.921</td>\n <td>Dysphasia following unspecified cerebrovascular disease</td>\n <td/>\n </tr>\n <tr>\n <td>I69.922</td>\n <td>Dysarthria following unspecified cerebrovascular disease</td>\n <td/>\n </tr>\n <tr>\n <td>I69.923</td>\n <td>Fluency disorder following unspecified cerebrovascular disease</td>\n <td/>\n </tr>\n <tr>\n <td>I69.928</td>\n <td>Other speech and language deficits following unspecified cerebrovascular disease</td>\n <td/>\n </tr>\n <tr>\n <td>I69.931</td>\n <td>Monoplegia of upper limb following unspecified cerebrovascular disease affecting right dominant side</td>\n <td/>\n </tr>\n <tr>\n <td>I69.932</td>\n <td>Monoplegia of upper limb following unspecified cerebrovascular disease affecting left dominant side</td>\n <td/>\n </tr>\n <tr>\n <td>I69.933</td>\n <td>Monoplegia of upper limb following unspecified cerebrovascular disease affecting right non-dominant side</td>\n <td/>\n </tr>\n <tr>\n <td>I69.934</td>\n <td>Monoplegia of upper limb following unspecified cerebrovascular disease affecting left non-dominant side</td>\n <td/>\n </tr>\n <tr>\n <td>I69.939</td>\n <td>Monoplegia of upper limb following unspecified cerebrovascular disease affecting unspecified side</td>\n <td/>\n </tr>\n <tr>\n <td>I69.941</td>\n <td>Monoplegia of lower limb following unspecified cerebrovascular disease affecting right dominant side</td>\n <td/>\n </tr>\n <tr>\n <td>I69.942</td>\n <td>Monoplegia of lower limb following unspecified cerebrovascular disease affecting left dominant side</td>\n <td/>\n </tr>\n <tr>\n <td>I69.943</td>\n <td>Monoplegia of lower limb following unspecified cerebrovascular disease affecting right non-dominant side</td>\n <td/>\n </tr>\n <tr>\n <td>I69.944</td>\n <td>Monoplegia of lower limb following unspecified cerebrovascular disease affecting left non-dominant side</td>\n <td/>\n </tr>\n <tr>\n <td>I69.949</td>\n <td>Monoplegia of lower limb following unspecified cerebrovascular disease affecting unspecified side</td>\n <td/>\n </tr>\n <tr>\n <td>I69.951</td>\n <td>Hemiplegia and hemiparesis following unspecified cerebrovascular disease affecting right dominant side</td>\n <td/>\n </tr>\n <tr>\n <td>I69.952</td>\n <td>Hemiplegia and hemiparesis following unspecified cerebrovascular disease affecting left dominant side</td>\n <td/>\n </tr>\n <tr>\n <td>I69.953</td>\n <td>Hemiplegia and hemiparesis following unspecified cerebrovascular disease affecting right non-dominant side</td>\n <td/>\n </tr>\n <tr>\n <td>I69.954</td>\n <td>Hemiplegia and hemiparesis following unspecified cerebrovascular disease affecting left non-dominant side</td>\n <td/>\n </tr>\n <tr>\n <td>I69.959</td>\n <td>Hemiplegia and hemiparesis following unspecified cerebrovascular disease affecting unspecified side</td>\n <td/>\n </tr>\n <tr>\n <td>I69.961</td>\n <td>Other paralytic syndrome following unspecified cerebrovascular disease affecting right dominant side</td>\n <td/>\n </tr>\n <tr>\n <td>I69.962</td>\n <td>Other paralytic syndrome following unspecified cerebrovascular disease affecting left dominant side</td>\n <td/>\n </tr>\n <tr>\n <td>I69.963</td>\n <td>Other paralytic syndrome following unspecified cerebrovascular disease affecting right non-dominant side</td>\n <td/>\n </tr>\n <tr>\n <td>I69.964</td>\n <td>Other paralytic syndrome following unspecified cerebrovascular disease affecting left non-dominant side</td>\n <td/>\n </tr>\n <tr>\n <td>I69.965</td>\n <td>Other paralytic syndrome following unspecified cerebrovascular disease, bilateral</td>\n <td/>\n </tr>\n <tr>\n <td>I69.969</td>\n <td>Other paralytic syndrome following unspecified cerebrovascular disease affecting unspecified side</td>\n <td/>\n </tr>\n <tr>\n <td>I69.990</td>\n <td>Apraxia following unspecified cerebrovascular disease</td>\n <td/>\n </tr>\n <tr>\n <td>I69.991</td>\n <td>Dysphagia following unspecified cerebrovascular disease</td>\n <td/>\n </tr>\n <tr>\n <td>I69.992</td>\n <td>Facial weakness following unspecified cerebrovascular disease</td>\n <td/>\n </tr>\n <tr>\n <td>I69.993</td>\n <td>Ataxia following unspecified cerebrovascular disease</td>\n <td/>\n </tr>\n <tr>\n <td>I69.998</td>\n <td>Other sequelae following unspecified cerebrovascular disease</td>\n <td/>\n </tr>\n <tr>\n <td>I70.0</td>\n <td>Atherosclerosis of aorta</td>\n <td/>\n </tr>\n <tr>\n <td>I70.1</td>\n <td>Atherosclerosis of renal artery</td>\n <td/>\n </tr>\n <tr>\n <td>I70.201</td>\n <td>Unspecified atherosclerosis of native arteries of extremities, right leg</td>\n <td/>\n </tr>\n <tr>\n <td>I70.202</td>\n <td>Unspecified atherosclerosis of native arteries of extremities, left leg</td>\n <td/>\n </tr>\n <tr>\n <td>I70.203</td>\n <td>Unspecified atherosclerosis of native arteries of extremities, bilateral legs</td>\n <td/>\n </tr>\n <tr>\n <td>I70.208</td>\n <td>Unspecified atherosclerosis of native arteries of extremities, other extremity</td>\n <td/>\n </tr>\n <tr>\n <td>I70.209</td>\n <td>Unspecified atherosclerosis of native arteries of extremities, unspecified extremity</td>\n <td/>\n </tr>\n <tr>\n <td>I70.211</td>\n <td>Atherosclerosis of native arteries of extremities with intermittent claudication, right leg</td>\n <td/>\n </tr>\n <tr>\n <td>I70.212</td>\n <td>Atherosclerosis of native arteries of extremities with intermittent claudication, left leg</td>\n <td/>\n </tr>\n <tr>\n <td>I70.213</td>\n <td>Atherosclerosis of native arteries of extremities with intermittent claudication, bilateral legs</td>\n <td/>\n </tr>\n <tr>\n <td>I70.218</td>\n <td>Atherosclerosis of native arteries of extremities with intermittent claudication, other extremity</td>\n <td/>\n </tr>\n <tr>\n <td>I70.219</td>\n <td>Atherosclerosis of native arteries of extremities with intermittent claudication, unspecified extremity</td>\n <td/>\n </tr>\n <tr>\n <td>I70.221</td>\n <td>Atherosclerosis of native arteries of extremities with rest pain, right leg</td>\n <td/>\n </tr>\n <tr>\n <td>I70.222</td>\n <td>Atherosclerosis of native arteries of extremities with rest pain, left leg</td>\n <td/>\n </tr>\n <tr>\n <td>I70.223</td>\n <td>Atherosclerosis of native arteries of extremities with rest pain, bilateral legs</td>\n <td/>\n </tr>\n <tr>\n <td>I70.228</td>\n <td>Atherosclerosis of native arteries of extremities with rest pain, other extremity</td>\n <td/>\n </tr>\n <tr>\n <td>I70.229</td>\n <td>Atherosclerosis of native arteries of extremities with rest pain, unspecified extremity</td>\n <td/>\n </tr>\n <tr>\n <td>I70.231</td>\n <td>Atherosclerosis of native arteries of right leg with ulceration of thigh</td>\n <td/>\n </tr>\n <tr>\n <td>I70.232</td>\n <td>Atherosclerosis of native arteries of right leg with ulceration of calf</td>\n <td/>\n </tr>\n <tr>\n <td>I70.233</td>\n <td>Atherosclerosis of native arteries of right leg with ulceration of ankle</td>\n <td/>\n </tr>\n <tr>\n <td>I70.234</td>\n <td>Atherosclerosis of native arteries of right leg with ulceration of heel and midfoot</td>\n <td/>\n </tr>\n <tr>\n <td>I70.235</td>\n <td>Atherosclerosis of native arteries of right leg with ulceration of other part of foot</td>\n <td/>\n </tr>\n <tr>\n <td>I70.238</td>\n <td>Atherosclerosis of native arteries of right leg with ulceration of other part of lower leg</td>\n <td/>\n </tr>\n <tr>\n <td>I70.239</td>\n <td>Atherosclerosis of native arteries of right leg with ulceration of unspecified site</td>\n <td/>\n </tr>\n <tr>\n <td>I70.241</td>\n <td>Atherosclerosis of native arteries of left leg with ulceration of thigh</td>\n <td/>\n </tr>\n <tr>\n <td>I70.242</td>\n <td>Atherosclerosis of native arteries of left leg with ulceration of calf</td>\n <td/>\n </tr>\n <tr>\n <td>I70.243</td>\n <td>Atherosclerosis of native arteries of left leg with ulceration of ankle</td>\n <td/>\n </tr>\n <tr>\n <td>I70.244</td>\n <td>Atherosclerosis of native arteries of left leg with ulceration of heel and midfoot</td>\n <td/>\n </tr>\n <tr>\n <td>I70.245</td>\n <td>Atherosclerosis of native arteries of left leg with ulceration of other part of foot</td>\n <td/>\n </tr>\n <tr>\n <td>I70.248</td>\n <td>Atherosclerosis of native arteries of left leg with ulceration of other part of lower leg</td>\n <td/>\n </tr>\n <tr>\n <td>I70.249</td>\n <td>Atherosclerosis of native arteries of left leg with ulceration of unspecified site</td>\n <td/>\n </tr>\n <tr>\n <td>I70.25</td>\n <td>Atherosclerosis of native arteries of other extremities with ulceration</td>\n <td/>\n </tr>\n <tr>\n <td>I70.261</td>\n <td>Atherosclerosis of native arteries of extremities with gangrene, right leg</td>\n <td/>\n </tr>\n <tr>\n <td>I70.262</td>\n <td>Atherosclerosis of native arteries of extremities with gangrene, left leg</td>\n <td/>\n </tr>\n <tr>\n <td>I70.263</td>\n <td>Atherosclerosis of native arteries of extremities with gangrene, bilateral legs</td>\n <td/>\n </tr>\n <tr>\n <td>I70.268</td>\n <td>Atherosclerosis of native arteries of extremities with gangrene, other extremity</td>\n <td/>\n </tr>\n <tr>\n <td>I70.269</td>\n <td>Atherosclerosis of native arteries of extremities with gangrene, unspecified extremity</td>\n <td/>\n </tr>\n <tr>\n <td>I70.291</td>\n <td>Other atherosclerosis of native arteries of extremities, right leg</td>\n <td/>\n </tr>\n <tr>\n <td>I70.292</td>\n <td>Other atherosclerosis of native arteries of extremities, left leg</td>\n <td/>\n </tr>\n <tr>\n <td>I70.293</td>\n <td>Other atherosclerosis of native arteries of extremities, bilateral legs</td>\n <td/>\n </tr>\n <tr>\n <td>I70.298</td>\n <td>Other atherosclerosis of native arteries of extremities, other extremity</td>\n <td/>\n </tr>\n <tr>\n <td>I70.299</td>\n <td>Other atherosclerosis of native arteries of extremities, unspecified extremity</td>\n <td/>\n </tr>\n <tr>\n <td>I70.8</td>\n <td>Atherosclerosis of other arteries</td>\n <td/>\n </tr>\n <tr>\n <td>I70.90</td>\n <td>Unspecified atherosclerosis</td>\n <td/>\n </tr>\n <tr>\n <td>I70.91</td>\n <td>Generalized atherosclerosis</td>\n <td/>\n </tr>\n <tr>\n <td>I70.92</td>\n <td>Chronic total occlusion of artery of the extremities</td>\n <td/>\n </tr>\n <tr>\n <td>I71.00</td>\n <td>Dissection of unspecified site of aorta</td>\n <td/>\n </tr>\n <tr>\n <td>I71.01</td>\n <td>Dissection of thoracic aorta</td>\n <td/>\n </tr>\n <tr>\n <td>I71.02</td>\n <td>Dissection of abdominal aorta</td>\n <td/>\n </tr>\n <tr>\n <td>I71.03</td>\n <td>Dissection of thoracoabdominal aorta</td>\n <td/>\n </tr>\n <tr>\n <td>I71.1</td>\n <td>Thoracic aortic aneurysm, ruptured</td>\n <td/>\n </tr>\n <tr>\n <td>I71.2</td>\n <td>Thoracic aortic aneurysm, without rupture</td>\n <td/>\n </tr>\n <tr>\n <td>I71.3</td>\n <td>Abdominal aortic aneurysm, ruptured</td>\n <td/>\n </tr>\n <tr>\n <td>I71.4</td>\n <td>Abdominal aortic aneurysm, without rupture</td>\n <td/>\n </tr>\n <tr>\n <td>I71.5</td>\n <td>Thoracoabdominal aortic aneurysm, ruptured</td>\n <td/>\n </tr>\n <tr>\n <td>I71.6</td>\n <td>Thoracoabdominal aortic aneurysm, without rupture</td>\n <td/>\n </tr>\n <tr>\n <td>I71.8</td>\n <td>Aortic aneurysm of unspecified site, ruptured</td>\n <td/>\n </tr>\n <tr>\n <td>I71.9</td>\n <td>Aortic aneurysm of unspecified site, without rupture</td>\n <td/>\n </tr>\n <tr>\n <td>I72.0</td>\n <td>Aneurysm of carotid artery</td>\n <td/>\n </tr>\n <tr>\n <td>I72.1</td>\n <td>Aneurysm of artery of upper extremity</td>\n <td/>\n </tr>\n <tr>\n <td>I72.2</td>\n <td>Aneurysm of renal artery</td>\n <td/>\n </tr>\n <tr>\n <td>I72.3</td>\n <td>Aneurysm of iliac artery</td>\n <td/>\n </tr>\n <tr>\n <td>I72.4</td>\n <td>Aneurysm of artery of lower extremity</td>\n <td/>\n </tr>\n <tr>\n <td>I72.5</td>\n <td>Aneurysm of other precerebral arteries</td>\n <td/>\n </tr>\n <tr>\n <td>I72.6</td>\n <td>Aneurysm of vertebral artery</td>\n <td/>\n </tr>\n <tr>\n <td>I72.8</td>\n <td>Aneurysm of other specified arteries</td>\n <td/>\n </tr>\n <tr>\n <td>I72.9</td>\n <td>Aneurysm of unspecified site</td>\n <td/>\n </tr>\n <tr>\n <td>I73.00</td>\n <td>Raynaud's syndrome without gangrene</td>\n <td/>\n </tr>\n <tr>\n <td>I73.01</td>\n <td>Raynaud's syndrome with gangrene</td>\n <td/>\n </tr>\n <tr>\n <td>I73.1</td>\n <td>Thromboangiitis obliterans [Buerger's disease]</td>\n <td/>\n </tr>\n <tr>\n <td>I73.81</td>\n <td>Erythromelalgia</td>\n <td/>\n </tr>\n <tr>\n <td>I73.89</td>\n <td>Other specified peripheral vascular diseases</td>\n <td/>\n </tr>\n <tr>\n <td>I73.9</td>\n <td>Peripheral vascular disease, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>I74.01</td>\n <td>Saddle embolus of abdominal aorta</td>\n <td/>\n </tr>\n <tr>\n <td>I74.09</td>\n <td>Other arterial embolism and thrombosis of abdominal aorta</td>\n <td/>\n </tr>\n <tr>\n <td>I74.10</td>\n <td>Embolism and thrombosis of unspecified parts of aorta</td>\n <td/>\n </tr>\n <tr>\n <td>I74.11</td>\n <td>Embolism and thrombosis of thoracic aorta</td>\n <td/>\n </tr>\n <tr>\n <td>I74.19</td>\n <td>Embolism and thrombosis of other parts of aorta</td>\n <td/>\n </tr>\n <tr>\n <td>I74.2</td>\n <td>Embolism and thrombosis of arteries of the upper extremities</td>\n <td/>\n </tr>\n <tr>\n <td>I74.3</td>\n <td>Embolism and thrombosis of arteries of the lower extremities</td>\n <td/>\n </tr>\n <tr>\n <td>I74.4</td>\n <td>Embolism and thrombosis of arteries of extremities, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>I74.5</td>\n <td>Embolism and thrombosis of iliac artery</td>\n <td/>\n </tr>\n <tr>\n <td>I74.8</td>\n <td>Embolism and thrombosis of other arteries</td>\n <td/>\n </tr>\n <tr>\n <td>I74.9</td>\n <td>Embolism and thrombosis of unspecified artery</td>\n <td/>\n </tr>\n <tr>\n <td>I75.011</td>\n <td>Atheroembolism of right upper extremity</td>\n <td/>\n </tr>\n <tr>\n <td>I75.012</td>\n <td>Atheroembolism of left upper extremity</td>\n <td/>\n </tr>\n <tr>\n <td>I75.013</td>\n <td>Atheroembolism of bilateral upper extremities</td>\n <td/>\n </tr>\n <tr>\n <td>I75.019</td>\n <td>Atheroembolism of unspecified upper extremity</td>\n <td/>\n </tr>\n <tr>\n <td>I75.021</td>\n <td>Atheroembolism of right lower extremity</td>\n <td/>\n </tr>\n <tr>\n <td>I75.022</td>\n <td>Atheroembolism of left lower extremity</td>\n <td/>\n </tr>\n <tr>\n <td>I75.023</td>\n <td>Atheroembolism of bilateral lower extremities</td>\n <td/>\n </tr>\n <tr>\n <td>I75.029</td>\n <td>Atheroembolism of unspecified lower extremity</td>\n <td/>\n </tr>\n <tr>\n <td>I75.81</td>\n <td>Atheroembolism of kidney</td>\n <td/>\n </tr>\n <tr>\n <td>I75.89</td>\n <td>Atheroembolism of other site</td>\n <td/>\n </tr>\n <tr>\n <td>I77.0</td>\n <td>Arteriovenous fistula, acquired</td>\n <td/>\n </tr>\n <tr>\n <td>I77.1</td>\n <td>Stricture of artery</td>\n <td/>\n </tr>\n <tr>\n <td>I77.2</td>\n <td>Rupture of artery</td>\n <td/>\n </tr>\n <tr>\n <td>I77.3</td>\n <td>Arterial fibromuscular dysplasia</td>\n <td/>\n </tr>\n <tr>\n <td>I77.4</td>\n <td>Celiac artery compression syndrome</td>\n <td/>\n </tr>\n <tr>\n <td>I77.5</td>\n <td>Necrosis of artery</td>\n <td/>\n </tr>\n <tr>\n <td>I77.6</td>\n <td>Arteritis, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>I77.70</td>\n <td>Dissection of unspecified artery</td>\n <td/>\n </tr>\n <tr>\n <td>I77.71</td>\n <td>Dissection of carotid artery</td>\n <td/>\n </tr>\n <tr>\n <td>I77.72</td>\n <td>Dissection of iliac artery</td>\n <td/>\n </tr>\n <tr>\n <td>I77.73</td>\n <td>Dissection of renal artery</td>\n <td/>\n </tr>\n <tr>\n <td>I77.74</td>\n <td>Dissection of vertebral artery</td>\n <td/>\n </tr>\n <tr>\n <td>I77.75</td>\n <td>Dissection of other precerebral arteries</td>\n <td/>\n </tr>\n <tr>\n <td>I77.76</td>\n <td>Dissection of artery of upper extremity</td>\n <td/>\n </tr>\n <tr>\n <td>I77.77</td>\n <td>Dissection of artery of lower extremity</td>\n <td/>\n </tr>\n <tr>\n <td>I77.79</td>\n <td>Dissection of other specified artery</td>\n <td/>\n </tr>\n <tr>\n <td>I77.810</td>\n <td>Thoracic aortic ectasia</td>\n <td/>\n </tr>\n <tr>\n <td>I77.811</td>\n <td>Abdominal aortic ectasia</td>\n <td/>\n </tr>\n <tr>\n <td>I77.812</td>\n <td>Thoracoabdominal aortic ectasia</td>\n <td/>\n </tr>\n <tr>\n <td>I77.819</td>\n <td>Aortic ectasia, unspecified site</td>\n <td/>\n </tr>\n <tr>\n <td>I77.89</td>\n <td>Other specified disorders of arteries and arterioles</td>\n <td/>\n </tr>\n <tr>\n <td>I77.9</td>\n <td>Disorder of arteries and arterioles, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>I78.0</td>\n <td>Hereditary hemorrhagic telangiectasia</td>\n <td/>\n </tr>\n <tr>\n <td>I78.1</td>\n <td>Nevus, non-neoplastic</td>\n <td/>\n </tr>\n <tr>\n <td>I78.8</td>\n <td>Other diseases of capillaries</td>\n <td/>\n </tr>\n <tr>\n <td>I78.9</td>\n <td>Disease of capillaries, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>I79.0</td>\n <td>Aneurysm of aorta in diseases classified elsewhere</td>\n <td/>\n </tr>\n <tr>\n <td>I79.1</td>\n <td>Aortitis in diseases classified elsewhere</td>\n <td/>\n </tr>\n <tr>\n <td>I79.8</td>\n <td>Other disorders of arteries, arterioles and capillaries in diseases classified elsewhere</td>\n <td/>\n </tr>\n <tr>\n <td>I80.00</td>\n <td>Phlebitis and thrombophlebitis of superficial vessels of unspecified lower extremity</td>\n <td/>\n </tr>\n <tr>\n <td>I80.01</td>\n <td>Phlebitis and thrombophlebitis of superficial vessels of right lower extremity</td>\n <td/>\n </tr>\n <tr>\n <td>I80.02</td>\n <td>Phlebitis and thrombophlebitis of superficial vessels of left lower extremity</td>\n <td/>\n </tr>\n <tr>\n <td>I80.03</td>\n <td>Phlebitis and thrombophlebitis of superficial vessels of lower extremities, bilateral</td>\n <td/>\n </tr>\n <tr>\n <td>I80.10</td>\n <td>Phlebitis and thrombophlebitis of unspecified femoral vein</td>\n <td/>\n </tr>\n <tr>\n <td>I80.11</td>\n <td>Phlebitis and thrombophlebitis of right femoral vein</td>\n <td/>\n </tr>\n <tr>\n <td>I80.12</td>\n <td>Phlebitis and thrombophlebitis of left femoral vein</td>\n <td/>\n </tr>\n <tr>\n <td>I80.13</td>\n <td>Phlebitis and thrombophlebitis of femoral vein, bilateral</td>\n <td/>\n </tr>\n <tr>\n <td>I80.201</td>\n <td>Phlebitis and thrombophlebitis of unspecified deep vessels of right lower extremity</td>\n <td/>\n </tr>\n <tr>\n <td>I80.202</td>\n <td>Phlebitis and thrombophlebitis of unspecified deep vessels of left lower extremity</td>\n <td/>\n </tr>\n <tr>\n <td>I80.203</td>\n <td>Phlebitis and thrombophlebitis of unspecified deep vessels of lower extremities, bilateral</td>\n <td/>\n </tr>\n <tr>\n <td>I80.209</td>\n <td>Phlebitis and thrombophlebitis of unspecified deep vessels of unspecified lower extremity</td>\n <td/>\n </tr>\n <tr>\n <td>I80.211</td>\n <td>Phlebitis and thrombophlebitis of right iliac vein</td>\n <td/>\n </tr>\n <tr>\n <td>I80.212</td>\n <td>Phlebitis and thrombophlebitis of left iliac vein</td>\n <td/>\n </tr>\n <tr>\n <td>I80.213</td>\n <td>Phlebitis and thrombophlebitis of iliac vein, bilateral</td>\n <td/>\n </tr>\n <tr>\n <td>I80.219</td>\n <td>Phlebitis and thrombophlebitis of unspecified iliac vein</td>\n <td/>\n </tr>\n <tr>\n <td>I80.221</td>\n <td>Phlebitis and thrombophlebitis of right popliteal vein</td>\n <td/>\n </tr>\n <tr>\n <td>I80.222</td>\n <td>Phlebitis and thrombophlebitis of left popliteal vein</td>\n <td/>\n </tr>\n <tr>\n <td>I80.223</td>\n <td>Phlebitis and thrombophlebitis of popliteal vein, bilateral</td>\n <td/>\n </tr>\n <tr>\n <td>I80.229</td>\n <td>Phlebitis and thrombophlebitis of unspecified popliteal vein</td>\n <td/>\n </tr>\n <tr>\n <td>I80.231</td>\n <td>Phlebitis and thrombophlebitis of right tibial vein</td>\n <td/>\n </tr>\n <tr>\n <td>I80.232</td>\n <td>Phlebitis and thrombophlebitis of left tibial vein</td>\n <td/>\n </tr>\n <tr>\n <td>I80.233</td>\n <td>Phlebitis and thrombophlebitis of tibial vein, bilateral</td>\n <td/>\n </tr>\n <tr>\n <td>I80.239</td>\n <td>Phlebitis and thrombophlebitis of unspecified tibial vein</td>\n <td/>\n </tr>\n <tr>\n <td>I80.291</td>\n <td>Phlebitis and thrombophlebitis of other deep vessels of right lower extremity</td>\n <td/>\n </tr>\n <tr>\n <td>I80.292</td>\n <td>Phlebitis and thrombophlebitis of other deep vessels of left lower extremity</td>\n <td/>\n </tr>\n <tr>\n <td>I80.293</td>\n <td>Phlebitis and thrombophlebitis of other deep vessels of lower extremity, bilateral</td>\n <td/>\n </tr>\n <tr>\n <td>I80.299</td>\n <td>Phlebitis and thrombophlebitis of other deep vessels of unspecified lower extremity</td>\n <td/>\n </tr>\n <tr>\n <td>I80.3</td>\n <td>Phlebitis and thrombophlebitis of lower extremities, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>I80.8</td>\n <td>Phlebitis and thrombophlebitis of other sites</td>\n <td/>\n </tr>\n <tr>\n <td>I80.9</td>\n <td>Phlebitis and thrombophlebitis of unspecified site</td>\n <td/>\n </tr>\n <tr>\n <td>I81</td>\n <td>Portal vein thrombosis</td>\n <td/>\n </tr>\n <tr>\n <td>I82.0</td>\n <td>Budd-Chiari syndrome</td>\n <td/>\n </tr>\n <tr>\n <td>I82.1</td>\n <td>Thrombophlebitis migrans</td>\n <td/>\n </tr>\n <tr>\n <td>I82.210</td>\n <td>Acute embolism and thrombosis of superior vena cava</td>\n <td/>\n </tr>\n <tr>\n <td>I82.211</td>\n <td>Chronic embolism and thrombosis of superior vena cava</td>\n <td/>\n </tr>\n <tr>\n <td>I82.220</td>\n <td>Acute embolism and thrombosis of inferior vena cava</td>\n <td/>\n </tr>\n <tr>\n <td>I82.221</td>\n <td>Chronic embolism and thrombosis of inferior vena cava</td>\n <td/>\n </tr>\n <tr>\n <td>I82.290</td>\n <td>Acute embolism and thrombosis of other thoracic veins</td>\n <td/>\n </tr>\n <tr>\n <td>I82.291</td>\n <td>Chronic embolism and thrombosis of other thoracic veins</td>\n <td/>\n </tr>\n <tr>\n <td>I82.3</td>\n <td>Embolism and thrombosis of renal vein</td>\n <td/>\n </tr>\n <tr>\n <td>I82.401</td>\n <td>Acute embolism and thrombosis of unspecified deep veins of right lower extremity</td>\n <td/>\n </tr>\n <tr>\n <td>I82.402</td>\n <td>Acute embolism and thrombosis of unspecified deep veins of left lower extremity</td>\n <td/>\n </tr>\n <tr>\n <td>I82.403</td>\n <td>Acute embolism and thrombosis of unspecified deep veins of lower extremity, bilateral</td>\n <td/>\n </tr>\n <tr>\n <td>I82.409</td>\n <td>Acute embolism and thrombosis of unspecified deep veins of unspecified lower extremity</td>\n <td/>\n </tr>\n <tr>\n <td>I82.411</td>\n <td>Acute embolism and thrombosis of right femoral vein</td>\n <td/>\n </tr>\n <tr>\n <td>I82.412</td>\n <td>Acute embolism and thrombosis of left femoral vein</td>\n <td/>\n </tr>\n <tr>\n <td>I82.413</td>\n <td>Acute embolism and thrombosis of femoral vein, bilateral</td>\n <td/>\n </tr>\n <tr>\n <td>I82.419</td>\n <td>Acute embolism and thrombosis of unspecified femoral vein</td>\n <td/>\n </tr>\n <tr>\n <td>I82.421</td>\n <td>Acute embolism and thrombosis of right iliac vein</td>\n <td/>\n </tr>\n <tr>\n <td>I82.422</td>\n <td>Acute embolism and thrombosis of left iliac vein</td>\n <td/>\n </tr>\n <tr>\n <td>I82.423</td>\n <td>Acute embolism and thrombosis of iliac vein, bilateral</td>\n <td/>\n </tr>\n <tr>\n <td>I82.429</td>\n <td>Acute embolism and thrombosis of unspecified iliac vein</td>\n <td/>\n </tr>\n <tr>\n <td>I82.431</td>\n <td>Acute embolism and thrombosis of right popliteal vein</td>\n <td/>\n </tr>\n <tr>\n <td>I82.432</td>\n <td>Acute embolism and thrombosis of left popliteal vein</td>\n <td/>\n </tr>\n <tr>\n <td>I82.433</td>\n <td>Acute embolism and thrombosis of popliteal vein, bilateral</td>\n <td/>\n </tr>\n <tr>\n <td>I82.439</td>\n <td>Acute embolism and thrombosis of unspecified popliteal vein</td>\n <td/>\n </tr>\n <tr>\n <td>I82.441</td>\n <td>Acute embolism and thrombosis of right tibial vein</td>\n <td/>\n </tr>\n <tr>\n <td>I82.442</td>\n <td>Acute embolism and thrombosis of left tibial vein</td>\n <td/>\n </tr>\n <tr>\n <td>I82.443</td>\n <td>Acute embolism and thrombosis of tibial vein, bilateral</td>\n <td/>\n </tr>\n <tr>\n <td>I82.449</td>\n <td>Acute embolism and thrombosis of unspecified tibial vein</td>\n <td/>\n </tr>\n <tr>\n <td>I82.491</td>\n <td>Acute embolism and thrombosis of other specified deep vein of right lower extremity</td>\n <td/>\n </tr>\n <tr>\n <td>I82.492</td>\n <td>Acute embolism and thrombosis of other specified deep vein of left lower extremity</td>\n <td/>\n </tr>\n <tr>\n <td>I82.493</td>\n <td>Acute embolism and thrombosis of other specified deep vein of lower extremity, bilateral</td>\n <td/>\n </tr>\n <tr>\n <td>I82.499</td>\n <td>Acute embolism and thrombosis of other specified deep vein of unspecified lower extremity</td>\n <td/>\n </tr>\n <tr>\n <td>I82.4Y1</td>\n <td>Acute embolism and thrombosis of unspecified deep veins of right proximal lower extremity</td>\n <td/>\n </tr>\n <tr>\n <td>I82.4Y2</td>\n <td>Acute embolism and thrombosis of unspecified deep veins of left proximal lower extremity</td>\n <td/>\n </tr>\n <tr>\n <td>I82.4Y3</td>\n <td>Acute embolism and thrombosis of unspecified deep veins of proximal lower extremity, bilateral</td>\n <td/>\n </tr>\n <tr>\n <td>I82.4Y9</td>\n <td>Acute embolism and thrombosis of unspecified deep veins of unspecified proximal lower extremity</td>\n <td/>\n </tr>\n <tr>\n <td>I82.4Z1</td>\n <td>Acute embolism and thrombosis of unspecified deep veins of right distal lower extremity</td>\n <td/>\n </tr>\n <tr>\n <td>I82.4Z2</td>\n <td>Acute embolism and thrombosis of unspecified deep veins of left distal lower extremity</td>\n <td/>\n </tr>\n <tr>\n <td>I82.4Z3</td>\n <td>Acute embolism and thrombosis of unspecified deep veins of distal lower extremity, bilateral</td>\n <td/>\n </tr>\n <tr>\n <td>I82.4Z9</td>\n <td>Acute embolism and thrombosis of unspecified deep veins of unspecified distal lower extremity</td>\n <td/>\n </tr>\n <tr>\n <td>I82.501</td>\n <td>Chronic embolism and thrombosis of unspecified deep veins of right lower extremity</td>\n <td/>\n </tr>\n <tr>\n <td>I82.502</td>\n <td>Chronic embolism and thrombosis of unspecified deep veins of left lower extremity</td>\n <td/>\n </tr>\n <tr>\n <td>I82.503</td>\n <td>Chronic embolism and thrombosis of unspecified deep veins of lower extremity, bilateral</td>\n <td/>\n </tr>\n <tr>\n <td>I82.509</td>\n <td>Chronic embolism and thrombosis of unspecified deep veins of unspecified lower extremity</td>\n <td/>\n </tr>\n <tr>\n <td>I82.511</td>\n <td>Chronic embolism and thrombosis of right femoral vein</td>\n <td/>\n </tr>\n <tr>\n <td>I82.512</td>\n <td>Chronic embolism and thrombosis of left femoral vein</td>\n <td/>\n </tr>\n <tr>\n <td>I82.513</td>\n <td>Chronic embolism and thrombosis of femoral vein, bilateral</td>\n <td/>\n </tr>\n <tr>\n <td>I82.519</td>\n <td>Chronic embolism and thrombosis of unspecified femoral vein</td>\n <td/>\n </tr>\n <tr>\n <td>I82.521</td>\n <td>Chronic embolism and thrombosis of right iliac vein</td>\n <td/>\n </tr>\n <tr>\n <td>I82.522</td>\n <td>Chronic embolism and thrombosis of left iliac vein</td>\n <td/>\n </tr>\n <tr>\n <td>I82.523</td>\n <td>Chronic embolism and thrombosis of iliac vein, bilateral</td>\n <td/>\n </tr>\n <tr>\n <td>I82.529</td>\n <td>Chronic embolism and thrombosis of unspecified iliac vein</td>\n <td/>\n </tr>\n <tr>\n <td>I82.531</td>\n <td>Chronic embolism and thrombosis of right popliteal vein</td>\n <td/>\n </tr>\n <tr>\n <td>I82.532</td>\n <td>Chronic embolism and thrombosis of left popliteal vein</td>\n <td/>\n </tr>\n <tr>\n <td>I82.533</td>\n <td>Chronic embolism and thrombosis of popliteal vein, bilateral</td>\n <td/>\n </tr>\n <tr>\n <td>I82.539</td>\n <td>Chronic embolism and thrombosis of unspecified popliteal vein</td>\n <td/>\n </tr>\n <tr>\n <td>I82.541</td>\n <td>Chronic embolism and thrombosis of right tibial vein</td>\n <td/>\n </tr>\n <tr>\n <td>I82.542</td>\n <td>Chronic embolism and thrombosis of left tibial vein</td>\n <td/>\n </tr>\n <tr>\n <td>I82.543</td>\n <td>Chronic embolism and thrombosis of tibial vein, bilateral</td>\n <td/>\n </tr>\n <tr>\n <td>I82.549</td>\n <td>Chronic embolism and thrombosis of unspecified tibial vein</td>\n <td/>\n </tr>\n <tr>\n <td>I82.591</td>\n <td>Chronic embolism and thrombosis of other specified deep vein of right lower extremity</td>\n <td/>\n </tr>\n <tr>\n <td>I82.592</td>\n <td>Chronic embolism and thrombosis of other specified deep vein of left lower extremity</td>\n <td/>\n </tr>\n <tr>\n <td>I82.593</td>\n <td>Chronic embolism and thrombosis of other specified deep vein of lower extremity, bilateral</td>\n <td/>\n </tr>\n <tr>\n <td>I82.599</td>\n <td>Chronic embolism and thrombosis of other specified deep vein of unspecified lower extremity</td>\n <td/>\n </tr>\n <tr>\n <td>I82.5Y1</td>\n <td>Chronic embolism and thrombosis of unspecified deep veins of right proximal lower extremity</td>\n <td/>\n </tr>\n <tr>\n <td>I82.5Y2</td>\n <td>Chronic embolism and thrombosis of unspecified deep veins of left proximal lower extremity</td>\n <td/>\n </tr>\n <tr>\n <td>I82.5Y3</td>\n <td>Chronic embolism and thrombosis of unspecified deep veins of proximal lower extremity, bilateral</td>\n <td/>\n </tr>\n <tr>\n <td>I82.5Y9</td>\n <td>Chronic embolism and thrombosis of unspecified deep veins of unspecified proximal lower extremity</td>\n <td/>\n </tr>\n <tr>\n <td>I82.5Z1</td>\n <td>Chronic embolism and thrombosis of unspecified deep veins of right distal lower extremity</td>\n <td/>\n </tr>\n <tr>\n <td>I82.5Z2</td>\n <td>Chronic embolism and thrombosis of unspecified deep veins of left distal lower extremity</td>\n <td/>\n </tr>\n <tr>\n <td>I82.5Z3</td>\n <td>Chronic embolism and thrombosis of unspecified deep veins of distal lower extremity, bilateral</td>\n <td/>\n </tr>\n <tr>\n <td>I82.5Z9</td>\n <td>Chronic embolism and thrombosis of unspecified deep veins of unspecified distal lower extremity</td>\n <td/>\n </tr>\n <tr>\n <td>I82.601</td>\n <td>Acute embolism and thrombosis of unspecified veins of right upper extremity</td>\n <td/>\n </tr>\n <tr>\n <td>I82.602</td>\n <td>Acute embolism and thrombosis of unspecified veins of left upper extremity</td>\n <td/>\n </tr>\n <tr>\n <td>I82.603</td>\n <td>Acute embolism and thrombosis of unspecified veins of upper extremity, bilateral</td>\n <td/>\n </tr>\n <tr>\n <td>I82.609</td>\n <td>Acute embolism and thrombosis of unspecified veins of unspecified upper extremity</td>\n <td/>\n </tr>\n <tr>\n <td>I82.611</td>\n <td>Acute embolism and thrombosis of superficial veins of right upper extremity</td>\n <td/>\n </tr>\n <tr>\n <td>I82.612</td>\n <td>Acute embolism and thrombosis of superficial veins of left upper extremity</td>\n <td/>\n </tr>\n <tr>\n <td>I82.613</td>\n <td>Acute embolism and thrombosis of superficial veins of upper extremity, bilateral</td>\n <td/>\n </tr>\n <tr>\n <td>I82.619</td>\n <td>Acute embolism and thrombosis of superficial veins of unspecified upper extremity</td>\n <td/>\n </tr>\n <tr>\n <td>I82.621</td>\n <td>Acute embolism and thrombosis of deep veins of right upper extremity</td>\n <td/>\n </tr>\n <tr>\n <td>I82.622</td>\n <td>Acute embolism and thrombosis of deep veins of left upper extremity</td>\n <td/>\n </tr>\n <tr>\n <td>I82.623</td>\n <td>Acute embolism and thrombosis of deep veins of upper extremity, bilateral</td>\n <td/>\n </tr>\n <tr>\n <td>I82.629</td>\n <td>Acute embolism and thrombosis of deep veins of unspecified upper extremity</td>\n <td/>\n </tr>\n <tr>\n <td>I82.701</td>\n <td>Chronic embolism and thrombosis of unspecified veins of right upper extremity</td>\n <td/>\n </tr>\n <tr>\n <td>I82.702</td>\n <td>Chronic embolism and thrombosis of unspecified veins of left upper extremity</td>\n <td/>\n </tr>\n <tr>\n <td>I82.703</td>\n <td>Chronic embolism and thrombosis of unspecified veins of upper extremity, bilateral</td>\n <td/>\n </tr>\n <tr>\n <td>I82.709</td>\n <td>Chronic embolism and thrombosis of unspecified veins of unspecified upper extremity</td>\n <td/>\n </tr>\n <tr>\n <td>I82.711</td>\n <td>Chronic embolism and thrombosis of superficial veins of right upper extremity</td>\n <td/>\n </tr>\n <tr>\n <td>I82.712</td>\n <td>Chronic embolism and thrombosis of superficial veins of left upper extremity</td>\n <td/>\n </tr>\n <tr>\n <td>I82.713</td>\n <td>Chronic embolism and thrombosis of superficial veins of upper extremity, bilateral</td>\n <td/>\n </tr>\n <tr>\n <td>I82.719</td>\n <td>Chronic embolism and thrombosis of superficial veins of unspecified upper extremity</td>\n <td/>\n </tr>\n <tr>\n <td>I82.721</td>\n <td>Chronic embolism and thrombosis of deep veins of right upper extremity</td>\n <td/>\n </tr>\n <tr>\n <td>I82.722</td>\n <td>Chronic embolism and thrombosis of deep veins of left upper extremity</td>\n <td/>\n </tr>\n <tr>\n <td>I82.723</td>\n <td>Chronic embolism and thrombosis of deep veins of upper extremity, bilateral</td>\n <td/>\n </tr>\n <tr>\n <td>I82.729</td>\n <td>Chronic embolism and thrombosis of deep veins of unspecified upper extremity</td>\n <td/>\n </tr>\n <tr>\n <td>I82.811</td>\n <td>Embolism and thrombosis of superficial veins of right lower extremity</td>\n <td/>\n </tr>\n <tr>\n <td>I82.812</td>\n <td>Embolism and thrombosis of superficial veins of left lower extremity</td>\n <td/>\n </tr>\n <tr>\n <td>I82.813</td>\n <td>Embolism and thrombosis of superficial veins of lower extremities, bilateral</td>\n <td/>\n </tr>\n <tr>\n <td>I82.819</td>\n <td>Embolism and thrombosis of superficial veins of unspecified lower extremity</td>\n <td/>\n </tr>\n <tr>\n <td>I82.890</td>\n <td>Acute embolism and thrombosis of other specified veins</td>\n <td/>\n </tr>\n <tr>\n <td>I82.891</td>\n <td>Chronic embolism and thrombosis of other specified veins</td>\n <td/>\n </tr>\n <tr>\n <td>I82.90</td>\n <td>Acute embolism and thrombosis of unspecified vein</td>\n <td/>\n </tr>\n <tr>\n <td>I82.91</td>\n <td>Chronic embolism and thrombosis of unspecified vein</td>\n <td/>\n </tr>\n <tr>\n <td>I82.A11</td>\n <td>Acute embolism and thrombosis of right axillary vein</td>\n <td/>\n </tr>\n <tr>\n <td>I82.A12</td>\n <td>Acute embolism and thrombosis of left axillary vein</td>\n <td/>\n </tr>\n <tr>\n <td>I82.A13</td>\n <td>Acute embolism and thrombosis of axillary vein, bilateral</td>\n <td/>\n </tr>\n <tr>\n <td>I82.A19</td>\n <td>Acute embolism and thrombosis of unspecified axillary vein</td>\n <td/>\n </tr>\n <tr>\n <td>I82.A21</td>\n <td>Chronic embolism and thrombosis of right axillary vein</td>\n <td/>\n </tr>\n <tr>\n <td>I82.A22</td>\n <td>Chronic embolism and thrombosis of left axillary vein</td>\n <td/>\n </tr>\n <tr>\n <td>I82.A23</td>\n <td>Chronic embolism and thrombosis of axillary vein, bilateral</td>\n <td/>\n </tr>\n <tr>\n <td>I82.A29</td>\n <td>Chronic embolism and thrombosis of unspecified axillary vein</td>\n <td/>\n </tr>\n <tr>\n <td>I82.B11</td>\n <td>Acute embolism and thrombosis of right subclavian vein</td>\n <td/>\n </tr>\n <tr>\n <td>I82.B12</td>\n <td>Acute embolism and thrombosis of left subclavian vein</td>\n <td/>\n </tr>\n <tr>\n <td>I82.B13</td>\n <td>Acute embolism and thrombosis of subclavian vein, bilateral</td>\n <td/>\n </tr>\n <tr>\n <td>I82.B19</td>\n <td>Acute embolism and thrombosis of unspecified subclavian vein</td>\n <td/>\n </tr>\n <tr>\n <td>I82.B21</td>\n <td>Chronic embolism and thrombosis of right subclavian vein</td>\n <td/>\n </tr>\n <tr>\n <td>I82.B22</td>\n <td>Chronic embolism and thrombosis of left subclavian vein</td>\n <td/>\n </tr>\n <tr>\n <td>I82.B23</td>\n <td>Chronic embolism and thrombosis of subclavian vein, bilateral</td>\n <td/>\n </tr>\n <tr>\n <td>I82.B29</td>\n <td>Chronic embolism and thrombosis of unspecified subclavian vein</td>\n <td/>\n </tr>\n <tr>\n <td>I82.C11</td>\n <td>Acute embolism and thrombosis of right internal jugular vein</td>\n <td/>\n </tr>\n <tr>\n <td>I82.C12</td>\n <td>Acute embolism and thrombosis of left internal jugular vein</td>\n <td/>\n </tr>\n <tr>\n <td>I82.C13</td>\n <td>Acute embolism and thrombosis of internal jugular vein, bilateral</td>\n <td/>\n </tr>\n <tr>\n <td>I82.C19</td>\n <td>Acute embolism and thrombosis of unspecified internal jugular vein</td>\n <td/>\n </tr>\n <tr>\n <td>I82.C21</td>\n <td>Chronic embolism and thrombosis of right internal jugular vein</td>\n <td/>\n </tr>\n <tr>\n <td>I82.C22</td>\n <td>Chronic embolism and thrombosis of left internal jugular vein</td>\n <td/>\n </tr>\n <tr>\n <td>I82.C23</td>\n <td>Chronic embolism and thrombosis of internal jugular vein, bilateral</td>\n <td/>\n </tr>\n <tr>\n <td>I82.C29</td>\n <td>Chronic embolism and thrombosis of unspecified internal jugular vein</td>\n <td/>\n </tr>\n <tr>\n <td>I83.001</td>\n <td>Varicose veins of unspecified lower extremity with ulcer of thigh</td>\n <td/>\n </tr>\n <tr>\n <td>I83.002</td>\n <td>Varicose veins of unspecified lower extremity with ulcer of calf</td>\n <td/>\n </tr>\n <tr>\n <td>I83.003</td>\n <td>Varicose veins of unspecified lower extremity with ulcer of ankle</td>\n <td/>\n </tr>\n <tr>\n <td>I83.004</td>\n <td>Varicose veins of unspecified lower extremity with ulcer of heel and midfoot</td>\n <td/>\n </tr>\n <tr>\n <td>I83.005</td>\n <td>Varicose veins of unspecified lower extremity with ulcer other part of foot</td>\n <td/>\n </tr>\n <tr>\n <td>I83.008</td>\n <td>Varicose veins of unspecified lower extremity with ulcer other part of lower leg</td>\n <td/>\n </tr>\n <tr>\n <td>I83.009</td>\n <td>Varicose veins of unspecified lower extremity with ulcer of unspecified site</td>\n <td/>\n </tr>\n <tr>\n <td>I83.011</td>\n <td>Varicose veins of right lower extremity with ulcer of thigh</td>\n <td/>\n </tr>\n <tr>\n <td>I83.012</td>\n <td>Varicose veins of right lower extremity with ulcer of calf</td>\n <td/>\n </tr>\n <tr>\n <td>I83.013</td>\n <td>Varicose veins of right lower extremity with ulcer of ankle</td>\n <td/>\n </tr>\n <tr>\n <td>I83.014</td>\n <td>Varicose veins of right lower extremity with ulcer of heel and midfoot</td>\n <td/>\n </tr>\n <tr>\n <td>I83.015</td>\n <td>Varicose veins of right lower extremity with ulcer other part of foot</td>\n <td/>\n </tr>\n <tr>\n <td>I83.018</td>\n <td>Varicose veins of right lower extremity with ulcer other part of lower leg</td>\n <td/>\n </tr>\n <tr>\n <td>I83.019</td>\n <td>Varicose veins of right lower extremity with ulcer of unspecified site</td>\n <td/>\n </tr>\n <tr>\n <td>I83.021</td>\n <td>Varicose veins of left lower extremity with ulcer of thigh</td>\n <td/>\n </tr>\n <tr>\n <td>I83.022</td>\n <td>Varicose veins of left lower extremity with ulcer of calf</td>\n <td/>\n </tr>\n <tr>\n <td>I83.023</td>\n <td>Varicose veins of left lower extremity with ulcer of ankle</td>\n <td/>\n </tr>\n <tr>\n <td>I83.024</td>\n <td>Varicose veins of left lower extremity with ulcer of heel and midfoot</td>\n <td/>\n </tr>\n <tr>\n <td>I83.025</td>\n <td>Varicose veins of left lower extremity with ulcer other part of foot</td>\n <td/>\n </tr>\n <tr>\n <td>I83.028</td>\n <td>Varicose veins of left lower extremity with ulcer other part of lower leg</td>\n <td/>\n </tr>\n <tr>\n <td>I83.029</td>\n <td>Varicose veins of left lower extremity with ulcer of unspecified site</td>\n <td/>\n </tr>\n <tr>\n <td>I83.10</td>\n <td>Varicose veins of unspecified lower extremity with inflammation</td>\n <td/>\n </tr>\n <tr>\n <td>I83.11</td>\n <td>Varicose veins of right lower extremity with inflammation</td>\n <td/>\n </tr>\n <tr>\n <td>I83.12</td>\n <td>Varicose veins of left lower extremity with inflammation</td>\n <td/>\n </tr>\n <tr>\n <td>I83.201</td>\n <td>Varicose veins of unspecified lower extremity with both ulcer of thigh and inflammation</td>\n <td/>\n </tr>\n <tr>\n <td>I83.202</td>\n <td>Varicose veins of unspecified lower extremity with both ulcer of calf and inflammation</td>\n <td/>\n </tr>\n <tr>\n <td>I83.203</td>\n <td>Varicose veins of unspecified lower extremity with both ulcer of ankle and inflammation</td>\n <td/>\n </tr>\n <tr>\n <td>I83.204</td>\n <td>Varicose veins of unspecified lower extremity with both ulcer of heel and midfoot and inflammation</td>\n <td/>\n </tr>\n <tr>\n <td>I83.205</td>\n <td>Varicose veins of unspecified lower extremity with both ulcer other part of foot and inflammation</td>\n <td/>\n </tr>\n <tr>\n <td>I83.208</td>\n <td>Varicose veins of unspecified lower extremity with both ulcer of other part of lower extremity and inflammation</td>\n <td/>\n </tr>\n <tr>\n <td>I83.209</td>\n <td>Varicose veins of unspecified lower extremity with both ulcer of unspecified site and inflammation</td>\n <td/>\n </tr>\n <tr>\n <td>I83.211</td>\n <td>Varicose veins of right lower extremity with both ulcer of thigh and inflammation</td>\n <td/>\n </tr>\n <tr>\n <td>I83.212</td>\n <td>Varicose veins of right lower extremity with both ulcer of calf and inflammation</td>\n <td/>\n </tr>\n <tr>\n <td>I83.213</td>\n <td>Varicose veins of right lower extremity with both ulcer of ankle and inflammation</td>\n <td/>\n </tr>\n <tr>\n <td>I83.214</td>\n <td>Varicose veins of right lower extremity with both ulcer of heel and midfoot and inflammation</td>\n <td/>\n </tr>\n <tr>\n <td>I83.215</td>\n <td>Varicose veins of right lower extremity with both ulcer other part of foot and inflammation</td>\n <td/>\n </tr>\n <tr>\n <td>I83.218</td>\n <td>Varicose veins of right lower extremity with both ulcer of other part of lower extremity and inflammation</td>\n <td/>\n </tr>\n <tr>\n <td>I83.219</td>\n <td>Varicose veins of right lower extremity with both ulcer of unspecified site and inflammation</td>\n <td/>\n </tr>\n <tr>\n <td>I83.221</td>\n <td>Varicose veins of left lower extremity with both ulcer of thigh and inflammation</td>\n <td/>\n </tr>\n <tr>\n <td>I83.222</td>\n <td>Varicose veins of left lower extremity with both ulcer of calf and inflammation</td>\n <td/>\n </tr>\n <tr>\n <td>I83.223</td>\n <td>Varicose veins of left lower extremity with both ulcer of ankle and inflammation</td>\n <td/>\n </tr>\n <tr>\n <td>I83.224</td>\n <td>Varicose veins of left lower extremity with both ulcer of heel and midfoot and inflammation</td>\n <td/>\n </tr>\n <tr>\n <td>I83.225</td>\n <td>Varicose veins of left lower extremity with both ulcer other part of foot and inflammation</td>\n <td/>\n </tr>\n <tr>\n <td>I83.228</td>\n <td>Varicose veins of left lower extremity with both ulcer of other part of lower extremity and inflammation</td>\n <td/>\n </tr>\n <tr>\n <td>I83.229</td>\n <td>Varicose veins of left lower extremity with both ulcer of unspecified site and inflammation</td>\n <td/>\n </tr>\n <tr>\n <td>I83.811</td>\n <td>Varicose veins of right lower extremity with pain</td>\n <td/>\n </tr>\n <tr>\n <td>I83.812</td>\n <td>Varicose veins of left lower extremity with pain</td>\n <td/>\n </tr>\n <tr>\n <td>I83.813</td>\n <td>Varicose veins of bilateral lower extremities with pain</td>\n <td/>\n </tr>\n <tr>\n <td>I83.819</td>\n <td>Varicose veins of unspecified lower extremity with pain</td>\n <td/>\n </tr>\n <tr>\n <td>I83.891</td>\n <td>Varicose veins of right lower extremity with other complications</td>\n <td/>\n </tr>\n <tr>\n <td>I83.892</td>\n <td>Varicose veins of left lower extremity with other complications</td>\n <td/>\n </tr>\n <tr>\n <td>I83.893</td>\n <td>Varicose veins of bilateral lower extremities with other complications</td>\n <td/>\n </tr>\n <tr>\n <td>I83.899</td>\n <td>Varicose veins of unspecified lower extremity with other complications</td>\n <td/>\n </tr>\n <tr>\n <td>I83.90</td>\n <td>Asymptomatic varicose veins of unspecified lower extremity</td>\n <td/>\n </tr>\n <tr>\n <td>I83.91</td>\n <td>Asymptomatic varicose veins of right lower extremity</td>\n <td/>\n </tr>\n <tr>\n <td>I83.92</td>\n <td>Asymptomatic varicose veins of left lower extremity</td>\n <td/>\n </tr>\n <tr>\n <td>I83.93</td>\n <td>Asymptomatic varicose veins of bilateral lower extremities</td>\n <td/>\n </tr>\n <tr>\n <td>I86.0</td>\n <td>Sublingual varices</td>\n <td/>\n </tr>\n <tr>\n <td>I86.1</td>\n <td>Scrotal varices</td>\n <td/>\n </tr>\n <tr>\n <td>I86.2</td>\n <td>Pelvic varices</td>\n <td/>\n </tr>\n <tr>\n <td>I86.3</td>\n <td>Vulval varices</td>\n <td/>\n </tr>\n <tr>\n <td>I86.4</td>\n <td>Gastric varices</td>\n <td/>\n </tr>\n <tr>\n <td>I86.8</td>\n <td>Varicose veins of other specified sites</td>\n <td/>\n </tr>\n <tr>\n <td>I87.001</td>\n <td>Postthrombotic syndrome without complications of right lower extremity</td>\n <td/>\n </tr>\n <tr>\n <td>I87.002</td>\n <td>Postthrombotic syndrome without complications of left lower extremity</td>\n <td/>\n </tr>\n <tr>\n <td>I87.003</td>\n <td>Postthrombotic syndrome without complications of bilateral lower extremity</td>\n <td/>\n </tr>\n <tr>\n <td>I87.009</td>\n <td>Postthrombotic syndrome without complications of unspecified extremity</td>\n <td/>\n </tr>\n <tr>\n <td>I87.011</td>\n <td>Postthrombotic syndrome with ulcer of right lower extremity</td>\n <td/>\n </tr>\n <tr>\n <td>I87.012</td>\n <td>Postthrombotic syndrome with ulcer of left lower extremity</td>\n <td/>\n </tr>\n <tr>\n <td>I87.013</td>\n <td>Postthrombotic syndrome with ulcer of bilateral lower extremity</td>\n <td/>\n </tr>\n <tr>\n <td>I87.019</td>\n <td>Postthrombotic syndrome with ulcer of unspecified lower extremity</td>\n <td/>\n </tr>\n <tr>\n <td>I87.021</td>\n <td>Postthrombotic syndrome with inflammation of right lower extremity</td>\n <td/>\n </tr>\n <tr>\n <td>I87.022</td>\n <td>Postthrombotic syndrome with inflammation of left lower extremity</td>\n <td/>\n </tr>\n <tr>\n <td>I87.023</td>\n <td>Postthrombotic syndrome with inflammation of bilateral lower extremity</td>\n <td/>\n </tr>\n <tr>\n <td>I87.029</td>\n <td>Postthrombotic syndrome with inflammation of unspecified lower extremity</td>\n <td/>\n </tr>\n <tr>\n <td>I87.031</td>\n <td>Postthrombotic syndrome with ulcer and inflammation of right lower extremity</td>\n <td/>\n </tr>\n <tr>\n <td>I87.032</td>\n <td>Postthrombotic syndrome with ulcer and inflammation of left lower extremity</td>\n <td/>\n </tr>\n <tr>\n <td>I87.033</td>\n <td>Postthrombotic syndrome with ulcer and inflammation of bilateral lower extremity</td>\n <td/>\n </tr>\n <tr>\n <td>I87.039</td>\n <td>Postthrombotic syndrome with ulcer and inflammation of unspecified lower extremity</td>\n <td/>\n </tr>\n <tr>\n <td>I87.091</td>\n <td>Postthrombotic syndrome with other complications of right lower extremity</td>\n <td/>\n </tr>\n <tr>\n <td>I87.092</td>\n <td>Postthrombotic syndrome with other complications of left lower extremity</td>\n <td/>\n </tr>\n <tr>\n <td>I87.093</td>\n <td>Postthrombotic syndrome with other complications of bilateral lower extremity</td>\n <td/>\n </tr>\n <tr>\n <td>I87.099</td>\n <td>Postthrombotic syndrome with other complications of unspecified lower extremity</td>\n <td/>\n </tr>\n <tr>\n <td>I87.1</td>\n <td>Compression of vein</td>\n <td/>\n </tr>\n <tr>\n <td>I87.2</td>\n <td>Venous insufficiency (chronic) (peripheral)</td>\n <td/>\n </tr>\n <tr>\n <td>I87.301</td>\n <td>Chronic venous hypertension (idiopathic) without complications of right lower extremity</td>\n <td/>\n </tr>\n <tr>\n <td>I87.302</td>\n <td>Chronic venous hypertension (idiopathic) without complications of left lower extremity</td>\n <td/>\n </tr>\n <tr>\n <td>I87.303</td>\n <td>Chronic venous hypertension (idiopathic) without complications of bilateral lower extremity</td>\n <td/>\n </tr>\n <tr>\n <td>I87.309</td>\n <td>Chronic venous hypertension (idiopathic) without complications of unspecified lower extremity</td>\n <td/>\n </tr>\n <tr>\n <td>I87.311</td>\n <td>Chronic venous hypertension (idiopathic) with ulcer of right lower extremity</td>\n <td/>\n </tr>\n <tr>\n <td>I87.312</td>\n <td>Chronic venous hypertension (idiopathic) with ulcer of left lower extremity</td>\n <td/>\n </tr>\n <tr>\n <td>I87.313</td>\n <td>Chronic venous hypertension (idiopathic) with ulcer of bilateral lower extremity</td>\n <td/>\n </tr>\n <tr>\n <td>I87.319</td>\n <td>Chronic venous hypertension (idiopathic) with ulcer of unspecified lower extremity</td>\n <td/>\n </tr>\n <tr>\n <td>I87.321</td>\n <td>Chronic venous hypertension (idiopathic) with inflammation of right lower extremity</td>\n <td/>\n </tr>\n <tr>\n <td>I87.322</td>\n <td>Chronic venous hypertension (idiopathic) with inflammation of left lower extremity</td>\n <td/>\n </tr>\n <tr>\n <td>I87.323</td>\n <td>Chronic venous hypertension (idiopathic) with inflammation of bilateral lower extremity</td>\n <td/>\n </tr>\n <tr>\n <td>I87.329</td>\n <td>Chronic venous hypertension (idiopathic) with inflammation of unspecified lower extremity</td>\n <td/>\n </tr>\n <tr>\n <td>I87.331</td>\n <td>Chronic venous hypertension (idiopathic) with ulcer and inflammation of right lower extremity</td>\n <td/>\n </tr>\n <tr>\n <td>I87.332</td>\n <td>Chronic venous hypertension (idiopathic) with ulcer and inflammation of left lower extremity</td>\n <td/>\n </tr>\n <tr>\n <td>I87.333</td>\n <td>Chronic venous hypertension (idiopathic) with ulcer and inflammation of bilateral lower extremity</td>\n <td/>\n </tr>\n <tr>\n <td>I87.339</td>\n <td>Chronic venous hypertension (idiopathic) with ulcer and inflammation of unspecified lower extremity</td>\n <td/>\n </tr>\n <tr>\n <td>I87.391</td>\n <td>Chronic venous hypertension (idiopathic) with other complications of right lower extremity</td>\n <td/>\n </tr>\n <tr>\n <td>I87.392</td>\n <td>Chronic venous hypertension (idiopathic) with other complications of left lower extremity</td>\n <td/>\n </tr>\n <tr>\n <td>I87.393</td>\n <td>Chronic venous hypertension (idiopathic) with other complications of bilateral lower extremity</td>\n <td/>\n </tr>\n <tr>\n <td>I87.399</td>\n <td>Chronic venous hypertension (idiopathic) with other complications of unspecified lower extremity</td>\n <td/>\n </tr>\n <tr>\n <td>I87.8</td>\n <td>Other specified disorders of veins</td>\n <td/>\n </tr>\n <tr>\n <td>I87.9</td>\n <td>Disorder of vein, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>I88.0</td>\n <td>Nonspecific mesenteric lymphadenitis</td>\n <td/>\n </tr>\n <tr>\n <td>I88.1</td>\n <td>Chronic lymphadenitis, except mesenteric</td>\n <td/>\n </tr>\n <tr>\n <td>I88.8</td>\n <td>Other nonspecific lymphadenitis</td>\n <td/>\n </tr>\n <tr>\n <td>I88.9</td>\n <td>Nonspecific lymphadenitis, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>I89.0</td>\n <td>Lymphedema, not elsewhere classified</td>\n <td/>\n </tr>\n <tr>\n <td>I89.1</td>\n <td>Lymphangitis</td>\n <td/>\n </tr>\n <tr>\n <td>I89.8</td>\n <td>Other specified noninfective disorders of lymphatic vessels and lymph nodes</td>\n <td/>\n </tr>\n <tr>\n <td>I89.9</td>\n <td>Noninfective disorder of lymphatic vessels and lymph nodes, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>I95.0</td>\n <td>Idiopathic hypotension</td>\n <td/>\n </tr>\n <tr>\n <td>I95.1</td>\n <td>Orthostatic hypotension</td>\n <td/>\n </tr>\n <tr>\n <td>I95.89</td>\n <td>Other hypotension</td>\n <td/>\n </tr>\n <tr>\n <td>I95.9</td>\n <td>Hypotension, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>I96</td>\n <td>Gangrene, not elsewhere classified</td>\n <td/>\n </tr>\n <tr>\n <td>I99.8</td>\n <td>Other disorder of circulatory system</td>\n <td/>\n </tr>\n <tr>\n <td>I99.9</td>\n <td>Unspecified disorder of circulatory system</td>\n <td/>\n </tr>\n <tr>\n <td>J10.82</td>\n <td>Influenza due to other identified influenza virus with myocarditis</td>\n <td/>\n </tr>\n <tr>\n <td>J30.5</td>\n <td>Allergic rhinitis due to food</td>\n <td/>\n </tr>\n <tr>\n <td>J85.0</td>\n <td>Gangrene and necrosis of lung</td>\n <td/>\n </tr>\n <tr>\n <td>J91.0</td>\n <td>Malignant pleural effusion</td>\n <td/>\n </tr>\n <tr>\n <td>K31.7</td>\n <td>Polyp of stomach and duodenum</td>\n <td/>\n </tr>\n <tr>\n <td>K52.2</td>\n <td>Allergic and dietetic gastroenteritis and colitis</td>\n <td/>\n </tr>\n <tr>\n <td>K52.21</td>\n <td>Food protein-induced enterocolitis syndrome</td>\n <td/>\n </tr>\n <tr>\n <td>K52.22</td>\n <td>Food protein-induced enteropathy</td>\n <td/>\n </tr>\n <tr>\n <td>K52.29</td>\n <td>Other allergic and dietetic gastroenteritis and colitis</td>\n <td/>\n </tr>\n <tr>\n <td>K55.0</td>\n <td>Acute vascular disorders of intestine</td>\n <td/>\n </tr>\n <tr>\n <td>K55.011</td>\n <td>Focal (segmental) acute (reversible) ischemia of small intestine</td>\n <td/>\n </tr>\n <tr>\n <td>K55.012</td>\n <td>Diffuse acute (reversible) ischemia of small intestine</td>\n <td/>\n </tr>\n <tr>\n <td>K55.019</td>\n <td>Acute (reversible) ischemia of small intestine, extent unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>K55.021</td>\n <td>Focal (segmental) acute infarction of small intestine</td>\n <td/>\n </tr>\n <tr>\n <td>K55.022</td>\n <td>Diffuse acute infarction of small intestine</td>\n <td/>\n </tr>\n <tr>\n <td>K55.029</td>\n <td>Acute infarction of small intestine, extent unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>K55.031</td>\n <td>Focal (segmental) acute (reversible) ischemia of large intestine</td>\n <td/>\n </tr>\n <tr>\n <td>K55.032</td>\n <td>Diffuse acute (reversible) ischemia of large intestine</td>\n <td/>\n </tr>\n <tr>\n <td>K55.039</td>\n <td>Acute (reversible) ischemia of large intestine, extent unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>K55.041</td>\n <td>Focal (segmental) acute infarction of large intestine</td>\n <td/>\n </tr>\n <tr>\n <td>K55.042</td>\n <td>Diffuse acute infarction of large intestine</td>\n <td/>\n </tr>\n <tr>\n <td>K55.049</td>\n <td>Acute infarction of large intestine, extent unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>K55.051</td>\n <td>Focal (segmental) acute (reversible) ischemia of intestine, part unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>K55.052</td>\n <td>Diffuse acute (reversible) ischemia of intestine, part unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>K55.059</td>\n <td>Acute (reversible) ischemia of intestine, part and extent unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>K55.061</td>\n <td>Focal (segmental) acute infarction of intestine, part unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>K55.062</td>\n <td>Diffuse acute infarction of intestine, part unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>K55.069</td>\n <td>Acute infarction of intestine, part and extent unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>K55.1</td>\n <td>Chronic vascular disorders of intestine</td>\n <td/>\n </tr>\n <tr>\n <td>K55.8</td>\n <td>Other vascular disorders of intestine</td>\n <td/>\n </tr>\n <tr>\n <td>K55.9</td>\n <td>Vascular disorder of intestine, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>K63.5</td>\n <td>Polyp of colon</td>\n <td/>\n </tr>\n <tr>\n <td>K64.0</td>\n <td>First degree hemorrhoids</td>\n <td/>\n </tr>\n <tr>\n <td>K64.1</td>\n <td>Second degree hemorrhoids</td>\n <td/>\n </tr>\n <tr>\n <td>K64.2</td>\n <td>Third degree hemorrhoids</td>\n <td/>\n </tr>\n <tr>\n <td>K64.3</td>\n <td>Fourth degree hemorrhoids</td>\n <td/>\n </tr>\n <tr>\n <td>K64.4</td>\n <td>Residual hemorrhoidal skin tags</td>\n <td/>\n </tr>\n <tr>\n <td>K64.5</td>\n <td>Perianal venous thrombosis</td>\n <td/>\n </tr>\n <tr>\n <td>K64.8</td>\n <td>Other hemorrhoids</td>\n <td/>\n </tr>\n <tr>\n <td>K64.9</td>\n <td>Unspecified hemorrhoids</td>\n <td/>\n </tr>\n <tr>\n <td>K90.41</td>\n <td>Non-celiac gluten sensitivity</td>\n <td/>\n </tr>\n <tr>\n <td>L04.0</td>\n <td>Acute lymphadenitis of face, head and neck</td>\n <td/>\n </tr>\n <tr>\n <td>L04.1</td>\n <td>Acute lymphadenitis of trunk</td>\n <td/>\n </tr>\n <tr>\n <td>L04.2</td>\n <td>Acute lymphadenitis of upper limb</td>\n <td/>\n </tr>\n <tr>\n <td>L04.3</td>\n <td>Acute lymphadenitis of lower limb</td>\n <td/>\n </tr>\n <tr>\n <td>L04.8</td>\n <td>Acute lymphadenitis of other sites</td>\n <td/>\n </tr>\n <tr>\n <td>L04.9</td>\n <td>Acute lymphadenitis, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>L20.0</td>\n <td>Besnier's prurigo</td>\n <td/>\n </tr>\n <tr>\n <td>L20.81</td>\n <td>Atopic neurodermatitis</td>\n <td/>\n </tr>\n <tr>\n <td>L20.82</td>\n <td>Flexural eczema</td>\n <td/>\n </tr>\n <tr>\n <td>L20.83</td>\n <td>Infantile (acute) (chronic) eczema</td>\n <td/>\n </tr>\n <tr>\n <td>L20.84</td>\n <td>Intrinsic (allergic) eczema</td>\n <td/>\n </tr>\n <tr>\n <td>L20.89</td>\n <td>Other atopic dermatitis</td>\n <td/>\n </tr>\n <tr>\n <td>L20.9</td>\n <td>Atopic dermatitis, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>L22</td>\n <td>Diaper dermatitis</td>\n <td/>\n </tr>\n <tr>\n <td>L23.0</td>\n <td>Allergic contact dermatitis due to metals</td>\n <td/>\n </tr>\n <tr>\n <td>L23.1</td>\n <td>Allergic contact dermatitis due to adhesives</td>\n <td/>\n </tr>\n <tr>\n <td>L23.2</td>\n <td>Allergic contact dermatitis due to cosmetics</td>\n <td/>\n </tr>\n <tr>\n <td>L23.3</td>\n <td>Allergic contact dermatitis due to drugs in contact with skin</td>\n <td/>\n </tr>\n <tr>\n <td>L23.4</td>\n <td>Allergic contact dermatitis due to dyes</td>\n <td/>\n </tr>\n <tr>\n <td>L23.5</td>\n <td>Allergic contact dermatitis due to other chemical products</td>\n <td/>\n </tr>\n <tr>\n <td>L23.6</td>\n <td>Allergic contact dermatitis due to food in contact with the skin</td>\n <td/>\n </tr>\n <tr>\n <td>L23.7</td>\n <td>Allergic contact dermatitis due to plants, except food</td>\n <td/>\n </tr>\n <tr>\n <td>L23.81</td>\n <td>Allergic contact dermatitis due to animal (cat) (dog) dander</td>\n <td/>\n </tr>\n <tr>\n <td>L23.89</td>\n <td>Allergic contact dermatitis due to other agents</td>\n <td/>\n </tr>\n <tr>\n <td>L23.9</td>\n <td>Allergic contact dermatitis, unspecified cause</td>\n <td/>\n </tr>\n <tr>\n <td>L24.0</td>\n <td>Irritant contact dermatitis due to detergents</td>\n <td/>\n </tr>\n <tr>\n <td>L24.1</td>\n <td>Irritant contact dermatitis due to oils and greases</td>\n <td/>\n </tr>\n <tr>\n <td>L24.2</td>\n <td>Irritant contact dermatitis due to solvents</td>\n <td/>\n </tr>\n <tr>\n <td>L24.3</td>\n <td>Irritant contact dermatitis due to cosmetics</td>\n <td/>\n </tr>\n <tr>\n <td>L24.4</td>\n <td>Irritant contact dermatitis due to drugs in contact with skin</td>\n <td/>\n </tr>\n <tr>\n <td>L24.5</td>\n <td>Irritant contact dermatitis due to other chemical products</td>\n <td/>\n </tr>\n <tr>\n <td>L24.6</td>\n <td>Irritant contact dermatitis due to food in contact with skin</td>\n <td/>\n </tr>\n <tr>\n <td>L24.7</td>\n <td>Irritant contact dermatitis due to plants, except food</td>\n <td/>\n </tr>\n <tr>\n <td>L24.81</td>\n <td>Irritant contact dermatitis due to metals</td>\n <td/>\n </tr>\n <tr>\n <td>L24.89</td>\n <td>Irritant contact dermatitis due to other agents</td>\n <td/>\n </tr>\n <tr>\n <td>L24.9</td>\n <td>Irritant contact dermatitis, unspecified cause</td>\n <td/>\n </tr>\n <tr>\n <td>L25.0</td>\n <td>Unspecified contact dermatitis due to cosmetics</td>\n <td/>\n </tr>\n <tr>\n <td>L25.1</td>\n <td>Unspecified contact dermatitis due to drugs in contact with skin</td>\n <td/>\n </tr>\n <tr>\n <td>L25.2</td>\n <td>Unspecified contact dermatitis due to dyes</td>\n <td/>\n </tr>\n <tr>\n <td>L25.3</td>\n <td>Unspecified contact dermatitis due to other chemical products</td>\n <td/>\n </tr>\n <tr>\n <td>L25.4</td>\n <td>Unspecified contact dermatitis due to food in contact with skin</td>\n <td/>\n </tr>\n <tr>\n <td>L25.5</td>\n <td>Unspecified contact dermatitis due to plants, except food</td>\n <td/>\n </tr>\n <tr>\n <td>L25.8</td>\n <td>Unspecified contact dermatitis due to other agents</td>\n <td/>\n </tr>\n <tr>\n <td>L25.9</td>\n <td>Unspecified contact dermatitis, unspecified cause</td>\n <td/>\n </tr>\n <tr>\n <td>L27.0</td>\n <td>Generalized skin eruption due to drugs and medicaments taken internally</td>\n <td/>\n </tr>\n <tr>\n <td>L27.1</td>\n <td>Localized skin eruption due to drugs and medicaments taken internally</td>\n <td/>\n </tr>\n <tr>\n <td>L27.2</td>\n <td>Dermatitis due to ingested food</td>\n <td/>\n </tr>\n <tr>\n <td>L27.8</td>\n <td>Dermatitis due to other substances taken internally</td>\n <td/>\n </tr>\n <tr>\n <td>L27.9</td>\n <td>Dermatitis due to unspecified substance taken internally</td>\n <td/>\n </tr>\n <tr>\n <td>L30.0</td>\n <td>Nummular dermatitis</td>\n <td/>\n </tr>\n <tr>\n <td>L30.2</td>\n <td>Cutaneous autosensitization</td>\n <td/>\n </tr>\n <tr>\n <td>L30.8</td>\n <td>Other specified dermatitis</td>\n <td/>\n </tr>\n <tr>\n <td>L30.9</td>\n <td>Dermatitis, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>L50.0</td>\n <td>Allergic urticaria</td>\n <td/>\n </tr>\n <tr>\n <td>L50.1</td>\n <td>Idiopathic urticaria</td>\n <td/>\n </tr>\n <tr>\n <td>L50.2</td>\n <td>Urticaria due to cold and heat</td>\n <td/>\n </tr>\n <tr>\n <td>L50.3</td>\n <td>Dermatographic urticaria</td>\n <td/>\n </tr>\n <tr>\n <td>L50.4</td>\n <td>Vibratory urticaria</td>\n <td/>\n </tr>\n <tr>\n <td>L50.5</td>\n <td>Cholinergic urticaria</td>\n <td/>\n </tr>\n <tr>\n <td>L50.6</td>\n <td>Contact urticaria</td>\n <td/>\n </tr>\n <tr>\n <td>L50.8</td>\n <td>Other urticaria</td>\n <td/>\n </tr>\n <tr>\n <td>L50.9</td>\n <td>Urticaria, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>L56.0</td>\n <td>Drug phototoxic response</td>\n <td/>\n </tr>\n <tr>\n <td>L56.1</td>\n <td>Drug photoallergic response</td>\n <td/>\n </tr>\n <tr>\n <td>L56.2</td>\n <td>Photocontact dermatitis [berloque dermatitis]</td>\n <td/>\n </tr>\n <tr>\n <td>L56.3</td>\n <td>Solar urticaria</td>\n <td/>\n </tr>\n <tr>\n <td>L56.4</td>\n <td>Polymorphous light eruption</td>\n <td/>\n </tr>\n <tr>\n <td>L56.8</td>\n <td>Other specified acute skin changes due to ultraviolet radiation</td>\n <td/>\n </tr>\n <tr>\n <td>L56.9</td>\n <td>Acute skin change due to ultraviolet radiation, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>L57.8</td>\n <td>Other skin changes due to chronic exposure to nonionizing radiation</td>\n <td/>\n </tr>\n <tr>\n <td>L57.9</td>\n <td>Skin changes due to chronic exposure to nonionizing radiation, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>L58.0</td>\n <td>Acute radiodermatitis</td>\n <td/>\n </tr>\n <tr>\n <td>L58.1</td>\n <td>Chronic radiodermatitis</td>\n <td/>\n </tr>\n <tr>\n <td>L58.9</td>\n <td>Radiodermatitis, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>L59.0</td>\n <td>Erythema ab igne [dermatitis ab igne]</td>\n <td/>\n </tr>\n <tr>\n <td>L59.8</td>\n <td>Other specified disorders of the skin and subcutaneous tissue related to radiation</td>\n <td/>\n </tr>\n <tr>\n <td>L59.9</td>\n <td>Disorder of the skin and subcutaneous tissue related to radiation, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>M31.0</td>\n <td>Hypersensitivity angiitis</td>\n <td/>\n </tr>\n <tr>\n <td>N26.2</td>\n <td>Page kidney</td>\n <td/>\n </tr>\n <tr>\n <td>R00.0</td>\n <td>Tachycardia, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>R00.1</td>\n <td>Bradycardia, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>R00.2</td>\n <td>Palpitations</td>\n <td/>\n </tr>\n <tr>\n <td>R00.8</td>\n <td>Other abnormalities of heart beat</td>\n <td/>\n </tr>\n <tr>\n <td>R00.9</td>\n <td>Unspecified abnormalities of heart beat</td>\n <td/>\n </tr>\n <tr>\n <td>R01.0</td>\n <td>Benign and innocent cardiac murmurs</td>\n <td/>\n </tr>\n <tr>\n <td>R01.1</td>\n <td>Cardiac murmur, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>R01.2</td>\n <td>Other cardiac sounds</td>\n <td/>\n </tr>\n <tr>\n <td>R03.0</td>\n <td>Elevated blood-pressure reading, without diagnosis of hypertension</td>\n <td/>\n </tr>\n <tr>\n <td>R03.1</td>\n <td>Nonspecific low blood-pressure reading</td>\n <td/>\n </tr>\n <tr>\n <td>R07.2</td>\n <td>Precordial pain</td>\n <td/>\n </tr>\n <tr>\n <td>R07.82</td>\n <td>Intercostal pain</td>\n <td/>\n </tr>\n <tr>\n <td>R07.89</td>\n <td>Other chest pain</td>\n <td/>\n </tr>\n <tr>\n <td>R07.9</td>\n <td>Chest pain, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>R09.89</td>\n <td>Other specified symptoms and signs involving the circulatory and respiratory systems</td>\n <td/>\n </tr>\n <tr>\n <td>R10.0</td>\n <td>Acute abdomen</td>\n <td/>\n </tr>\n <tr>\n <td>R10.10</td>\n <td>Upper abdominal pain, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>R10.11</td>\n <td>Right upper quadrant pain</td>\n <td/>\n </tr>\n <tr>\n <td>R10.12</td>\n <td>Left upper quadrant pain</td>\n <td/>\n </tr>\n <tr>\n <td>R10.13</td>\n <td>Epigastric pain</td>\n <td/>\n </tr>\n <tr>\n <td>R10.2</td>\n <td>Pelvic and perineal pain</td>\n <td/>\n </tr>\n <tr>\n <td>R10.30</td>\n <td>Lower abdominal pain, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>R10.31</td>\n <td>Right lower quadrant pain</td>\n <td/>\n </tr>\n <tr>\n <td>R10.32</td>\n <td>Left lower quadrant pain</td>\n <td/>\n </tr>\n <tr>\n <td>R10.33</td>\n <td>Periumbilical pain</td>\n <td/>\n </tr>\n <tr>\n <td>R10.811</td>\n <td>Right upper quadrant abdominal tenderness</td>\n <td/>\n </tr>\n <tr>\n <td>R10.812</td>\n <td>Left upper quadrant abdominal tenderness</td>\n <td/>\n </tr>\n <tr>\n <td>R10.813</td>\n <td>Right lower quadrant abdominal tenderness</td>\n <td/>\n </tr>\n <tr>\n <td>R10.814</td>\n <td>Left lower quadrant abdominal tenderness</td>\n <td/>\n </tr>\n <tr>\n <td>R10.815</td>\n <td>Periumbilic abdominal tenderness</td>\n <td/>\n </tr>\n <tr>\n <td>R10.816</td>\n <td>Epigastric abdominal tenderness</td>\n <td/>\n </tr>\n <tr>\n <td>R10.817</td>\n <td>Generalized abdominal tenderness</td>\n <td/>\n </tr>\n <tr>\n <td>R10.819</td>\n <td>Abdominal tenderness, unspecified site</td>\n <td/>\n </tr>\n <tr>\n <td>R10.821</td>\n <td>Right upper quadrant rebound abdominal tenderness</td>\n <td/>\n </tr>\n <tr>\n <td>R10.822</td>\n <td>Left upper quadrant rebound abdominal tenderness</td>\n <td/>\n </tr>\n <tr>\n <td>R10.823</td>\n <td>Right lower quadrant rebound abdominal tenderness</td>\n <td/>\n </tr>\n <tr>\n <td>R10.824</td>\n <td>Left lower quadrant rebound abdominal tenderness</td>\n <td/>\n </tr>\n <tr>\n <td>R10.825</td>\n <td>Periumbilic rebound abdominal tenderness</td>\n <td/>\n </tr>\n <tr>\n <td>R10.826</td>\n <td>Epigastric rebound abdominal tenderness</td>\n <td/>\n </tr>\n <tr>\n <td>R10.827</td>\n <td>Generalized rebound abdominal tenderness</td>\n <td/>\n </tr>\n <tr>\n <td>R10.829</td>\n <td>Rebound abdominal tenderness, unspecified site</td>\n <td/>\n </tr>\n <tr>\n <td>R10.84</td>\n <td>Generalized abdominal pain</td>\n <td/>\n </tr>\n <tr>\n <td>R10.9</td>\n <td>Unspecified abdominal pain</td>\n <td/>\n </tr>\n <tr>\n <td>R11.0</td>\n <td>Nausea</td>\n <td/>\n </tr>\n <tr>\n <td>R11.10</td>\n <td>Vomiting, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>R11.11</td>\n <td>Vomiting without nausea</td>\n <td/>\n </tr>\n <tr>\n <td>R11.12</td>\n <td>Projectile vomiting</td>\n <td/>\n </tr>\n <tr>\n <td>R11.14</td>\n <td>Bilious vomiting</td>\n <td/>\n </tr>\n <tr>\n <td>R11.2</td>\n <td>Nausea with vomiting, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>R18.0</td>\n <td>Malignant ascites</td>\n <td/>\n </tr>\n <tr>\n <td>R29.700</td>\n <td>NIHSS score 0</td>\n <td/>\n </tr>\n <tr>\n <td>R29.701</td>\n <td>NIHSS score 1</td>\n <td/>\n </tr>\n <tr>\n <td>R29.702</td>\n <td>NIHSS score 2</td>\n <td/>\n </tr>\n <tr>\n <td>R29.703</td>\n <td>NIHSS score 3</td>\n <td/>\n </tr>\n <tr>\n <td>R29.704</td>\n <td>NIHSS score 4</td>\n <td/>\n </tr>\n <tr>\n <td>R29.705</td>\n <td>NIHSS score 5</td>\n <td/>\n </tr>\n <tr>\n <td>R29.706</td>\n <td>NIHSS score 6</td>\n <td/>\n </tr>\n <tr>\n <td>R29.707</td>\n <td>NIHSS score 7</td>\n <td/>\n </tr>\n <tr>\n <td>R29.708</td>\n <td>NIHSS score 8</td>\n <td/>\n </tr>\n <tr>\n <td>R29.709</td>\n <td>NIHSS score 9</td>\n <td/>\n </tr>\n <tr>\n <td>R29.710</td>\n <td>NIHSS score 10</td>\n <td/>\n </tr>\n <tr>\n <td>R29.711</td>\n <td>NIHSS score 11</td>\n <td/>\n </tr>\n <tr>\n <td>R29.712</td>\n <td>NIHSS score 12</td>\n <td/>\n </tr>\n <tr>\n <td>R29.713</td>\n <td>NIHSS score 13</td>\n <td/>\n </tr>\n <tr>\n <td>R29.714</td>\n <td>NIHSS score 14</td>\n <td/>\n </tr>\n <tr>\n <td>R29.715</td>\n <td>NIHSS score 15</td>\n <td/>\n </tr>\n <tr>\n <td>R29.716</td>\n <td>NIHSS score 16</td>\n <td/>\n </tr>\n <tr>\n <td>R29.717</td>\n <td>NIHSS score 17</td>\n <td/>\n </tr>\n <tr>\n <td>R29.718</td>\n <td>NIHSS score 18</td>\n <td/>\n </tr>\n <tr>\n <td>R29.719</td>\n <td>NIHSS score 19</td>\n <td/>\n </tr>\n <tr>\n <td>R29.720</td>\n <td>NIHSS score 20</td>\n <td/>\n </tr>\n <tr>\n <td>R29.721</td>\n <td>NIHSS score 21</td>\n <td/>\n </tr>\n <tr>\n <td>R29.722</td>\n <td>NIHSS score 22</td>\n <td/>\n </tr>\n <tr>\n <td>R29.723</td>\n <td>NIHSS score 23</td>\n <td/>\n </tr>\n <tr>\n <td>R29.724</td>\n <td>NIHSS score 24</td>\n <td/>\n </tr>\n <tr>\n <td>R29.725</td>\n <td>NIHSS score 25</td>\n <td/>\n </tr>\n <tr>\n <td>R29.726</td>\n <td>NIHSS score 26</td>\n <td/>\n </tr>\n <tr>\n <td>R29.727</td>\n <td>NIHSS score 27</td>\n <td/>\n </tr>\n <tr>\n <td>R29.728</td>\n <td>NIHSS score 28</td>\n <td/>\n </tr>\n <tr>\n <td>R29.729</td>\n <td>NIHSS score 29</td>\n <td/>\n </tr>\n <tr>\n <td>R29.730</td>\n <td>NIHSS score 30</td>\n <td/>\n </tr>\n <tr>\n <td>R29.731</td>\n <td>NIHSS score 31</td>\n <td/>\n </tr>\n <tr>\n <td>R29.732</td>\n <td>NIHSS score 32</td>\n <td/>\n </tr>\n <tr>\n <td>R29.733</td>\n <td>NIHSS score 33</td>\n <td/>\n </tr>\n <tr>\n <td>R29.734</td>\n <td>NIHSS score 34</td>\n <td/>\n </tr>\n <tr>\n <td>R29.735</td>\n <td>NIHSS score 35</td>\n <td/>\n </tr>\n <tr>\n <td>R29.736</td>\n <td>NIHSS score 36</td>\n <td/>\n </tr>\n <tr>\n <td>R29.737</td>\n <td>NIHSS score 37</td>\n <td/>\n </tr>\n <tr>\n <td>R29.738</td>\n <td>NIHSS score 38</td>\n <td/>\n </tr>\n <tr>\n <td>R29.739</td>\n <td>NIHSS score 39</td>\n <td/>\n </tr>\n <tr>\n <td>R29.740</td>\n <td>NIHSS score 40</td>\n <td/>\n </tr>\n <tr>\n <td>R29.741</td>\n <td>NIHSS score 41</td>\n <td/>\n </tr>\n <tr>\n <td>R29.742</td>\n <td>NIHSS score 42</td>\n <td/>\n </tr>\n <tr>\n <td>R50.81</td>\n <td>Fever presenting with conditions classified elsewhere</td>\n <td/>\n </tr>\n <tr>\n <td>R50.9</td>\n <td>Fever, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>R53.0</td>\n <td>Neoplastic (malignant) related fatigue</td>\n <td/>\n </tr>\n <tr>\n <td>R53.1</td>\n <td>Weakness</td>\n <td/>\n </tr>\n <tr>\n <td>R53.81</td>\n <td>Other malaise</td>\n <td/>\n </tr>\n <tr>\n <td>R53.82</td>\n <td>Chronic fatigue, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>R53.83</td>\n <td>Other fatigue</td>\n <td/>\n </tr>\n <tr>\n <td>R55</td>\n <td>Syncope and collapse</td>\n <td/>\n </tr>\n <tr>\n <td>R57.0</td>\n <td>Cardiogenic shock</td>\n <td/>\n </tr>\n <tr>\n <td>R57.1</td>\n <td>Hypovolemic shock</td>\n <td/>\n </tr>\n <tr>\n <td>R57.8</td>\n <td>Other shock</td>\n <td/>\n </tr>\n <tr>\n <td>R57.9</td>\n <td>Shock, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>R58</td>\n <td>Hemorrhage, not elsewhere classified</td>\n <td/>\n </tr>\n <tr>\n <td>R59.0</td>\n <td>Localized enlarged lymph nodes</td>\n <td/>\n </tr>\n <tr>\n <td>R59.1</td>\n <td>Generalized enlarged lymph nodes</td>\n <td/>\n </tr>\n <tr>\n <td>R59.9</td>\n <td>Enlarged lymph nodes, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>R65.21</td>\n <td>Severe sepsis with septic shock</td>\n <td/>\n </tr>\n <tr>\n <td>R78.71</td>\n <td>Abnormal lead level in blood</td>\n <td/>\n </tr>\n <tr>\n <td>R78.79</td>\n <td>Finding of abnormal level of heavy metals in blood</td>\n <td/>\n </tr>\n <tr>\n <td>R78.89</td>\n <td>Finding of other specified substances, not normally found in blood</td>\n <td/>\n </tr>\n <tr>\n <td>R78.9</td>\n <td>Finding of unspecified substance, not normally found in blood</td>\n <td/>\n </tr>\n <tr>\n <td>R79.0</td>\n <td>Abnormal level of blood mineral</td>\n <td/>\n </tr>\n <tr>\n <td>R79.1</td>\n <td>Abnormal coagulation profile</td>\n <td/>\n </tr>\n <tr>\n <td>R79.81</td>\n <td>Abnormal blood-gas level</td>\n <td/>\n </tr>\n <tr>\n <td>R79.82</td>\n <td>Elevated C-reactive protein (CRP)</td>\n <td/>\n </tr>\n <tr>\n <td>R79.89</td>\n <td>Other specified abnormal findings of blood chemistry</td>\n <td/>\n </tr>\n <tr>\n <td>R79.9</td>\n <td>Abnormal finding of blood chemistry, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>R83.0</td>\n <td>Abnormal level of enzymes in cerebrospinal fluid</td>\n <td/>\n </tr>\n <tr>\n <td>R83.1</td>\n <td>Abnormal level of hormones in cerebrospinal fluid</td>\n <td/>\n </tr>\n <tr>\n <td>R83.2</td>\n <td>Abnormal level of other drugs, medicaments and biological substances in cerebrospinal fluid</td>\n <td/>\n </tr>\n <tr>\n <td>R83.3</td>\n <td>Abnormal level of substances chiefly nonmedicinal as to source in cerebrospinal fluid</td>\n <td/>\n </tr>\n <tr>\n <td>R83.4</td>\n <td>Abnormal immunological findings in cerebrospinal fluid</td>\n <td/>\n </tr>\n <tr>\n <td>R83.5</td>\n <td>Abnormal microbiological findings in cerebrospinal fluid</td>\n <td/>\n </tr>\n <tr>\n <td>R83.6</td>\n <td>Abnormal cytological findings in cerebrospinal fluid</td>\n <td/>\n </tr>\n <tr>\n <td>R83.8</td>\n <td>Other abnormal findings in cerebrospinal fluid</td>\n <td/>\n </tr>\n <tr>\n <td>R83.9</td>\n <td>Unspecified abnormal finding in cerebrospinal fluid</td>\n <td/>\n </tr>\n <tr>\n <td>R84.0</td>\n <td>Abnormal level of enzymes in specimens from respiratory organs and thorax</td>\n <td/>\n </tr>\n <tr>\n <td>R84.1</td>\n <td>Abnormal level of hormones in specimens from respiratory organs and thorax</td>\n <td/>\n </tr>\n <tr>\n <td>R84.2</td>\n <td>Abnormal level of other drugs, medicaments and biological substances in specimens from respiratory organs and thorax</td>\n <td/>\n </tr>\n <tr>\n <td>R84.3</td>\n <td>Abnormal level of substances chiefly nonmedicinal as to source in specimens from respiratory organs and thorax</td>\n <td/>\n </tr>\n <tr>\n <td>R84.4</td>\n <td>Abnormal immunological findings in specimens from respiratory organs and thorax</td>\n <td/>\n </tr>\n <tr>\n <td>R84.5</td>\n <td>Abnormal microbiological findings in specimens from respiratory organs and thorax</td>\n <td/>\n </tr>\n <tr>\n <td>R84.6</td>\n <td>Abnormal cytological findings in specimens from respiratory organs and thorax</td>\n <td/>\n </tr>\n <tr>\n <td>R84.7</td>\n <td>Abnormal histological findings in specimens from respiratory organs and thorax</td>\n <td/>\n </tr>\n <tr>\n <td>R84.8</td>\n <td>Other abnormal findings in specimens from respiratory organs and thorax</td>\n <td/>\n </tr>\n <tr>\n <td>R84.9</td>\n <td>Unspecified abnormal finding in specimens from respiratory organs and thorax</td>\n <td/>\n </tr>\n <tr>\n <td>R85.0</td>\n <td>Abnormal level of enzymes in specimens from digestive organs and abdominal cavity</td>\n <td/>\n </tr>\n <tr>\n <td>R85.1</td>\n <td>Abnormal level of hormones in specimens from digestive organs and abdominal cavity</td>\n <td/>\n </tr>\n <tr>\n <td>R85.2</td>\n <td>Abnormal level of other drugs, medicaments and biological substances in specimens from digestive organs and abdominal cavity</td>\n <td/>\n </tr>\n <tr>\n <td>R85.3</td>\n <td>Abnormal level of substances chiefly nonmedicinal as to source in specimens from digestive organs and abdominal cavity</td>\n <td/>\n </tr>\n <tr>\n <td>R85.4</td>\n <td>Abnormal immunological findings in specimens from digestive organs and abdominal cavity</td>\n <td/>\n </tr>\n <tr>\n <td>R85.5</td>\n <td>Abnormal microbiological findings in specimens from digestive organs and abdominal cavity</td>\n <td/>\n </tr>\n <tr>\n <td>R85.610</td>\n <td>Atypical squamous cells of undetermined significance on cytologic smear of anus (ASC-US)</td>\n <td/>\n </tr>\n <tr>\n <td>R85.611</td>\n <td>Atypical squamous cells cannot exclude high grade squamous intraepithelial lesion on cytologic smear of anus (ASC-H)</td>\n <td/>\n </tr>\n <tr>\n <td>R85.612</td>\n <td>Low grade squamous intraepithelial lesion on cytologic smear of anus (LGSIL)</td>\n <td/>\n </tr>\n <tr>\n <td>R85.613</td>\n <td>High grade squamous intraepithelial lesion on cytologic smear of anus (HGSIL)</td>\n <td/>\n </tr>\n <tr>\n <td>R85.614</td>\n <td>Cytologic evidence of malignancy on smear of anus</td>\n <td/>\n </tr>\n <tr>\n <td>R85.615</td>\n <td>Unsatisfactory cytologic smear of anus</td>\n <td/>\n </tr>\n <tr>\n <td>R85.616</td>\n <td>Satisfactory anal smear but lacking transformation zone</td>\n <td/>\n </tr>\n <tr>\n <td>R85.618</td>\n <td>Other abnormal cytological findings on specimens from anus</td>\n <td/>\n </tr>\n <tr>\n <td>R85.619</td>\n <td>Unspecified abnormal cytological findings in specimens from anus</td>\n <td/>\n </tr>\n <tr>\n <td>R85.69</td>\n <td>Abnormal cytological findings in specimens from other digestive organs and abdominal cavity</td>\n <td/>\n </tr>\n <tr>\n <td>R85.7</td>\n <td>Abnormal histological findings in specimens from digestive organs and abdominal cavity</td>\n <td/>\n </tr>\n <tr>\n <td>R85.89</td>\n <td>Other abnormal findings in specimens from digestive organs and abdominal cavity</td>\n <td/>\n </tr>\n <tr>\n <td>R85.9</td>\n <td>Unspecified abnormal finding in specimens from digestive organs and abdominal cavity</td>\n <td/>\n </tr>\n <tr>\n <td>R86.0</td>\n <td>Abnormal level of enzymes in specimens from male genital organs</td>\n <td/>\n </tr>\n <tr>\n <td>R86.1</td>\n <td>Abnormal level of hormones in specimens from male genital organs</td>\n <td/>\n </tr>\n <tr>\n <td>R86.2</td>\n <td>Abnormal level of other drugs, medicaments and biological substances in specimens from male genital organs</td>\n <td/>\n </tr>\n <tr>\n <td>R86.3</td>\n <td>Abnormal level of substances chiefly nonmedicinal as to source in specimens from male genital organs</td>\n <td/>\n </tr>\n <tr>\n <td>R86.4</td>\n <td>Abnormal immunological findings in specimens from male genital organs</td>\n <td/>\n </tr>\n <tr>\n <td>R86.5</td>\n <td>Abnormal microbiological findings in specimens from male genital organs</td>\n <td/>\n </tr>\n <tr>\n <td>R86.6</td>\n <td>Abnormal cytological findings in specimens from male genital organs</td>\n <td/>\n </tr>\n <tr>\n <td>R86.7</td>\n <td>Abnormal histological findings in specimens from male genital organs</td>\n <td/>\n </tr>\n <tr>\n <td>R86.8</td>\n <td>Other abnormal findings in specimens from male genital organs</td>\n <td/>\n </tr>\n <tr>\n <td>R86.9</td>\n <td>Unspecified abnormal finding in specimens from male genital organs</td>\n <td/>\n </tr>\n <tr>\n <td>R87.0</td>\n <td>Abnormal level of enzymes in specimens from female genital organs</td>\n <td/>\n </tr>\n <tr>\n <td>R87.1</td>\n <td>Abnormal level of hormones in specimens from female genital organs</td>\n <td/>\n </tr>\n <tr>\n <td>R87.2</td>\n <td>Abnormal level of other drugs, medicaments and biological substances in specimens from female genital organs</td>\n <td/>\n </tr>\n <tr>\n <td>R87.3</td>\n <td>Abnormal level of substances chiefly nonmedicinal as to source in specimens from female genital organs</td>\n <td/>\n </tr>\n <tr>\n <td>R87.4</td>\n <td>Abnormal immunological findings in specimens from female genital organs</td>\n <td/>\n </tr>\n <tr>\n <td>R87.5</td>\n <td>Abnormal microbiological findings in specimens from female genital organs</td>\n <td/>\n </tr>\n <tr>\n <td>R87.610</td>\n <td>Atypical squamous cells of undetermined significance on cytologic smear of cervix (ASC-US)</td>\n <td/>\n </tr>\n <tr>\n <td>R87.611</td>\n <td>Atypical squamous cells cannot exclude high grade squamous intraepithelial lesion on cytologic smear of cervix (ASC-H)</td>\n <td/>\n </tr>\n <tr>\n <td>R87.612</td>\n <td>Low grade squamous intraepithelial lesion on cytologic smear of cervix (LGSIL)</td>\n <td/>\n </tr>\n <tr>\n <td>R87.613</td>\n <td>High grade squamous intraepithelial lesion on cytologic smear of cervix (HGSIL)</td>\n <td/>\n </tr>\n <tr>\n <td>R87.614</td>\n <td>Cytologic evidence of malignancy on smear of cervix</td>\n <td/>\n </tr>\n <tr>\n <td>R87.615</td>\n <td>Unsatisfactory cytologic smear of cervix</td>\n <td/>\n </tr>\n <tr>\n <td>R87.616</td>\n <td>Satisfactory cervical smear but lacking transformation zone</td>\n <td/>\n </tr>\n <tr>\n <td>R87.618</td>\n <td>Other abnormal cytological findings on specimens from cervix uteri</td>\n <td/>\n </tr>\n <tr>\n <td>R87.619</td>\n <td>Unspecified abnormal cytological findings in specimens from cervix uteri</td>\n <td/>\n </tr>\n <tr>\n <td>R87.620</td>\n <td>Atypical squamous cells of undetermined significance on cytologic smear of vagina (ASC-US)</td>\n <td/>\n </tr>\n <tr>\n <td>R87.621</td>\n <td>Atypical squamous cells cannot exclude high grade squamous intraepithelial lesion on cytologic smear of vagina (ASC-H)</td>\n <td/>\n </tr>\n <tr>\n <td>R87.622</td>\n <td>Low grade squamous intraepithelial lesion on cytologic smear of vagina (LGSIL)</td>\n <td/>\n </tr>\n <tr>\n <td>R87.623</td>\n <td>High grade squamous intraepithelial lesion on cytologic smear of vagina (HGSIL)</td>\n <td/>\n </tr>\n <tr>\n <td>R87.624</td>\n <td>Cytologic evidence of malignancy on smear of vagina</td>\n <td/>\n </tr>\n <tr>\n <td>R87.625</td>\n <td>Unsatisfactory cytologic smear of vagina</td>\n <td/>\n </tr>\n <tr>\n <td>R87.628</td>\n <td>Other abnormal cytological findings on specimens from vagina</td>\n <td/>\n </tr>\n <tr>\n <td>R87.629</td>\n <td>Unspecified abnormal cytological findings in specimens from vagina</td>\n <td/>\n </tr>\n <tr>\n <td>R87.69</td>\n <td>Abnormal cytological findings in specimens from other female genital organs</td>\n <td/>\n </tr>\n <tr>\n <td>R87.7</td>\n <td>Abnormal histological findings in specimens from female genital organs</td>\n <td/>\n </tr>\n <tr>\n <td>R87.89</td>\n <td>Other abnormal findings in specimens from female genital organs</td>\n <td/>\n </tr>\n <tr>\n <td>R87.9</td>\n <td>Unspecified abnormal finding in specimens from female genital organs</td>\n <td/>\n </tr>\n <tr>\n <td>R88.8</td>\n <td>Abnormal findings in other body fluids and substances</td>\n <td/>\n </tr>\n <tr>\n <td>R89.0</td>\n <td>Abnormal level of enzymes in specimens from other organs, systems and tissues</td>\n <td/>\n </tr>\n <tr>\n <td>R89.1</td>\n <td>Abnormal level of hormones in specimens from other organs, systems and tissues</td>\n <td/>\n </tr>\n <tr>\n <td>R89.2</td>\n <td>Abnormal level of other drugs, medicaments and biological substances in specimens from other organs, systems and tissues</td>\n <td/>\n </tr>\n <tr>\n <td>R89.3</td>\n <td>Abnormal level of substances chiefly nonmedicinal as to source in specimens from other organs, systems and tissues</td>\n <td/>\n </tr>\n <tr>\n <td>R89.4</td>\n <td>Abnormal immunological findings in specimens from other organs, systems and tissues</td>\n <td/>\n </tr>\n <tr>\n <td>R89.5</td>\n <td>Abnormal microbiological findings in specimens from other organs, systems and tissues</td>\n <td/>\n </tr>\n <tr>\n <td>R89.6</td>\n <td>Abnormal cytological findings in specimens from other organs, systems and tissues</td>\n <td/>\n </tr>\n <tr>\n <td>R89.7</td>\n <td>Abnormal histological findings in specimens from other organs, systems and tissues</td>\n <td/>\n </tr>\n <tr>\n <td>R89.8</td>\n <td>Other abnormal findings in specimens from other organs, systems and tissues</td>\n <td/>\n </tr>\n <tr>\n <td>R89.9</td>\n <td>Unspecified abnormal finding in specimens from other organs, systems and tissues</td>\n <td/>\n </tr>\n <tr>\n <td>R90.81</td>\n <td>Abnormal echoencephalogram</td>\n <td/>\n </tr>\n <tr>\n <td>R90.89</td>\n <td>Other abnormal findings on diagnostic imaging of central nervous system</td>\n <td/>\n </tr>\n <tr>\n <td>R92.2</td>\n <td>Inconclusive mammogram</td>\n <td/>\n </tr>\n <tr>\n <td>R92.8</td>\n <td>Other abnormal and inconclusive findings on diagnostic imaging of breast</td>\n <td/>\n </tr>\n <tr>\n <td>R93.0</td>\n <td>Abnormal findings on diagnostic imaging of skull and head, not elsewhere classified</td>\n <td/>\n </tr>\n <tr>\n <td>R93.1</td>\n <td>Abnormal findings on diagnostic imaging of heart and coronary circulation</td>\n <td/>\n </tr>\n <tr>\n <td>R93.2</td>\n <td>Abnormal findings on diagnostic imaging of liver and biliary tract</td>\n <td/>\n </tr>\n <tr>\n <td>R93.3</td>\n <td>Abnormal findings on diagnostic imaging of other parts of digestive tract</td>\n <td/>\n </tr>\n <tr>\n <td>R93.4</td>\n <td>Abnormal findings on diagnostic imaging of urinary organs</td>\n <td/>\n </tr>\n <tr>\n <td>R93.41</td>\n <td>Abnormal radiologic findings on diagnostic imaging of renal pelvis, ureter, or bladder</td>\n <td/>\n </tr>\n <tr>\n <td>R93.421</td>\n <td>Abnormal radiologic findings on diagnostic imaging of right kidney</td>\n <td/>\n </tr>\n <tr>\n <td>R93.422</td>\n <td>Abnormal radiologic findings on diagnostic imaging of left kidney</td>\n <td/>\n </tr>\n <tr>\n <td>R93.429</td>\n <td>Abnormal radiologic findings on diagnostic imaging of unspecified kidney</td>\n <td/>\n </tr>\n <tr>\n <td>R93.49</td>\n <td>Abnormal radiologic findings on diagnostic imaging of other urinary organs</td>\n <td/>\n </tr>\n <tr>\n <td>R93.5</td>\n <td>Abnormal findings on diagnostic imaging of other abdominal regions, including retroperitoneum</td>\n <td/>\n </tr>\n <tr>\n <td>R93.6</td>\n <td>Abnormal findings on diagnostic imaging of limbs</td>\n <td/>\n </tr>\n <tr>\n <td>R93.7</td>\n <td>Abnormal findings on diagnostic imaging of other parts of musculoskeletal system</td>\n <td/>\n </tr>\n <tr>\n <td>R93.8</td>\n <td>Abnormal findings on diagnostic imaging of other specified body structures</td>\n <td/>\n </tr>\n <tr>\n <td>R93.811</td>\n <td>Abnormal radiologic findings on diagnostic imaging of right testicle</td>\n <td/>\n </tr>\n <tr>\n <td>R93.812</td>\n <td>Abnormal radiologic findings on diagnostic imaging of left testicle</td>\n <td/>\n </tr>\n <tr>\n <td>R93.813</td>\n <td>Abnormal radiologic findings on diagnostic imaging of testicles, bilateral</td>\n <td/>\n </tr>\n <tr>\n <td>R93.819</td>\n <td>Abnormal radiologic findings on diagnostic imaging of unspecified testicle</td>\n <td/>\n </tr>\n <tr>\n <td>R93.89</td>\n <td>Abnormal findings on diagnostic imaging of other specified body structures</td>\n <td/>\n </tr>\n <tr>\n <td>R93.9</td>\n <td>Diagnostic imaging inconclusive due to excess body fat of patient</td>\n <td/>\n </tr>\n <tr>\n <td>R94.01</td>\n <td>Abnormal electroencephalogram [EEG]</td>\n <td/>\n </tr>\n <tr>\n <td>R94.02</td>\n <td>Abnormal brain scan</td>\n <td/>\n </tr>\n <tr>\n <td>R94.09</td>\n <td>Abnormal results of other function studies of central nervous system</td>\n <td/>\n </tr>\n <tr>\n <td>R94.110</td>\n <td>Abnormal electro-oculogram [EOG]</td>\n <td/>\n </tr>\n <tr>\n <td>R94.111</td>\n <td>Abnormal electroretinogram [ERG]</td>\n <td/>\n </tr>\n <tr>\n <td>R94.112</td>\n <td>Abnormal visually evoked potential [VEP]</td>\n <td/>\n </tr>\n <tr>\n <td>R94.113</td>\n <td>Abnormal oculomotor study</td>\n <td/>\n </tr>\n <tr>\n <td>R94.118</td>\n <td>Abnormal results of other function studies of eye</td>\n <td/>\n </tr>\n <tr>\n <td>R94.120</td>\n <td>Abnormal auditory function study</td>\n <td/>\n </tr>\n <tr>\n <td>R94.121</td>\n <td>Abnormal vestibular function study</td>\n <td/>\n </tr>\n <tr>\n <td>R94.128</td>\n <td>Abnormal results of other function studies of ear and other special senses</td>\n <td/>\n </tr>\n <tr>\n <td>R94.130</td>\n <td>Abnormal response to nerve stimulation, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>R94.131</td>\n <td>Abnormal electromyogram [EMG]</td>\n <td/>\n </tr>\n <tr>\n <td>R94.138</td>\n <td>Abnormal results of other function studies of peripheral nervous system</td>\n <td/>\n </tr>\n <tr>\n <td>R94.2</td>\n <td>Abnormal results of pulmonary function studies</td>\n <td/>\n </tr>\n <tr>\n <td>R94.30</td>\n <td>Abnormal result of cardiovascular function study, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>R94.31</td>\n <td>Abnormal electrocardiogram [ECG] [EKG]</td>\n <td/>\n </tr>\n <tr>\n <td>R94.39</td>\n <td>Abnormal result of other cardiovascular function study</td>\n <td/>\n </tr>\n <tr>\n <td>R94.4</td>\n <td>Abnormal results of kidney function studies</td>\n <td/>\n </tr>\n <tr>\n <td>R94.5</td>\n <td>Abnormal results of liver function studies</td>\n <td/>\n </tr>\n <tr>\n <td>R94.6</td>\n <td>Abnormal results of thyroid function studies</td>\n <td/>\n </tr>\n <tr>\n <td>R94.7</td>\n <td>Abnormal results of other endocrine function studies</td>\n <td/>\n </tr>\n <tr>\n <td>R94.8</td>\n <td>Abnormal results of function studies of other organs and systems</td>\n <td/>\n </tr>\n <tr>\n <td>R97.0</td>\n <td>Elevated carcinoembryonic antigen [CEA]</td>\n <td/>\n </tr>\n <tr>\n <td>R97.1</td>\n <td>Elevated cancer antigen 125 [CA 125]</td>\n <td/>\n </tr>\n <tr>\n <td>R97.2</td>\n <td>Elevated prostate specific antigen [PSA]</td>\n <td/>\n </tr>\n <tr>\n <td>R97.20</td>\n <td>Elevated prostate specific antigen [PSA]</td>\n <td/>\n </tr>\n <tr>\n <td>R97.21</td>\n <td>Rising PSA following treatment for malignant neoplasm of prostate</td>\n <td/>\n </tr>\n <tr>\n <td>R97.8</td>\n <td>Other abnormal tumor markers</td>\n <td/>\n </tr>\n <tr>\n <td>T78.00XA</td>\n <td>Anaphylactic reaction due to unspecified food, initial encounter</td>\n <td/>\n </tr>\n <tr>\n <td>T78.00XD</td>\n <td>Anaphylactic reaction due to unspecified food, subsequent encounter</td>\n <td/>\n </tr>\n <tr>\n <td>T78.00XS</td>\n <td>Anaphylactic reaction due to unspecified food, sequela</td>\n <td/>\n </tr>\n <tr>\n <td>T78.01XA</td>\n <td>Anaphylactic reaction due to peanuts, initial encounter</td>\n <td/>\n </tr>\n <tr>\n <td>T78.01XD</td>\n <td>Anaphylactic reaction due to peanuts, subsequent encounter</td>\n <td/>\n </tr>\n <tr>\n <td>T78.01XS</td>\n <td>Anaphylactic reaction due to peanuts, sequela</td>\n <td/>\n </tr>\n <tr>\n <td>T78.02XA</td>\n <td>Anaphylactic reaction due to shellfish (crustaceans), initial encounter</td>\n <td/>\n </tr>\n <tr>\n <td>T78.02XD</td>\n <td>Anaphylactic reaction due to shellfish (crustaceans), subsequent encounter</td>\n <td/>\n </tr>\n <tr>\n <td>T78.02XS</td>\n <td>Anaphylactic reaction due to shellfish (crustaceans), sequela</td>\n <td/>\n </tr>\n <tr>\n <td>T78.03XA</td>\n <td>Anaphylactic reaction due to other fish, initial encounter</td>\n <td/>\n </tr>\n <tr>\n <td>T78.03XD</td>\n <td>Anaphylactic reaction due to other fish, subsequent encounter</td>\n <td/>\n </tr>\n <tr>\n <td>T78.03XS</td>\n <td>Anaphylactic reaction due to other fish, sequela</td>\n <td/>\n </tr>\n <tr>\n <td>T78.04XA</td>\n <td>Anaphylactic reaction due to fruits and vegetables, initial encounter</td>\n <td/>\n </tr>\n <tr>\n <td>T78.04XD</td>\n <td>Anaphylactic reaction due to fruits and vegetables, subsequent encounter</td>\n <td/>\n </tr>\n <tr>\n <td>T78.04XS</td>\n <td>Anaphylactic reaction due to fruits and vegetables, sequela</td>\n <td/>\n </tr>\n <tr>\n <td>T78.05XA</td>\n <td>Anaphylactic reaction due to tree nuts and seeds, initial encounter</td>\n <td/>\n </tr>\n <tr>\n <td>T78.05XD</td>\n <td>Anaphylactic reaction due to tree nuts and seeds, subsequent encounter</td>\n <td/>\n </tr>\n <tr>\n <td>T78.05XS</td>\n <td>Anaphylactic reaction due to tree nuts and seeds, sequela</td>\n <td/>\n </tr>\n <tr>\n <td>T78.06XA</td>\n <td>Anaphylactic reaction due to food additives, initial encounter</td>\n <td/>\n </tr>\n <tr>\n <td>T78.06XD</td>\n <td>Anaphylactic reaction due to food additives, subsequent encounter</td>\n <td/>\n </tr>\n <tr>\n <td>T78.06XS</td>\n <td>Anaphylactic reaction due to food additives, sequela</td>\n <td/>\n </tr>\n <tr>\n <td>T78.07XA</td>\n <td>Anaphylactic reaction due to milk and dairy products, initial encounter</td>\n <td/>\n </tr>\n <tr>\n <td>T78.07XD</td>\n <td>Anaphylactic reaction due to milk and dairy products, subsequent encounter</td>\n <td/>\n </tr>\n <tr>\n <td>T78.07XS</td>\n <td>Anaphylactic reaction due to milk and dairy products, sequela</td>\n <td/>\n </tr>\n <tr>\n <td>T78.08XA</td>\n <td>Anaphylactic reaction due to eggs, initial encounter</td>\n <td/>\n </tr>\n <tr>\n <td>T78.08XD</td>\n <td>Anaphylactic reaction due to eggs, subsequent encounter</td>\n <td/>\n </tr>\n <tr>\n <td>T78.08XS</td>\n <td>Anaphylactic reaction due to eggs, sequela</td>\n <td/>\n </tr>\n <tr>\n <td>T78.09XA</td>\n <td>Anaphylactic reaction due to other food products, initial encounter</td>\n <td/>\n </tr>\n <tr>\n <td>T78.09XD</td>\n <td>Anaphylactic reaction due to other food products, subsequent encounter</td>\n <td/>\n </tr>\n <tr>\n <td>T78.09XS</td>\n <td>Anaphylactic reaction due to other food products, sequela</td>\n <td/>\n </tr>\n <tr>\n <td>T78.1XXA</td>\n <td>Other adverse food reactions, not elsewhere classified, initial encounter</td>\n <td/>\n </tr>\n <tr>\n <td>T78.1XXD</td>\n <td>Other adverse food reactions, not elsewhere classified, subsequent encounter</td>\n <td/>\n </tr>\n <tr>\n <td>T78.1XXS</td>\n <td>Other adverse food reactions, not elsewhere classified, sequela</td>\n <td/>\n </tr>\n <tr>\n <td>T78.2XXA</td>\n <td>Anaphylactic shock, unspecified, initial encounter</td>\n <td/>\n </tr>\n <tr>\n <td>T78.40XA</td>\n <td>Allergy, unspecified, initial encounter</td>\n <td/>\n </tr>\n <tr>\n <td>T78.49XA</td>\n <td>Other allergy, initial encounter</td>\n <td/>\n </tr>\n <tr>\n <td>Z00.00</td>\n <td>Encounter for general adult medical examination without abnormal findings</td>\n <td/>\n </tr>\n <tr>\n <td>Z00.01</td>\n <td>Encounter for general adult medical examination with abnormal findings</td>\n <td/>\n </tr>\n <tr>\n <td>Z00.110</td>\n <td>Health examination for newborn under 8 days old</td>\n <td/>\n </tr>\n <tr>\n <td>Z00.111</td>\n <td>Health examination for newborn 8 to 28 days old</td>\n <td/>\n </tr>\n <tr>\n <td>Z00.121</td>\n <td>Encounter for routine child health examination with abnormal findings</td>\n <td/>\n </tr>\n <tr>\n <td>Z00.129</td>\n <td>Encounter for routine child health examination without abnormal findings</td>\n <td/>\n </tr>\n <tr>\n <td>Z00.2</td>\n <td>Encounter for examination for period of rapid growth in childhood</td>\n <td/>\n </tr>\n <tr>\n <td>Z00.3</td>\n <td>Encounter for examination for adolescent development state</td>\n <td/>\n </tr>\n <tr>\n <td>Z00.5</td>\n <td>Encounter for examination of potential donor of organ and tissue</td>\n <td/>\n </tr>\n <tr>\n <td>Z00.6</td>\n <td>Encounter for examination for normal comparison and control in clinical research program</td>\n <td/>\n </tr>\n <tr>\n <td>Z00.70</td>\n <td>Encounter for examination for period of delayed growth in childhood without abnormal findings</td>\n <td/>\n </tr>\n <tr>\n <td>Z00.71</td>\n <td>Encounter for examination for period of delayed growth in childhood with abnormal findings</td>\n <td/>\n </tr>\n <tr>\n <td>Z00.8</td>\n <td>Encounter for other general examination</td>\n <td/>\n </tr>\n <tr>\n <td>Z01.00</td>\n <td>Encounter for examination of eyes and vision without abnormal findings</td>\n <td/>\n </tr>\n <tr>\n <td>Z01.01</td>\n <td>Encounter for examination of eyes and vision with abnormal findings</td>\n <td/>\n </tr>\n <tr>\n <td>Z01.10</td>\n <td>Encounter for examination of ears and hearing without abnormal findings</td>\n <td/>\n </tr>\n <tr>\n <td>Z01.110</td>\n <td>Encounter for hearing examination following failed hearing screening</td>\n <td/>\n </tr>\n <tr>\n <td>Z01.118</td>\n <td>Encounter for examination of ears and hearing with other abnormal findings</td>\n <td/>\n </tr>\n <tr>\n <td>Z01.12</td>\n <td>Encounter for hearing conservation and treatment</td>\n <td/>\n </tr>\n <tr>\n <td>Z01.20</td>\n <td>Encounter for dental examination and cleaning without abnormal findings</td>\n <td/>\n </tr>\n <tr>\n <td>Z01.21</td>\n <td>Encounter for dental examination and cleaning with abnormal findings</td>\n <td/>\n </tr>\n <tr>\n <td>Z01.30</td>\n <td>Encounter for examination of blood pressure without abnormal findings</td>\n <td/>\n </tr>\n <tr>\n <td>Z01.31</td>\n <td>Encounter for examination of blood pressure with abnormal findings</td>\n <td/>\n </tr>\n <tr>\n <td>Z01.411</td>\n <td>Encounter for gynecological examination (general) (routine) with abnormal findings</td>\n <td/>\n </tr>\n <tr>\n <td>Z01.419</td>\n <td>Encounter for gynecological examination (general) (routine) without abnormal findings</td>\n <td/>\n </tr>\n <tr>\n <td>Z01.42</td>\n <td>Encounter for cervical smear to confirm findings of recent normal smear following initial abnormal smear</td>\n <td/>\n </tr>\n <tr>\n <td>Z01.810</td>\n <td>Encounter for preprocedural cardiovascular examination</td>\n <td/>\n </tr>\n <tr>\n <td>Z01.811</td>\n <td>Encounter for preprocedural respiratory examination</td>\n <td/>\n </tr>\n <tr>\n <td>Z01.812</td>\n <td>Encounter for preprocedural laboratory examination</td>\n <td/>\n </tr>\n <tr>\n <td>Z01.818</td>\n <td>Encounter for other preprocedural examination</td>\n <td/>\n </tr>\n <tr>\n <td>Z01.82</td>\n <td>Encounter for allergy testing</td>\n <td/>\n </tr>\n <tr>\n <td>Z01.83</td>\n <td>Encounter for blood typing</td>\n <td/>\n </tr>\n <tr>\n <td>Z01.84</td>\n <td>Encounter for antibody response examination</td>\n <td/>\n </tr>\n <tr>\n <td>Z01.89</td>\n <td>Encounter for other specified special examinations</td>\n <td/>\n </tr>\n <tr>\n <td>Z02.0</td>\n <td>Encounter for examination for admission to educational institution</td>\n <td/>\n </tr>\n <tr>\n <td>Z02.1</td>\n <td>Encounter for pre-employment examination</td>\n <td/>\n </tr>\n <tr>\n <td>Z02.2</td>\n <td>Encounter for examination for admission to residential institution</td>\n <td/>\n </tr>\n <tr>\n <td>Z02.3</td>\n <td>Encounter for examination for recruitment to armed forces</td>\n <td/>\n </tr>\n <tr>\n <td>Z02.4</td>\n <td>Encounter for examination for driving license</td>\n <td/>\n </tr>\n <tr>\n <td>Z02.5</td>\n <td>Encounter for examination for participation in sport</td>\n <td/>\n </tr>\n <tr>\n <td>Z02.6</td>\n <td>Encounter for examination for insurance purposes</td>\n <td/>\n </tr>\n <tr>\n <td>Z02.71</td>\n <td>Encounter for disability determination</td>\n <td/>\n </tr>\n <tr>\n <td>Z02.79</td>\n <td>Encounter for issue of other medical certificate</td>\n <td/>\n </tr>\n <tr>\n <td>Z02.81</td>\n <td>Encounter for paternity testing</td>\n <td/>\n </tr>\n <tr>\n <td>Z02.82</td>\n <td>Encounter for adoption services</td>\n <td/>\n </tr>\n <tr>\n <td>Z02.83</td>\n <td>Encounter for blood-alcohol and blood-drug test</td>\n <td/>\n </tr>\n <tr>\n <td>Z02.89</td>\n <td>Encounter for other administrative examinations</td>\n <td/>\n </tr>\n <tr>\n <td>Z02.9</td>\n <td>Encounter for administrative examinations, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>Z03.6</td>\n <td>Encounter for observation for suspected toxic effect from ingested substance ruled out</td>\n <td/>\n </tr>\n <tr>\n <td>Z03.71</td>\n <td>Encounter for suspected problem with amniotic cavity and membrane ruled out</td>\n <td/>\n </tr>\n <tr>\n <td>Z03.72</td>\n <td>Encounter for suspected placental problem ruled out</td>\n <td/>\n </tr>\n <tr>\n <td>Z03.73</td>\n <td>Encounter for suspected fetal anomaly ruled out</td>\n <td/>\n </tr>\n <tr>\n <td>Z03.74</td>\n <td>Encounter for suspected problem with fetal growth ruled out</td>\n <td/>\n </tr>\n <tr>\n <td>Z03.75</td>\n <td>Encounter for suspected cervical shortening ruled out</td>\n <td/>\n </tr>\n <tr>\n <td>Z03.79</td>\n <td>Encounter for other suspected maternal and fetal conditions ruled out</td>\n <td/>\n </tr>\n <tr>\n <td>Z03.89</td>\n <td>Encounter for observation for other suspected diseases and conditions ruled out</td>\n <td/>\n </tr>\n <tr>\n <td>Z04.41</td>\n <td>Encounter for examination and observation following alleged adult rape</td>\n <td/>\n </tr>\n <tr>\n <td>Z04.42</td>\n <td>Encounter for examination and observation following alleged child rape</td>\n <td/>\n </tr>\n <tr>\n <td>Z04.71</td>\n <td>Encounter for examination and observation following alleged adult physical abuse</td>\n <td/>\n </tr>\n <tr>\n <td>Z04.72</td>\n <td>Encounter for examination and observation following alleged child physical abuse</td>\n <td/>\n </tr>\n <tr>\n <td>Z04.8</td>\n <td>Encounter for examination and observation for other specified reasons</td>\n <td/>\n </tr>\n <tr>\n <td>Z04.81</td>\n <td>Encounter for examination and observation of victim following forced sexual exploitation</td>\n <td/>\n </tr>\n <tr>\n <td>Z04.82</td>\n <td>Encounter for examination and observation of victim following forced labor exploitation</td>\n <td/>\n </tr>\n <tr>\n <td>Z04.89</td>\n <td>Encounter for examination and observation for other specified reasons</td>\n <td/>\n </tr>\n <tr>\n <td>Z04.9</td>\n <td>Encounter for examination and observation for unspecified reason</td>\n <td/>\n </tr>\n <tr>\n <td>Z05.0</td>\n <td>Observation and evaluation of newborn for suspected cardiac condition ruled out</td>\n <td/>\n </tr>\n <tr>\n <td>Z05.2</td>\n <td>Observation and evaluation of newborn for suspected neurological condition ruled out</td>\n <td/>\n </tr>\n <tr>\n <td>Z05.3</td>\n <td>Observation and evaluation of newborn for suspected respiratory condition ruled out</td>\n <td/>\n </tr>\n <tr>\n <td>Z05.41</td>\n <td>Observation and evaluation of newborn for suspected genetic condition ruled out</td>\n <td/>\n </tr>\n <tr>\n <td>Z05.42</td>\n <td>Observation and evaluation of newborn for suspected metabolic condition ruled out</td>\n <td/>\n </tr>\n <tr>\n <td>Z05.43</td>\n <td>Observation and evaluation of newborn for suspected immunologic condition ruled out</td>\n <td/>\n </tr>\n <tr>\n <td>Z05.5</td>\n <td>Observation and evaluation of newborn for suspected gastrointestinal condition ruled out</td>\n <td/>\n </tr>\n <tr>\n <td>Z05.6</td>\n <td>Observation and evaluation of newborn for suspected genitourinary condition ruled out</td>\n <td/>\n </tr>\n <tr>\n <td>Z05.71</td>\n <td>Observation and evaluation of newborn for suspected skin and subcutaneous tissue condition ruled out</td>\n <td/>\n </tr>\n <tr>\n <td>Z05.72</td>\n <td>Observation and evaluation of newborn for suspected musculoskeletal condition ruled out</td>\n <td/>\n </tr>\n <tr>\n <td>Z05.73</td>\n <td>Observation and evaluation of newborn for suspected connective tissue condition ruled out</td>\n <td/>\n </tr>\n <tr>\n <td>Z05.8</td>\n <td>Observation and evaluation of newborn for other specified suspected condition ruled out</td>\n <td/>\n </tr>\n <tr>\n <td>Z05.9</td>\n <td>Observation and evaluation of newborn for unspecified suspected condition ruled out</td>\n <td/>\n </tr>\n <tr>\n <td>Z08</td>\n <td>Encounter for follow-up examination after completed treatment for malignant neoplasm</td>\n <td/>\n </tr>\n <tr>\n <td>Z09</td>\n <td>Encounter for follow-up examination after completed treatment for conditions other than malignant neoplasm</td>\n <td/>\n </tr>\n <tr>\n <td>Z12.0</td>\n <td>Encounter for screening for malignant neoplasm of stomach</td>\n <td/>\n </tr>\n <tr>\n <td>Z12.10</td>\n <td>Encounter for screening for malignant neoplasm of intestinal tract, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>Z12.11</td>\n <td>Encounter for screening for malignant neoplasm of colon</td>\n <td/>\n </tr>\n <tr>\n <td>Z12.12</td>\n <td>Encounter for screening for malignant neoplasm of rectum</td>\n <td/>\n </tr>\n <tr>\n <td>Z12.13</td>\n <td>Encounter for screening for malignant neoplasm of small intestine</td>\n <td/>\n </tr>\n <tr>\n <td>Z12.2</td>\n <td>Encounter for screening for malignant neoplasm of respiratory organs</td>\n <td/>\n </tr>\n <tr>\n <td>Z12.31</td>\n <td>Encounter for screening mammogram for malignant neoplasm of breast</td>\n <td/>\n </tr>\n <tr>\n <td>Z12.39</td>\n <td>Encounter for other screening for malignant neoplasm of breast</td>\n <td/>\n </tr>\n <tr>\n <td>Z12.4</td>\n <td>Encounter for screening for malignant neoplasm of cervix</td>\n <td/>\n </tr>\n <tr>\n <td>Z12.5</td>\n <td>Encounter for screening for malignant neoplasm of prostate</td>\n <td/>\n </tr>\n <tr>\n <td>Z12.6</td>\n <td>Encounter for screening for malignant neoplasm of bladder</td>\n <td/>\n </tr>\n <tr>\n <td>Z12.71</td>\n <td>Encounter for screening for malignant neoplasm of testis</td>\n <td/>\n </tr>\n <tr>\n <td>Z12.72</td>\n <td>Encounter for screening for malignant neoplasm of vagina</td>\n <td/>\n </tr>\n <tr>\n <td>Z12.73</td>\n <td>Encounter for screening for malignant neoplasm of ovary</td>\n <td/>\n </tr>\n <tr>\n <td>Z12.79</td>\n <td>Encounter for screening for malignant neoplasm of other genitourinary organs</td>\n <td/>\n </tr>\n <tr>\n <td>Z12.81</td>\n <td>Encounter for screening for malignant neoplasm of oral cavity</td>\n <td/>\n </tr>\n <tr>\n <td>Z12.82</td>\n <td>Encounter for screening for malignant neoplasm of nervous system</td>\n <td/>\n </tr>\n <tr>\n <td>Z12.83</td>\n <td>Encounter for screening for malignant neoplasm of skin</td>\n <td/>\n </tr>\n <tr>\n <td>Z12.89</td>\n <td>Encounter for screening for malignant neoplasm of other sites</td>\n <td/>\n </tr>\n <tr>\n <td>Z12.9</td>\n <td>Encounter for screening for malignant neoplasm, site unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>Z13.0</td>\n <td>Encounter for screening for diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism</td>\n <td/>\n </tr>\n <tr>\n <td>Z13.1</td>\n <td>Encounter for screening for diabetes mellitus</td>\n <td/>\n </tr>\n <tr>\n <td>Z13.21</td>\n <td>Encounter for screening for nutritional disorder</td>\n <td/>\n </tr>\n <tr>\n <td>Z13.220</td>\n <td>Encounter for screening for lipoid disorders</td>\n <td/>\n </tr>\n <tr>\n <td>Z13.228</td>\n <td>Encounter for screening for other metabolic disorders</td>\n <td/>\n </tr>\n <tr>\n <td>Z13.29</td>\n <td>Encounter for screening for other suspected endocrine disorder</td>\n <td/>\n </tr>\n <tr>\n <td>Z13.5</td>\n <td>Encounter for screening for eye and ear disorders</td>\n <td/>\n </tr>\n <tr>\n <td>Z13.6</td>\n <td>Encounter for screening for cardiovascular disorders</td>\n <td/>\n </tr>\n <tr>\n <td>Z13.71</td>\n <td>Encounter for nonprocreative screening for genetic disease carrier status</td>\n <td/>\n </tr>\n <tr>\n <td>Z13.79</td>\n <td>Encounter for other screening for genetic and chromosomal anomalies</td>\n <td/>\n </tr>\n <tr>\n <td>Z13.810</td>\n <td>Encounter for screening for upper gastrointestinal disorder</td>\n <td/>\n </tr>\n <tr>\n <td>Z13.811</td>\n <td>Encounter for screening for lower gastrointestinal disorder</td>\n <td/>\n </tr>\n <tr>\n <td>Z13.818</td>\n <td>Encounter for screening for other digestive system disorders</td>\n <td/>\n </tr>\n <tr>\n <td>Z13.820</td>\n <td>Encounter for screening for osteoporosis</td>\n <td/>\n </tr>\n <tr>\n <td>Z13.828</td>\n <td>Encounter for screening for other musculoskeletal disorder</td>\n <td/>\n </tr>\n <tr>\n <td>Z13.83</td>\n <td>Encounter for screening for respiratory disorder NEC</td>\n <td/>\n </tr>\n <tr>\n <td>Z13.84</td>\n <td>Encounter for screening for dental disorders</td>\n <td/>\n </tr>\n <tr>\n <td>Z13.850</td>\n <td>Encounter for screening for traumatic brain injury</td>\n <td/>\n </tr>\n <tr>\n <td>Z13.858</td>\n <td>Encounter for screening for other nervous system disorders</td>\n <td/>\n </tr>\n <tr>\n <td>Z13.88</td>\n <td>Encounter for screening for disorder due to exposure to contaminants</td>\n <td/>\n </tr>\n <tr>\n <td>Z13.89</td>\n <td>Encounter for screening for other disorder</td>\n <td/>\n </tr>\n <tr>\n <td>Z13.9</td>\n <td>Encounter for screening, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>Z32.00</td>\n <td>Encounter for pregnancy test, result unknown</td>\n <td/>\n </tr>\n <tr>\n <td>Z32.02</td>\n <td>Encounter for pregnancy test, result negative</td>\n <td/>\n </tr>\n <tr>\n <td>Z32.2</td>\n <td>Encounter for childbirth instruction</td>\n <td/>\n </tr>\n <tr>\n <td>Z32.3</td>\n <td>Encounter for childcare instruction</td>\n <td/>\n </tr>\n <tr>\n <td>Z36</td>\n <td>Encounter for antenatal screening of mother</td>\n <td/>\n </tr>\n <tr>\n <td>Z36.0</td>\n <td>Encounter for antenatal screening for chromosomal anomalies</td>\n <td/>\n </tr>\n <tr>\n <td>Z36.1</td>\n <td>Encounter for antenatal screening for raised alphafetoprotein level</td>\n <td/>\n </tr>\n <tr>\n <td>Z36.2</td>\n <td>Encounter for other antenatal screening follow-up</td>\n <td/>\n </tr>\n <tr>\n <td>Z36.3</td>\n <td>Encounter for antenatal screening for malformations</td>\n <td/>\n </tr>\n <tr>\n <td>Z36.4</td>\n <td>Encounter for antenatal screening for fetal growth retardation</td>\n <td/>\n </tr>\n <tr>\n <td>Z36.5</td>\n <td>Encounter for antenatal screening for isoimmunization</td>\n <td/>\n </tr>\n <tr>\n <td>Z36.81</td>\n <td>Encounter for antenatal screening for hydrops fetalis</td>\n <td/>\n </tr>\n <tr>\n <td>Z36.82</td>\n <td>Encounter for antenatal screening for nuchal translucency</td>\n <td/>\n </tr>\n <tr>\n <td>Z36.83</td>\n <td>Encounter for fetal screening for congenital cardiac abnormalities</td>\n <td/>\n </tr>\n <tr>\n <td>Z36.84</td>\n <td>Encounter for antenatal screening for fetal lung maturity</td>\n <td/>\n </tr>\n <tr>\n <td>Z36.85</td>\n <td>Encounter for antenatal screening for Streptococcus B</td>\n <td/>\n </tr>\n <tr>\n <td>Z36.86</td>\n <td>Encounter for antenatal screening for cervical length</td>\n <td/>\n </tr>\n <tr>\n <td>Z36.87</td>\n <td>Encounter for antenatal screening for uncertain dates</td>\n <td/>\n </tr>\n <tr>\n <td>Z36.88</td>\n <td>Encounter for antenatal screening for fetal macrosomia</td>\n <td/>\n </tr>\n <tr>\n <td>Z36.89</td>\n <td>Encounter for other specified antenatal screening</td>\n <td/>\n </tr>\n <tr>\n <td>Z36.8A</td>\n <td>Encounter for antenatal screening for other genetic defects</td>\n <td/>\n </tr>\n <tr>\n <td>Z36.9</td>\n <td>Encounter for antenatal screening, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>Z42.1</td>\n <td>Encounter for breast reconstruction following mastectomy</td>\n <td/>\n </tr>\n <tr>\n <td>Z42.8</td>\n <td>Encounter for other plastic and reconstructive surgery following medical procedure or healed injury</td>\n <td/>\n </tr>\n <tr>\n <td>Z43.8</td>\n <td>Encounter for attention to other artificial openings</td>\n <td/>\n </tr>\n <tr>\n <td>Z43.9</td>\n <td>Encounter for attention to unspecified artificial opening</td>\n <td/>\n </tr>\n <tr>\n <td>Z44.001</td>\n <td>Encounter for fitting and adjustment of unspecified right artificial arm</td>\n <td/>\n </tr>\n <tr>\n <td>Z44.002</td>\n <td>Encounter for fitting and adjustment of unspecified left artificial arm</td>\n <td/>\n </tr>\n <tr>\n <td>Z44.009</td>\n <td>Encounter for fitting and adjustment of unspecified artificial arm, unspecified arm</td>\n <td/>\n </tr>\n <tr>\n <td>Z44.011</td>\n <td>Encounter for fitting and adjustment of complete right artificial arm</td>\n <td/>\n </tr>\n <tr>\n <td>Z44.012</td>\n <td>Encounter for fitting and adjustment of complete left artificial arm</td>\n <td/>\n </tr>\n <tr>\n <td>Z44.019</td>\n <td>Encounter for fitting and adjustment of complete artificial arm, unspecified arm</td>\n <td/>\n </tr>\n <tr>\n <td>Z44.021</td>\n <td>Encounter for fitting and adjustment of partial artificial right arm</td>\n <td/>\n </tr>\n <tr>\n <td>Z44.022</td>\n <td>Encounter for fitting and adjustment of partial artificial left arm</td>\n <td/>\n </tr>\n <tr>\n <td>Z44.029</td>\n <td>Encounter for fitting and adjustment of partial artificial arm, unspecified arm</td>\n <td/>\n </tr>\n <tr>\n <td>Z44.101</td>\n <td>Encounter for fitting and adjustment of unspecified right artificial leg</td>\n <td/>\n </tr>\n <tr>\n <td>Z44.102</td>\n <td>Encounter for fitting and adjustment of unspecified left artificial leg</td>\n <td/>\n </tr>\n <tr>\n <td>Z44.109</td>\n <td>Encounter for fitting and adjustment of unspecified artificial leg, unspecified leg</td>\n <td/>\n </tr>\n <tr>\n <td>Z44.111</td>\n <td>Encounter for fitting and adjustment of complete right artificial leg</td>\n <td/>\n </tr>\n <tr>\n <td>Z44.112</td>\n <td>Encounter for fitting and adjustment of complete left artificial leg</td>\n <td/>\n </tr>\n <tr>\n <td>Z44.119</td>\n <td>Encounter for fitting and adjustment of complete artificial leg, unspecified leg</td>\n <td/>\n </tr>\n <tr>\n <td>Z44.121</td>\n <td>Encounter for fitting and adjustment of partial artificial right leg</td>\n <td/>\n </tr>\n <tr>\n <td>Z44.122</td>\n <td>Encounter for fitting and adjustment of partial artificial left leg</td>\n <td/>\n </tr>\n <tr>\n <td>Z44.129</td>\n <td>Encounter for fitting and adjustment of partial artificial leg, unspecified leg</td>\n <td/>\n </tr>\n <tr>\n <td>Z44.30</td>\n <td>Encounter for fitting and adjustment of external breast prosthesis, unspecified breast</td>\n <td/>\n </tr>\n <tr>\n <td>Z44.31</td>\n <td>Encounter for fitting and adjustment of external right breast prosthesis</td>\n <td/>\n </tr>\n <tr>\n <td>Z44.32</td>\n <td>Encounter for fitting and adjustment of external left breast prosthesis</td>\n <td/>\n </tr>\n <tr>\n <td>Z44.8</td>\n <td>Encounter for fitting and adjustment of other external prosthetic devices</td>\n <td/>\n </tr>\n <tr>\n <td>Z44.9</td>\n <td>Encounter for fitting and adjustment of unspecified external prosthetic device</td>\n <td/>\n </tr>\n <tr>\n <td>Z45.010</td>\n <td>Encounter for checking and testing of cardiac pacemaker pulse generator [battery]</td>\n <td/>\n </tr>\n <tr>\n <td>Z45.018</td>\n <td>Encounter for adjustment and management of other part of cardiac pacemaker</td>\n <td/>\n </tr>\n <tr>\n <td>Z45.02</td>\n <td>Encounter for adjustment and management of automatic implantable cardiac defibrillator</td>\n <td/>\n </tr>\n <tr>\n <td>Z45.09</td>\n <td>Encounter for adjustment and management of other cardiac device</td>\n <td/>\n </tr>\n <tr>\n <td>Z45.1</td>\n <td>Encounter for adjustment and management of infusion pump</td>\n <td/>\n </tr>\n <tr>\n <td>Z45.2</td>\n <td>Encounter for adjustment and management of vascular access device</td>\n <td/>\n </tr>\n <tr>\n <td>Z45.31</td>\n <td>Encounter for adjustment and management of implanted visual substitution device</td>\n <td/>\n </tr>\n <tr>\n <td>Z45.320</td>\n <td>Encounter for adjustment and management of bone conduction device</td>\n <td/>\n </tr>\n <tr>\n <td>Z45.321</td>\n <td>Encounter for adjustment and management of cochlear device</td>\n <td/>\n </tr>\n <tr>\n <td>Z45.328</td>\n <td>Encounter for adjustment and management of other implanted hearing device</td>\n <td/>\n </tr>\n <tr>\n <td>Z45.41</td>\n <td>Encounter for adjustment and management of cerebrospinal fluid drainage device</td>\n <td/>\n </tr>\n <tr>\n <td>Z45.42</td>\n <td>Encounter for adjustment and management of neurostimulator</td>\n <td/>\n </tr>\n <tr>\n <td>Z45.49</td>\n <td>Encounter for adjustment and management of other implanted nervous system device</td>\n <td/>\n </tr>\n <tr>\n <td>Z45.811</td>\n <td>Encounter for adjustment or removal of right breast implant</td>\n <td/>\n </tr>\n <tr>\n <td>Z45.812</td>\n <td>Encounter for adjustment or removal of left breast implant</td>\n <td/>\n </tr>\n <tr>\n <td>Z45.819</td>\n <td>Encounter for adjustment or removal of unspecified breast implant</td>\n <td/>\n </tr>\n <tr>\n <td>Z45.82</td>\n <td>Encounter for adjustment or removal of myringotomy device (stent) (tube)</td>\n <td/>\n </tr>\n <tr>\n <td>Z45.89</td>\n <td>Encounter for adjustment and management of other implanted devices</td>\n <td/>\n </tr>\n <tr>\n <td>Z45.9</td>\n <td>Encounter for adjustment and management of unspecified implanted device</td>\n <td/>\n </tr>\n <tr>\n <td>Z46.82</td>\n <td>Encounter for fitting and adjustment of non-vascular catheter</td>\n <td/>\n </tr>\n <tr>\n <td>Z46.89</td>\n <td>Encounter for fitting and adjustment of other specified devices</td>\n <td/>\n </tr>\n <tr>\n <td>Z46.9</td>\n <td>Encounter for fitting and adjustment of unspecified device</td>\n <td/>\n </tr>\n <tr>\n <td>Z47.1</td>\n <td>Aftercare following joint replacement surgery</td>\n <td/>\n </tr>\n <tr>\n <td>Z47.2</td>\n <td>Encounter for removal of internal fixation device</td>\n <td/>\n </tr>\n <tr>\n <td>Z47.31</td>\n <td>Aftercare following explantation of shoulder joint prosthesis</td>\n <td/>\n </tr>\n <tr>\n <td>Z47.32</td>\n <td>Aftercare following explantation of hip joint prosthesis</td>\n <td/>\n </tr>\n <tr>\n <td>Z47.33</td>\n <td>Aftercare following explantation of knee joint prosthesis</td>\n <td/>\n </tr>\n <tr>\n <td>Z47.81</td>\n <td>Encounter for orthopedic aftercare following surgical amputation</td>\n <td/>\n </tr>\n <tr>\n <td>Z47.82</td>\n <td>Encounter for orthopedic aftercare following scoliosis surgery</td>\n <td/>\n </tr>\n <tr>\n <td>Z47.89</td>\n <td>Encounter for other orthopedic aftercare</td>\n <td/>\n </tr>\n <tr>\n <td>Z48.00</td>\n <td>Encounter for change or removal of nonsurgical wound dressing</td>\n <td/>\n </tr>\n <tr>\n <td>Z48.01</td>\n <td>Encounter for change or removal of surgical wound dressing</td>\n <td/>\n </tr>\n <tr>\n <td>Z48.02</td>\n <td>Encounter for removal of sutures</td>\n <td/>\n </tr>\n <tr>\n <td>Z48.03</td>\n <td>Encounter for change or removal of drains</td>\n <td/>\n </tr>\n <tr>\n <td>Z48.1</td>\n <td>Encounter for planned postprocedural wound closure</td>\n <td/>\n </tr>\n <tr>\n <td>Z48.21</td>\n <td>Encounter for aftercare following heart transplant</td>\n <td/>\n </tr>\n <tr>\n <td>Z48.22</td>\n <td>Encounter for aftercare following kidney transplant</td>\n <td/>\n </tr>\n <tr>\n <td>Z48.23</td>\n <td>Encounter for aftercare following liver transplant</td>\n <td/>\n </tr>\n <tr>\n <td>Z48.24</td>\n <td>Encounter for aftercare following lung transplant</td>\n <td/>\n </tr>\n <tr>\n <td>Z48.280</td>\n <td>Encounter for aftercare following heart-lung transplant</td>\n <td/>\n </tr>\n <tr>\n <td>Z48.288</td>\n <td>Encounter for aftercare following multiple organ transplant</td>\n <td/>\n </tr>\n <tr>\n <td>Z48.290</td>\n <td>Encounter for aftercare following bone marrow transplant</td>\n <td/>\n </tr>\n <tr>\n <td>Z48.298</td>\n <td>Encounter for aftercare following other organ transplant</td>\n <td/>\n </tr>\n <tr>\n <td>Z48.3</td>\n <td>Aftercare following surgery for neoplasm</td>\n <td/>\n </tr>\n <tr>\n <td>Z48.810</td>\n <td>Encounter for surgical aftercare following surgery on the sense organs</td>\n <td/>\n </tr>\n <tr>\n <td>Z48.811</td>\n <td>Encounter for surgical aftercare following surgery on the nervous system</td>\n <td/>\n </tr>\n <tr>\n <td>Z48.812</td>\n <td>Encounter for surgical aftercare following surgery on the circulatory system</td>\n <td/>\n </tr>\n <tr>\n <td>Z48.813</td>\n <td>Encounter for surgical aftercare following surgery on the respiratory system</td>\n <td/>\n </tr>\n <tr>\n <td>Z48.814</td>\n <td>Encounter for surgical aftercare following surgery on the teeth or oral cavity</td>\n <td/>\n </tr>\n <tr>\n <td>Z48.815</td>\n <td>Encounter for surgical aftercare following surgery on the digestive system</td>\n <td/>\n </tr>\n <tr>\n <td>Z48.816</td>\n <td>Encounter for surgical aftercare following surgery on the genitourinary system</td>\n <td/>\n </tr>\n <tr>\n <td>Z48.817</td>\n <td>Encounter for surgical aftercare following surgery on the skin and subcutaneous tissue</td>\n <td/>\n </tr>\n <tr>\n <td>Z48.89</td>\n <td>Encounter for other specified surgical aftercare</td>\n <td/>\n </tr>\n <tr>\n <td>Z51.0</td>\n <td>Encounter for antineoplastic radiation therapy</td>\n <td/>\n </tr>\n <tr>\n <td>Z51.11</td>\n <td>Encounter for antineoplastic chemotherapy</td>\n <td/>\n </tr>\n <tr>\n <td>Z51.12</td>\n <td>Encounter for antineoplastic immunotherapy</td>\n <td/>\n </tr>\n <tr>\n <td>Z51.5</td>\n <td>Encounter for palliative care</td>\n <td/>\n </tr>\n <tr>\n <td>Z51.6</td>\n <td>Encounter for desensitization to allergens</td>\n <td/>\n </tr>\n <tr>\n <td>Z51.81</td>\n <td>Encounter for therapeutic drug level monitoring</td>\n <td/>\n </tr>\n <tr>\n <td>Z51.89</td>\n <td>Encounter for other specified aftercare</td>\n <td/>\n </tr>\n <tr>\n <td>Z55.0</td>\n <td>Illiteracy and low-level literacy</td>\n <td/>\n </tr>\n <tr>\n <td>Z55.1</td>\n <td>Schooling unavailable and unattainable</td>\n <td/>\n </tr>\n <tr>\n <td>Z55.2</td>\n <td>Failed school examinations</td>\n <td/>\n </tr>\n <tr>\n <td>Z55.3</td>\n <td>Underachievement in school</td>\n <td/>\n </tr>\n <tr>\n <td>Z55.4</td>\n <td>Educational maladjustment and discord with teachers and classmates</td>\n <td/>\n </tr>\n <tr>\n <td>Z55.8</td>\n <td>Other problems related to education and literacy</td>\n <td/>\n </tr>\n <tr>\n <td>Z55.9</td>\n <td>Problems related to education and literacy, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>Z56.0</td>\n <td>Unemployment, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>Z56.1</td>\n <td>Change of job</td>\n <td/>\n </tr>\n <tr>\n <td>Z56.2</td>\n <td>Threat of job loss</td>\n <td/>\n </tr>\n <tr>\n <td>Z56.3</td>\n <td>Stressful work schedule</td>\n <td/>\n </tr>\n <tr>\n <td>Z56.4</td>\n <td>Discord with boss and workmates</td>\n <td/>\n </tr>\n <tr>\n <td>Z56.5</td>\n <td>Uncongenial work environment</td>\n <td/>\n </tr>\n <tr>\n <td>Z56.6</td>\n <td>Other physical and mental strain related to work</td>\n <td/>\n </tr>\n <tr>\n <td>Z56.81</td>\n <td>Sexual harassment on the job</td>\n <td/>\n </tr>\n <tr>\n <td>Z56.82</td>\n <td>Military deployment status</td>\n <td/>\n </tr>\n <tr>\n <td>Z56.89</td>\n <td>Other problems related to employment</td>\n <td/>\n </tr>\n <tr>\n <td>Z56.9</td>\n <td>Unspecified problems related to employment</td>\n <td/>\n </tr>\n <tr>\n <td>Z57.0</td>\n <td>Occupational exposure to noise</td>\n <td/>\n </tr>\n <tr>\n <td>Z57.1</td>\n <td>Occupational exposure to radiation</td>\n <td/>\n </tr>\n <tr>\n <td>Z57.2</td>\n <td>Occupational exposure to dust</td>\n <td/>\n </tr>\n <tr>\n <td>Z57.31</td>\n <td>Occupational exposure to environmental tobacco smoke</td>\n <td/>\n </tr>\n <tr>\n <td>Z57.39</td>\n <td>Occupational exposure to other air contaminants</td>\n <td/>\n </tr>\n <tr>\n <td>Z57.4</td>\n <td>Occupational exposure to toxic agents in agriculture</td>\n <td/>\n </tr>\n <tr>\n <td>Z57.5</td>\n <td>Occupational exposure to toxic agents in other industries</td>\n <td/>\n </tr>\n <tr>\n <td>Z57.6</td>\n <td>Occupational exposure to extreme temperature</td>\n <td/>\n </tr>\n <tr>\n <td>Z57.7</td>\n <td>Occupational exposure to vibration</td>\n <td/>\n </tr>\n <tr>\n <td>Z57.8</td>\n <td>Occupational exposure to other risk factors</td>\n <td/>\n </tr>\n <tr>\n <td>Z57.9</td>\n <td>Occupational exposure to unspecified risk factor</td>\n <td/>\n </tr>\n <tr>\n <td>Z59.0</td>\n <td>Homelessness</td>\n <td/>\n </tr>\n <tr>\n <td>Z59.1</td>\n <td>Inadequate housing</td>\n <td/>\n </tr>\n <tr>\n <td>Z59.2</td>\n <td>Discord with neighbors, lodgers and landlord</td>\n <td/>\n </tr>\n <tr>\n <td>Z59.3</td>\n <td>Problems related to living in residential institution</td>\n <td/>\n </tr>\n <tr>\n <td>Z59.4</td>\n <td>Lack of adequate food and safe drinking water</td>\n <td/>\n </tr>\n <tr>\n <td>Z59.5</td>\n <td>Extreme poverty</td>\n <td/>\n </tr>\n <tr>\n <td>Z59.6</td>\n <td>Low income</td>\n <td/>\n </tr>\n <tr>\n <td>Z59.7</td>\n <td>Insufficient social insurance and welfare support</td>\n <td/>\n </tr>\n <tr>\n <td>Z59.8</td>\n <td>Other problems related to housing and economic circumstances</td>\n <td/>\n </tr>\n <tr>\n <td>Z59.9</td>\n <td>Problem related to housing and economic circumstances, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>Z60.0</td>\n <td>Problems of adjustment to life-cycle transitions</td>\n <td/>\n </tr>\n <tr>\n <td>Z60.2</td>\n <td>Problems related to living alone</td>\n <td/>\n </tr>\n <tr>\n <td>Z60.3</td>\n <td>Acculturation difficulty</td>\n <td/>\n </tr>\n <tr>\n <td>Z60.4</td>\n <td>Social exclusion and rejection</td>\n <td/>\n </tr>\n <tr>\n <td>Z60.5</td>\n <td>Target of (perceived) adverse discrimination and persecution</td>\n <td/>\n </tr>\n <tr>\n <td>Z60.8</td>\n <td>Other problems related to social environment</td>\n <td/>\n </tr>\n <tr>\n <td>Z60.9</td>\n <td>Problem related to social environment, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>Z62.0</td>\n <td>Inadequate parental supervision and control</td>\n <td/>\n </tr>\n <tr>\n <td>Z62.1</td>\n <td>Parental overprotection</td>\n <td/>\n </tr>\n <tr>\n <td>Z62.21</td>\n <td>Child in welfare custody</td>\n <td/>\n </tr>\n <tr>\n <td>Z62.22</td>\n <td>Institutional upbringing</td>\n <td/>\n </tr>\n <tr>\n <td>Z62.29</td>\n <td>Other upbringing away from parents</td>\n <td/>\n </tr>\n <tr>\n <td>Z62.3</td>\n <td>Hostility towards and scapegoating of child</td>\n <td/>\n </tr>\n <tr>\n <td>Z62.6</td>\n <td>Inappropriate (excessive) parental pressure</td>\n <td/>\n </tr>\n <tr>\n <td>Z62.810</td>\n <td>Personal history of physical and sexual abuse in childhood</td>\n <td/>\n </tr>\n <tr>\n <td>Z62.811</td>\n <td>Personal history of psychological abuse in childhood</td>\n <td/>\n </tr>\n <tr>\n <td>Z62.812</td>\n <td>Personal history of neglect in childhood</td>\n <td/>\n </tr>\n <tr>\n <td>Z62.813</td>\n <td>Personal history of forced labor or sexual exploitation in childhood</td>\n <td/>\n </tr>\n <tr>\n <td>Z62.819</td>\n <td>Personal history of unspecified abuse in childhood</td>\n <td/>\n </tr>\n <tr>\n <td>Z62.820</td>\n <td>Parent-biological child conflict</td>\n <td/>\n </tr>\n <tr>\n <td>Z62.821</td>\n <td>Parent-adopted child conflict</td>\n <td/>\n </tr>\n <tr>\n <td>Z62.822</td>\n <td>Parent-foster child conflict</td>\n <td/>\n </tr>\n <tr>\n <td>Z62.890</td>\n <td>Parent-child estrangement NEC</td>\n <td/>\n </tr>\n <tr>\n <td>Z62.891</td>\n <td>Sibling rivalry</td>\n <td/>\n </tr>\n <tr>\n <td>Z62.898</td>\n <td>Other specified problems related to upbringing</td>\n <td/>\n </tr>\n <tr>\n <td>Z62.9</td>\n <td>Problem related to upbringing, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>Z63.0</td>\n <td>Problems in relationship with spouse or partner</td>\n <td/>\n </tr>\n <tr>\n <td>Z63.1</td>\n <td>Problems in relationship with in-laws</td>\n <td/>\n </tr>\n <tr>\n <td>Z63.31</td>\n <td>Absence of family member due to military deployment</td>\n <td/>\n </tr>\n <tr>\n <td>Z63.32</td>\n <td>Other absence of family member</td>\n <td/>\n </tr>\n <tr>\n <td>Z63.4</td>\n <td>Disappearance and death of family member</td>\n <td/>\n </tr>\n <tr>\n <td>Z63.5</td>\n <td>Disruption of family by separation and divorce</td>\n <td/>\n </tr>\n <tr>\n <td>Z63.6</td>\n <td>Dependent relative needing care at home</td>\n <td/>\n </tr>\n <tr>\n <td>Z63.71</td>\n <td>Stress on family due to return of family member from military deployment</td>\n <td/>\n </tr>\n <tr>\n <td>Z63.72</td>\n <td>Alcoholism and drug addiction in family</td>\n <td/>\n </tr>\n <tr>\n <td>Z63.79</td>\n <td>Other stressful life events affecting family and household</td>\n <td/>\n </tr>\n <tr>\n <td>Z63.8</td>\n <td>Other specified problems related to primary support group</td>\n <td/>\n </tr>\n <tr>\n <td>Z63.9</td>\n <td>Problem related to primary support group, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>Z64.0</td>\n <td>Problems related to unwanted pregnancy</td>\n <td/>\n </tr>\n <tr>\n <td>Z64.1</td>\n <td>Problems related to multiparity</td>\n <td/>\n </tr>\n <tr>\n <td>Z64.4</td>\n <td>Discord with counselors</td>\n <td/>\n </tr>\n <tr>\n <td>Z65.0</td>\n <td>Conviction in civil and criminal proceedings without imprisonment</td>\n <td/>\n </tr>\n <tr>\n <td>Z65.1</td>\n <td>Imprisonment and other incarceration</td>\n <td/>\n </tr>\n <tr>\n <td>Z65.2</td>\n <td>Problems related to release from prison</td>\n <td/>\n </tr>\n <tr>\n <td>Z65.3</td>\n <td>Problems related to other legal circumstances</td>\n <td/>\n </tr>\n <tr>\n <td>Z65.4</td>\n <td>Victim of crime and terrorism</td>\n <td/>\n </tr>\n <tr>\n <td>Z65.5</td>\n <td>Exposure to disaster, war and other hostilities</td>\n <td/>\n </tr>\n <tr>\n <td>Z65.8</td>\n <td>Other specified problems related to psychosocial circumstances</td>\n <td/>\n </tr>\n <tr>\n <td>Z65.9</td>\n <td>Problem related to unspecified psychosocial circumstances</td>\n <td/>\n </tr>\n <tr>\n <td>Z69.010</td>\n <td>Encounter for mental health services for victim of parental child abuse</td>\n <td/>\n </tr>\n <tr>\n <td>Z69.011</td>\n <td>Encounter for mental health services for perpetrator of parental child abuse</td>\n <td/>\n </tr>\n <tr>\n <td>Z69.020</td>\n <td>Encounter for mental health services for victim of non-parental child abuse</td>\n <td/>\n </tr>\n <tr>\n <td>Z69.021</td>\n <td>Encounter for mental health services for perpetrator of non-parental child abuse</td>\n <td/>\n </tr>\n <tr>\n <td>Z69.11</td>\n <td>Encounter for mental health services for victim of spousal or partner abuse</td>\n <td/>\n </tr>\n <tr>\n <td>Z69.12</td>\n <td>Encounter for mental health services for perpetrator of spousal or partner abuse</td>\n <td/>\n </tr>\n <tr>\n <td>Z69.81</td>\n <td>Encounter for mental health services for victim of other abuse</td>\n <td/>\n </tr>\n <tr>\n <td>Z69.82</td>\n <td>Encounter for mental health services for perpetrator of other abuse</td>\n <td/>\n </tr>\n <tr>\n <td>Z70.0</td>\n <td>Counseling related to sexual attitude</td>\n <td/>\n </tr>\n <tr>\n <td>Z70.1</td>\n <td>Counseling related to patient's sexual behavior and orientation</td>\n <td/>\n </tr>\n <tr>\n <td>Z70.2</td>\n <td>Counseling related to sexual behavior and orientation of third party</td>\n <td/>\n </tr>\n <tr>\n <td>Z70.3</td>\n <td>Counseling related to combined concerns regarding sexual attitude, behavior and orientation</td>\n <td/>\n </tr>\n <tr>\n <td>Z70.8</td>\n <td>Other sex counseling</td>\n <td/>\n </tr>\n <tr>\n <td>Z70.9</td>\n <td>Sex counseling, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>Z71.0</td>\n <td>Person encountering health services to consult on behalf of another person</td>\n <td/>\n </tr>\n <tr>\n <td>Z71.1</td>\n <td>Person with feared health complaint in whom no diagnosis is made</td>\n <td/>\n </tr>\n <tr>\n <td>Z71.2</td>\n <td>Person consulting for explanation of examination or test findings</td>\n <td/>\n </tr>\n <tr>\n <td>Z71.3</td>\n <td>Dietary counseling and surveillance</td>\n <td/>\n </tr>\n <tr>\n <td>Z71.41</td>\n <td>Alcohol abuse counseling and surveillance of alcoholic</td>\n <td/>\n </tr>\n <tr>\n <td>Z71.42</td>\n <td>Counseling for family member of alcoholic</td>\n <td/>\n </tr>\n <tr>\n <td>Z71.51</td>\n <td>Drug abuse counseling and surveillance of drug abuser</td>\n <td/>\n </tr>\n <tr>\n <td>Z71.52</td>\n <td>Counseling for family member of drug abuser</td>\n <td/>\n </tr>\n <tr>\n <td>Z71.6</td>\n <td>Tobacco abuse counseling</td>\n <td/>\n </tr>\n <tr>\n <td>Z71.7</td>\n <td>Human immunodeficiency virus [HIV] counseling</td>\n <td/>\n </tr>\n <tr>\n <td>Z71.81</td>\n <td>Spiritual or religious counseling</td>\n <td/>\n </tr>\n <tr>\n <td>Z71.82</td>\n <td>Exercise counseling</td>\n <td/>\n </tr>\n <tr>\n <td>Z71.83</td>\n <td>Encounter for nonprocreative genetic counseling</td>\n <td/>\n </tr>\n <tr>\n <td>Z71.89</td>\n <td>Other specified counseling</td>\n <td/>\n </tr>\n <tr>\n <td>Z71.9</td>\n <td>Counseling, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>Z73.0</td>\n <td>Burn-out</td>\n <td/>\n </tr>\n <tr>\n <td>Z73.1</td>\n <td>Type A behavior pattern</td>\n <td/>\n </tr>\n <tr>\n <td>Z73.2</td>\n <td>Lack of relaxation and leisure</td>\n <td/>\n </tr>\n <tr>\n <td>Z73.3</td>\n <td>Stress, not elsewhere classified</td>\n <td/>\n </tr>\n <tr>\n <td>Z73.4</td>\n <td>Inadequate social skills, not elsewhere classified</td>\n <td/>\n </tr>\n <tr>\n <td>Z73.5</td>\n <td>Social role conflict, not elsewhere classified</td>\n <td/>\n </tr>\n <tr>\n <td>Z73.6</td>\n <td>Limitation of activities due to disability</td>\n <td/>\n </tr>\n <tr>\n <td>Z73.810</td>\n <td>Behavioral insomnia of childhood, sleep-onset association type</td>\n <td/>\n </tr>\n <tr>\n <td>Z73.811</td>\n <td>Behavioral insomnia of childhood, limit setting type</td>\n <td/>\n </tr>\n <tr>\n <td>Z73.812</td>\n <td>Behavioral insomnia of childhood, combined type</td>\n <td/>\n </tr>\n <tr>\n <td>Z73.819</td>\n <td>Behavioral insomnia of childhood, unspecified type</td>\n <td/>\n </tr>\n <tr>\n <td>Z73.89</td>\n <td>Other problems related to life management difficulty</td>\n <td/>\n </tr>\n <tr>\n <td>Z73.9</td>\n <td>Problem related to life management difficulty, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>Z74.01</td>\n <td>Bed confinement status</td>\n <td/>\n </tr>\n <tr>\n <td>Z74.09</td>\n <td>Other reduced mobility</td>\n <td/>\n </tr>\n <tr>\n <td>Z74.1</td>\n <td>Need for assistance with personal care</td>\n <td/>\n </tr>\n <tr>\n <td>Z74.2</td>\n <td>Need for assistance at home and no other household member able to render care</td>\n <td/>\n </tr>\n <tr>\n <td>Z74.3</td>\n <td>Need for continuous supervision</td>\n <td/>\n </tr>\n <tr>\n <td>Z74.8</td>\n <td>Other problems related to care provider dependency</td>\n <td/>\n </tr>\n <tr>\n <td>Z74.9</td>\n <td>Problem related to care provider dependency, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>Z75.0</td>\n <td>Medical services not available in home</td>\n <td/>\n </tr>\n <tr>\n <td>Z75.1</td>\n <td>Person awaiting admission to adequate facility elsewhere</td>\n <td/>\n </tr>\n <tr>\n <td>Z75.2</td>\n <td>Other waiting period for investigation and treatment</td>\n <td/>\n </tr>\n <tr>\n <td>Z75.3</td>\n <td>Unavailability and inaccessibility of health-care facilities</td>\n <td/>\n </tr>\n <tr>\n <td>Z75.4</td>\n <td>Unavailability and inaccessibility of other helping agencies</td>\n <td/>\n </tr>\n <tr>\n <td>Z75.5</td>\n <td>Holiday relief care</td>\n <td/>\n </tr>\n <tr>\n <td>Z75.8</td>\n <td>Other problems related to medical facilities and other health care</td>\n <td/>\n </tr>\n <tr>\n <td>Z75.9</td>\n <td>Unspecified problem related to medical facilities and other health care</td>\n <td/>\n </tr>\n <tr>\n <td>Z76.0</td>\n <td>Encounter for issue of repeat prescription</td>\n <td/>\n </tr>\n <tr>\n <td>Z76.1</td>\n <td>Encounter for health supervision and care of foundling</td>\n <td/>\n </tr>\n <tr>\n <td>Z76.2</td>\n <td>Encounter for health supervision and care of other healthy infant and child</td>\n <td/>\n </tr>\n <tr>\n <td>Z76.3</td>\n <td>Healthy person accompanying sick person</td>\n <td/>\n </tr>\n <tr>\n <td>Z76.4</td>\n <td>Other boarder to healthcare facility</td>\n <td/>\n </tr>\n <tr>\n <td>Z76.5</td>\n <td>Malingerer [conscious simulation]</td>\n <td/>\n </tr>\n <tr>\n <td>Z76.81</td>\n <td>Expectant parent(s) prebirth pediatrician visit</td>\n <td/>\n </tr>\n <tr>\n <td>Z76.89</td>\n <td>Persons encountering health services in other specified circumstances</td>\n <td/>\n </tr>\n <tr>\n <td>Z79.01</td>\n <td>Long term (current) use of anticoagulants</td>\n <td/>\n </tr>\n <tr>\n <td>Z79.02</td>\n <td>Long term (current) use of antithrombotics/antiplatelets</td>\n <td/>\n </tr>\n <tr>\n <td>Z79.1</td>\n <td>Long term (current) use of non-steroidal anti-inflammatories (NSAID)</td>\n <td/>\n </tr>\n <tr>\n <td>Z79.2</td>\n <td>Long term (current) use of antibiotics</td>\n <td/>\n </tr>\n <tr>\n <td>Z79.3</td>\n <td>Long term (current) use of hormonal contraceptives</td>\n <td/>\n </tr>\n <tr>\n <td>Z79.4</td>\n <td>Long term (current) use of insulin</td>\n <td/>\n </tr>\n <tr>\n <td>Z79.51</td>\n <td>Long term (current) use of inhaled steroids</td>\n <td/>\n </tr>\n <tr>\n <td>Z79.52</td>\n <td>Long term (current) use of systemic steroids</td>\n <td/>\n </tr>\n <tr>\n <td>Z79.810</td>\n <td>Long term (current) use of selective estrogen receptor modulators (SERMs)</td>\n <td/>\n </tr>\n <tr>\n <td>Z79.811</td>\n <td>Long term (current) use of aromatase inhibitors</td>\n <td/>\n </tr>\n <tr>\n <td>Z79.818</td>\n <td>Long term (current) use of other agents affecting estrogen receptors and estrogen levels</td>\n <td/>\n </tr>\n <tr>\n <td>Z79.82</td>\n <td>Long term (current) use of aspirin</td>\n <td/>\n </tr>\n <tr>\n <td>Z79.83</td>\n <td>Long term (current) use of bisphosphonates</td>\n <td/>\n </tr>\n <tr>\n <td>Z79.84</td>\n <td>Long term (current) use of oral hypoglycemic drugs</td>\n <td/>\n </tr>\n <tr>\n <td>Z79.891</td>\n <td>Long term (current) use of opiate analgesic</td>\n <td/>\n </tr>\n <tr>\n <td>Z79.899</td>\n <td>Other long term (current) drug therapy</td>\n <td/>\n </tr>\n <tr>\n <td>Z85.00</td>\n <td>Personal history of malignant neoplasm of unspecified digestive organ</td>\n <td/>\n </tr>\n <tr>\n <td>Z85.01</td>\n <td>Personal history of malignant neoplasm of esophagus</td>\n <td/>\n </tr>\n <tr>\n <td>Z85.020</td>\n <td>Personal history of malignant carcinoid tumor of stomach</td>\n <td/>\n </tr>\n <tr>\n <td>Z85.028</td>\n <td>Personal history of other malignant neoplasm of stomach</td>\n <td/>\n </tr>\n <tr>\n <td>Z85.030</td>\n <td>Personal history of malignant carcinoid tumor of large intestine</td>\n <td/>\n </tr>\n <tr>\n <td>Z85.038</td>\n <td>Personal history of other malignant neoplasm of large intestine</td>\n <td/>\n </tr>\n <tr>\n <td>Z85.040</td>\n <td>Personal history of malignant carcinoid tumor of rectum</td>\n <td/>\n </tr>\n <tr>\n <td>Z85.048</td>\n <td>Personal history of other malignant neoplasm of rectum, rectosigmoid junction, and anus</td>\n <td/>\n </tr>\n <tr>\n <td>Z85.05</td>\n <td>Personal history of malignant neoplasm of liver</td>\n <td/>\n </tr>\n <tr>\n <td>Z85.060</td>\n <td>Personal history of malignant carcinoid tumor of small intestine</td>\n <td/>\n </tr>\n <tr>\n <td>Z85.068</td>\n <td>Personal history of other malignant neoplasm of small intestine</td>\n <td/>\n </tr>\n <tr>\n <td>Z85.07</td>\n <td>Personal history of malignant neoplasm of pancreas</td>\n <td/>\n </tr>\n <tr>\n <td>Z85.09</td>\n <td>Personal history of malignant neoplasm of other digestive organs</td>\n <td/>\n </tr>\n <tr>\n <td>Z85.110</td>\n <td>Personal history of malignant carcinoid tumor of bronchus and lung</td>\n <td/>\n </tr>\n <tr>\n <td>Z85.118</td>\n <td>Personal history of other malignant neoplasm of bronchus and lung</td>\n <td/>\n </tr>\n <tr>\n <td>Z85.12</td>\n <td>Personal history of malignant neoplasm of trachea</td>\n <td/>\n </tr>\n <tr>\n <td>Z85.20</td>\n <td>Personal history of malignant neoplasm of unspecified respiratory organ</td>\n <td/>\n </tr>\n <tr>\n <td>Z85.21</td>\n <td>Personal history of malignant neoplasm of larynx</td>\n <td/>\n </tr>\n <tr>\n <td>Z85.22</td>\n <td>Personal history of malignant neoplasm of nasal cavities, middle ear, and accessory sinuses</td>\n <td/>\n </tr>\n <tr>\n <td>Z85.230</td>\n <td>Personal history of malignant carcinoid tumor of thymus</td>\n <td/>\n </tr>\n <tr>\n <td>Z85.238</td>\n <td>Personal history of other malignant neoplasm of thymus</td>\n <td/>\n </tr>\n <tr>\n <td>Z85.29</td>\n <td>Personal history of malignant neoplasm of other respiratory and intrathoracic organs</td>\n <td/>\n </tr>\n <tr>\n <td>Z85.3</td>\n <td>Personal history of malignant neoplasm of breast</td>\n <td/>\n </tr>\n <tr>\n <td>Z85.40</td>\n <td>Personal history of malignant neoplasm of unspecified female genital organ</td>\n <td/>\n </tr>\n <tr>\n <td>Z85.41</td>\n <td>Personal history of malignant neoplasm of cervix uteri</td>\n <td/>\n </tr>\n <tr>\n <td>Z85.42</td>\n <td>Personal history of malignant neoplasm of other parts of uterus</td>\n <td/>\n </tr>\n <tr>\n <td>Z85.43</td>\n <td>Personal history of malignant neoplasm of ovary</td>\n <td/>\n </tr>\n <tr>\n <td>Z85.44</td>\n <td>Personal history of malignant neoplasm of other female genital organs</td>\n <td/>\n </tr>\n <tr>\n <td>Z85.45</td>\n <td>Personal history of malignant neoplasm of unspecified male genital organ</td>\n <td/>\n </tr>\n <tr>\n <td>Z85.46</td>\n <td>Personal history of malignant neoplasm of prostate</td>\n <td/>\n </tr>\n <tr>\n <td>Z85.47</td>\n <td>Personal history of malignant neoplasm of testis</td>\n <td/>\n </tr>\n <tr>\n <td>Z85.48</td>\n <td>Personal history of malignant neoplasm of epididymis</td>\n <td/>\n </tr>\n <tr>\n <td>Z85.49</td>\n <td>Personal history of malignant neoplasm of other male genital organs</td>\n <td/>\n </tr>\n <tr>\n <td>Z85.50</td>\n <td>Personal history of malignant neoplasm of unspecified urinary tract organ</td>\n <td/>\n </tr>\n <tr>\n <td>Z85.51</td>\n <td>Personal history of malignant neoplasm of bladder</td>\n <td/>\n </tr>\n <tr>\n <td>Z85.520</td>\n <td>Personal history of malignant carcinoid tumor of kidney</td>\n <td/>\n </tr>\n <tr>\n <td>Z85.528</td>\n <td>Personal history of other malignant neoplasm of kidney</td>\n <td/>\n </tr>\n <tr>\n <td>Z85.53</td>\n <td>Personal history of malignant neoplasm of renal pelvis</td>\n <td/>\n </tr>\n <tr>\n <td>Z85.54</td>\n <td>Personal history of malignant neoplasm of ureter</td>\n <td/>\n </tr>\n <tr>\n <td>Z85.59</td>\n <td>Personal history of malignant neoplasm of other urinary tract organ</td>\n <td/>\n </tr>\n <tr>\n <td>Z85.6</td>\n <td>Personal history of leukemia</td>\n <td/>\n </tr>\n <tr>\n <td>Z85.71</td>\n <td>Personal history of Hodgkin lymphoma</td>\n <td/>\n </tr>\n <tr>\n <td>Z85.72</td>\n <td>Personal history of non-Hodgkin lymphomas</td>\n <td/>\n </tr>\n <tr>\n <td>Z85.79</td>\n <td>Personal history of other malignant neoplasms of lymphoid, hematopoietic and related tissues</td>\n <td/>\n </tr>\n <tr>\n <td>Z85.810</td>\n <td>Personal history of malignant neoplasm of tongue</td>\n <td/>\n </tr>\n <tr>\n <td>Z85.818</td>\n <td>Personal history of malignant neoplasm of other sites of lip, oral cavity, and pharynx</td>\n <td/>\n </tr>\n <tr>\n <td>Z85.819</td>\n <td>Personal history of malignant neoplasm of unspecified site of lip, oral cavity, and pharynx</td>\n <td/>\n </tr>\n <tr>\n <td>Z85.820</td>\n <td>Personal history of malignant melanoma of skin</td>\n <td/>\n </tr>\n <tr>\n <td>Z85.821</td>\n <td>Personal history of Merkel cell carcinoma</td>\n <td/>\n </tr>\n <tr>\n <td>Z85.828</td>\n <td>Personal history of other malignant neoplasm of skin</td>\n <td/>\n </tr>\n <tr>\n <td>Z85.830</td>\n <td>Personal history of malignant neoplasm of bone</td>\n <td/>\n </tr>\n <tr>\n <td>Z85.831</td>\n <td>Personal history of malignant neoplasm of soft tissue</td>\n <td/>\n </tr>\n <tr>\n <td>Z85.840</td>\n <td>Personal history of malignant neoplasm of eye</td>\n <td/>\n </tr>\n <tr>\n <td>Z85.841</td>\n <td>Personal history of malignant neoplasm of brain</td>\n <td/>\n </tr>\n <tr>\n <td>Z85.848</td>\n <td>Personal history of malignant neoplasm of other parts of nervous tissue</td>\n <td/>\n </tr>\n <tr>\n <td>Z85.850</td>\n <td>Personal history of malignant neoplasm of thyroid</td>\n <td/>\n </tr>\n <tr>\n <td>Z85.858</td>\n <td>Personal history of malignant neoplasm of other endocrine glands</td>\n <td/>\n </tr>\n <tr>\n <td>Z85.89</td>\n <td>Personal history of malignant neoplasm of other organs and systems</td>\n <td/>\n </tr>\n <tr>\n <td>Z85.9</td>\n <td>Personal history of malignant neoplasm, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>Z86.000</td>\n <td>Personal history of in-situ neoplasm of breast</td>\n <td/>\n </tr>\n <tr>\n <td>Z86.001</td>\n <td>Personal history of in-situ neoplasm of cervix uteri</td>\n <td/>\n </tr>\n <tr>\n <td>Z86.008</td>\n <td>Personal history of in-situ neoplasm of other site</td>\n <td/>\n </tr>\n <tr>\n <td>Z86.010</td>\n <td>Personal history of colonic polyps</td>\n <td/>\n </tr>\n <tr>\n <td>Z86.012</td>\n <td>Personal history of benign carcinoid tumor</td>\n <td/>\n </tr>\n <tr>\n <td>Z86.018</td>\n <td>Personal history of other benign neoplasm</td>\n <td/>\n </tr>\n <tr>\n <td>Z86.03</td>\n <td>Personal history of neoplasm of uncertain behavior</td>\n <td/>\n </tr>\n <tr>\n <td>Z86.711</td>\n <td>Personal history of pulmonary embolism</td>\n <td/>\n </tr>\n <tr>\n <td>Z86.718</td>\n <td>Personal history of other venous thrombosis and embolism</td>\n <td/>\n </tr>\n <tr>\n <td>Z86.72</td>\n <td>Personal history of thrombophlebitis</td>\n <td/>\n </tr>\n <tr>\n <td>Z86.73</td>\n <td>Personal history of transient ischemic attack (TIA), and cerebral infarction without residual deficits</td>\n <td/>\n </tr>\n <tr>\n <td>Z86.74</td>\n <td>Personal history of sudden cardiac arrest</td>\n <td/>\n </tr>\n <tr>\n <td>Z86.79</td>\n <td>Personal history of other diseases of the circulatory system</td>\n <td/>\n </tr>\n <tr>\n <td>Z87.892</td>\n <td>Personal history of anaphylaxis</td>\n <td/>\n </tr>\n <tr>\n <td>Z88.0</td>\n <td>Allergy status to penicillin</td>\n <td/>\n </tr>\n <tr>\n <td>Z88.1</td>\n <td>Allergy status to other antibiotic agents status</td>\n <td/>\n </tr>\n <tr>\n <td>Z88.2</td>\n <td>Allergy status to sulfonamides status</td>\n <td/>\n </tr>\n <tr>\n <td>Z88.3</td>\n <td>Allergy status to other anti-infective agents status</td>\n <td/>\n </tr>\n <tr>\n <td>Z88.4</td>\n <td>Allergy status to anesthetic agent status</td>\n <td/>\n </tr>\n <tr>\n <td>Z88.5</td>\n <td>Allergy status to narcotic agent status</td>\n <td/>\n </tr>\n <tr>\n <td>Z88.6</td>\n <td>Allergy status to analgesic agent status</td>\n <td/>\n </tr>\n <tr>\n <td>Z88.7</td>\n <td>Allergy status to serum and vaccine status</td>\n <td/>\n </tr>\n <tr>\n <td>Z88.8</td>\n <td>Allergy status to other drugs, medicaments and biological substances status</td>\n <td/>\n </tr>\n <tr>\n <td>Z88.9</td>\n <td>Allergy status to unspecified drugs, medicaments and biological substances status</td>\n <td/>\n </tr>\n <tr>\n <td>Z91.010</td>\n <td>Allergy to peanuts</td>\n <td/>\n </tr>\n <tr>\n <td>Z91.011</td>\n <td>Allergy to milk products</td>\n <td/>\n </tr>\n <tr>\n <td>Z91.012</td>\n <td>Allergy to eggs</td>\n <td/>\n </tr>\n <tr>\n <td>Z91.013</td>\n <td>Allergy to seafood</td>\n <td/>\n </tr>\n <tr>\n <td>Z91.018</td>\n <td>Allergy to other foods</td>\n <td/>\n </tr>\n <tr>\n <td>Z91.02</td>\n <td>Food additives allergy status</td>\n <td/>\n </tr>\n <tr>\n <td>Z91.030</td>\n <td>Bee allergy status</td>\n <td/>\n </tr>\n <tr>\n <td>Z91.038</td>\n <td>Other insect allergy status</td>\n <td/>\n </tr>\n <tr>\n <td>Z91.040</td>\n <td>Latex allergy status</td>\n <td/>\n </tr>\n <tr>\n <td>Z91.041</td>\n <td>Radiographic dye allergy status</td>\n <td/>\n </tr>\n <tr>\n <td>Z91.048</td>\n <td>Other nonmedicinal substance allergy status</td>\n <td/>\n </tr>\n <tr>\n <td>Z91.09</td>\n <td>Other allergy status, other than to drugs and biological substances</td>\n <td/>\n </tr>\n <tr>\n <td>Z94.1</td>\n <td>Heart transplant status</td>\n <td/>\n </tr>\n <tr>\n <td>Z94.3</td>\n <td>Heart and lungs transplant status</td>\n <td/>\n </tr>\n <tr>\n <td>Z95.0</td>\n <td>Presence of cardiac pacemaker</td>\n <td/>\n </tr>\n <tr>\n <td>Z95.1</td>\n <td>Presence of aortocoronary bypass graft</td>\n <td/>\n </tr>\n <tr>\n <td>Z95.2</td>\n <td>Presence of prosthetic heart valve</td>\n <td/>\n </tr>\n <tr>\n <td>Z95.3</td>\n <td>Presence of xenogenic heart valve</td>\n <td/>\n </tr>\n <tr>\n <td>Z95.4</td>\n <td>Presence of other heart-valve replacement</td>\n <td/>\n </tr>\n <tr>\n <td>Z95.5</td>\n <td>Presence of coronary angioplasty implant and graft</td>\n <td/>\n </tr>\n <tr>\n <td>Z95.810</td>\n <td>Presence of automatic (implantable) cardiac defibrillator</td>\n <td/>\n </tr>\n <tr>\n <td>Z95.811</td>\n <td>Presence of heart assist device</td>\n <td/>\n </tr>\n <tr>\n <td>Z95.812</td>\n <td>Presence of fully implantable artificial heart</td>\n <td/>\n </tr>\n <tr>\n <td>Z95.818</td>\n <td>Presence of other cardiac implants and grafts</td>\n <td/>\n </tr>\n <tr>\n <td>Z95.820</td>\n <td>Peripheral vascular angioplasty status with implants and grafts</td>\n <td/>\n </tr>\n <tr>\n <td>Z95.828</td>\n <td>Presence of other vascular implants and grafts</td>\n <td/>\n </tr>\n <tr>\n <td>Z95.9</td>\n <td>Presence of cardiac and vascular implant and graft, unspecified</td>\n <td/>\n </tr>\n <tr>\n <td>Z98.61</td>\n <td>Coronary angioplasty status</td>\n <td/>\n </tr>\n <tr>\n <td>Z98.62</td>\n <td>Peripheral vascular angioplasty status</td>\n <td/>\n </tr>\n </table>\n </li>\n </ul>\n </div>",
"status" : "generated"
}
}| Title | Version | Status | Publisher | Date |
|---|---|---|---|---|
| Complications of Care | 20191111 | retired | Change Healthcare Steward | - |
| Complications of Care | 20191111 | active | Change Healthcare Steward | - |